<SEC-DOCUMENT>0001104659-23-077802.txt : 20230705
<SEC-HEADER>0001104659-23-077802.hdr.sgml : 20230705
<ACCEPTANCE-DATETIME>20230705063357
ACCESSION NUMBER:		0001104659-23-077802
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20230704
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230705
DATE AS OF CHANGE:		20230705

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMERICAN EQUITY INVESTMENT LIFE HOLDING CO
		CENTRAL INDEX KEY:			0001039828
		STANDARD INDUSTRIAL CLASSIFICATION:	LIFE INSURANCE [6311]
		IRS NUMBER:				421447959
		STATE OF INCORPORATION:			IA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31911
		FILM NUMBER:		231066597

	BUSINESS ADDRESS:	
		STREET 1:		6000 WESTOWN PARKWAY
		CITY:			WEST DEMOINES
		STATE:			IA
		ZIP:			50266
		BUSINESS PHONE:		5152210002

	MAIL ADDRESS:	
		STREET 1:		6000 WESTOWN PARKWAY
		CITY:			WEST DES MOINES
		STATE:			IA
		ZIP:			50266
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2320561d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:ael="http://american-equity.com/20230704">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_032_ael_american%2Dequity.com_20230704 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20230704_20230704 -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DEntityCentralIndexKey_0001039828 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_072_SO_T%2D%2D\DeptFiles%2DiXBRL 8%2DK Covers Templates\+++%2DROOT%2DElement%2D+++\DocumentInformationLineItems.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-07-04to2023-07-04" name="dei:EntityCentralIndexKey">0001039828</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-07-04to2023-07-04" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ael-20230704.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-07-04to2023-07-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001039828</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-04</xbrli:startDate>
        <xbrli:endDate>2023-07-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-042023-07-04_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001039828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-04</xbrli:startDate>
        <xbrli:endDate>2023-07-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-042023-07-04_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001039828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-04</xbrli:startDate>
        <xbrli:endDate>2023-07-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-042023-07-04_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001039828</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-04</xbrli:startDate>
        <xbrli:endDate>2023-07-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"><b>&#160;</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES </b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_905_edei--DocumentType_c20230704__20230704_z2EHzvxiH4Cb"><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" name="dei:DocumentType">8-K</ix:nonNumeric></span> </b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d)
of The Securities Exchange Act of 1934 </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<span id="xdx_90F_edei--DocumentPeriodEndDate_c20230704__20230704_zqWclMBvcYx"><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">July 4, 2023</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityRegistrantName_c20230704__20230704_zYyhmd44ck87"><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" name="dei:EntityRegistrantName">AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
<td style="vertical-align: top; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20230704__20230704_z0Yiwd4an676"><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Iowa</ix:nonNumeric></span></b></span></td>
<td style="vertical-align: bottom; width: 2%">&#160;</td>
<td style="vertical-align: top; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityFileNumber_c20230704__20230704_zJBUSxl6kur3"><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" name="dei:EntityFileNumber">001-31911</ix:nonNumeric></span></b></span></td>
<td style="vertical-align: bottom; width: 2%">&#160;</td>
<td style="vertical-align: top; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_90A_edei--EntityTaxIdentificationNumber_c20230704__20230704_ztVZGAzClEVi"><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" name="dei:EntityTaxIdentificationNumber">42-1447959</ix:nonNumeric></span></b></span></td></tr>
<tr>
<td style="vertical-align: top; text-align: center">(State or other jurisdiction<br /> of incorporation) </td>
<td style="vertical-align: bottom; text-align: center">&#160;</td>
<td style="vertical-align: top; text-align: center">(Commission File Number)</td>
<td style="vertical-align: bottom; text-align: center">&#160;</td>
<td style="vertical-align: top; text-align: center">(IRS Employer<br /> Identification No.) </td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; text-align: center; width: 100%"><span id="xdx_90D_edei--EntityAddressAddressLine1_c20230704__20230704_zC9KFgSwOy6b" style="font-size: 10pt"><b><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" name="dei:EntityAddressAddressLine1">6000
    Westown Parkway</ix:nonNumeric></b></span><b><span style="font-size: 10pt"></span></b></td>
    </tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span id="xdx_905_edei--EntityAddressCityOrTown_c20230704__20230704_z2o4j8SL94ei"><b><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" name="dei:EntityAddressCityOrTown">West
    Des Moines</ix:nonNumeric></b></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20230704__20230704_zpf5KcEDFUE4"><b><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" name="dei:EntityAddressStateOrProvince">IA</ix:nonNumeric></b></span><b>
    <span id="xdx_90C_edei--EntityAddressPostalZipCode_c20230704__20230704_zTHPoxwVoA0d"><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" name="dei:EntityAddressPostalZipCode">50266</ix:nonNumeric></span></b></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(Address of principal executive offices and zip
    code)</span></td>
    </tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <b>(<span id="xdx_903_edei--CityAreaCode_c20230704__20230704_zgrFaWQnDAH1"><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" name="dei:CityAreaCode">515</ix:nonNumeric></span>) <span id="xdx_90D_edei--LocalPhoneNumber_c20230704__20230704_z9Xbo0ttiJGh"><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" name="dei:LocalPhoneNumber">221-0002</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Registrant&#8217;s telephone
number, including area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Former name or former address, if changed
since last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0"></td><td style="width: 0.25in; text-align: left"><span style="font: 10pt Wingdings"><span style="font-family: Wingdings"><span id="xdx_90E_edei--WrittenCommunications_c20230704__20230704_z9HO8QOMQvfd"><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" format="ixt:booleantrue" name="dei:WrittenCommunications">&#120;</ix:nonNumeric></span></span></span></td><td style="text-align: justify"><span style="font-size: 10pt">Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0"></td><td style="width: 0.25in; text-align: left"><span style="font: 10pt Wingdings"><span style="font-family: Wingdings"><span id="xdx_908_edei--SolicitingMaterial_c20230704__20230704_z0vSacn4KCt3"><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td><td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0"></td><td style="width: 0.25in; text-align: left"><span style="font: 10pt Wingdings"><span style="font-family: Wingdings"><span id="xdx_90E_edei--PreCommencementTenderOffer_c20230704__20230704_zVVNJZyYQeQ"><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td><td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td>
</tr></table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0"></td><td style="width: 0.25in; text-align: left"><span style="font: 10pt Wingdings"><span style="font-family: Wingdings"><span id="xdx_90A_edei--PreCommencementIssuerTenderOffer_c20230704__20230704_zUAVfL0DGCl6"><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td><td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b) of the
Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; width: 58%; text-align: center">Title of each class</td>
    <td style="text-align: center; width: 1%; vertical-align: bottom">&#160;</td>
<td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; width: 15%; text-align: center">Trading <br />
Symbol(s)</td>
    <td style="text-align: center; width: 1%; vertical-align: bottom">&#160;</td>
<td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-top: 2pt; width: 25%; text-align: center">Name of each exchange on <br />
which registered</td></tr>
<tr style="vertical-align: top">
<td style="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><span id="xdx_90C_edei--Security12bTitle_c20230704__20230704__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3WhTcIlZP5h"><ix:nonNumeric contextRef="From2023-07-042023-07-04_us-gaap_CommonStockMember" name="dei:Security12bTitle">Common
stock, par value $1</ix:nonNumeric></span></td>
    <td>&#160;</td>
<td style="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><span id="xdx_90E_edei--TradingSymbol_c20230704__20230704__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z4yrQXC1vFF3"><ix:nonNumeric contextRef="From2023-07-042023-07-04_us-gaap_CommonStockMember" name="dei:TradingSymbol">AEL</ix:nonNumeric></span></td>
    <td>&#160;</td>
<td style="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><span id="xdx_90D_edei--SecurityExchangeName_c20230704__20230704__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z0djq4UCTdN5"><ix:nonNumeric contextRef="From2023-07-042023-07-04_us-gaap_CommonStockMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
<td style="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><span id="xdx_909_edei--Security12bTitle_c20230704__20230704__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z1pcMz31v0zk"><ix:nonNumeric contextRef="From2023-07-042023-07-04_us-gaap_SeriesAPreferredStockMember" name="dei:Security12bTitle">Depositary Shares, each representing a 1/1,000th interest in a share of 5.95% Fixed-Rate Reset Non-Cumulative Preferred Stock,
Series A</ix:nonNumeric></span></td>
    <td>&#160;</td>
<td style="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><span id="xdx_907_edei--TradingSymbol_c20230704__20230704__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z53yENh9IjH9"><ix:nonNumeric contextRef="From2023-07-042023-07-04_us-gaap_SeriesAPreferredStockMember" name="dei:TradingSymbol">AELPRA</ix:nonNumeric></span></td>
    <td>&#160;</td>
<td style="padding-top: 2pt; text-align: center; padding-bottom: 2pt"><span id="xdx_90A_edei--SecurityExchangeName_c20230704__20230704__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zeH9QrTBxX7c"><ix:nonNumeric contextRef="From2023-07-042023-07-04_us-gaap_SeriesAPreferredStockMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></td></tr>

<tr>
    <td style="vertical-align: top; padding-top: 1.5pt; padding-right: 1.25pt; padding-left: 1.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--Security12bTitle_c20230704__20230704__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zu4qafRleES3"><ix:nonNumeric contextRef="From2023-07-042023-07-04_us-gaap_SeriesBPreferredStockMember" name="dei:Security12bTitle">Depositary
    Shares, each representing a 1/1,000th interest in a share of 6.625% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series
    B</ix:nonNumeric></span></span></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td style="vertical-align: top; padding-top: 1.5pt; padding-right: 1.25pt; padding-left: 1.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--TradingSymbol_c20230704__20230704__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zdCzovoiVq5a"><ix:nonNumeric contextRef="From2023-07-042023-07-04_us-gaap_SeriesBPreferredStockMember" name="dei:TradingSymbol">AELPRB</ix:nonNumeric></span></span></td>
    <td style="padding-right: 1.25pt; padding-left: 1.25pt">&#160;</td>
    <td style="vertical-align: top; padding-top: 1.5pt; padding-right: 1.25pt; padding-left: 1.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--SecurityExchangeName_c20230704__20230704__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zgFylQTGsfRe"><ix:nonNumeric contextRef="From2023-07-042023-07-04_us-gaap_SeriesBPreferredStockMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the
registrant is an emerging growth company as defined in  Rule&#160;405 of the Securities Act of 1933
(&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this
chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company&#160;<span style="font-family: Wingdings"><span id="xdx_902_edei--EntityEmergingGrowthCompany_c20230704__20230704_zUeNpz6Any43"><ix:nonNumeric contextRef="From2023-07-04to2023-07-04" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Wingdings">&#168;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01 Entry into a Material Definitive Agreement.</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><b><i>Agreement and Plan of Merger</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">On July 4, 2023, American
Equity Investment Life Holding Company, an Iowa corporation (the &#8220;<b><i>Company</i></b>&#8221;), entered into an Agreement and Plan
of Merger (the &#8220;<b><i>Merger Agreement</i></b>&#8221;) with Brookfield Reinsurance Ltd., a Bermuda exempted company limited by shares
(&#8220;<b><i>Parent</i></b>&#8221;), Arches Merger Sub, Inc., an Iowa corporation and a wholly owned subsidiary of Parent (&#8220;<b><i>Merger
Sub</i></b>&#8221;), and solely for the purposes set forth in the Merger Agreement, Brookfield Asset Management Ltd., a company incorporated
under the laws of the Province of British Columbia (&#8220;<b><i>BAM</i></b>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The Merger Agreement provides,
among other things and subject to the terms and conditions of the Merger Agreement, that (a) Merger Sub will be merged with and into the
Company (the &#8220;<b><i>Merger</i></b>&#8221;), with the Company being the surviving company in the Merger, and, (b) at the effective
time of the Merger (the&#160;&#8220;<b><i>Effective Time</i></b>&#8221;), each issued and outstanding share of common stock, par value
$1.00 per share, of the Company (&#8220;<b><i>Company Common Share</i></b>&#8221;) (excluding Company Common Shares held by holders exercising
appraisal rights, shares owned by the Company as treasury stock, shares owned by Parent, Merger Sub or their subsidiaries including North
End RE (Cayman) SPC (&#8220;<b><i>North End</i></b>&#8221;) and Freestone Re Ltd. (&#8220;<b><i>Freestone</i></b>&#8221;, and together,
the &#8220;<b><i>Parent Group Shareholders</i></b>&#8221;), or shares subject to Company restricted stock awards (as discussed further
below)) will be converted into the right to receive (i) $38.85 per share in cash, without interest (the &#8220;<b><i>Cash Consideration</i></b>&#8221;)
and (ii) a number of fully-paid and nonassessable shares of class A limited voting shares of BAM (&#8220;<b><i>BAM Class A Stock</i></b>&#8221;)
equal to the Exchange Ratio (as defined in the Merger Agreement) (the &#8220;<b><i>Stock Consideration</i></b>&#8221;, together with the
Cash Consideration, the &#8220;<b><i>Merger Consideration</i></b>&#8221;). The Exchange Ratio is subject to adjustment such that if, based
on the 10-day volume-weighted average share price of BAM Class A Stock (measured five business days prior to closing of the Merger) (the
&#8220;<b><i>BAM Final Stock Price</i></b>&#8221;), BAM Class A Stock is trading at a price such that the aggregate Merger Consideration
would be less than $54.00 per share, the number of shares of BAM Class A Stock delivered for each Company Common Share will be increased
such that the value of the aggregate Merger Consideration delivered for each Company Common Share will equal $54.00 and Parent will have
the option to pay cash in lieu of some or all of the Stock Consideration. In the event that the BAM Final Stock Price would result in
the aggregate Merger Consideration per Company Common Share being greater than $56.50, the number of shares of BAM Class A Stock delivered
for each Company Common Share will be decreased such that the value of the aggregate Merger Consideration delivered for each Common Share
will equal $56.50.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The Merger Agreement does
not provide for the payment of any consideration with respect to the issued and outstanding shares of Series A and Series B preferred
stock, each, par value $1.00 per share, of the Company, which shares will be unaffected by the Merger and remain outstanding in accordance
with the terms of the Merger Agreement. In accordance with the terms of the Merger Agreement, from the Effective Time, Parent will cause
the Surviving Company to cause the depositary shares representing one-thousandth of one share of Series A or Series B preferred stock,
as applicable, to continue to be listed on the New York Stock Exchange,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">In addition, the Merger Agreement
provides for the following treatment of the Company&#8217;s equity awards at the Effective Time:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">each outstanding and unexercised stock option (&#8220;<b><i>Company Option</i></b>&#8221;) (whether vested
or unvested) will be automatically canceled and converted into the right to receive a cash payment, without interest, equal to the product
of (1) the number of Company Common Shares subject to such Company Option immediately prior to the Effective Time and (2)&#160;the excess,
if any, of the Merger Consideration (valuing the Stock Consideration at $16.15) over the exercise price per share of such Company Option;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">each outstanding Company restricted stock unit (&#8220;<b><i>Company RSU</i></b>&#8221;) other than certain
Company RSUs granted following the date of the Merger Agreement (&#8220;<b><i>Rollover Company RSUs</i></b>&#8221;) will be automatically
canceled and converted into the right to receive a cash payment, without interest, equal to the product of (1) the number of Company Common
Shares subject to such Company RSU immediately prior to the Effective Time and (2) the Merger Consideration (valuing the Stock Consideration
at $16.15);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">each outstanding Company RSU subject to performance-based vesting conditions (&#8220;<b><i>Company PSU</i></b>&#8221;)
will be automatically canceled and converted into the right to receive a cash payment, without interest, equal to the product of (1) the
number of Company Common Shares subject to such Company PSU immediately prior to the Effective Time (based on (A) for Company PSUs other
than the Company PSUs granted pursuant to the employee restricted stock unit award agreement, dated November 29, 2022, by and between
the Company and the Chief Executive Officer of the Company (the &#8220;<b><i>CEO</i></b>&#8221; and such PSUs, the &#8220;<b><i>VWAP PSUs</i></b>&#8221;),
a performance level determined based on the greater of target and actual performance as reasonably determined by the Compensation and
Talent Management Committee of the Board of Directors of the Company (the &#8220;<b><i>Board</i></b>&#8221;) immediately prior to the
Effective Time and (B) for VWAP PSUs, attainment of applicable performance goals based on the Merger Consideration) (valuing the Stock
Consideration at $16.15) and (2) the Merger Consideration (valuing the Stock Consideration at $16.15);</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">each outstanding award of Company Common Share subject to vesting conditions (&#8220;<b><i>Company Restricted
Stock</i></b>&#8221;) will automatically have any restrictions thereon lapse and be converted into the right to receive a cash payment,
without interest, equal to the product of (1) the number of shares of Company Restricted Stock subject to such award immediately prior
to the Effective Time and (2) the Merger Consideration (valuing the Stock Consideration at $16.15); and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 42.5pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">any outstanding Company RSU that is a Rollover Company RSU will automatically cease to represent an award
denominated in Company Common Share and will be converted into an award of cash-settled restricted stock units denominated in shares of
BAM Class A Stock (an &#8220;<b><i>Exchanged RSU</i></b>&#8221;), with the number of shares of common stock subject to each such Exchanged
RSU equal to the product of (1) the number of Company Common Shares subject to such Rollover Company RSU immediately prior to the Effective
Time multiplied by (2) the quotient of (i) the Merger Consideration (valuing the Stock Consideration at $16.15) divided by (ii) the BAM
Class A Stock Price, and except as specifically provided in the Merger Agreement, following the Effective Time, each Exchanged RSU will
continue to be governed by the same material terms and conditions (including vesting schedule and the termination protections established
for such Company RSU) as were applicable to the Rollover Company RSU immediately prior to the Effective Time.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.5pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The Board has unanimously
(1) determined that the Merger Agreement and the transactions contemplated thereby, including the Merger, are advisable, fair to, and
in the best interests of, the Company and its shareholders (other than the Parent Group Shareholders and any other shareholders affiliated
with Parent), (2) adopted the Merger Agreement and the transactions contemplated thereby, including the Merger, (3) directed that the
Merger Agreement and the transactions contemplated thereby, including the Merger, be submitted to the Company&#8217;s shareholders for
approval and (4) resolved to recommend that the Company&#8217;s shareholders vote to approve the Merger and the Merger Agreement (the
&#8220;<b><i>Company Shareholder Approval</i></b>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The closing of the Merger
is subject to satisfaction or waiver of customary closing conditions, including (1)&#160;the receipt of the Company Shareholder Approval,
(2) receipt of certain regulatory approvals, including the expiration or termination of the waiting period (and any extension thereof)
under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, (3) the absence of any injunction or restraint making illegal
or otherwise prohibiting the consummation of the Merger, (4)&#160;the effectiveness of the registration statement on Form F-4 to be filed
by BAM pursuant to which the shares of BAM Class A Stock to be issued as Stock Consideration will be registered with the Securities and
Exchange Commission (the &#8220;<b><i>SEC</i></b>&#8221;) and (5)&#160;listing approval of the shares of BAM Class A Stock to be issued
as Stock Consideration (i) on the New York Stock Exchange and (ii) subject to official notice of issuance, on the Toronto Stock Exchange.
Parent&#8217;s, Merger Sub&#8217;s and BAM&#8217;s obligations to close the Merger are also conditioned upon the absence of a Company
Material Adverse Effect (as defined in the Merger Agreement) and the absence of the imposition of a Burdensome Condition (as defined in
the Merger Agreement) by any regulator as part of the regulatory approval process. The closing of the Merger may not occur prior to January
5, 2024, unless Parent elects to waive such inside date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The Merger Agreement contains
customary representations and warranties of the Company, Parent, Merger Sub and BAM, in each case generally subject to customary qualifications.
Additionally, the Merger Agreement provides for customary pre-closing covenants of the Company, Parent, Merger Sub and BAM, including,
subject to certain exceptions, covenants relating to the conduct by the Company and BAM of their respective businesses in the ordinary
course consistent with past practice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The Company has agreed not
to solicit alternative takeover proposals from third parties or to engage in discussions with third parties regarding alternative takeover
proposals. However, prior to the receipt of the Company Shareholder Approval, the Board may change its recommendation that the Company&#8217;s
shareholders vote to approve the Merger following certain intervening events or receipt of a &#8220;Superior Proposal&#8221; (as defined
in the Merger Agreement), or terminate the Merger Agreement in order to enter into an agreement providing for a Superior Proposal, subject
to the Company paying a termination fee, as described below, if the failure to do so would be inconsistent with the directors&#8217; fiduciary
duties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The Merger Agreement provides
termination rights for each of the Company and Parent, including, among others, in the event the closing of the Merger does not occur
on or before April 4, 2024 (the &#8220;<b><i>Outside Date</i></b>&#8221;), provided that the Outside Date may be extended by either party
to July 5, 2024, if, as of the initial Outside Date, all conditions to the Merger are satisfied or validly waived other than with respect
to conditions relating to regulatory approvals. If, in connection with a termination of the Merger Agreement (1) by Parent due to a change
of the Board&#8217;s recommendation that the Company&#8217;s shareholders vote to approve the Merger or by the Company to enter into an
agreement in connection with a Superior Proposal or (2) by either party as a result of a failure to obtain the Company Shareholder Approval
and within twelve months of such termination, the Company consummates or enters into a definitive agreement to consummate an alternative
takeover proposal that was publicly made known and not withdrawn prior to such termination, then the Company may be required to pay Parent
a termination fee of $102,000,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The foregoing description
of the Merger Agreement and the transactions contemplated thereby in this Current Report on Form&#160;8-K is only a summary and does not
purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement, a copy of which is filed
as Exhibit 2.1 hereto and incorporated by reference herein. It is not intended to provide any other factual information about the Company,
Parent, BAM or their respective subsidiaries and affiliates. The Merger Agreement contains representations and warranties by each of the
parties to the Merger Agreement, which were made only for purposes of that agreement and as of specified dates. The representations, warranties
and covenants in the Merger Agreement were made solely for the benefit of the parties to the Merger Agreement, are subject to limitations
agreed upon by the contracting parties, including being qualified by confidential disclosures made for the purposes of allocating contractual
risk between the parties to the Merger Agreement instead of establishing these matters as facts, as well as by information contained in
each party&#8217;s periodic reports filed with the SEC, and may be subject to standards of materiality applicable to the contracting parties
that may differ from those applicable to investors. Investors are not entitled to, and should not, rely on the representations, warranties
and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Company, Parent, BAM or
any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of the representations, warranties
and covenants may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in the
Company&#8217;s public disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 5.02 Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Amendment to Change in Control Agreement with Axel Andr&#233;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Concurrently with the Merger Agreement, the Company
and Axel Andr&#233;, the Company&#8217;s Executive Vice President and Chief Financial Officer, entered into an Amended and Restated
Change in Control Agreement (the &#8220;<span style="text-decoration: underline">Amended and Restated CIC Agreement</span>&#8221;). The Amended and Restated CIC Agreement provides
for, upon a qualifying termination of employment thereunder, (1) an increased cash severance amount equal to three (rather than two) times
Mr. Andr&#233;&#8217;s annual base salary and target annual cash bonus and (2) the continued provision of certain welfare benefits for
a period of three (rather than two) years following the date of termination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing description of the Amended and Restated
CIC Agreement is not complete and is qualified in its entirety by reference to the complete text of the Amended and Restated CIC Agreement,
a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 8.01 Other Events<br />
<br />
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Voting Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">Concurrently with the execution
of the Merger Agreement, the Company entered into a voting agreement (the &#8220;<b><i>Voting Agreement</i></b>&#8221;) with Freestone
and North End.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">Pursuant to the Voting Agreement,
subject to the terms and conditions therein, each of Freestone and North End have agreed to vote all of the outstanding Company Common
Shares then beneficially owned by Freestone, North End or any of their respective affiliates (1) in favor of the approval of the Merger
Agreement and the Merger and (2) against any other takeover proposal or other proposal or transaction that would in any manner impede,
frustrate, prevent or nullify any provision of the Merger Agreement or the Merger. The Voting Agreement also includes waivers of certain
provisions of that certain Investment Agreement, dated October 17, 2020, by and among the Company, Brookfield Corporation (formerly, Brookfield
Asset Management Inc.) and Freestone and North End (as successors and assigns of Burgundy Acquisitions I Ltd.) (as amended, restated or
otherwise modified from time to time, the &#8220;<b><i>Investment Agreement</i></b>&#8221;), in order to, among other things, permit Parent
to exercise certain rights under the Merger Agreement and to remove any limitations on voting under the Investment Agreement that would
conflict with the Parent Group Shareholders&#8217; voting obligations under the Voting Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">As of the date of the Voting
Agreement, an aggregate of 15,886,066 Company Common Shares, representing approximately 20% of the total voting power of the holders of
capital stock of the Company, were beneficially owned by the Parent Group Shareholders and subject to the Voting Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The foregoing description
of the Voting Agreement does not purport to be complete and is subject to, and qualified in its entirety by the full text of such agreement,
a copy of which is filed as Exhibit 10.2 to this Current Report on Form 8-K and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Joint Press Release</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">On July 5, 2023, the Company
and Parent issued a joint press release announcing the execution of the Merger Agreement. A copy of the&#160;joint press release&#160;is
filed herewith as Exhibit 99.1 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>No Offer or Solicitation </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No person has commenced soliciting proxies in
connection with the proposed transaction referenced in this press release, and this press release is not an offer or a solicitation of
an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities or a solicitation of any vote or approval
in any jurisdiction, in contravention of applicable law, nor shall there be any sale, issuance or transfer of securities in any jurisdiction
in contravention of applicable law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Forward-Looking Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except for historical information, all other information
in this Form 8-K consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements, and related oral statements the Company, Parent or BAM may make, are subject to risks and uncertainties that
could cause actual results to differ materially from those projected, anticipated or implied. For example, (1) conditions to the closing
of the proposed transaction may not be satisfied, (2) regulatory approvals required for the proposed transaction may not be obtained,
or required regulatory approvals may delay the proposed transaction or result in the imposition of conditions that could have a material
adverse effect on the Company, Parent or BAM or cause certain conditions to closing not to be satisfied, which could result in the termination
of the merger agreement, (3) the timing of completion of the proposed transaction is uncertain, (4) the business of the Company, Parent
or BAM may suffer as a result of uncertainty surrounding the proposed transaction, (5) events, changes or other circumstances could occur
that could give rise to the termination of the merger agreement, (6) there are risks related to disruption of management&#8217;s attention
from the ongoing business operations of the Company, Parent or BAM due to the proposed transaction, (7) the announcement or pendency of
the proposed transaction could affect the relationships of the Company, Parent or BAM with its clients, operating results and business
generally, including on each of the Company&#8217;s, Parent&#8217;s and BAM&#8217;s ability to retain employees, (8) the announcement,
pendency or consummation of the proposed transaction may have negative effects on the market price of the Company&#8217;s common stock
or BAM&#8217;s class A limited voting shares and/or the Company&#8217;s, Parent&#8217;s or BAM&#8217;s operating results, (9) the outcome
of any legal proceedings initiated against the Company, Parent or BAM following the announcement of the proposed transaction could adversely
affect the Company, Parent or BAM, including their ability to consummate the proposed transaction and (10) the Company, Parent or BAM
may be adversely affected by other economic, business, and/or competitive factors as well as managements response to any of the aforementioned
factors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing review of important factors should
not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included herein or elsewhere,
including the risk factors included in the Company&#8217;s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, Parent&#8217;s
Form 20-F, BAM&#8217;s Form 20-F and other documents of the Company, Parent or BAM on file with, or furnished to, the SEC. Any forward-looking
statements made in this press release are qualified by these cautionary statements, and there can be no assurance that the actual results
or developments anticipated by the Company, Parent or BAM will be realized or, even if substantially realized, that they will have the
expected consequences to, or effects on, the Company, Parent or BAM or their business or operations. None of the Company, Parent or BAM
undertake any obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments
or otherwise, except as required by the federal securities laws. All subsequent written or oral forward-looking statements attributable
to the Company, Parent or BAM and/or any person acting on behalf of any of them are expressly qualified in their entirety by this paragraph.
References to additional information about the Company, Parent and BAM have been provided as a convenience, and the information contained
on such websites is not incorporated by reference into this Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Additional Information about the Merger and
Where to Find It</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In
connection with the proposed transaction, the Company will file with the SEC a proxy statement on Schedule 14A that will be combined with
a registration statement filed by BAM on Form F-4 with respect to the BAM Shares to be issued as part of the proposed transaction (such
combined proxy statement and Form F-4, the &#8220;proxy statement/prospectus&#8221;) and the Company, </span>Parent or BAM may file or
furnish other documents with the SEC and, in the case of Parent and BAM, with the applicable Canadian securities regulatory authorities,
regarding the proposed transaction. This press release is not a substitute for the proxy statement/prospectus (if and when available)
or any other document that the Company, Parent or BAM may file with the SEC, or in the case of Parent and BAM, with the applicable Canadian
securities regulatory authorities, with respect to the proposed transaction. INVESTORS IN AND SECURITY HOLDERS OF AEL ARE URGED TO READ
THE PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED OR FURNISHED OR WILL BE FILED OR WILL BE FURNISHED WITH
THE SEC OR APPLICABLE CANADIAN SECURITIES REGULATORY AUTHORITIES, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, CAREFULLY
AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND RELATED MATTERS. Investors
and security holders may obtain free copies of the proxy statement/prospectus (if and when available) and other documents filed with,
or furnished to, the SEC or the applicable Canadian securities regulatory authorities by Parent or BAM through the website maintained
by the SEC or applicable Canadian securities regulatory authorities, as applicable, at www.sec.gov or www.sedar.com, respectively, or
on Parent&#8217;s or BAM&#8217;s investor relations website, as applicable, at https://bnre.brookfield.com/reports-filings/regulatory-filings
and https://bam.brookfield.com/reports-filings/regulatory-filings, respectively. Investors and security holders may obtain free copies
of the proxy statement/prospectus (if and when available) and other documents filed with, or furnished to, the SEC by the Company through
the website maintained by the SEC at www.sec.gov, on the Company&#8217;s investor relations website at https://ir.american-equity.com/,
or by contacting Steven Schwartz, head of the investor relations department of AEL: sschwartz@american-equity.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Participants in the Solicitation </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company, </span>Parent, BAM and their respective directors and executive officers may be deemed to be participants in the solicitation
of proxies from the Company&#8217;s shareholders in connection with the proposed transaction. Information regarding the Company&#8217;s
directors and executive officers, including a description of their direct interests, by security holdings or otherwise, is contained in
the Company&#8217;s annual proxy statement filed with the SEC on April 28, 2023 and in other filings with the SEC. A more complete description
will be available in the proxy statement on Schedule 14A that will be filed with the SEC in connection with the proposed transaction.
Information regarding Parent&#8217;s directors and executive officers is contained in Parent&#8217;s Form 20-F filed on March 31, 2023.
Information regarding BAM&#8217;s directors and executive officers is contained in BAM&#8217;s Form 20-F filed on April 3, 2023. You may
obtain free copies of these documents as described in the preceding paragraph filed with, or furnished to, the SEC. All such documents,
when filed or furnished are available free of charge on the SEC&#8217;s website (www.sec.gov), on the Company, Parent or BAM&#8217;s respective
investor relations webpages listed above, or, in the case of such documents filed or furnished with the SEC by the Company, by directing
a request to the Company at the Investor Relations contact above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01 Financial Statements and Exhibits.<br /></b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Exhibit No.</span></b></span></td>
    <td style="width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Description</span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2320561d1_ex2-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></a></td>
    <td style="text-align: justify"><a href="tm2320561d1_ex2-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreement and Plan of Merger, dated July 4, 2023, by and among the Company, the Parent and Merger Sub and, solely for the purposes set forth therein, BAM.*</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2320561d1_ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></a></td>
    <td><a href="tm2320561d1_ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Change in Control Agreement, dated as of July 4, 2023, by and between the Company and Axel Andr&#233;.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2320561d1_ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></a></td>
    <td><a href="tm2320561d1_ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting Agreement, dated July 4, 2023, by and among the Company, Freestone Re Ltd. and North End RE SPC</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2320561d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td><a href="tm2320561d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint Press Release dated July 5, 2023.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0.25in">* Schedules omitted pursuant to Item 601(b)(2) of Regulation S-K. The
Company agrees to furnish supplementally a copy of any omitted schedule to the SEC upon request; provided, however, that the Company may
request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any schedules or exhibits
so furnished.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>&#160;</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>AMERICAN
    EQUITY INVESTMENT LIFE HOLDING COMPANY</b></span></p></td></tr>
  <tr style="font-size: 10pt">
    <td style="font-size: 10pt; text-align: left; vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt; text-align: left; width: 50%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 3%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 47%"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: July 5, 2023</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Axel Andre</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Axel Andre</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice President and
    Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6Pdw6UXCXDhVxigwRb6vLpLg1I61/j+Rb2m2IIRCSk+8cIUKxoqWukeE0L3I4YNPWyiEUWCGjuaD/yNabFPws8KqtY2Vcv/7AjDyDnpmM5Nnf+8+HtlimIGUkk0jOIB6n8RT2WxF0ekam0iUap1UNypSwZ2pZo1P8HhwO6kWGmnefdES2moy3G8WD/IEklgns6KGexDcLeZ6JIOwrECume9vF3K2jBhY1Nj7LDui/gy/bh0kW -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>tm2320561d1_ex2-1.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 2.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">EXECUTION VERSION</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AGREEMENT AND PLAN OF
MERGER</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>by and among</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>American
Equity Investment Life Holding Company,</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Brookfield
Reinsurance Ltd.</B></FONT><B>,</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Arches
Merger Sub Inc.,</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>and, solely for the limited
purposes set forth herein,</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Brookfield
Asset Management Ltd.</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Dated as of July&nbsp;4,
2023</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><U>Page</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;I</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFINITIONS
    AND TERMS</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;1.01.</FONT></TD>
    <TD STYLE="width: 83%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions</FONT></TD>
    <TD STYLE="text-align: right; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;1.02.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interpretation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;II</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE MERGER</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.01.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.02.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing; Effective Time</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.03.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effects of Merger</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.04.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Incorporation and Bylaws of the Surviving
    Company</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.05.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board of Directors and Officers of Surviving Company</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;III</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EFFECT ON THE
    SHARE CAPITAL OF THE CONSTITUENT ENTITIES; PAYMENT OF CONSIDERATION</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.01.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of Merger on the Share Capital of Merger Sub
    and the Company</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.02.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange Fund</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.03.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Awards</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.04.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments with Respect to Company Awards</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.05.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of Dissenting Holders</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;IV</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS
    AND WARRANTIES OF THE COMPANY</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.01.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organization; Standing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.02.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.03.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authority; Noncontravention; Voting Requirements</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.04.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governmental Approvals</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.05.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company SEC Documents; Undisclosed Liabilities</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.06.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absence of Certain Changes</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.07.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Proceedings</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.08.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance with Laws; Permits</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.09.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.10.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee Benefits</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.11.</FONT></TD>
    <TD STYLE="width: 83%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Labor Matters</FONT></TD>
    <TD STYLE="text-align: right; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.12.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual Property; Data Privacy and Cybersecurity</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.13.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anti-Takeover Provisions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.14.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real Property</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.15.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contracts</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.16.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actuarial Appraisals; Reserves</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.17.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reinsurance</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.18.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment Assets</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.19.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance Business</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.20.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance Policies</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.21.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance Producers</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.22.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance Product-Related Tax Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.23.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statutory Statements</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.24.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Financial Advisor</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.25.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokers and Other Advisors</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.26.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical Technology</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;V</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS
    AND WARRANTIES OF PARENT AND MERGER SUB</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.01.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organization; Standing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.02.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authority; Noncontravention</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.03.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governmental Approvals</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.04.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership and Operations of Merger Sub</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.05.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sufficient Funds</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.06.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guaranty and Voting Agreement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.07.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Arrangements</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.08.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information Supplied</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.09.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Proceedings</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.10.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance with Laws</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.11.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership of Common Stock or Preferred Stock</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.12.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokers and Other Advisors</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.13.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending Transactions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.14.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership Structure</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;VI</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS
    AND WARRANTIES OF BAM</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.01.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organization; Standing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.02.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.03.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authority; Noncontravention</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.04.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governmental Approvals</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.05.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment Company Act</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.06.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Arrangements</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.07.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information Supplied</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.08.</FONT></TD>
    <TD STYLE="width: 83%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BAM SEC Documents; Undisclosed Liabilities</FONT></TD>
    <TD STYLE="text-align: right; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.09.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absence of Certain Changes</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.10.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Proceedings</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.11.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance with Laws</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.12.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brokers and Other Advisors</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;VII</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADDITIONAL COVENANTS
    AND AGREEMENTS</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.01.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct of Business by the Company</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">78</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.02.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct of Business by BAM</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.03.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Solicitation by the Company; Change in Recommendation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">84</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.04.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparation of the Proxy Statement/Prospectus, Form&nbsp;F-4;
    Shareholders Meeting and Approval</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.05.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reasonable Best Efforts</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.06.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public Announcements</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">93</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.07.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Access to Information; Confidentiality</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">93</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.08.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification and Insurance</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.09.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule&nbsp;16b-3</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">96</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.10.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">96</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.11.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notification of Certain Matters; Shareholder Litigation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.12.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger Sub Shareholder Approval</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.13.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Exchange De-listing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.14.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continued Listing of Depositary Shares</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.15.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices of Certain Events</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.16.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment Assets</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.17.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">103</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.18.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payoff Letters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.19.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Closing Actions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.20.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Exchange Listing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;VIII</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDITIONS PRECEDENT</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;8.01.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions to Each Party&rsquo;s Obligation To Effect
    the Merger</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;8.02.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions to Obligations of Parent, Merger Sub and
    BAM</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">108</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;8.03.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions to Obligations of the Company</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">109</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;8.04.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frustration of Closing Conditions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">110</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;IX</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TERMINATION</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;9.01.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">110</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;9.02.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of Termination</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">112</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;9.03.</FONT></TD>
    <TD STYLE="width: 83%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination Fee</FONT></TD>
    <TD STYLE="text-align: right; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">112</FONT></TD></TR>
</TABLE>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Article&nbsp;X</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MISCELLANEOUS</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.01.</FONT></TD>
    <TD STYLE="width: 83%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Survival of Representations and Warranties</FONT></TD>
    <TD STYLE="text-align: right; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">113</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.02.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment or Supplement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">114</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.03.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extension of Time, Waiver, Etc.</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">114</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.04.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assignment</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">114</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.05.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counterparts</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">114</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.06.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entire Agreement; No Third-Party Beneficiaries</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">115</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.07.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governing Law; Jurisdiction</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">115</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.08.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specific Enforcement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.09.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WAIVER OF JURY TRIAL</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.10.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">117</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.11.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Severability</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">118</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.12.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees and Expenses</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">119</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.13.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer Taxes</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">119</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.14.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Other Representations and Warranties</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">119</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.15.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Other Duties and Obligations</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">120</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AGREEMENT AND PLAN OF MERGER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">This AGREEMENT AND PLAN OF MERGER (this &ldquo;<U>Agreement</U>&rdquo;),
dated as of July&nbsp;4, 2023, is by and among American Equity Investment Life Holding Company, an Iowa corporation (the &ldquo;<U>Company</U>&rdquo;),
Brookfield Reinsurance Ltd., a Bermuda exempted company limited by shares (&ldquo;<U>Parent</U>&rdquo;), Arches Merger Sub Inc., an Iowa
corporation and a wholly owned Subsidiary of Parent (&ldquo;<U>Merger Sub</U>&rdquo; and, together with Parent, the &ldquo;<U>Parent
Entities</U>&rdquo;), and solely for purposes of <U>Article&nbsp;VI</U> and <U>Sections 3.02(a)(ii)(B)</U>, <U>3.02(d)</U>, <U>7.02</U>,
<U>7.04</U>, <U>7.14(d)</U>, <U>7.20</U> and <U>8.03(c)</U>, Brookfield Asset Management Ltd., a company incorporated under the laws
of the Province of British Columbia (&ldquo;<U>BAM</U>&rdquo;). The Company, Parent, Merger Sub and BAM are each referred to in this
Agreement as a &ldquo;<U>party</U>&rdquo; and collectively as the &ldquo;<U>parties</U>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, as of the date hereof, North End RE (Cayman)
SPC and Freestone Re Ltd. (together, the &ldquo;<U>Parent Group Shareholders</U>&rdquo;), each an affiliate of Parent, collectively own
15,886,163 shares of common stock, par value $1.00, of the Company (&ldquo;<U>Common Stock</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, the Board of Directors of each of Parent
(the &ldquo;<U>Parent Board</U>&rdquo;) and Merger Sub (the &ldquo;<U>Merger Sub Board</U>&rdquo;) have unanimously (i)&nbsp;determined
that the terms of this Agreement are in the best interests of Parent and Merger Sub, as applicable, (ii)&nbsp;adopted this Agreement
and the transactions provided for herein in which Merger Sub will, in accordance with the Laws of the State of Iowa and subject to the
terms and conditions set forth herein, merge with and into the Company, with the Company surviving such merger (the &ldquo;<U>Merger</U>&rdquo;)
and (iii)&nbsp;declared the advisability of this Agreement and the Merger, and the Merger Sub Board has (x)&nbsp;directed that this Agreement
and the transactions contemplated by this Agreement, including the Merger, be submitted to Parent (as Merger Sub&rsquo;s sole shareholder)
for its approval and (y)&nbsp;resolved to recommend approval of the Merger and this Agreement to Parent (as Merger Sub&rsquo;s sole shareholder);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, the Board of Directors of the Company (the
 &ldquo;<U>Company Board</U>&rdquo;) has unanimously (i)&nbsp;determined that this Agreement and the transactions contemplated by this
Agreement, including the Merger, are advisable, fair to and in the best interests of the Company and its shareholders (other than the
Parent Group Shareholders and any other Affiliates of Parent that are holders of Common Stock (collectively, &ldquo;<U>Parent Affiliated
Shareholders</U>&rdquo;)), including in consideration of community interest factors as authorized to be considered by Section&nbsp;490.1108A
of the IBCA (&ldquo;c<U>ommunity interest factors</U>&rdquo;), (ii)&nbsp;adopted this Agreement and the transactions contemplated by
this Agreement, including the Merger, (iii)&nbsp;directed that this Agreement and the transactions contemplated by this Agreement, including
the Merger, be submitted to the shareholders of the Company for their approval and (iv)&nbsp;resolved, subject to <U>Section&nbsp;7.03</U>,
to recommend approval of the Merger and this Agreement to the Company&rsquo;s shareholders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, concurrently with the execution of this
Agreement and as a condition to the willingness of Parent and Merger Sub to enter into this Agreement, the Chief Executive Officer of
the Company (the &ldquo;<U>CEO</U>&rdquo;) has entered into a consulting agreement with Parent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, concurrently with the execution of this
Agreement, and as a condition to the willingness of the Company to enter into this Agreement, Parent has delivered to the Company a guaranty,
dated as of the date hereof (the &ldquo;<U>Guaranty</U>&rdquo;), in favor of the Company and certain other Persons, and pursuant to which
BN is guaranteeing certain obligations of certain persons under this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, simultaneously with the execution and delivery
of this Agreement, as a condition to the willingness of the Company to enter into this Agreement, the Parent Group Shareholders have
entered into an agreement with the Company substantially in the form attached as Exhibit&nbsp;A (the &ldquo;<U>Voting Agreement</U>&rdquo;),
pursuant to which, subject to the terms and conditions therein, the Parent Group Shareholders have agreed to vote all of their respective
shares of Common Stock in favor of, and to otherwise support, the Merger; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, the Company, the Parent Entities and BAM
desire to make certain representations, warranties, covenants and agreements in connection with the Merger and also to prescribe various
conditions to the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">NOW, THEREFORE, in consideration of the foregoing,
each party agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;I</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>DEFINITIONS AND TERMS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;1.01.</FONT><FONT STYLE="text-transform: uppercase"> &#8239;&#8239;&#8239;&#8239;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Definitions</U>.
As used in this Agreement, the following terms have the meanings ascribed thereto below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Acceptable Confidentiality Agreement</U>&rdquo;
means any confidentiality agreement entered into by the Company from and after the date of this Agreement that contains provisions that
are not materially less favorable in the aggregate to the Company than those contained in the Confidentiality Agreement and does not
prohibit the Company from complying with its obligations set forth in <U>Section&nbsp;7.03</U> (it being understood that such confidentiality
agreement need not contain a standstill provision or otherwise prohibit the making or amending of a Takeover Proposal if such Takeover
Proposal is made directly to the Company and not publicly disclosed).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Action</U>&rdquo; means any action, suit
or proceeding by or before any Governmental Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Actuarial Appraisal</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;4.16(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Adverse Recommendation Change</U>&rdquo;
has the meaning set forth in Section&nbsp;7.03(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Affiliate</U>&rdquo; means, as to any
Person, any other Person that, directly or indirectly, controls, or is controlled by, or is under common control with, such Person. For
this purpose, &ldquo;control&rdquo; (including, with its correlative meanings, &ldquo;controlled by&rdquo; and &ldquo;under common control
with&rdquo;) shall mean the possession, directly or indirectly, of the power to direct or cause the direction of management or policies
of a Person, whether through the ownership of securities or partnership or other ownership interests, by Contract or otherwise. For purposes
of this Agreement, (a)&nbsp;Parent and its Subsidiaries shall be deemed not to be Affiliates or portfolio companies of BN, BAM and their
respective Subsidiaries, (b)&nbsp;BAM shall be deemed not to be an Affiliate or portfolio company of BN and its Subsidiaries and (c)&nbsp;Parent,
BN and BAM and their respective Subsidiaries shall be deemed not to be Affiliates of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Agreement</U>&rdquo; has the meaning set
forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Anti-Bribery Legislation</U>&rdquo; means
all and any of the following: the U.S. Foreign Corrupt Practices Act of 1977; the Organisation for Economic Cooperation and Development
Convention on Combating Bribery of Foreign Public Officials in International Business Transactions and related implementing legislation;
the relevant common law or legislation in England and Wales relating to bribery and/or corruption, including the Public Bodies Corrupt
Practices Act 1889, the Prevention of Corruption Act 1906 as supplemented by the Prevention of Corruption Act 1916 and the Anti-Terrorism,
Crime and Security Act 2001, the Bribery Act 2010, the Proceeds of Crime Act 2002, the Bermuda Bribery Act 2016 and any other applicable
anti-bribery or anti-corruption related provisions in criminal and anti-competition Laws and/or other applicable Laws relating to bribery
or corruption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Antitrust Laws</U>&rdquo; means the Sherman
Antitrust Act of 1890, the Clayton Antitrust Act of 1914, the HSR Act, the Federal Trade Commission Act, all applicable non-U.S. antitrust
Laws and all other applicable Laws issued by a Governmental Authority that are designed or intended to prohibit, restrict or regulate
actions having the purpose or effect of monopolization or restraint of trade or lessening of competition through merger or acquisition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Applicable SAP</U>&rdquo; means, with
respect to any Company Insurance Subsidiary, the applicable statutory accounting principles (or local equivalents in the applicable jurisdiction)
prescribed or permitted by the Insurance Regulator of such Company Insurance Subsidiary&rsquo;s domiciliary jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Ardea Partners</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;4.24</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Articles of Merger</U>&rdquo; shall mean
the articles of merger in the form mutually agreed to by Parent and the Company, as required by and executed in accordance with the IBCA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<U>BAM</U>&rdquo;
</FONT>has the meaning set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>BAM Class&nbsp;A Fixed Stock Price</U>&rdquo;
means an amount in cash equal to $16.15.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>BAM Class&nbsp;A Stock</U>&rdquo; has
the meaning set forth in <U>Section&nbsp;6.02</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>BAM Class&nbsp;A Stock Price</U>&rdquo;
means the volume-weighted average sales price per share taken to four decimal places of BAM Class&nbsp;A Stock on the US Consolidated
Tape over the period of 10 consecutive trading days concluding with the market closing trade on the NYSE on the fifth trading day immediately
preceding the Closing Date (such period, the &ldquo;<U>BAM Class&nbsp;A Stock Price Measuring Period</U>&rdquo;), as calculated by Bloomberg
Financial LP under the function &ldquo;VWAP&rdquo; by using the instruction &ldquo;BAM US Equity AQR&rdquo; (or, if not available, in
another authoritative source mutually selected by the Company and Parent).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>BAM Class&nbsp;A Stock Price Measuring
Period</U>&rdquo; has the meaning set forth in the definition of &ldquo;BAM Class&nbsp;A Stock Price&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<U>BAM
Class&nbsp;B Stock</U>&rdquo; </FONT>has the meaning set forth in <U>Section&nbsp;6.02</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>BAM Disclosure Letter</U>&rdquo; has the
meaning set forth in <U>Article&nbsp;VI</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>BAM Material Adverse Effect</U>&rdquo;
means any effect, change, event, circumstance or development that, individually or in the aggregate with all other effects, changes,
events, circumstances or developments, has or would reasonably be expected to have a material adverse effect on the business, assets,
results of operations or condition (financial or otherwise) of BAM and its Subsidiaries taken as a whole; <U>provided</U>, <U>however</U>,
that in no event shall any of the following, or any effect, change, event, circumstance or development arising out of, or resulting from,
the following, constitute or be taken into account, individually or in the aggregate, in determining whether a BAM Material Adverse Effect
has occurred or may occur (except to the extent contemplated by the proviso at the end of this definition): (a)&nbsp;general economic
or regulatory, legislative or political conditions or securities, credit, financial or other capital markets conditions in any jurisdiction
(including with respect to interest rates, exchange rates for currencies, monetary policy or inflation), (b)&nbsp;any failure, in and
of itself, by BAM to meet any internal or published projections, forecasts, guidance, estimates, milestones, budgets or predictions in
respect of internal or published revenues, earnings, expenses, cash flow, cash position or other financial or operating metrics for any
period (it being understood that the effect, change, event, circumstance or development giving rise or contributing to such failure that
are not otherwise excluded pursuant to another clause of this definition may be deemed to constitute or be taken into account in determining
whether there has been or would reasonably be expected to be a BAM Material Adverse Effect), (c)&nbsp;geopolitical conditions, the outbreak
or escalation of hostilities, any acts of war (whether or not declared) (including civil war and including with respect to the Russian
Federation and Ukraine or any matter arising therefrom), sabotage, terrorism (including cyber-terrorism), man-made disaster, epidemics,
pandemics or disease outbreaks (including COVID-19 or any COVID Measures) or any escalation or worsening of any of the foregoing, (d)&nbsp;any
volcano, tsunami, hurricane, tornado, windstorm, flood, earthquake, wildfire or other natural disaster or any conditions resulting from
such natural disasters, (e)&nbsp;the negotiation, execution and delivery of this Agreement, the announcement, pendency or performance
of the Transactions, or the identity of, or facts relating to, the Company, (f)&nbsp;the suspension of trading in securities of BAM on
the NYSE or TSX or any change, in and of itself, in the market price, ratings or trading volume of BAM&rsquo;s or any of its Subsidiaries&rsquo;
securities (it being understood that the effect, change, event, circumstance or development giving rise or contributing to such change
that are not otherwise excluded pursuant to another clause of this definition may be deemed to constitute or be taken into account in
determining whether there has been or would reasonably be expected to be a BAM Material Adverse Effect), (g)&nbsp;any change in applicable
Law (including COVID Measures) (or interpretation or enforcement thereof) or GAAP (or interpretation or enforcement thereof), including
but not limited to legal or regulatory requirements and accounting and financial reporting pronouncements by the SEC and the FASB or
rating agency methodology or (h)&nbsp;any action taken or not taken by BAM or any of its Subsidiaries as expressly required by the terms
of this Agreement (but, in the event of any such failure to take an action, only if the Company has refused to provide a waiver to the
applicable prohibition in this Agreement); <U>provided further</U>, <U>however</U>, that any effect, change, event, circumstance or development
referred to in clause (a), (c), (d)&nbsp;or (g)&nbsp;(other than with respect to interest rates) may be taken into account in determining
whether or not there has been a BAM Material Adverse Effect to the extent such effect, change, event, circumstance or development has
a disproportionate adverse effect on BAM and its Subsidiaries, taken as a whole, relative to other participants in BAM&rsquo;s industries
in the geographic regions or product markets in which BAM and its Subsidiaries operate (in which case only the incremental disproportionate
effect or effects may be taken into account in determining whether or not a BAM Material Adverse Effect has occurred).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>BAM Organizational Documents</U>&rdquo;
means, collectively, BAM&rsquo;s Notice of Articles and Articles of BAM in each case, as amended up to and including the date of this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>BAM SEC Documents</U>&rdquo; has the meaning
set forth in <U>Article&nbsp;VI</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>BAM ULC</U>&rdquo; means Brookfield Asset
Management ULC, a company organized under the laws of British Columbia, Canada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Bankruptcy and Equity Exception</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;4.03(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Barclays</U>&rdquo; has the meaning set
forth in <U>Section 5.12</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>BN</U>&rdquo; means Brookfield Corporation,
a corporation organized under the laws of Ontario, Canada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Book-Entry Share</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;3.01(d)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Broker-Dealer Subsidiary</U>&rdquo; means
AEL Financial Services, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Burdensome Condition</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;7.05(f)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>business day</U>&rdquo; means any day
except a Saturday, a Sunday or other day on which the SEC or banks in the City of New York, the City of Toronto, Canada or the City of
Des Moines,&nbsp;Iowa are authorized or required by applicable Law to be closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Cap Amount</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;7.08(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Capitalization Date</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;4.02(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Cash Consideration</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;3.01(d)(i)(A)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>CEO</U>&rdquo; has the meaning set forth
in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Certificate</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;3.01(d)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Claim</U>&rdquo; has the meaning set forth
in <U>Section&nbsp;7.08(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Closing</U>&rdquo; has the meaning set
forth in <U>Section&nbsp;2.02</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Closing Date</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;2.02</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Code</U>&rdquo; means the U.S. Internal
Revenue Code of 1986, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Common Stock</U>&rdquo; has the meaning
set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>community interest factors</U>&rdquo;
has the meaning set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company</U>&rdquo; has the meaning set
forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company 401(k)&nbsp;Plan</U>&rdquo; means
the Company&rsquo;s Profit Sharing and 401(k)&nbsp;Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Acquisition Agreement</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;7.03(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Awards</U>&rdquo; means, collectively,
Company Restricted Stock, Company RSUs, Company PSUs and Company Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Award Conversion Ratio</U>&rdquo;
means the quotient of (i)&nbsp;the Merger Consideration (valuing the Stock Consideration at the BAM Class&nbsp;A Fixed Stock Price for
this purpose) <U>divided by</U> (ii)&nbsp;the BAM Class&nbsp;A Stock Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Board</U>&rdquo; has the meaning
set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Board Recommendation</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;4.03(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Book-Entry Shares</U>&rdquo; has
the meaning set forth in <U>Section&nbsp;3.02(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Bylaws</U>&rdquo; means the Company&rsquo;s
Amended and Restated Bylaws, as amended up to and including the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Charter</U>&rdquo; means the Company&rsquo;s
Articles of Incorporation, as amended up to and including the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Disclosure Letter</U>&rdquo; has
the meaning set forth in <U>Article&nbsp;IV</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Employee</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;7.10(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Employee List</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;7.10(g)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company ESOP</U>&rdquo; means the Company&rsquo;s
Employee Stock Ownership Plan, as amended and restated generally effective January&nbsp;1, 2014, as may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Insurance Approvals</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;4.04</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Insurance Policies</U>&rdquo;
means all insurance policies and contracts, together with all binders, slips, certificates, endorsements and riders thereto, that are
issued by a Company Insurance Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Insurance Subsidiary</U>&rdquo;
means each Subsidiary of the Company that conducts the business of insurance or reinsurance as an insurance company or a reinsurance
company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Intellectual Property</U>&rdquo;
means all Intellectual Property owned or purported to be owned by the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Lease</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;4.14(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Material Adverse Effect</U>&rdquo;
means any effect, change, event, circumstance or development that, individually or in the aggregate with all other effects, changes,
events, circumstances or developments, has or would reasonably be expected to have a material adverse effect on the business, assets,
results of operations or condition (financial or otherwise) of the Company and its Subsidiaries taken as a whole; <U>provided</U>, <U>however</U>,
that in no event shall any of the following, or any effect, change, event, circumstance or development arising out of, or resulting from,
the following, constitute or be taken into account, individually or in the aggregate, in determining whether a Company Material Adverse
Effect has occurred or may occur (except to the extent contemplated by the proviso at the end of this definition): (a)&nbsp;effects,
changes or events generally affecting the insurance, reinsurance or risk management industries in the geographic regions or product markets
in which the Company and its Subsidiaries operate or underwrite insurance or reinsurance or manage risk (including changes to interest
rates, general market prices and regulatory changes affecting such industries), (b)&nbsp;general economic or regulatory, legislative
or political conditions or securities, credit, financial or other capital markets conditions in any jurisdiction (including with respect
to interest rates, exchange rates for currencies, monetary policy or inflation and any changes in the Investment Assets resulting therefrom),
(c)&nbsp;any failure, in and of itself, by the Company to meet any internal or published projections, forecasts, guidance, estimates,
milestones, budgets or predictions in respect of internal or published revenues, earnings, premiums written, expenses, cash flow, cash
position or other financial or operating metrics for any period (it being understood that the effect, change, event, circumstance or
development giving rise or contributing to such failure that are not otherwise excluded pursuant to another clause of this definition
may be deemed to constitute or be taken into account in determining whether there has been or would reasonably be expected to be a Company
Material Adverse Effect), (d)&nbsp;geopolitical conditions, the outbreak or escalation of hostilities, any acts of war (whether or not
declared) (including civil war and including with respect to the Russian Federation and Ukraine or any matter arising therefrom), sabotage,
terrorism (including cyber-terrorism), man-made disaster, epidemics, pandemics or disease outbreaks (including COVID-19 or any COVID
Measures) or any escalation or worsening of any of the foregoing, (e)&nbsp;any volcano, tsunami, hurricane, tornado, windstorm, flood,
earthquake, wildfire or other natural disaster or any conditions resulting from such natural disasters, (f)&nbsp;the negotiation, execution
and delivery of this Agreement, the announcement, pendency or performance of the Transactions, or the identity of, or facts relating
to, Parent or any of its Affiliates, including the impact thereof on the relationships of the Company or any of its Subsidiaries with
employees, customers, insureds, cedants, policyholders, brokers, agents, financing sources, investment managers, business partners, service
providers, Governmental Authorities or reinsurance providers, and including any Action with respect to the Transactions, (g)&nbsp;any
change or announcement of a potential change, in and of itself, in the Company&rsquo;s or any of its Subsidiaries&rsquo; credit, financial
strength or claims paying ratings or the ratings of any of the Company&rsquo;s or its Subsidiaries&rsquo; businesses (it being understood
that the effect, change, event, circumstance or development giving rise or contributing to such ratings that are not otherwise excluded
pursuant to another clause of this definition may be deemed to constitute or be taken into account in determining whether there has been
or would reasonably be expected to be a Company Material Adverse Effect), (h)&nbsp;the suspension of trading in securities of the Company
on the NYSE or any change, in and of itself, in the market price, ratings or trading volume of the Company&rsquo;s or any of its Subsidiaries&rsquo;
securities (it being understood that the effect, change, event, circumstance or development giving rise or contributing to such change
that are not otherwise excluded pursuant to another clause of this definition may be deemed to constitute or be taken into account in
determining whether there has been or would reasonably be expected to be a Company Material Adverse Effect), (i)&nbsp;any change in applicable
Law (including COVID Measures) (or interpretation or enforcement thereof), GAAP (or interpretation or enforcement thereof) or in Applicable
SAP (or, other than with respect to any permitted practices, interpretation or enforcement thereof), including but not limited to legal
or regulatory requirements and accounting and financial reporting pronouncements by the SEC, the National Association of Insurance Commissioners,
any Insurance Regulator and the FASB or rating agency methodology, (j)&nbsp;any action taken or not taken by the Company or any of its
Subsidiaries as expressly required by the terms of this Agreement (but, in the event of any such failure to take an action, only if Parent
has refused to provide a waiver to the applicable prohibition in this Agreement) or (k)&nbsp;any of the matters set forth on <U>Section&nbsp;4.06(b)</U>&nbsp;of
the Company Disclosure Letter; <U>provided further</U>, <U>however</U>, that any effect, change, event, circumstance or development referred
to in clause (a), (b), (d)&nbsp;or (e)&nbsp;(other than with respect to interest rates) may be taken into account in determining whether
or not there has been a Company Material Adverse Effect to the extent such effect, change, event, circumstance or development has a disproportionate
adverse effect on the Company and its Subsidiaries, taken as a whole, relative to other participants engaged primarily in the insurance
or reinsurance or risk management industries in the geographic regions or product markets in which the Company and its Subsidiaries operate
or underwrite insurance or reinsurance or manage risk (in which case only the incremental disproportionate effect or effects may be taken
into account in determining whether or not a Company Material Adverse Effect has occurred).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Notice</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;7.03(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Option</U>&rdquo; means each option
(whether vested or unvested) to purchase Common Stock granted pursuant to a Company Stock Plan (including for the avoidance of doubt
any Performance-Vesting Company Option).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Organizational Documents</U>&rdquo;
means the Company Charter and the Company Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Plan</U>&rdquo; means each plan,
program, policy, agreement or other arrangement covering current or former directors, officers, employees or natural independent contractors
of the Company or any of its Subsidiaries, that is (a)&nbsp;an &ldquo;employee benefit plan&rdquo; within the meaning of Section&nbsp;3(3)&nbsp;of
ERISA (whether or not such plan is subject to ERISA), (b)&nbsp;a share option, share purchase, share appreciation right, restricted share,
restricted share unit or other share-based or equity-based compensation agreement, program or plan, (c)&nbsp;an individual employment,
consulting, severance, retention, termination, restrictive covenant, change-in-control or other similar agreement between such Person
and the Company or any of its Subsidiaries or (d)&nbsp;a bonus, incentive, deferred compensation, profit-sharing, retirement, post-employment
or post-retirement health, medical, life insurance or other welfare benefit plan, program, policy or arrangement, spending or reimbursement
account, paid time off, severance or termination pay, benefit or fringe-benefit plan, program, policy, agreement or other arrangement
(other than, in each case, any such plan, program, policy, agreement or other arrangement required by applicable Law, sponsored by a
Governmental Authority), whether or not in writing and whether or not funded, in each case, that is sponsored, maintained or contributed
to by the Company or any of its Affiliates or with respect to which the Company or any of its Subsidiaries has any actual or contingent
liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company PSU</U>&rdquo; means each award
of Company RSUs subject to performance-based vesting conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Restricted Stock</U>&rdquo; means
Common Stock granted pursuant to a Company Stock Plan that is subject to vesting restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Rights</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;4.02(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company RSU</U>&rdquo; means each restricted
stock unit payable in Common Stock or whose value is determined with reference to the value of Common Stock, granted pursuant to the
Company Stock Plans, other than a Company PSU.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company SEC Documents</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;4.05(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Securities</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;4.02(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Shareholders Meeting</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;7.04(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Stock Certificates</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;3.02(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Stock Plans</U>&rdquo; means the
Company&rsquo;s (a)&nbsp;2023 Equity Incentive Plan, (b)&nbsp;Amended and Restated Equity Incentive Plan and (c)&nbsp;2016 Employee Incentive
Plan, in each case, as may be amended or restated from time to time and, in each case, the award agreements thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Company Termination Fee</U>&rdquo; means
a cash amount equal to $102,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Confidentiality Agreement</U>&rdquo; has
the meaning set forth in <U>Section&nbsp;7.07</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Consent</U>&rdquo; means any consent,
waiver, approval, license, Permit, order, non-objection or authorization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Contract</U>&rdquo; means any legally
binding agreement, debenture, note, bond, mortgage, indenture, deed, lease, sublease, license or contract other than any Company Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>COVID-19</U>&rdquo; means SARS-CoV-2 and
its disease commonly known as COVID-19, including any intensification, resurgence and any evolutions or additional strains, variations,
sequences or mutations thereof or any related or associated epidemics, pandemics, disease outbreaks or public health emergencies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>COVID Measures</U>&rdquo; means (a)&nbsp;any
quarantine, &ldquo;shelter in place,&rdquo; &ldquo;stay at home,&rdquo; workforce reduction, social distancing, shutdown, closure, sequester,
safety or similar applicable Law, directive, guidelines or recommendations promulgated by any Governmental Authority, including the Centers
for Disease Control and Prevention and the World Health Organization, in each case, in connection with or in response to COVID-19, including
the CARES Act and the Families First Coronavirus Response Act, or any other response to COVID-19, and (b)&nbsp;the reversal or discontinuation
of any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Credit Agreement</U>&rdquo; means the
Credit Agreement, dated as of February&nbsp;15, 2022, among the Company, the lenders party thereto, and Citizens Bank, N.A., as administrative
agent thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Credit Agreement Amendments</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;7.17(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Credit Document</U>&rdquo; means each
Contract pursuant to which the Company or any of its Subsidiaries has created, incurred, assumed or guaranteed any Indebtedness for borrowed
money.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Current D&amp;O Insurance</U>&rdquo; has
the meaning set forth in <U>Section&nbsp;7.08(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Cybersecurity Incident</U>&rdquo; means
unauthorized access to or use or corruption of the IT Systems (including a ransomware or denial-of-service attack), or the unauthorized
access, disclosure, use, corruption or loss of Personal Information or other non-public information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Debt Financing</U>&rdquo; means any debt
financing obtained by Parent or any of its Subsidiaries in connection with the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Debt Financing Sources</U>&rdquo; means
the Persons that provide or arrange all or any part of any Debt Financing in connection with the Transactions, including the parties
to any commitment letters, engagement letters, credit agreements, indentures or similar debt agreements entered into relating to such
Debt Financing. Notwithstanding the foregoing, in no event shall Parent or any of its Affiliates constitute &ldquo;Debt Financing Sources&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Depositary Shares</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;3.01(f)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Disclaiming Person Information</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;7.04(c)</U>&nbsp;of the Parent Disclosure Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Dissenting Shares</U>&rdquo; means Common
Stock held by a holder of Common Stock, who, as of the Effective Time, (a)&nbsp;neither voted in favor of the Merger nor consented thereto
in writing, and (b)&nbsp;demanded properly in writing appraisal for such shares in accordance with Sections 490.1301 through 490.1303
and Sections 490.1320 through 490.1326 of the IBCA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>DTC</U>&rdquo; means The Depositary Trust
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Effective Time</U>&rdquo; means the date
and time when the Merger becomes effective, as set forth in the Articles of Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>ERISA</U>&rdquo; means the Employee Retirement
Income Security Act of 1974.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>ERISA Affiliate</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;4.10(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>ESOP Loan</U>&rdquo; means loans outstanding
under the Company ESOP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>ESOP Termination Date</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;7.10(j)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Exchange Act</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;4.04</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Exchange Agent</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;3.02(a)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Exchange Fund</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;3.02(a)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Exchange Ratio</U>&rdquo; means: if the
BAM Class&nbsp;A Stock Price is (i)&nbsp;greater than $35.51, the quotient (rounded to five decimal places) obtained by dividing (x)&nbsp;$17.65
by (y)&nbsp;the BAM Class&nbsp;A Stock Price; (ii)&nbsp;less than or equal to $35.51, but greater than or equal to $30.48, 0.49707; or
(iii)&nbsp;less than $30.48, the quotient (rounded to five decimal places) obtained by dividing (x)&nbsp;$15.15 by (y)&nbsp;the BAM Class&nbsp;A
Stock Price, subject to reduction pursuant to <U>Section&nbsp;3.01(e)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Exchanged RSU</U>&rdquo; has the meaning
set forth in Section&nbsp;3.03(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>FASB</U>&rdquo; means the Financial Accounting
Standards Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Filed SEC Documents</U>&rdquo; has the
meaning set forth in <U>Article&nbsp;IV</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Filing Person Information</U>&rdquo; has
the meaning set forth in <U>Section&nbsp;7.05(c)</U>&nbsp;of the Parent Disclosure Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>FINRA</U>&rdquo; has the meaning set forth
in <U>Section&nbsp;4.04</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Form&nbsp;F-4</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;5.03</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Fraud</U>&rdquo; means an actual fraud
involving a knowing and intentional misrepresentation by a party that resulted in a representation or warranty set forth in <U>Article&nbsp;IV</U>,
<U>Article&nbsp;V</U> or <U>Article&nbsp;VI</U> being materially breached (made with the Knowledge that a representation or warranty
set forth in <U>Article&nbsp;IV, Article&nbsp;V</U> or <U>Article&nbsp;VI</U> was actually breached when made), and made with the express
intent of inducing the other party to enter into this Agreement and upon which such other party has relied to its detriment; <U>provided</U>,
<U>however</U>, &ldquo;Fraud&rdquo; shall not include any fraud claim based on constructive knowledge, negligent misrepresentation or
a similar theory.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>GAAP</U>&rdquo; means generally accepted
accounting principles in the United States, consistently applied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Governmental Authority</U>&rdquo; means
any government, legislature, political subdivision, court, board, regulatory or administrative agency, self-regulatory organization or
agency, commission or authority or other legislative, executive or judicial governmental entity, whether federal, national, provincial,
state, local, foreign or multinational, in each case of competent jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Guaranty</U>&rdquo; has the meaning set
forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>HSR Act</U>&rdquo; means the Hart-Scott-Rodino
Antitrust Improvements Act of 1976.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>IBCA</U>&rdquo; shall mean the Iowa Business
Corporation Act, Chapter 490 of the Iowa Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>IMA&rdquo;</U> has the meaning set forth
in <U>Section&nbsp;4.18(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Indebtedness</U>&rdquo; means, with respect
to any Person at the time of determination, without duplication and regardless of the maturity or when due or payable, (a)&nbsp;any indebtedness
for borrowed money, including loans or advances or the issuance and sale of debt securities, (b)&nbsp;any capitalized lease obligations
or sale leaseback obligations as determined in accordance with GAAP, (c)&nbsp;any indebtedness under any credit agreement or facility
or obligations evidenced by bonds, debentures, notes or other similar instruments, (d)&nbsp;any obligations to pay the deferred purchase
price of property or services, except trade accounts payable and other current liabilities arising in the ordinary course of business
consistent with past practice, (e)&nbsp;net cash payment obligations that will be payable upon termination of (assuming termination on
the date of determination) any agreement in respect of any cap, swap, collar, future, derivative or similar transactions, or any option
or similar agreement involving, or settled by reference to, any rate, currency, commodity, price of any equity or debt security or instrument,
or economic, financial or pricing index or measure of economic, financial or pricing risk or value, or any similar transaction or combination
of the foregoing transactions, (f)&nbsp;any obligations in respect of letters of credit or similar instruments issued or accepted by
banks or financial institutions for the account of any Person (including surety bonds and off-balance sheet financing arrangements),
to the extent drawn, (g)&nbsp;all interest, indemnities, premiums, penalties, breakage costs (including on interest rate swaps and any
other hedging obligations (including foreign currency or exchange contracts)), fees and other obligations related to any of the foregoing,
(h)&nbsp;all direct or indirect guarantees or other financial accommodations (or arrangements having the economic effect of a guarantee
or financial accommodation) in respect of any of the foregoing for the benefit of another Person and (i)&nbsp;all other obligations which
would be required to be shown as indebtedness on a balance sheet of such Person prepared in accordance with GAAP; provided that Indebtedness
shall not include any intercompany indebtedness owing between or among the Company and/or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Indemnitee</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;7.08(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Insurance Contract</U>&rdquo; means each
insurance or annuity policy and contract, together with all binders, slips, certificates, endorsements and riders thereto, issued by
any Company Insurance Subsidiary prior to the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Insurance Law</U>&rdquo; means all Laws
applicable to the business of insurance or reinsurance or the regulation of insurance or reinsurance companies, whether federal, national,
provincial, state, local, foreign or multinational, and all applicable orders, directives of, and market conduct recommendations resulting
from market conduct or other examinations by,&nbsp;Insurance Regulators.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Insurance Producer</U>&rdquo; means the
agents, general agents, sub-agents, brokers, wholesale brokers, insurance solicitors, producers or other Persons who solicit, negotiate
or sell the Insurance Contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Insurance Regulators</U>&rdquo; means
all Governmental Authorities regulating the business of insurance or reinsurance, or regulating insurance or reinsurance companies, under
Insurance Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Intellectual Property</U>&rdquo; means
all intellectual property rights in any and all jurisdictions worldwide, including all: (a)&nbsp;patents and patent applications, including
all reissues, divisions, renewals, extensions, provisionals, continuations and continuations-in-part thereof; (b)&nbsp;trademarks, service
marks, trade names, trade dress, acronyms, tag-lines, slogans, logos, URLs and Internet domain names, social media usernames and other
digital identifiers and other indicia of origin, together with all goodwill associated with the foregoing; (c)&nbsp;copyrights and rights
in copyrightable subject matter in published and unpublished works of authorship, database and design rights, and data collections; (d)&nbsp;trade
secrets, inventions and invention disclosures (whether or not patentable), discoveries, techniques, research and development, data and
databases, customer and supplier lists, and other confidential and proprietary information (collectively, &ldquo;<U>Trade Secrets</U>&rdquo;);
(e)&nbsp;all registrations and applications to register or renew the registration of any of the foregoing; and (f)&nbsp;all intellectual
property rights in Software and other technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Intervening Event</U>&rdquo; means a material
effect, change, event, circumstance or development that (a)&nbsp;was not known to, or reasonably foreseeable by, the Company Board on
the date of this Agreement, which effect, change, event, circumstance or development becomes known to the Company Board prior to the
receipt of the Required Shareholder Approval, or if known, the consequences of which were not known to, or reasonably foreseeable by,
the Company Board on or prior to the date of this Agreement, and (b)&nbsp;does not relate to (i)&nbsp;a Takeover Proposal or (ii)&nbsp;any
(x)&nbsp;changes in the market price or trading volume of the Company or (y)&nbsp;the Company&rsquo;s meeting, failing to meet or exceeding
published or unpublished revenue or earnings projections, in each case in and of itself (it being understood that the effect, change,
event, circumstance or development giving rise or contributing to the foregoing may be deemed to constitute or be taken into account
in determining whether an Intervening Event has occurred).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Investment Assets</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;4.18(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Investment Guidelines</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;4.18(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>IRS</U>&rdquo; means the U.S. Internal
Revenue Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>IT Systems</U>&rdquo; means the hardware,
Software, data, databases, data communication lines, network and telecommunications equipment,&nbsp;Internet-related information technology
infrastructure, wide area network and other information technology and communications equipment, owned, leased or licensed by the Company
or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>JPM</U>&rdquo; has the meaning set forth
in <U>Section&nbsp;4.24</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Knowledge</U>&rdquo; means, (a)&nbsp;with
respect to the Company, the actual knowledge of the individuals listed on <U>Section&nbsp;1.01</U> of the Company Disclosure Letter,
(b)&nbsp;with respect to Parent or Merger Sub, the actual knowledge of the individuals listed on <U>Section&nbsp;1.01</U> of the Parent
Disclosure Letter and (c)&nbsp;with respect to BAM, the actual knowledge of the individuals listed on <U>Section&nbsp;1.01</U> of the
BAM Disclosure Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Laws</U>&rdquo; has the meaning set forth
in <U>Section&nbsp;4.08(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Leased Real Property</U>&rdquo; means
all material real property leased or subleased by the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Liens</U>&rdquo; means any pledges, liens,
charges, mortgages, encumbrances, leases, licenses, hypothecations or security interests of any kind or nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Malware</U>&rdquo; means any virus, Trojan
horse, time bomb, key-lock, spyware, worm, malicious code or other software designed or able to, without the knowledge or authorization
of the Company or its Subsidiaries, disrupt, disable, or harm the operation of any IT Systems.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Material Contract</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;4.15(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Merger</U>&rdquo; has the meaning set
forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Merger Consideration</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;3.01(d)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Merger Sub</U>&rdquo; has the meaning
set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Merger Sub Board</U>&rdquo; has the meaning
set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Merger Sub Shareholder Approval</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;7.12</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Merger Sub Stock</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;3.01</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>NAIC</U>&rdquo; has the meaning set forth
in <U>Section&nbsp;7.01(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>NYSE</U>&rdquo; means the New York Stock
Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>OFAC</U>&rdquo; means the U.S. Treasury
Department&rsquo;s Office of Foreign Assets Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Open Source Software</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;4.12(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Originally Scheduled Date</U>&rdquo; means
the date of the Company Shareholders Meeting set forth in the definitive Proxy Statement/Prospectus mailed by the Company to its shareholders
for the Company Shareholders Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Outside Date</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;9.01(b)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Owned Real Property</U>&rdquo; means all
real property owned in fee simple by the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Parent</U>&rdquo; has the meaning set
forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Parent Affiliated Shareholders</U>&rdquo;
has the meaning set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Parent Board</U>&rdquo; has the meaning
set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Parent Disclosure Letter</U>&rdquo; has
the meaning set forth in <U>Article&nbsp;V</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Parent Entities</U>&rdquo; has the meaning
set forth in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Parent Group Shareholders</U>&rdquo; has
the meaning set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Parent Insurance Approvals</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;5.03</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Parent Material Adverse Effect</U>&rdquo;
means any effect, change, event, circumstance or development that, individually or in the aggregate with all other effects, changes,
events, circumstances or developments, has or would reasonably be expected to have a material adverse effect on the business, assets,
results of operations or condition (financial or otherwise) of Parent and its Subsidiaries taken as a whole; <U>provided</U>, <U>however</U>,
that in no event shall any of the following, or any effect, change, event, circumstance or development arising out of, or resulting from,
the following, constitute or be taken into account, individually or in the aggregate, in determining whether a Parent Material Adverse
Effect has occurred or may occur (except to the extent contemplated by the proviso at the end of this definition): (a)&nbsp;effects,
changes or events generally affecting the insurance, reinsurance or risk management industries in the geographic regions or product markets
in which Parent and its Subsidiaries operate or underwrite insurance or reinsurance or manage risk (including changes to interest rates,
general market prices and regulatory changes affecting such industries), (b)&nbsp;general economic or regulatory, legislative or political
conditions or securities, credit, financial or other capital markets conditions in any jurisdiction (including with respect to interest
rates, exchange rates for currencies, monetary policy or inflation and any changes in the Investment Assets resulting therefrom), (c)&nbsp;any
failure, in and of itself, by Parent to meet any internal or published projections, forecasts, guidance, estimates, milestones, budgets
or predictions in respect of internal or published revenues, earnings, premiums written, expenses, cash flow, cash position or other
financial or operating metrics for any period (it being understood that the effect, change, event, circumstance or development giving
rise or contributing to such failure that are not otherwise excluded pursuant to another clause of this definition may be deemed to constitute
or be taken into account in determining whether there has been or would reasonably be expected to be a Parent Material Adverse Effect),
(d)&nbsp;geopolitical conditions, the outbreak or escalation of hostilities, any acts of war (whether or not declared) (including civil
war and including with respect to the Russian Federation and Ukraine or any matter arising therefrom), sabotage, terrorism (including
cyber-terrorism), man-made disaster, epidemics, pandemics or disease outbreaks (including COVID-19 or any COVID Measures) or any escalation
or worsening of any of the foregoing, (e)&nbsp;any volcano, tsunami, hurricane, tornado, windstorm, flood, earthquake, wildfire or other
natural disaster or any conditions resulting from such natural disasters, (f)&nbsp;the negotiation, execution and delivery of this Agreement,
the announcement, pendency or performance of the Transactions, or the identity of, or facts relating to, Company or any of its Affiliates,
(g)&nbsp;any change or announcement of a potential change, in and of itself, in Parent&rsquo;s or any of its Subsidiaries&rsquo; credit,
financial strength or claims paying ratings or the ratings of any of Parent&rsquo;s or its Subsidiaries&rsquo; businesses (it being understood
that the effect, change, event, circumstance or development giving rise or contributing to such ratings that are not otherwise excluded
pursuant to another clause of this definition may be deemed to constitute or be taken into account in determining whether there has been
or would reasonably be expected to be a Parent Material Adverse Effect), (h)&nbsp;the suspension of trading in securities of Parent on
the NYSE or any change, in and of itself, in the market price, ratings or trading volume of Parent&rsquo;s or any of its Subsidiaries&rsquo;
securities (it being understood that the effect, change, event, circumstance or development giving rise or contributing to such change
that are not otherwise excluded pursuant to another clause of this definition may be deemed to constitute or be taken into account in
determining whether there has been or would reasonably be expected to be a Parent Material Adverse Effect), (i)&nbsp;any change in applicable
Law (including COVID Measures) (or interpretation or enforcement thereof), GAAP (or interpretation or enforcement thereof) or in Applicable
SAP (or, other than with respect to any permitted practices, interpretation or enforcement thereof), including but not limited to legal
or regulatory requirements and accounting and financial reporting pronouncements by the SEC, the National Association of Insurance Commissioners,
any Insurance Regulator and the FASB or rating agency methodology or (j)&nbsp;any action taken or not taken by Parent or any of its Subsidiaries
as expressly required by the terms of this Agreement (but, in the event of any such failure to take an action, only if Company has refused
to provide a waiver to the applicable prohibition in this Agreement); <U>provided further</U>, <U>however</U>, that any effect, change,
event, circumstance or development referred to in clause (a), (b), (d)&nbsp;or (e)&nbsp;(other than with respect to interest rates) may
be taken into account in determining whether or not there has been a Parent Material Adverse Effect to the extent such effect, change,
event, circumstance or development has a disproportionate adverse effect on Parent and its Subsidiaries, taken as a whole, relative to
other participants engaged primarily in the insurance or reinsurance or risk management industries in the geographic regions or product
markets in which Parent and its Subsidiaries operate or underwrite insurance or reinsurance or manage risk (in which case only the incremental
disproportionate effect or effects may be taken into account in determining whether or not a Parent Material Adverse Effect has occurred).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Parent SEC Documents</U>&rdquo; has the
meaning set forth in <U>Article&nbsp;V</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>party</U>&rdquo; has the meaning set forth
in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Patriot Act</U>&rdquo; means the USA PATRIOT
Act (Title III of Pub. L. 107-56 (signed into law October&nbsp;26, 2001)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Payoff Amount</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;7.18.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Payoff Indebtedness</U>&rdquo; means any
Indebtedness of the Company that is required to be paid at the Closing as a result of the consummation of the Closing pursuant to the
Credit Agreement or any other Credit Document evidencing such Indebtedness, other than to the extent a waiver or amendment is obtained
with respect thereto as contemplated by <U>Section&nbsp;7.17</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Payoff Letter</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;7.18</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Performance-Vesting Company Option</U>&rdquo;
means each Company Option subject to performance-based vesting conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Permits</U>&rdquo; has the meaning set
forth in <U>Section&nbsp;4.08(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Permitted Liens</U>&rdquo; means (a)&nbsp;statutory
Liens for Taxes, assessments or other charges by Governmental Authorities not yet due and payable or the amount or validity of which
is being contested in good faith and by appropriate proceedings and for which adequate reserves are being maintained in accordance with
GAAP and Applicable SAP, (b)&nbsp;mechanics&rsquo;, materialmen&rsquo;s, carriers&rsquo;, workmen&rsquo;s, warehousemen&rsquo;s, repairmen&rsquo;s,
landlords&rsquo; and similar Liens granted or which arise in the ordinary course of business or the amount or validity of which is being
contested in good faith and by appropriate proceedings and for which adequate reserves are being maintained in accordance with GAAP and
Applicable SAP, (c)&nbsp;Liens securing payment, or any obligation, of the Company or its Subsidiaries with respect to outstanding Indebtedness,
(d)&nbsp;Liens granted in the ordinary course of business in connection with the insurance or reinsurance business of the Company or
its Subsidiaries on cash and cash equivalent instruments or other investments, including Liens granted (i)&nbsp;in connection with (A)&nbsp;pledges
of such instruments or investments to collateralize letters of credit delivered by the Company or its Subsidiaries, (B)&nbsp;the creation
of trust funds for the benefit of ceding companies, (C)&nbsp;underwriting activities of the Company or its Subsidiaries, (D)&nbsp;deposit
liabilities, (E)&nbsp;statutory deposits, (F)&nbsp;ordinary-course securities lending, repurchase, reverse repurchase, short-sale, derivatives,
swap or hedging transactions, (G)&nbsp;any collateral pledged in connection with reinsurance transactions, and (H)&nbsp;any collateral
pledged to a Federal Home Loan Bank, and (ii)&nbsp;with respect to investment securities held in the name of a nominee, custodian, depository,
clearinghouse or other record owner, (e)&nbsp;pledges or deposits by the Company or any of its Subsidiaries under workmen&rsquo;s compensation
Laws, unemployment Insurance Laws or similar legislation, or good-faith deposits in connection with bids, tenders, Contracts (other than
for the payment of Indebtedness) or leases to which such entity is a party, or deposits to secure public or statutory obligations of
such entity or to secure surety or appeal bonds to which such entity is a party, or deposits as security for contested Taxes, in each
case incurred or made in the ordinary course of business, (f)&nbsp;zoning, building codes, entitlement and other land use and environmental
regulations by any Governmental Authority provided the same are not presently materially violated and do not, individually or in the
aggregate, impair the continued use of the property or asset affected by such restrictions or exclusions that would be shown by a current
title report or other similar report and any condition or other matter, if any, that may be shown or disclosed by a current and accurate
survey or physical inspection, (g)&nbsp; licenses and other rights or immunities with respect to Intellectual Property, (h)&nbsp;Liens
created by or through the actions of Parent or any of its Affiliates, (i)&nbsp;such other Liens or imperfections that are not material
in amount or do not materially detract from the value of or materially impair the continued use of the property or asset affected by
such Lien or imperfection, (j)&nbsp;Liens arising under or relating to applicable securities laws, (k)&nbsp;Liens that will be terminated
at or prior to the Closing in accordance with this Agreement, (l)&nbsp;Liens permitted to be incurred under the Credit Agreement as in
effect on the date hereof, (m)&nbsp;Liens arising in the ordinary course of business and not incurred in connection with the borrowing
of money and (n)&nbsp;title of a lessor, sub-lessor, licensor or sub-licensor or secured by a lessor&rsquo;s, sub-lessor&rsquo;s, licensor&rsquo;s
or sublicensor&rsquo;s interest under a capital or operating lease, sublease, license or sublicense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Person</U>&rdquo; means an individual,
corporation, limited liability company, partnership, joint venture, association, trust, unincorporated organization or any other entity,
including a Governmental Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Personal Information</U>&rdquo; means
any information in possession or control of any of the Company or its Subsidiaries that enables a Person in possession thereof to identify
a natural person or that is otherwise considered personally identifiable information or personal data under applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Preferred Stock</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;4.02(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Privacy Obligations</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;4.12(g)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Proxy Statement/Prospectus</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;4.04</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Reinsurance Agreement</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;4.17(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Representatives</U>&rdquo; means, with
respect to any Person, (a)&nbsp;its officers, directors and employees and (b)&nbsp;its agents, financial advisors, investment bankers,
consultants, attorneys, accountants and other advisors acting on such Person&rsquo;s behalf in connection with the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Required Regulatory Approvals</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;8.01(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Required Shareholder Approval</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;4.03(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Reserves</U>&rdquo; means the reserves
of any Company Insurance Subsidiary for losses, claims, unearned premiums, policy benefits and expenses, including unearned premium reserves,
reserves for incurred losses, technical reserves, incurred loss adjustment expenses, incurred but not reported losses and loss adjustment
expenses, in respect of insurance policies issued, reinsured or assumed by such Company Insurance Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Restraints</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;8.01(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Rollover Company RSU</U>&rdquo; means
each Company RSU that is granted following the date hereof and prior to the Closing Date in accordance with the terms set forth in <U>Section&nbsp;7.01(a)(vi)</U>&nbsp;of
the Company Disclosure Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Rule&nbsp;1017 Application</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;4.04</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Sanctioned Person</U>&rdquo; means any
Person or Governmental Authority that is the subject or target of sanctions or trade/export restrictions under U.S., EU, UK or other
applicable sanctions or export controls Laws, including: (a)&nbsp;any Person listed on any list of designated Persons maintained by OFAC;
the U.S. Department of Commerce&rsquo;s Entity List, Denied Persons List, or Unverified List; any debarment or sanctions list maintained
by the U.S. Department of State; or any other list maintained by U.S. or a non-U.S. Governmental Authority under sanctions or export
control Laws; (b)&nbsp;where relevant under applicable sanctions Laws or export control Laws, any Person that is, in the aggregate, 50%
or greater owned, directly or indirectly, or controlled by any such Person or Persons described in clause (a)&nbsp;or acting for or on
behalf of such Person or Persons described in clause (a); (c)&nbsp;any person located, organized or resident in a country or territory
which is itself the subject or target of any comprehensive U.S. sanctions (that is, at the time of this Agreement, the Crimea region
of Ukraine, the so-called &ldquo;Donetsk People&rsquo;s Republic&rdquo; or &ldquo;Luhansk People&rsquo;s Republic&rdquo; regions of Ukraine,
the non-government controlled areas of Ukraine in the oblasts of Kherson and Zaporizhzhia, Cuba,&nbsp;Iran, North Korea and Syria); or
(d)&nbsp;the Government of Venezuela, or any other Person subject to asset-blocking sanctions under applicable sanctions Laws; <U>provided
</U>that the representations and warranties contained in <U>Sections 5.10</U> and <U>6.11</U> hereof shall not be made by any party in
so far as such representation or warranty would result in a violation of, or conflict with, the Foreign Extraterritorial Measures (United
States) Order, 1992.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Sarbanes-Oxley Act</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;4.05(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>SEC</U>&rdquo; has the meaning set forth
in <U>Section&nbsp;4.04</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Securities Act</U>&rdquo; means the Securities
Act of 1933 and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Senior Notes</U>&rdquo; means the 5.000%
Senior Notes due 2027 issued by the Company pursuant to the Senior Notes Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Senior Notes Indenture</U>&rdquo; means
the Senior Amended and Restated Indenture, dated as of April&nbsp;22, 2004, between the Company and U.S. Bank National Association, as
trustee, as supplemented by the Third Supplemental Indenture, dated as of June&nbsp;16, 2017, between the Company and U.S. Bank National
Association, as trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Series&nbsp;A Deposit Agreement</U>&rdquo;
means the Deposit Agreement, dated November&nbsp;21, 2019, among the Company, Computershare Inc. and Computershare Trust Company, N.A.,
collectively, as depositary (the &ldquo;<U>Depositary</U>&rdquo;), Computershare Inc., as registrar and transfer agent, and the holders
from time to time of the depositary receipts described therein relating to the Series&nbsp;A Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Series&nbsp;A Depositary Share</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;3.01(f)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Series&nbsp;A Preferred Stock</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;4.02(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Series&nbsp;B Deposit Agreement</U>&rdquo;
means the Deposit Agreement, dated June&nbsp;17, 2020, among the Company, the Depositary, Computershare Trust Company, N.A., as registrar
and transfer agent, and the holders from time to time of the depositary receipts described therein relating to the Series&nbsp;B Preferred
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Series&nbsp;B Depositary Share</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;3.01(f)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Series&nbsp;B Preferred Stock</U>&rdquo;
has the meaning set forth in <U>Section&nbsp;4.02(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Software</U>&rdquo; means any (a)&nbsp;computer
programs, including all software implementations of algorithms, models and methodologies, whether in source code or object code, (b)&nbsp;databases,
(c)&nbsp;descriptions, flow-charts and other work product used to design, plan, organize and develop any of the foregoing, screens, user
interfaces, report formats, firmware, development tools, templates, menus, buttons and icons, in each case, in any and all forms of media,
and (d)&nbsp;documentation, including user manuals and other training documentation, related to any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Specified Business Conduct Laws</U>&rdquo;
means: (a)&nbsp;the Anti-Bribery Legislation; (b)&nbsp;all legal requirements imposing trade sanctions on any Person, including all legal
requirements administered by OFAC, all sanctions laws or embargos imposed or administered by the U.S. Department of State, the United
Nations Security Council, His Majesty&rsquo;s Treasury or the European Union and all anti-boycott or anti-embargo laws; (c)&nbsp;all
legal requirements relating to the import, export, re-export, transfer of information, data, goods and technology, including the Export
Administration Regulations administered by the U.S. Department of Commerce, the International Traffic in Arms Regulations administered
by the U.S. Department of State and customs Laws and regulations administered by U.S. Customs and Border Protection; and (d)&nbsp;the
Money Laundering Control Act of 1986, the Currency and Foreign Transactions Reporting Act of 1970, The Uniting and Strengthening America
by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001, and other applicable legal requirements relating
to money laundering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Statutory Statements</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;4.23</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Stock Consideration</U>&rdquo; has the
meaning set forth in <U>Section&nbsp;3.01(d)(i)(B)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Subsidiary</U>&rdquo; when used with respect
to any party, means any corporation, limited liability company, partnership, association, trust or other entity of which securities or
other ownership interests representing more than 50% of the equity or more than 50% of the ordinary voting power (or, in the case of
a partnership, more than 50% of the general partnership interests) are, as of such date, owned by such party or one or more Subsidiaries
of such party or by such party and one or more Subsidiaries of such party. For purposes of this Agreement, (a)&nbsp;BAM ULC shall be
deemed a Subsidiary of BAM and (b)&nbsp;any joint ventures or any Investment Assets that are not wholly-owned and not controlled (as
defined in the definition of &ldquo;Affiliate&rdquo;) by the Company or any of its Subsidiaries shall be deemed not to be Subsidiaries
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Superior Proposal</U>&rdquo; means any
bona fide written Takeover Proposal that did not result from a breach of <U>Section&nbsp;7.03</U> and that the Company Board has determined
in its good-faith judgment, after consultation with its financial advisors and outside legal counsel, and taking into account all relevant
(in the view of the Company Board) legal, regulatory, financial and other aspects of such proposal (including the conditionality, timing
and likelihood of consummation of such proposal and the payment of any termination fee, as well as community interest factors), would
be reasonably likely to be consummated on the terms proposed and would be more favorable to the shareholders of the Company than the
Merger; <U>provided</U> that for purposes of the definition of &ldquo;Superior Proposal,&rdquo; the references to &ldquo;20%&rdquo; in
the definition of Takeover Proposal shall be deemed to be references to &ldquo;50%.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Surviving Common Stock</U>&rdquo; has
the meaning set forth in <U>Section&nbsp;3.01(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Surviving Company</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;2.01</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Takeover Law</U>&rdquo; has the meaning
set forth in <U>Section&nbsp;4.13</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Takeover Proposal</U>&rdquo; means any
inquiry, proposal (whether or not in writing) or offer from any Person or group (other than Parent and its Affiliates) relating to, in
a single transaction or series of related transactions, any direct or indirect (a)&nbsp;acquisition (including any reinsurance or retrocession
transaction, or transaction that has similar risk transfer effects, and any asset management transaction) that if consummated would result
in any Person or group owning or managing 20% or more of the consolidated assets (based on the fair market value thereof, as determined
in good faith by the Company Board), reserves, revenues or net income of the Company and its Subsidiaries, (b)&nbsp;acquisition of Common
Stock representing 20% or more of the outstanding Common Stock, (c)&nbsp;tender offer or exchange offer that if consummated would result
in any Person or group having beneficial ownership of Common Stock representing 20% or more of the outstanding Common Stock, (d)&nbsp;merger,
amalgamation, consolidation, share exchange, share purchase, business combination, recapitalization, liquidation, dissolution or similar
transaction involving the Company or any of its Subsidiaries pursuant to which such Person or group (or the shareholders of any Person)
would acquire, directly or indirectly, 20% or more of the aggregate voting power of the Company or of the surviving entity in such transaction
or the resulting direct or indirect parent of the Company or such surviving entity or (e)&nbsp;any combination of the foregoing, in each
case, other than by or on behalf of Parent or any of its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Tax</U>&rdquo; means any federal, state,
local or non-U.S. income, gross receipts, property, sales, use, license, excise, franchise, employment, payroll, premium, withholding,
alternative or added minimum, ad valorem, transfer or excise tax, or any other tax, governmental fee or similar duty, fee or charge or
assessment in the nature of a tax, together with any interest or penalty or additions thereto imposed by any Governmental Authority with
respect to such amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Tax Returns</U>&rdquo; means all reports,
returns, statements, declarations or forms required or permitted to be filed with a Governmental Authority relating to Taxes, including
any amendment thereof or schedule or supplement thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Trade Secrets</U>&rdquo; has the meaning
set forth in the definition of &ldquo;Intellectual Property.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Transactions</U>&rdquo; means, collectively,
the transactions contemplated by this Agreement, including the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Trust</U>&rdquo; has the meaning as set
forth in <U>Section&nbsp;4.10(l)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Trustee</U>&rdquo; means, Principal Financial
Group Inc, an Iowa corporation, not in its corporate capacity but solely in its capacity as trustee of the Company ESOP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>TSX</U>&rdquo; has the meaning as set
forth in <U>Section&nbsp;6.08(f)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>VWAP PSUs</U>&rdquo; means the Company
PSUs granted pursuant to the employee restricted stock unit award agreement, dated November&nbsp;29, 2022, by and between the Company
and the CEO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Voting Agreement</U>&rdquo; has the meaning
set forth in the recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&ldquo;<U>Willful Breach</U>&rdquo; means, with
respect to any party, a material breach of this Agreement by such party that is a consequence of an act or omission undertaken by the
breaching party with the knowledge that the taking of or the omission of taking such act would, or would reasonably be expected to, cause
or constitute a material breach of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;1.02.</FONT><FONT STYLE="text-transform: uppercase"> &#8239;&#8239;&#8239;&#8239;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Interpretation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
used in this Agreement, references to the following terms have the meanings indicated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">to
the Preamble or to the Recitals, Sections, Articles, Exhibits or Schedules are to the Preamble or a Recital, Section&nbsp;or Article&nbsp;of,
or an Exhibit&nbsp;or Schedule to, this Agreement unless otherwise clearly indicated to the contrary;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">to
any Contract (including this Agreement) or &ldquo;organizational document&rdquo; are to the Contract or organizational document as amended,
modified, supplemented or replaced from time to time;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">to
any Law are to such Law as amended, modified, supplemented or replaced from time to time and any rules&nbsp;or regulations promulgated
thereunder and to any section of any Law include any successor to such section;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">to
any Governmental Authority include any successor to the Governmental Authority and to any Affiliate include any successor to the Affiliate;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">to
any &ldquo;copy&rdquo; of any Contract or other document or instrument are to a true and complete copy thereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">to
 &ldquo;hereof,&rdquo; &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo; &ldquo;hereby,&rdquo; &ldquo;herewith&rdquo; and words of similar
import refer to this Agreement as a whole and not to any particular Article, Section&nbsp;or clause of this Agreement, unless otherwise
clearly indicated to the contrary;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">to
the &ldquo;date of this Agreement,&rdquo; &ldquo;the date hereof&rdquo; and words of similar import refer to July&nbsp;4, 2023; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">to
 &ldquo;this Agreement&rdquo; includes the Exhibits and Schedules (including the Company Disclosure Letter, the Parent Disclosure Letter
and the BAM Disclosure Letter) to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Whenever
the words &ldquo;include,&rdquo; &ldquo;includes&rdquo; or &ldquo;including&rdquo; are used in this Agreement, they will be deemed to
be followed by the words &ldquo;without limitation.&rdquo; The word &ldquo;or&rdquo; shall not be exclusive. Any singular term in this
Agreement will be deemed to include the plural, and any plural term the singular. All pronouns and variations of pronouns will be deemed
to refer to the feminine, masculine or neuter, singular or plural, as the identity of the Person referred to may require. Where a word
or phrase is defined herein, each of its other grammatical forms shall have a corresponding meaning.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Whenever
the last day for the exercise of any right or the discharge of any duty under this Agreement falls on a day other than a business day,
the party having such right or duty shall have until the next business day to exercise such right or discharge such duty. Unless otherwise
indicated, the word &ldquo;day&rdquo; shall be interpreted as a calendar day. With respect to any determination of any period of time,
unless otherwise set forth herein, the word &ldquo;from&rdquo; means &ldquo;from and including&rdquo; and the word &ldquo;to&rdquo; means
 &ldquo;to but excluding.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
table of contents and headings contained in this Agreement are for reference purposes only and will not affect in any way the meaning
or interpretation of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">References
to &ldquo;dollars&rdquo; or &ldquo;$&rdquo; mean United States dollars, unless otherwise clearly indicated to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
document shall be determined to have been &ldquo;delivered,&rdquo; &ldquo;furnished,&rdquo; &ldquo;provided&rdquo; or &ldquo;made available&rdquo;
to a Person if such document has been uploaded to the electronic data rooms established by the Company at Intralinks entitled &ldquo;Project
Janus&rdquo; or electronically delivered to such Person or its Representatives at least by 11:59 p.m.&nbsp;New York City time on the
date immediately preceding the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Parent Entities, BAM and the Company have participated jointly in the negotiation and drafting of this Agreement; consequently, in the
event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the Parent
Entities, BAM and the Company and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship
of any provision of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
summary of this Agreement prepared by or on behalf of any party shall affect the meaning or interpretation of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
capitalized terms used without definition in the Exhibits and Schedules (including the Company Disclosure Letter, the Parent Disclosure
Letter and the BAM Disclosure Letter) to this Agreement shall have the meanings ascribed to such terms in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;II</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>THE MERGER</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.01.</FONT><FONT STYLE="text-transform: uppercase"> &#8239;&#8239;&#8239;&#8239;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Merger</U>.
Upon the terms and subject to the conditions set forth in this Agreement, and pursuant to applicable provisions of the IBCA, at the Effective
Time, Merger Sub shall be merged with and into the Company, the separate corporate existence of Merger Sub shall thereupon cease, and
the Company shall be the surviving company in the Merger (such surviving company, the &ldquo;<U>Surviving Company</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.02.</FONT><FONT STYLE="text-transform: uppercase"> &#8239;&#8239;&#8239;&#8239;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Closing;
Effective Time</U>. The closing (the &ldquo;<U>Closing</U>&rdquo;) shall take place as soon as practicable, and in any event not later
than five business days after the satisfaction or (to the extent permitted herein and by applicable Law) waiver by the party entitled
to the benefits thereof of the conditions set forth in <U>Article&nbsp;VIII</U> (other than those conditions that by their nature are
to be satisfied at the Closing, but subject to the satisfaction or (to the extent permitted herein and by applicable Law) waiver of those
conditions at such time) or at such other time as each party hereto may agree in writing; <U>provided</U> that, notwithstanding the satisfaction
or waiver of such conditions, in no event shall the Closing occur prior to January&nbsp;5, 2024, unless Parent elects to waive this proviso
in its sole discretion (which election must be made by Parent no later than December&nbsp;11, 2023) (the date on which the Closing occurs
is referred to in this Agreement as the &ldquo;<U>Closing Date</U>&rdquo;). The Closing shall take place remotely by the exchange of
electronic documents by facsimile, PDF or other electronic means. The Merger shall become effective at the Effective Time as set forth
in the Articles of Merger, which Merger Sub and the Company shall file with the Secretary of State of the State of Iowa on the Closing
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Split-Segment; Name: a2 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.03.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Effects
of Merger</U>. From and after the Effective Time, the Merger shall have the effects set forth in this Agreement and the applicable provisions
of the IBCA. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time, all of the property owned,
and every contractual right possessed, by the Company and Merger Sub shall vest in the Surviving Company, and all liabilities of the
Company and Merger Sub shall become the liabilities of the Surviving Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.04.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Articles
of Incorporation and Bylaws of the Surviving Company</U>. At the Effective Time, the articles of incorporation and bylaws of the Surviving
Company shall be amended and, with respect to the bylaws, restated in substantially the form of the articles of incorporation and bylaws
of Merger Sub as in effect immediately prior to the Effective Time, except (i)&nbsp;that the name of the Surviving Company shall remain
as American Equity Investment Life Holding Company, until thereafter changed or amended as provided therein or pursuant to applicable
Law (in each case, subject to <U>Section&nbsp;7.08</U>), and (ii)&nbsp;as required pursuant to <U>Section&nbsp;3.01(f)</U>&nbsp;with
respect to the preferred stock of the Surviving Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;2.05.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Board
of Directors and Officers of Surviving Company</U>. The directors of Merger Sub in office immediately prior to the Effective Time shall
be the directors of the Surviving Company until the earlier of their death, resignation or removal or until their respective successors
are duly elected or appointed and qualified, as the case may be, in accordance with the IBCA and the bylaws of the Surviving Company.
Except to the extent requested in writing by Parent in advance of the Effective Time, the officers of the Company in office immediately
prior to the Effective Time shall be the officers of the Surviving Company until the earlier of their death, resignation or removal or
until their respective successors are duly elected or appointed and qualified, as the case may be, in accordance with the bylaws of the
Surviving Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;III</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>EFFECT ON THE SHARE CAPITAL OF THE CONSTITUENT
ENTITIES;<BR>
PAYMENT OF CONSIDERATION</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.01.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Effect
of Merger on the Share Capital of Merger Sub and the Company</U>. At the Effective Time, by virtue of the occurrence of the Merger, and
without any action on the part of the Company, Parent, Merger Sub or any holder of any shares of Common Stock, any shares of Preferred
Stock or any shares, par value $1.00 per share, of Merger Sub (&ldquo;<U>Merger Sub Stock</U>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Share
Capital of Merger Sub.</U> Each share of Merger Sub Stock issued and outstanding immediately prior to the Effective Time shall automatically
be converted into and become one duly authorized, validly issued, fully paid and nonassessable share of common stock, par value $1.00
per share, of the Surviving Company (&ldquo;<U>Surviving Common Stock</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Parent-Owned
Common Stock</U>. Each issued and outstanding share of Common Stock that is owned by Parent, any Parent Group Shareholder, Merger Sub
or any other direct or indirect Subsidiary of Parent immediately prior to the Effective Time shall automatically become one duly authorized,
validly issued, fully paid and nonassessable share of Surviving Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Cancelation
of Treasury Stock</U>. Each share of Common Stock owned by the Company as treasury stock and each share of Common Stock issued and outstanding
immediately prior to the Effective Time and owned by the Company or any direct or indirect Subsidiary of the Company immediately prior
to the Effective Time shall automatically be canceled and shall cease to exist and be outstanding, and no consideration shall be delivered
in exchange therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Conversion
of Common Stock.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Subject
to <U>Section&nbsp;3.01(b)</U>, <U>Section&nbsp;3.01(c)</U>&nbsp;and <U>Section&nbsp;3.05</U>, each share of Common Stock issued and
outstanding immediately prior to the Effective Time, shall automatically be canceled and converted into and shall thereafter represent
the right to receive the following consideration (the &ldquo;<U>Merger Consideration</U>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">an
amount in cash equal to $38.85, without interest (the &ldquo;<U>Cash Consideration</U>&rdquo;), subject to adjustment as provided for
in <U>Section&nbsp;3.01(e)</U>; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">a
number of fully paid and nonassessable shares of BAM Class&nbsp;A Stock equal to the Exchange Ratio (the &ldquo;<U>Stock Consideration</U>&rdquo;),
subject to adjustment as provided for in <U>Section&nbsp;3.01(e)</U>, and cash in lieu of fractional shares of BAM Class&nbsp;A Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
of the Effective Time, each share of Common Stock canceled pursuant to <U>Section&nbsp;3.01(d)(i)</U>&nbsp;shall no longer be issued
and outstanding and shall automatically be canceled and shall cease to exist, and each holder of a certificate that immediately prior
to the Effective Time evidenced any such shares of Common Stock (each, a &ldquo;<U>Certificate</U>&rdquo;) or any such Common Stock in
uncertified form through a direct registry system immediately prior to the Effective Time (each, a &ldquo;<U>Book-Entry Share</U>&rdquo;)
shall cease to have any rights with respect thereto, except the right to receive the Merger Consideration, cash in lieu of fractional
shares of BAM Class&nbsp;A Stock, if any, and any unpaid dividends or other distributions pertaining to the Common Stock represented
by such Certificate or Book-Entry Share, as applicable, to be paid in consideration therefor, in accordance with <U>Section&nbsp;3.02(b)</U>&nbsp;without
interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Adjustments
to Merger Consideration.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
at any time during the period between the date of this Agreement and the Effective Time, any change in the outstanding BAM Class&nbsp;A
Stock or Common Stock shall occur by reason of any reclassification, recapitalization, split or combination (including a reverse stock
split), exchange, merger, consolidation or readjustment of shares, or any stock dividend thereon with a record date during such period,
or any similar transaction or event, the Merger Consideration, the Exchange Ratio and any other similarly dependent items, as the case
may be, shall be appropriately and equitably adjusted to provide the holders of Common Stock the same economic effect as contemplated
by this Agreement prior to such event. Nothing in this <U>Section&nbsp;3.01(e)(i)</U>&nbsp;shall be construed as permitting the Company
or BAM to take any action or enter into any transaction otherwise prohibited by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notwithstanding
anything to the contrary in this Agreement, if the BAM Class&nbsp;A Stock Price is less than $30.48, Parent and BAM shall have the right
(in their sole discretion) to elect to reduce (but not to below zero) the Exchange Ratio by delivering written notice of such election
to the Company no later than 4:00 p.m.&nbsp;New York time on the second trading day immediately preceding the Closing Date; <U>provided
</U>that, unless Parent and BAM elect to reduce the Exchange Ratio to zero, any such reduction in the Exchange Ratio shall not result
in the value of the aggregate amount of Stock Consideration (determined on the basis of the BAM Class&nbsp;A Stock Price) after giving
effect to such reduction being less than $200,000,000. If Parent and BAM make such an election, (A)&nbsp;the amount of the Cash Consideration
shall be increased by an amount equal to the product of (1)&nbsp;the positive excess of (x)&nbsp;the Exchange Ratio as determined in
accordance with the definition thereof prior to giving effect to such reduction, over (y)&nbsp;the Exchange Ratio after giving effect
to such reduction, multiplied by (2)&nbsp;the BAM Class&nbsp;A Stock Price and (B)&nbsp;if such election reduces the Exchange Ratio to
zero, (1)&nbsp;all of BAM&rsquo;s obligations pursuant to <U>Sections 3.02(a)(ii)(B)</U>&nbsp;and <U>3.02(d)</U>, Article&nbsp;VI and
Sections <U>7.02</U>, <U>7.04</U>, <U>7.14(d)</U>, <U>7.20</U> and <U>8.03(c)</U>&nbsp;shall automatically cease to have any further
force and effect and (2)&nbsp;the conditions set forth in <U>Sections 8.01(b)</U>, <U>8.01(e)</U>, <U>8.03(c)</U>&nbsp;and <U>8.03(d)</U>&nbsp;shall
be deemed waived by all of the parties hereto and of no further force or effect (provided, however, that this subclause (1)&nbsp;shall
not relieve BAM of any liability for any breach of any such provision by BAM prior to the making of such election).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Preferred
Stock.</U> At the Effective Time, by virtue of the Merger and without any action on the part of any holder thereof,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">each
share of Series&nbsp;A Preferred Stock issued and outstanding immediately prior to the Effective Time shall be unaffected by the Merger
and remain outstanding as one share of Series&nbsp;A Preferred Stock of the Surviving Company entitled to the same dividends and all
other preferences and privileges, voting rights, relative, participating, optional and other special rights, and subject to the same
qualifications, limitations and restrictions, set forth in the certificate of designations applicable thereto as of immediately prior
to the Effective Time, and (B)&nbsp;each depositary share issued pursuant to the Series&nbsp;A Deposit Agreement, representing one-thousandth
of one share of Series&nbsp;A Preferred Stock (&ldquo;<U>Series&nbsp;A Depositary Share</U>&rdquo;) issued and outstanding immediately
prior to the Effective Time shall be unaffected by the Merger and remain outstanding and represent one-thousandth of one share of Series&nbsp;A
Preferred Stock of the Surviving Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">each
share of Series&nbsp;B Preferred Stock issued and outstanding immediately prior to the Effective Time shall be unaffected by the Merger
and remain outstanding as one share of Series&nbsp;B Preferred Stock of the Surviving Company entitled to the same dividends and all
other preferences and privileges, voting rights, relative, participating, optional and other special rights, and subject to the same
qualifications, limitations and restrictions, set forth in the certificate of designations applicable thereto as of immediately prior
to the Effective Time, and (B)&nbsp;each depositary share issued pursuant to the Series&nbsp;B Deposit Agreement, representing one-thousandth
of one share of Series&nbsp;B Preferred Stock (&ldquo;<U>Series&nbsp;B Depositary Share</U>&rdquo;, together with the Series&nbsp;A Depositary
Shares, the &ldquo;<U>Depositary Shares</U>&rdquo;) issued and outstanding immediately prior to the Effective Time shall be unaffected
by the Merger and remain outstanding and represent one-thousandth of one share of Series&nbsp;B Preferred Stock of the Surviving Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Preferred
Stock Dividends Declared Prior to Closing.</U> Parent acknowledges and agrees on its behalf and on behalf of the Surviving Company that
if, prior to the Closing Date, any dividend for which a record date prior to the Closing Date and a payment date following the Closing
Date has been declared to holders of Preferred Stock, that such dividend shall be paid by or on behalf of the Surviving Company to holders
of record as of such record date on the applicable payment date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Surviving
Company Stock</U>. At the Effective Time, if any Stock Consideration is included in the Merger Consideration, the Surviving Company will
issue shares of Surviving Common Stock to Parent in consideration for Parent depositing or causing to be deposited such Stock Consideration
pursuant to <U>Section&nbsp;3.02(a)(ii)</U>. The number of shares of Surviving Common Stock issued to Parent pursuant to this <U>Section&nbsp;3.01(h)</U>&nbsp;will
have a fair market value equal to the fair market value of such Stock Consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.02.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Exchange
Fund</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Exchange
Agent</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Not
less than 30&nbsp;days prior to the anticipated Closing Date, Parent shall designate a bank or trust company reasonably acceptable to
the Company to act as agent (the &ldquo;<U>Exchange Agent</U>&rdquo;) for the purpose of exchanging shares of Common Stock for the Merger
Consideration in accordance with this <U>Article&nbsp;III</U> and, in connection therewith, shall enter into an agreement with the Exchange
Agent prior to the Closing Date in a form reasonably acceptable to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Prior
to the Effective Time, (A)&nbsp;Parent shall deposit or cause to be deposited with the Exchange Agent an amount in cash in U.S. dollars
that is sufficient to pay the aggregate Cash Consideration, and any cash payable in lieu of fractional shares of BAM Class&nbsp;A Stock
pursuant to <U>Section&nbsp;3.02(e)</U>; and (B)&nbsp;BAM and Parent shall deposit or cause to be deposited with the Exchange Agent evidence
of BAM Class&nbsp;A Stock in book-entry form in the name of the Exchange Agent (or its designee) representing an aggregate number of
shares of BAM Class&nbsp;A Stock sufficient to deliver the aggregate Stock Consideration (such cash and shares of BAM Class&nbsp;A Stock
being hereinafter referred to as the &ldquo;<U>Exchange Fund</U>&rdquo;). Parent agrees to deposit, or cause to be deposited, with the
Exchange Agent from time to time, as needed, cash in U.S. dollars sufficient to pay any dividends and other distributions pursuant to
<U>Section&nbsp;3.02(h)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Exchange Fund shall be held in trust by the Exchange Agent for the benefit of the holders of Common Stock that are entitled to receive
the Merger Consideration. Pending its disbursement in accordance with this <U>Section&nbsp;3.02</U>, the cash portion of the Exchange
Fund shall be invested by the Exchange Agent as directed by Parent in (i)&nbsp;short-term direct obligations of the United States of
America, (ii)&nbsp;short-term obligations for which the full faith and credit of the United States of America is pledged to provide for
the payment of principal and interest, (iii)&nbsp;short-term commercial paper rated the highest quality by either Moody&rsquo;s Investors
Service,&nbsp;Inc. or Standard and Poor&rsquo;s Ratings Services or (iv)&nbsp;certificates of deposit, bank repurchase agreements or
banker&rsquo;s acceptances of commercial banks with capital exceeding $10,000,000,000 (based on the most recent financial statements
of such bank that are then publicly available). Parent shall or shall cause the Surviving Company to promptly replace or restore the
cash in the Exchange Fund so as to ensure that the Exchange Fund is at all times maintained at a level sufficient for the Exchange Agent
to promptly make all payments to former holders of Common Stock of the Merger Consideration. No investment losses resulting from investment
of the funds deposited with the Exchange Agent shall diminish the rights of any former holder of Common Stock to receive the Merger Consideration.
The Exchange Fund shall not be used for any purpose other than the payment to holders of Common Stock of the Merger Consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Letter
of Transmittal; Exchange of Common Stock.</U> As soon as practicable after the Effective Time (but in no event later than three&nbsp;business
days after the Effective Time), the Surviving Company or Parent shall cause the Exchange Agent to mail to each holder of record of a
Certificate that immediately prior to the Effective Time evidenced any Common Stock to be canceled pursuant to <U>Section&nbsp;3.01(d)(i)</U>&nbsp;(&ldquo;<U>Company
Stock Certificates</U>&rdquo;) a form of letter of transmittal (which (i)&nbsp;shall specify that delivery of a Company Stock Certificate
shall be effected, and risk of loss and title to such Company Stock Certificate shall pass, only upon delivery of such Company Stock
Certificate to the Exchange Agent and (ii)&nbsp;shall be in such form and have such other customary provisions as the Surviving Company
may specify, subject to the Company&rsquo;s reasonable approval (to be obtained prior to the Effective Time)), together with instructions
thereto, setting forth, <I>inter alia</I>, the procedures by which holders of Company Stock Certificates may receive the Merger Consideration
pursuant to this <U>Article&nbsp;III</U>. Upon the completion of such applicable procedures by a holder and the surrender of such holder&rsquo;s
Company Stock Certificates (or affidavit of loss in lieu thereof in accordance with <U>Section&nbsp;3.02(c)</U>) for cancellation to
the Exchange Agent, and without any action by any holder of record of Book-Entry Shares that immediately prior to the Effective Time
represented any Common Stock (&ldquo;<U>Company Book-Entry Shares</U>&rdquo;), the Exchange Agent shall deliver to such holder (other
than any holder of Common Stock representing Dissenting Shares), (A)&nbsp;in the case of Company Book-Entry Shares, a notice of the effectiveness
of the Merger, (B)&nbsp;the number of shares of BAM Class&nbsp;A Stock representing, in the aggregate, the whole number of shares of
BAM Class&nbsp;A Stock, if any, that such holder has the right to receive as Stock Consideration and (C)&nbsp;an amount of cash that
such holder has the right to receive as Cash Consideration and cash in lieu of fractional shares of BAM Class&nbsp;A Stock, if any, in
each case, with respect to the shares of Common Stock represented by such Company Stock Certificate or Company Book-Entry Shares immediately
prior to the Effective Time, and such Company Stock Certificates or Company Book-Entry Shares shall forthwith be canceled. If payment
of the Merger Consideration is to be made to a Person other than the Person in whose name a Company Stock Certificate surrendered is
registered, it shall be a condition of payment that (x)&nbsp;the Company Stock Certificate so surrendered shall be properly endorsed
or shall otherwise be in proper form for transfer and (y)&nbsp;the Person requesting such payment shall have established to the reasonable
satisfaction of the Surviving Company that any transfer and other Taxes required by reason of the payment of the Merger Consideration
to a Person other than the registered holder either has been paid or is not applicable. Notwithstanding the foregoing, with respect to
any shares of Common Stock held through DTC, Parent and the Company shall cooperate to establish procedures with the Exchange Agent and
DTC to ensure that the Exchange Agent will transmit to DTC or its nominees as soon as reasonably practicable on or after the Closing
Date, upon surrender of Common Stock held of record by DTC or its nominees in accordance with DTC&rsquo;s customary surrender procedures,
the Merger Consideration, and cash in lieu of fractional shares of BAM Class&nbsp;A Stock, if any, in each case, that such holder has
the right to receive pursuant to this <U>Article&nbsp;III</U>. Until satisfaction of the applicable procedures contemplated by this <U>Section&nbsp;3.02
</U>and subject to <U>Section&nbsp;3.05</U>, each Company Stock Certificate or Company Book-Entry Share shall be deemed at any time after
the Effective Time to represent only the right to receive the Merger Consideration formerly represented by such Company Stock Certificate
or Company Book-Entry Share as contemplated by this <U>Article&nbsp;III</U>. No interest shall be paid or shall accrue on the cash payable
with respect to any Common Stock pursuant to this <U>Article&nbsp;III</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Lost,
Stolen or Destroyed Company Stock Certificates.</U> If any Company Stock Certificate shall have been lost, stolen or destroyed, upon
the making of an affidavit of that fact by the Person claiming such Company Stock Certificate to be lost, stolen or destroyed and, if
required by the Surviving Company, the posting by such Person of a bond, in such reasonable amount as Parent may direct, as indemnity
against any claim that may be made against it with respect to such Company Stock Certificate, the Surviving Company shall cause the Exchange
Agent to pay, in exchange for such lost, stolen or destroyed Company Stock Certificate, the applicable Merger Consideration as contemplated
by this <U>Article&nbsp;III</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Termination
of Exchange Fund.</U> At any time following the first anniversary of the Closing Date, the Surviving Company shall be entitled to require
the Exchange Agent to deliver to it any portion of the Exchange Fund (including any interest received with respect to the Exchange Fund
and any shares of BAM Class&nbsp;A Stock) that had been delivered to the Exchange Agent and which has not been disbursed to former holders
of Common Stock, and thereafter such former holders shall be entitled to look only to Parent, BAM and the Surviving Company for, and
Parent, BAM and the Surviving Company shall remain liable for, payment of their claims of the Merger Consideration that such former holders
have the right to receive pursuant to the provisions of this <U>Article&nbsp;III</U>. Any amounts remaining unclaimed by such holders
at such time at which such amounts would otherwise escheat to or become property of any Governmental Authority shall become, to the extent
permitted by applicable Law, the property of Parent or its designee, free and clear of all claims or interest of any Person previously
entitled thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Fractional Shares</U>. No certificates, receipts or scrip representing fractional interests in BAM Class&nbsp;A Stock will be issued
upon the surrender or transfer for exchange of Company Stock Certificates or Company Book-Entry Shares, no dividend or distribution of
BAM will relate to such fractional BAM Class&nbsp;A Stock interests, and such fractional BAM Class&nbsp;A Stock interests will not entitle
the owner thereof to vote or to any rights of a holder of BAM Class&nbsp;A Stock. Parent shall pay to the Exchange Agent an amount in
cash to be deposited promptly following the Effective Time, sufficient for the Exchange Agent to pay each holder of Company Stock Certificates
or Company Book-Entry Shares an amount in cash (rounded to the nearest cent) equal to the product of (1)&nbsp;the fraction of a share
of BAM Class&nbsp;A Stock (rounded to the nearest thousandth when expressed in decimal form) to which such holder (after aggregating
all fractional BAM Class&nbsp;A Stock interests to be received by such holder) would otherwise have been entitled to receive, multiplied
by (2)&nbsp;an amount equal to the BAM Class&nbsp;A Stock Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Liability.</U> Notwithstanding any provision of this Agreement to the contrary, none of the Company, BAM, the Parent Entities, the Surviving
Company or the Exchange Agent shall be liable to any Person for Merger Consideration lawfully delivered to a public official pursuant
to any applicable state, federal or other abandoned property, escheat or similar applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Transfer
Books; No Further Ownership Rights in Common Stock.</U> The Merger Consideration paid in respect of each share of Common Stock in accordance
with the terms of this <U>Article&nbsp;III</U> shall be deemed to have been paid in full satisfaction of all rights pertaining to such
Common Stock previously represented by such Certificates or Book-Entry Shares, <U>subject</U>, <U>however</U>, to <U>Section&nbsp;3.05</U>.
At the Effective Time, the share transfer books of the Company shall be closed and thereafter there shall be no further registration
of transfers on the share transfer books of the Surviving Company of any shares of Common Stock that were issued and outstanding immediately
prior to the Effective Time. From and after the Effective Time, the holders of Common Stock formerly represented by Certificates or Book-Entry
Shares immediately prior to the Effective Time shall cease to have any rights with respect to such underlying Common Stock, except as
otherwise provided for herein or by applicable Law. Subject to the last sentence of <U>Section&nbsp;3.02(d)</U>, if, at any time after
the Effective Time, Certificates or Book-Entry Shares are presented to the Surviving Company for any reason, they shall be canceled and
exchanged as provided in this <U>Article&nbsp;III</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Distributions
with Respect to Un-surrendered Shares. </U>All shares of BAM Class&nbsp;A Stock to be delivered as Stock Consideration to a holder of
Common Stock pursuant to this Agreement shall be deemed delivered as of the Effective Time and whenever a dividend or other distribution
is declared by BAM in respect of the BAM Class&nbsp;A Stock, the record date for which is at or after the Effective Time, that declaration
shall include dividends or other distributions in respect of all shares of BAM Class&nbsp;A Stock to be delivered as Stock Consideration
pursuant to this Agreement. No dividends or other distributions in respect of shares of BAM Class&nbsp;A Stock delivered as Stock Consideration
pursuant to this Agreement shall be paid to any holder of any un-surrendered Company Stock Certificate until the Company Stock Certificate
(or affidavit of loss in lieu of such Company Stock Certificate as provided in <U>Section&nbsp;3.02(c)</U>) is surrendered for exchange
in accordance with this <U>Article&nbsp;III</U>. Subject to applicable Law, following such surrender, there shall be issued or paid to
the holder of record of the whole shares of BAM Class&nbsp;A Stock delivered as Stock Consideration in exchange for the Company Stock
Certificates (and any Company Book-Entry Shares held by such holder) in accordance with this <U>Article&nbsp;III</U>, without interest,
(i)&nbsp;at the time of such surrender, the dividends or other distributions with a record date after the Effective Time theretofore
payable with respect to such whole shares of BAM Class&nbsp;A Stock and not paid and (ii)&nbsp;at the appropriate payment date, the dividends
or other distributions payable with respect to such whole shares of BAM Class&nbsp;A Stock with a record date after the Effective Time
and prior to surrender, but with a payment date subsequent to surrender. Such holder of Company Book-Entry Shares shall be entitled to
vote after the Effective Time at any meeting of holders of BAM Class&nbsp;A Stock with a record date at or after the Effective Time the
number of whole shares of BAM Class&nbsp;A Stock into which the shares represented by such Company Book-Entry Shares have been exchanged
pursuant to this Agreement, regardless of whether such holder has exchanged its Company Stock Certificates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Withholding
Taxes.</U> Parent, Merger Sub, the Surviving Company and the Exchange Agent (without duplication) shall be entitled to deduct and withhold
from the amounts otherwise payable pursuant to this Agreement (including in respect of Company Awards) such amounts as are required to
be deducted and withheld with respect to the making of such payment under the Code, or any provision of other applicable Tax Law. To
the extent amounts are so withheld and paid over to the appropriate Governmental Authority in accordance with applicable Law, the withheld
amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and
withholding was made. The parties hereby agree to use commercially reasonable efforts to provide written notice to the party entitled
to the relevant payment of any anticipated withholding or deduction prior to making any deduction or withholding from amounts payable
pursuant to this Agreement, and further agree to take commercially reasonable efforts to cooperate to eliminate or reduce any such deduction
or withholding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.03.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Company
Awards</U>. Prior to the Effective Time, the Company Board (or, if appropriate, any duly authorized committee thereof administering the
Company Stock Plans) shall adopt such resolutions and take such other actions as may be required to provide for the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Company
Options.</U> Each Company Option (whether vested or unvested) outstanding immediately prior to the Effective Time shall, as of the Effective
Time, automatically and without any required action by the holder thereof, be canceled and the holder thereof shall then become entitled
to receive, in full satisfaction of the rights of such holder with respect thereto, a cash payment, without interest, equal to the product,
rounded to the nearest cent, of (i)&nbsp;the number of shares of Common Stock subject to such Company Option immediately prior to the
Effective Time and (ii)&nbsp;the excess, if any, of the Merger Consideration (valuing the Stock Consideration for purpose of this <U>Section&nbsp;3.03(a)</U>&nbsp;at
the BAM Class&nbsp;A Fixed Stock Price) over the exercise price per share of such Company Option; <U>provided</U> that any Company Option
with an exercise price per share that is equal to or greater than the Merger Consideration (valuing the Stock Consideration for purpose
of this <U>Section&nbsp;3.03(a)</U>&nbsp;at the BAM Class&nbsp;A Fixed Stock Price) shall be automatically canceled as of Closing for
no consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Company
RSUs.</U> Each Company RSU (other than a Rollover Company RSU) outstanding immediately prior to the Effective Time shall, as of the Effective
Time, automatically and without any required action by the holder thereof, vest and be canceled and the holder thereof shall then become
entitled to receive, in full satisfaction of the rights of such holder with respect thereto, a cash payment, without interest, equal
to the product, rounded to the nearest cent, of (i)&nbsp;the number of shares of Common Stock subject to such Company RSU immediately
prior to the Effective Time and (ii)&nbsp;the Merger Consideration (valuing the Stock Consideration for purpose of this <U>Section&nbsp;3.03(b)</U>&nbsp;at
the BAM Class&nbsp;A Fixed Stock Price).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Company
PSUs.</U> Each Company PSU outstanding immediately prior to the Effective Time shall, as of the Effective Time, automatically and without
any required action by the holder thereof, vest and be canceled and the holder thereof shall then become entitled to receive, in full
satisfaction of the rights of such holder with respect thereto, a cash payment, without interest, equal to the product, rounded to the
nearest cent, of (i)&nbsp;the number of shares of Common Stock subject to such Company PSU immediately prior to the Effective Time (assuming
for (A)&nbsp;Company PSUs other than VWAP PSUs, a performance level determined based on the greater of target and actual performance
as reasonably determined by the Compensation and Talent Management Committee of the Company Board immediately prior to the Effective
Time and (B)&nbsp;for VWAP PSUs, attainment of applicable performance goals based on the Merger Consideration (valuing the Stock Consideration
for purpose of this <U>Section&nbsp;3.03(c)</U>&nbsp;at the BAM Class&nbsp;A Fixed Stock Price)) and (ii)&nbsp;the Merger Consideration
(valuing the Stock Consideration for purpose of this <U>Section&nbsp;3.03(c)</U>&nbsp;at the BAM Class&nbsp;A Fixed Stock Price).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Company
Restricted Stock.</U> Each award of Company Restricted Stock outstanding immediately prior to the Effective Time shall, at the Effective
Time, automatically and without any required action on the part of the holder thereof, have any restrictions thereon lapse and the holder
thereof shall then become entitled to receive, in full satisfaction of the rights of such holder with respect thereto, a cash payment,
without interest, equal to the product, rounded to the nearest cent, of (i)&nbsp;the number of shares of Company Restricted Stock held
by such holder immediately prior to the Effective Time and (ii)&nbsp;the Merger Consideration (valuing the Stock Consideration for purpose
of this <U>Section&nbsp;3.03(d)</U>&nbsp;at the BAM Class&nbsp;A Fixed Stock Price).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Rollover
Company RSUs.</U> Any Company RSU that is a Rollover Company RSU outstanding immediately prior to the Effective Time shall, at the Effective
Time, automatically and without any required action by the holder thereof, cease to represent an award denominated in Common Stock and
shall be converted into an award of cash-settled restricted stock units denominated in shares of BAM Class&nbsp;A Stock(an &ldquo;<U>Exchanged
RSU</U>&rdquo;), with the number of shares subject to each such Exchanged RSU equal to the product (rounded to the nearest whole number)
of (i)&nbsp;the number of shares of Common Stock subject to such Rollover Company RSU immediately prior to the Effective Time and (ii)&nbsp;the
Company Award Conversion Ratio. Except as specifically provided above, following the Effective Time, each Exchanged RSU shall continue
to be governed by the same material terms and conditions (including vesting schedule and termination protections established for the
applicable Company RSU) as were applicable to the Rollover Company RSU immediately prior to the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.04.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Payments
with Respect to Company Awards</U>. Notwithstanding anything in this Agreement to the contrary, all amounts payable pursuant to this
<U>Article&nbsp;III</U> in respect of each Company Award (other than the Rollover Company RSUs) shall be paid as promptly as reasonably
practicable after the Effective Time, but in no event later than the second regularly scheduled payroll date following the Effective
Time, by the Surviving Company or any of its Subsidiaries through their payroll systems, less applicable Tax withholdings (or, in the
case of non-employee directors, such other method as the Company typically utilizes for payments to such Persons), to the holders of
the Company Awards; <U>provided</U> that, with respect to any Company Awards that constitute nonqualified deferred compensation subject
to Section&nbsp;409A of the Code and that are not permitted to be paid at the Effective Time without triggering a Tax or penalty under
Section&nbsp;409A of the Code, such payment shall be made at the earliest time permitted under the applicable Company Stock Plan and
award agreement that will not trigger a Tax or penalty under Section&nbsp;409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;3.05.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Shares
of Dissenting Holders</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notwithstanding
any provision of this Agreement to the contrary, Dissenting Shares shall not be converted into, or represent the right to receive, the
Merger Consideration. As of the Effective Time, each Dissenting Share shall no longer be issued and outstanding and shall automatically
be canceled and shall cease to exist, and each holder of a Dissenting Share immediately prior to the Effective Time shall be entitled
to receive payment of the appraised value of such shares of Common Stock held by them in accordance with the applicable provisions of
the IBCA, except that all Dissenting Shares held by shareholders who shall have failed to perfect or who effectively shall have withdrawn
or lost their rights to appraisal of such shares of Common Stock under the IBCA shall thereupon be deemed to have been converted into,
and to have become exchangeable for, as of the Effective Time, the right to receive the Merger Consideration, without any interest thereon,
upon completion of applicable procedures and surrender of the Company Stock Certificates in accordance with <U>Section&nbsp;3.02(b)</U>&nbsp;or,
in the case of holders of Company Book-Entry Shares, without any action by such holder in accordance with <U>Section&nbsp;3.02(b)</U>,
and in each case, shall cease to be Dissenting Shares hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall give Parent (i)&nbsp;prompt notice of any demands for appraisal received by the Company, withdrawals of such demands, and
any other related instruments received by the Company; and (ii)&nbsp;the opportunity to direct all negotiations and proceedings with
respect to demands for appraisal under the IBCA. The Company shall not, except with the prior written consent of Parent, make any payment
with respect to any demands for appraisal or offer to settle or settle any such demands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;IV</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Company represents and warrants to Parent and
Merger Sub that, except as (A)&nbsp;set forth in the corresponding section of the disclosure letter delivered by the Company to Parent
and Merger Sub on the date of this Agreement (the &ldquo;<U>Company Disclosure Letter</U>&rdquo;) (it being agreed that disclosure set
forth in one section or sub-section of the Company Disclosure Letter shall be deemed disclosure with respect to, and shall be deemed
to apply to and qualify, the section or sub-section of this <U>Article&nbsp;IV</U> to which it corresponds in number and each other section
or sub-section of this <U>Article&nbsp;IV</U> to the extent the qualifying nature of such disclosure with respect to such other section
or sub-section is reasonably apparent on the face of such disclosure) or (B)&nbsp;disclosed in any report, schedule, form, statement
or other document (including exhibits) filed with, or furnished to, the SEC by the Company and publicly available at least three&nbsp;business
days prior to the date of this Agreement (the &ldquo;<U>Filed SEC Documents</U>&rdquo;), other than any disclosure contained in such
Filed SEC Documents under the heading &ldquo;Risk Factor&rdquo; or &ldquo;Forward-Looking Statements&rdquo; or sections of such reports,
or that otherwise constitute risk factors or forward-looking statements:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.01.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Organization;
Standing</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company is an Iowa corporation duly incorporated and organized and validly existing under the IBCA. The Company has all requisite power
and authority necessary to carry on its business as it is now being conducted, and to own, lease and operate its assets, rights and properties
in all material respects. The Company is duly licensed or qualified to do business and is in good standing (where such concept is recognized
under applicable Law) in each jurisdiction in which the nature of the business conducted by it or the character or location of the properties
and assets owned or leased by it makes such licensing or qualification necessary, except where the failure to be so licensed, qualified
or in good standing would not reasonably be expected to have a Company Material Adverse Effect or prevent, materially delay or materially
impair the consummation by the Company of the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">A
true, complete and correct copy of each of the Company Organizational Documents is included in the Filed SEC Documents. The Company is
not in material violation of any provision of the Company Organizational Documents, and no Subsidiary of the Company is in material violation
of its certificates or articles of incorporation, memorandum of association, bylaws, bye-laws or other comparable charter or organizational
documents except as would not be material to the Company and its Subsidiaries, taken as a whole. The Company has made available to Parent
true, complete and correct copies of the organizational documents of each of the Company&rsquo;s Subsidiaries set forth in <U>Section&nbsp;4.01(b)</U>&nbsp;of
the Company Disclosure Letter, in each case as amended and in effect as of the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
of the Company&rsquo;s Subsidiaries is duly incorporated or organized, validly existing and in good standing (where such concept is recognized
under applicable Law) under the Laws of the jurisdiction of its incorporation or organization, except where the failure to be so incorporated
or organized, existing and in good standing would not reasonably be expected to have a Company Material Adverse Effect, taken as a whole.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.02.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Capitalization</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
authorized share capital of the Company consists of 200,000,000 shares of Common Stock and 2,000,000 shares of Preferred Stock.&nbsp;
At the close of business on June&nbsp;30, 2023 (the &ldquo;<U>Capitalization Date</U>&rdquo;), (i)&nbsp;77,885,597 shares of Common Stock
(including 959,314 shares of Common Stock held by the Company ESOP, of which 959,314 shares are allocated and no shares are unallocated)
were issued and outstanding, (ii)&nbsp;2,895,500 shares of Common Stock under the Company Stock Plans of which (A)&nbsp;196,394 are shares
of Company Restricted Stock, (B)&nbsp;447,308 shares are subject to outstanding Company RSUs, (C)&nbsp;628,841 and 1,691,015 shares of
Common Stock are subject to outstanding Company PSUs (assuming achievement of any applicable performance criteria at the target and maximum
levels, respectively), and (D)&nbsp;1,622,957 shares are subject to unexercised Company Options (whether vested or unvested, including
1,405,820 shares subject to vested and unexercised Company Options), (iii)&nbsp;3,056,407 shares of Common Stock are reserved and available
for issuance under the Company Stock Plans, (iv)&nbsp;16,000 shares of 5.95% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series&nbsp;A,
of the Company (the &ldquo;<U>Series&nbsp;A Preferred Stock</U>&rdquo;) were issued and outstanding, (v)&nbsp;12,000 shares of 6.625%
Fixed-Rate Reset Non-Cumulative Preferred Stock, Series&nbsp;B, of the Company (the &ldquo;<U>Series&nbsp;B Preferred Stock</U>&rdquo;,
and together with the Series&nbsp;A Preferred Stock, the &ldquo;<U>Preferred Stock</U>&rdquo;) were issued and outstanding and (vi)&nbsp;31,693,317
shares of Common Stock were held by the Company as treasury stock or held by its Subsidiaries.&nbsp; Since the Capitalization Date through
the date of this Agreement, other than in connection with the vesting, settlement or exercise of Company Awards or pursuant to allocation
under the Company ESOP, neither the Company nor any of its Subsidiaries has issued any Company Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as described in this <U>Section&nbsp;4.02</U>, as of the Capitalization Date, there were (i)&nbsp;no outstanding shares of Common Stock,
Preferred Stock or other equity or voting interests in the Company (including bonds, debentures, notes or other Indebtedness of the Company
having the right to vote), (ii)&nbsp;no outstanding securities of the Company convertible into or exchangeable for Common Stock or other
equity or voting interests in the Company, (iii)&nbsp;except pursuant to any Company Awards, any Company Stock Plan or the Company ESOP,
no outstanding options, warrants, rights or other commitments or agreements to acquire from the Company, or that obligate the Company
to issue, any Common Stock, Preferred Stock or other equity or voting interests in, or any securities convertible into or exchangeable
for Common Stock, Preferred Stock or other equity or voting interests in the Company (collectively, &ldquo;<U>Company Rights</U>,&rdquo;
and the items in clauses (i), (ii)&nbsp;and (iii)&nbsp;being referred to collectively as &ldquo;<U>Company Securities</U>&rdquo;) and
(iv)&nbsp;no other obligations by the Company or any of its Subsidiaries to make any payments based on the price or value of any Company
Securities or dividends paid thereon. Other than in connection with the Company Awards or pursuant to a Company Stock Plan, there are
no outstanding agreements of any kind that obligate the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire
any Company Securities or that grant from the Company or any of its Subsidiaries any preemptive rights, anti-dilutive rights, rights
of first refusal or similar rights with respect to any Company Securities. Except as described in this <U>Section&nbsp;4.02</U>, no direct
or indirect Subsidiary of the Company owns any Common Stock or Preferred Stock. None of the Company or any Subsidiary of the Company
is a party to any shareholders&rsquo; agreement, voting trust agreement, registration rights agreement or other similar agreement or
understanding relating to any Company Securities or any other agreement relating to the disposition or voting with respect to any Company
Securities. All issued and outstanding Common Stock and Preferred Stock have been duly authorized and validly issued and are fully paid,
nonassessable and free of preemptive rights. As of the date of this Agreement, there are no accrued and unpaid dividends with respect
to the Common Stock or the Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Common Stock and the Depositary Shares constitute the only issued classes of shares or other securities of the Company or its Subsidiaries
registered under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
of the issued and outstanding share capital or shares of capital stock of, or other equity or voting interests in, each Subsidiary of
the Company (except for directors&rsquo; qualifying shares or the like) are owned, directly or indirectly, beneficially and of record,
by the Company free and clear of all Liens, except for Permitted Liens. Each issued and outstanding share capital or share of capital
stock of each Subsidiary of the Company that is held, directly or indirectly, by the Company, is duly authorized, validly issued, fully
paid, nonassessable and free of preemptive rights, and there are no subscriptions, options, warrants, rights, calls, contracts or other
commitments that obligate the Company or any Subsidiary of the Company to issue any share capital or shares of capital stock or other
equity or voting interests of any Subsidiary of the Company, including any right of conversion or exchange under any outstanding security,
instrument or agreement, any agreements granting any preemptive rights, subscription rights, anti-dilutive rights, rights of first refusal
or similar rights with respect to any securities of any Subsidiary of the Company. None of the Subsidiaries of the Company has any outstanding
equity compensation plans relating to the share capital or capital stock of, or other equity or voting interests in, any Subsidiary of
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has made available to Parent accurate and complete copies of all Company Stock Plans, any other Contracts pursuant to which any
Company Awards are outstanding as of the date of this Agreement and the forms of all Company Award agreements (and any individual award
agreements whose terms materially deviate from such forms) evidencing such Company Awards as of the date of this Agreement. The exercise
price of each Company Option is no less than the fair market value of a share of Common Stock as determined on the date of grant of such
Company Option. All grants of Company Awards were recorded on the Company&rsquo;s financial statements (including any related notes thereto)
contained in all reports filed with the SEC in accordance with GAAP. All Company Awards have been issued and granted in compliance in
all material respects with the terms of the applicable Company Stock Plan and all applicable Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.03.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Authority;
Noncontravention; Voting Requirements</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has all necessary corporate power and authority to execute and deliver this Agreement, to perform its obligations hereunder and,
subject to obtaining the Required Shareholder Approval, to consummate the Transactions. The execution, delivery and performance by the
Company of this Agreement, and the consummation by the Company of the Transactions, have been duly and unanimously authorized and approved
by the Company Board, and, except for obtaining the Required Shareholder Approval, no other corporate action (including any shareholder
vote or other action) on the part of the Company is necessary to authorize the execution, delivery and performance by the Company of
this Agreement and the consummation by the Company of the Transactions. This Agreement has been duly executed and delivered by the Company
and, assuming due authorization, execution and delivery hereof by each other party, constitutes a legal, valid and binding obligation
of the Company, enforceable against the Company in accordance with its terms, except that such enforceability (i)&nbsp;may be limited
by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium, rehabilitation, conservatorship, liquidation, receivership
and other similar Laws of general application affecting or relating to the enforcement of creditors&rsquo; rights generally and (ii)&nbsp;is
subject to general principles of equity, whether considered in a proceeding at law or in equity (together, the &ldquo;<U>Bankruptcy and
Equity Exception</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company Board has unanimously (i)&nbsp;determined that this Agreement and the Transactions, including the Merger, are advisable, fair
to and in the best interests of the Company and its shareholders (other than the Parent Group Shareholders and any other Parent Affiliated
Shareholders), including in consideration of community interest factors, (ii)&nbsp;approved and adopted this Agreement and the Transactions,
including the Merger, (iii)&nbsp;directed that this Agreement and the Transactions, including the Merger, be submitted to the shareholders
of the Company for their approval and (iv)&nbsp;resolved, subject to <U>Section&nbsp;7.03</U>, to recommend approval of the Merger and
this Agreement to the Company&rsquo;s shareholders (such recommendation, the &ldquo;<U>Company Board Recommendation</U>&rdquo;), and,
as of the date of this Agreement, such resolutions have not been subsequently rescinded, modified or withdrawn in any way.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the execution and delivery of this Agreement by the Company, nor the consummation by the Company of the Transactions, nor performance
of or compliance by the Company with any of the terms or provisions hereof, will (i)&nbsp;conflict with or violate any provision of (A)&nbsp;the
Company Organizational Documents or (B)&nbsp;the certificates or articles of incorporation, memorandums of association, bylaws, bye-laws
or other comparable charter or organizational documents of any of the Company&rsquo;s Subsidiaries or (ii)&nbsp;assuming (A)&nbsp;compliance
with the matters set forth in <U>Section&nbsp;5.02(c)</U>&nbsp;(other than <U>Section&nbsp;5.02(c)(ii)(A))</U> (and assuming the accuracy
of the representations and warranties made in such <U>Section&nbsp;5.02(c)</U>), (B)&nbsp;that the actions described in <U>Section&nbsp;4.03(a)</U>&nbsp;have
been completed, (C)&nbsp;that the Consents referred to in <U>Section&nbsp;4.04</U> and the Required Shareholder Approval are obtained
and (D)&nbsp;that the filings referred to in <U>Section&nbsp;4.04</U> are made and any waiting periods thereunder have terminated or
expired, in the case of each of the foregoing clauses (A)&nbsp;through (D), prior to the Effective Time, (x)&nbsp;violate in any material
respect any Law applicable to the Company or any of its Subsidiaries, (y)&nbsp;require any consent or notice, or conflict with, violate
or constitute a default under any of the terms, conditions or provisions of any Material Contract, or any Reinsurance Agreement or IMA
or give rise to any right of purchase, termination, amendment, acceleration or cancellation under, result in the loss of any benefit
to the Company or, if applicable, its Subsidiaries under, or result in the triggering of any payments by the Company or, if applicable,
its Subsidiaries pursuant to, any such Material Contract, or Reinsurance Agreement or IMA or (z)&nbsp;result in the creation of any Lien
on any properties or assets of the Company or any of its Subsidiaries, except, in the case of clauses (ii)(y)&nbsp;and (ii)(z), as would
not reasonably be expected to have a Company Material Adverse Effect or prevent, materially delay or materially impair the consummation
by the Company of the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">A
majority of the votes cast (in person or by proxy) in favor of the approval of this Agreement and the Merger by the holders of the Common
Stock present and voting together as a single class at the Company Shareholders Meeting (the &ldquo;<U>Required Shareholder Approval</U>&rdquo;),
is the only vote of, or approval by, the holders of any class or series of share capital of the Company or any of its Subsidiaries that
is necessary to approve this Agreement and the Merger; <U>provided</U> that a quorum is established at the Company Shareholders Meeting
by attendance (in person or by proxy) of the holders of a majority of the Common Stock issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.04.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Governmental
Approvals.</U> Except for (a)&nbsp;compliance with the applicable requirements of the Securities Exchange Act of 1934 and the rules&nbsp;and
regulations promulgated thereunder (collectively, the &ldquo;<U>Exchange Act</U>&rdquo;), including the filing with the Securities and
Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;) of a proxy statement on Schedule 14A relating to the Company Shareholders Meeting
(as amended or supplemented from time to time, the &ldquo;<U>Proxy Statement/Prospectus</U>&rdquo;), (b)&nbsp;compliance with the rules&nbsp;and
regulations of the NYSE, (c)&nbsp;the filing of the Articles of Merger as required by the IBCA, (d)&nbsp;filings required under, and
compliance with other applicable requirements of, the HSR Act, and such other Consents, filings, declarations or registrations as are
required to be made or obtained under any other Antitrust Laws set forth in <U>Section&nbsp;4.04(d)</U>&nbsp;of the Company Disclosure
Letter, (e)&nbsp;the filing with the Financial Industry Regulatory Authority (&ldquo;<U>FINRA</U>&rdquo;) of an application by the Broker-Dealer
Subsidiary under FINRA Rule&nbsp;1017 (the &ldquo;<U>Rule&nbsp;1017 Application</U>&rdquo;) and the receipt of FINRA&rsquo;s approval
of such application, (f)&nbsp;compliance with any applicable state securities or blue sky laws, (g)&nbsp;approvals, filings and notices
under all applicable Insurance Laws as set forth in <U>Section&nbsp;4.04(g)</U>&nbsp;of the Company Disclosure Letter (the &ldquo;<U>Company
Insurance Approvals</U>&rdquo;), (h)&nbsp;the Parent Insurance Approvals (assuming the accuracy of the representations and warranties
made in <U>Section&nbsp;5.03</U> and the completeness of <U>Section&nbsp;5.03</U> of the Parent Disclosure Letter) and (i)&nbsp;such
other Consents, filings, declarations or registrations that, if not obtained, made or given, would not reasonably be expected to have
a Company Material Adverse Effect or prevent, materially delay or impair&nbsp;the consummation by the Company of the Transactions on
a timely basis, no Consent of, or filing, declaration or registration with, any Governmental Authority is necessary for the execution
and delivery of this Agreement by the Company, the performance by the Company of its obligations hereunder and the consummation by the
Company of the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.05.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Company
SEC Documents; Undisclosed Liabilities</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has filed with or furnished to (as applicable) the SEC all reports, schedules, forms, statements, registration statements, prospectuses,
proxy statements and other documents required to be filed or furnished by the Company with the SEC on a timely basis pursuant to the
Securities Act or the Exchange Act since January&nbsp;1, 2021 (collectively with any other reports, schedules, forms, certifications,
statements, registration statements, prospectuses, proxy statements and other documents, including the exhibits and other information
incorporated therein, filed or furnished by the Company with the SEC after the date hereof, the &ldquo;<U>Company SEC Documents</U>&rdquo;)
in all material respects. As of their respective effective dates (in the case of Company SEC Documents that are registration statements
filed pursuant to the requirements of the Securities Act) or their respective SEC filing dates (in the case of all other Company SEC
Documents), or, if supplemented, modified or amended since the time of filing, as of the date of the most recent supplement, modification
or amendment, the Company SEC Documents complied in all material respects with the requirements of the Securities Act, the Exchange Act,
the Sarbanes-Oxley Act and the applicable rules&nbsp;and regulations of the SEC promulgated thereunder, applicable to such Company SEC
Documents, and none of the Company SEC Documents contained any untrue statement of a material fact or omitted to state a material fact
necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. As of the
date of this Agreement, there are no outstanding or unresolved comments from the SEC staff with respect to any Company SEC Document.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
of the consolidated financial statements of the Company (including all related notes or schedules) included or incorporated by reference
in the Company SEC Documents complied as to form, as of the dates and for the periods referred to therein and as of their respective
dates of filing with the SEC, in all material respects with the applicable accounting requirements and published rules&nbsp;and regulations
of the SEC, the Securities Act and the Exchange Act with respect thereto, have been prepared in all material respects in accordance with
GAAP as in effect on the date of such statement (except, in the case of unaudited quarterly statements, for normal and recurring year-end
adjustments) applied on a consistent basis during the periods involved (except (i)&nbsp;as may be indicated in the notes thereto or (ii)&nbsp;as
permitted by Regulation S-X) and fairly present in all material respects the consolidated financial position of the Company and its consolidated
Subsidiaries as of the dates thereof and the consolidated results of their operations, changes in shareholders&rsquo; equity and cash
flows for the periods shown (subject, in the case of unaudited quarterly financial statements, to normal year-end adjustments). Since
January&nbsp;1, 2021, the Company has not made any material change in the accounting practices or policies applied in the preparation
of its financial statements prepared in accordance with GAAP, except as required by GAAP, SEC rule&nbsp;or policy or applicable Law.
None of the Company or its Subsidiaries is a party to, or has any obligation or other commitment to become a party to, any &ldquo;off
balance sheet arrangement&rdquo; (as defined in Item 303(a)&nbsp;of Regulation S-K promulgated by the SEC).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any of its Subsidiaries has any liabilities of any nature (whether accrued, absolute, contingent or otherwise) that would
be required under GAAP, as in effect on the date of this Agreement, to be reflected on a consolidated balance sheet of the Company (including
the notes thereto) except liabilities (i)&nbsp;reflected or reserved against in the balance sheet (or the notes thereto) of the Company
and its Subsidiaries as of December&nbsp;31, 2022, included in the Filed SEC Documents, (ii)&nbsp;incurred after December&nbsp;31, 2022,
in the ordinary course of business, (iii)&nbsp;as contemplated by this Agreement or otherwise incurred in connection with the Transactions,
(iv)&nbsp;as relate to Taxes or (v)&nbsp;as would not reasonably be expected to be material to the Company and its Subsidiaries, taken
as a whole.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company is, and since January&nbsp;1, 2021, has been, in compliance in all material respects with the provisions of the Sarbanes-Oxley
Act of 2002 and the rules&nbsp;and regulations of the SEC promulgated thereunder (the &ldquo;<U>Sarbanes-Oxley Act</U>&rdquo;) that are
applicable to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">None
of the information supplied or to be supplied by or on behalf of the Company or its Subsidiaries for inclusion or incorporation by reference
in the Proxy Statement/Prospectus shall, on the date it is first mailed to shareholders of the Company, at the time of any amendment
thereof or supplement thereto and at the time of any meeting of the Company&rsquo;s shareholders to be held in connection with the Merger,
including the Company Shareholders Meeting, contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not
misleading. The Proxy Statement/Prospectus will comply as to form with the requirements of the Exchange Act, the Securities Act and any
other applicable Law governing the preparation, distribution or dissemination of such documents. Notwithstanding the foregoing, the Company
makes no representation or warranty with respect to statements made or incorporated by reference therein based on information supplied
by or on behalf of Parent, Merger Sub or any Affiliates thereof for inclusion or incorporation by reference in the Proxy Statement/Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
material weaknesses exist with respect to the internal control over financial reporting of the Company that would be required to be disclosed
by the Company pursuant to Item 308(a)(3)&nbsp;of Regulation S-K promulgated by the SEC that have not been disclosed in the Company SEC
Documents as filed with or furnished to the SEC prior to the date of this Agreement. The Company maintains a system of internal controls
over financial reporting (as defined in Rules&nbsp;13a-15(f)&nbsp;and 15d-15(f)&nbsp;of the Exchange Act) that is designed to provide
reasonable assurances (x)&nbsp;regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with GAAP, (y)&nbsp;that receipts and expenditures of the Company are being made only in accordance with authorizations
of management and the directors of the Company and (z)&nbsp;regarding prevention or timely detection of the unauthorized acquisition,
use or disposition of the Company&rsquo;s and its Subsidiaries&rsquo; assets that could have a material effect on the Company&rsquo;s
financial statements. The Company has established and maintains disclosure controls and procedures (as such term is defined in Rule&nbsp;13a-15(e)&nbsp;and
Rule&nbsp;15d-15(e), as applicable, under the Exchange Act) as required by Rule&nbsp;13a-15 under the Exchange Act, designed to ensure
that information required to be disclosed by the Company in the reports that it files and submits under the Exchange Act is recorded,
processed, summarized and reported within the time periods specified in the SEC&rsquo;s rules&nbsp;and forms, including that information
required to be disclosed by the Company in the reports that it files and submits under the Exchange Act is accumulated and communicated
to management of the Company, as appropriate, to allow timely decisions regarding required disclosure and to make the certifications
required pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act. Since January&nbsp;1, 2021, neither the Company nor any of its Subsidiaries
has received any written complaint, allegation, assertion or claim regarding the accounting or auditing practices, procedures, methodologies
or methods of the Company or any of its Subsidiaries or their respective internal accounting controls or any allegation of fraud that
involves management of the Company or any other employee of the Company or any of its Subsidiaries who has a significant role in the
Company&rsquo;s internal controls over financial reporting or disclosure controls and procedures. The Company has disclosed, based on
its most recent evaluation, to the Company&rsquo;s outside auditors and the audit committee of the Company Board, (i)&nbsp;all significant
deficiencies and material weaknesses in the design and operation of internal control over financial reporting which are reasonably likely
to adversely affect in any material respect the Company&rsquo;s ability to record, process, summarize and report financial data and (ii)&nbsp;any
fraud, whether or not material, that involves management or other employees who have a significant role in the Company&rsquo;s internal
control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company is in compliance in all material respects with the applicable listing and corporate governance rules&nbsp;and regulations of
the NYSE.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
of the date hereof, except as disclosed in the Company SEC Documents, within the last twelve (12) months, no event has occurred and no
relationship exists that would be required to be reported by the Company pursuant to Item 404 of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.06.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Absence
of Certain Changes</U>. From December&nbsp;31, 2022 through the date of this Agreement, except for the execution, delivery and performance
of this Agreement and the discussions, negotiations and transactions related thereto (including the Transactions) and to alternative
transactions to the Transactions and any COVID Measures, (a)&nbsp;the business of the Company and its Subsidiaries has been conducted
in all material respects in the ordinary course of business and (b)&nbsp;there has not been any event or condition that has had, or would
reasonably be expected to have, a Company Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.07.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Legal
Proceedings</U>. Except as would not reasonably be expected to, individually or in the aggregate, have a Company Material Adverse Effect
or prevent, materially delay or materially impair the consummation by the Company of the Transactions, there is no (a)&nbsp;Action pending
or, to the Knowledge of the Company, threatened in writing against the Company or any of its Subsidiaries or any of their respective
officers, directors or employees (other than ordinary course claims made under or in connection with Contracts of insurance or reinsurance
issued or assumed by the Company or any of its Subsidiaries) or (b)&nbsp;outstanding injunction, order, judgment, ruling, decree or writ
imposed upon the Company or any of its Subsidiaries or, to the Knowledge of the Company, any director or officer of the Company or any
of its Subsidiaries in connection with the officer&rsquo;s or director&rsquo;s relationship with the Company, in each case, by or before
any Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.08.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Compliance
with Laws; Permits</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and each of its Subsidiaries and their respective officers, directors, and personnel are, and since January&nbsp;1, 2021, have
been, in compliance with all federal, national, provincial, state, local or multinational laws, statutes, common laws, ordinances, codes,
rules&nbsp;and regulations (collectively, &ldquo;<U>Laws</U>&rdquo;), judgments, decrees and orders of Governmental Authorities and Permits,
in each case, applicable to the Company or any of its Subsidiaries, except as would not reasonably be expected to have a Company Material
Adverse Effect or prevent, materially delay or materially impair the consummation by the Company of the Transactions. The Company and
each of its Subsidiaries hold, and since January&nbsp;1, 2021, have held, all licenses, memberships, franchises, permits, certificates,
approvals, authorizations and registrations from Governmental Authorities (collectively, &ldquo;<U>Permits</U>&rdquo;) necessary for
the lawful conduct of their respective businesses and all such Permits are in full force and effect, except where the failure to hold
the same or the failure of the same to be in full force and effect would not reasonably be expected to have a Company Material Adverse
Effect or prevent, materially delay or materially impair the consummation by the Company of the Transactions. There are no Actions pending
or, to the Knowledge of the Company, threatened, that seek the revocation, cancellation or adverse modification of any Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Company Material Adverse Effect or prevent, materially delay or materially impair the consummation
by the Company of the Transactions, neither the Company nor any of its Subsidiaries is a party to any agreement or settlement with any
Governmental Authority, under which it has any ongoing obligations or restrictions, with respect to any actual or alleged violation of
any applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company, each of its Subsidiaries, and to the Knowledge of the Company, each of their respective directors, officers, employees, agents,
representatives or sales intermediaries (each in their capacities as such) and any other third party acting on behalf of the Company
or any of its Subsidiaries, has, since January&nbsp;1, 2021, complied with all applicable Specified Business Conduct Laws, except as
would not reasonably be expected to have a Company Material Adverse Effect or prevent, materially delay or materially impair the consummation
by the Company of the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Company Material Adverse Effect or prevent, materially delay or materially impair the consummation
by the Company of the Transactions, since January&nbsp;1, 2021, neither the Company nor any of its Subsidiaries, nor, to the Knowledge
of the Company, any of their respective directors, officers or employees (each in their capacities as such) has been, subject to any
actual, pending or threatened civil, criminal or administrative actions, suits, demands, claims, hearings, notices of violation, investigations,
proceedings, demand letters, settlements or enforcement actions, or made any disclosures to any Governmental Authority, involving the
Company or any of its Subsidiaries, in any way relating to any applicable Specified Business Conduct Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any of its Subsidiaries, nor, to the Knowledge of the Company, any of their respective directors, officers, employees,
agents, representatives or sales intermediaries (each in their capacities as such) or any other third party acting on behalf of the Company
or any of its Subsidiaries, is a Sanctioned Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Company Material Adverse Effect or prevent, materially delay or materially impair the consummation
by the Company of the Transactions, since January&nbsp;1, 2021, neither the Company nor any of its Subsidiaries, nor, to the Knowledge
of the Company, any of their respective directors, officers, employees, agents, representatives, sales intermediaries or any other third
party acting on their behalf, has engaged in any dealings, transactions, activity or conduct with, involving or for the benefit of, any
Sanctioned Person in violation of any Specified Business Conduct Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Broker-Dealer Subsidiary, nor any person associated with it, is subject to a &ldquo;statutory disqualification&rdquo; as that term
is used for purposes of the Securities Exchange Act. The Broker-Dealer Subsidiary has in effect, and at all times required by legal or
regulatory requirements has had in effect, such written supervisory policies and procedures as may be required by the SEC, FINRA and
the Exchange Act, except where neither the failure to maintain any relevant components of such policies and procedures would not, either
individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect or prevent, materially delay or materially
impair the consummation by the Company of the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.09.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Tax
Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and each of its Subsidiaries has prepared (or caused to be prepared) and timely filed (or caused to be timely filed) (taking
into account valid extensions of time within which to file) all income or other Tax Returns required to be filed by any of them with
the appropriate Governmental Authority in all jurisdictions in which Tax Returns are required to be filed. All such filed Tax Returns
(taking into account all amendments thereto) are true, complete and accurate in all material respects, and all income or other material
Taxes owed by the Company and each of its Subsidiaries that are due (whether or not shown as due on any Tax Return) have been timely
paid or have been adequately reserved against in accordance with GAAP and Applicable SAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
Taxes with respect to any of the Company and its Subsidiaries are under audit or examination by any Governmental Authority, and there
are no audits, claims, assessments, levies, administrative or judicial proceedings pending or threatened in respect of any Taxes of any
of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">There
are no Liens for Taxes on any of the assets of the Company or any of its Subsidiaries other than Permitted Liens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any of its Subsidiaries has (A)&nbsp;waived any statute of limitations in respect of any Taxes or agreed to any extension
of time with respect to an assessment or deficiency for any Taxes, which waiver or agreement, as applicable, remains in effect (other
than pursuant to extensions of time to file Tax Returns obtained in the ordinary course), (B)&nbsp;applied for a private letter ruling
or similar ruling from any Governmental Authority relating to Taxes that has not been granted or has proposed to enter into an agreement
with a Governmental Authority relating to Taxes that is pending or (C)&nbsp;entered into any &ldquo;closing agreement&rdquo; as described
in Section&nbsp;7121 of the Code (or any similar provision of state, local or foreign Tax Law), offer in compromise or similar agreement
with a Governmental Authority relating to Taxes or has been issued any private letter rulings, technical advice memoranda or similar
agreement or rulings by any Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any of its Subsidiaries is a party to a Tax allocation, sharing, indemnity or similar agreement or arrangement, other
than (A)&nbsp;Contracts solely between the Company and its Subsidiaries and (B)&nbsp;agreements or arrangements entered into in the ordinary
course of business that does not relate principally to Taxes, or has any liability for Taxes of another Person (other than the Company
or any of its Subsidiaries) under U.S. Treasury Regulation Section&nbsp;1.1502-6 (or any similar provision of applicable Law), as a transferee
or successor or by Contract (other than any Contract that does not relate principally to Taxes).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any of its Subsidiaries will be required to include any item of income in, or exclude any item of deduction from, taxable
income for any taxable period (or portion thereof) ending after the Closing Date, as a result of any (A)&nbsp;change in method of accounting
for a taxable period ending on or prior to the Closing Date under Section&nbsp;481 of the Code (or any corresponding provision of state,
local or foreign income Tax law), (B)&nbsp;disposition accounted for under the installment sale method made on or prior to the Closing
Date or (C)&nbsp;prepaid amount received on or prior to the Closing Date. <U>Section&nbsp;4.09(a)(vi)</U>&nbsp;of the Company Disclosure
Letter sets forth a schedule of amounts that the Company or any of its Subsidiaries will be required to include in income after the Closing
Date under Section&nbsp;13517(c)(3)&nbsp;of the Tax Cuts and Jobs Act of 2017, Pub. L. No.&nbsp;115-97.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
excise Tax Returns and excise Taxes under Section&nbsp;4371 of the Code with respect to any reinsurance or retrocession agreement to
which the Company or any of its Subsidiaries is a party have been duly and timely filed and paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and each of its Subsidiaries have, within the time and manner prescribed by Law, withheld and paid over to the proper Governmental
Authority all amounts required to have been so withheld and paid over, and have complied with all related Tax information reporting requirements
under applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any of its Subsidiaries has been a &ldquo;controlled corporation&rdquo; or a &ldquo;distributing corporation&rdquo; in
any distribution occurring during the two-year period ending on the date of this Agreement that was intended to be governed by Section&nbsp;355
of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any of its Subsidiaries has participated in any &ldquo;listed transaction&rdquo; within the meaning of U.S. Treasury
Regulation Section&nbsp;1.6011-4(b)(2).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any of its Subsidiaries has or has ever had a permanent establishment in a jurisdiction outside of the jurisdiction in
which the Company or its Subsidiaries, respectively, are organized. For the avoidance of doubt, the entire United States (as defined
in Section&nbsp;7701(a)(9)&nbsp;of the Code) shall be treated as a single jurisdiction for purposes of this representation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">AEL
Re Bermuda Ltd. has made a valid election under Section&nbsp;953(d)&nbsp;of the Code to be treated as a domestic corporation. No other
Subsidiary of the Company organized outside of the United States has made an election under Section&nbsp;953(d)&nbsp;of the Code to be
treated as a domestic corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Section&nbsp;4.09(f)</U>&nbsp;of
the Company Disclosure Letter sets forth a true and correct list of any of the Company or its Subsidiaries that is a life insurance company
under Section&nbsp;816(a)&nbsp;of the Code as of the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
of the Company and its Subsidiaries (other than AEL Re Bermuda Ltd.) is a domestic corporation for U.S. federal income Tax purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notwithstanding
anything to the contrary in this Agreement, (i)&nbsp;except for the representations and warranties set forth in <U>Sections 4.05</U>,
<U>4.10</U>, and <U>4.22</U> and this <U>Section&nbsp;4.09</U>, neither the Company nor any of its Subsidiaries makes, and each such
party hereby expressly disclaims, any express or implied representations or warranties, statutory, common law or otherwise, of any nature,
with respect to Taxes, (ii)&nbsp;the representations and warranties of the Company and its Subsidiaries in this <U>Section&nbsp;4.09
</U>refer only to activities prior to the Closing and shall not serve as representations or warranties regarding, or a guarantee of,
nor can they be relied upon with respect to, Taxes attributable to any taxable period (or portion thereof) beginning, or Tax positions
taken, after the Closing Date, and (iii)&nbsp;nothing in this Agreement (including the representations and warranties in this <U>Section&nbsp;4.09</U>),
other than <U>Section&nbsp;4.05</U> shall be construed as providing a representation and warranty with respect to the existence, amount,
expiration date or limitations on (or availability of) any Tax attribute of the Company or its Subsidiaries. None of the representations
and warranties in this <U>Section&nbsp;4.09 </U>are made with respect to the tax treatment of any Insurance Contract, or as to any obligation
in respect of withholding, information reporting or record-keeping in respect thereof, which will be governed by <U>Section&nbsp;4.22</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.10.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Employee
Benefits</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Section&nbsp;4.10(a)</U>&nbsp;of
the Company Disclosure Letter contains a true and complete list, as of the date of this Agreement, of each material Company Plan. With
respect to each material Company Plan, the Company has made available to Parent true and complete copies (to the extent applicable) of
(i)&nbsp;the plan document, including any amendments thereto, or if such Company Plan is not in writing, a written description of such
plan, (ii)&nbsp;the most recent summary plan description for each material Company Plan for which such summary plan description is required
by applicable Law and each summary of material modifications (if any), (iii)&nbsp;if such Company Plan is funded through a trust or any
other funding arrangement, a copy of such trust or other funding arrangement, (iv)&nbsp;the most recently received IRS determination
letter (or opinion or advisory letter, if applicable) and (v)&nbsp;the most recent annual report on Form&nbsp;5500 required to be filed
with the IRS with respect thereto (if any).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not be expected to have a Company Material Adverse Effect, each of the Company Plans (including any related trusts) (i)&nbsp;has
been established, operated and administered in compliance with its terms and in accordance with applicable Laws, (ii)&nbsp;all contributions
required to be made with respect to any Company Plan have been timely made and deposited and (iii)&nbsp;to the Knowledge of the Company,
no circumstance, fact or event exists that could result in any material default under or material violation of any Company Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
Company Plan that is intended to be &ldquo;qualified&rdquo; within the meaning of Section&nbsp;401(a)&nbsp;of the Code has received a
favorable determination letter from the IRS regarding the Tax-qualified status of such Company Plan or is entitled to rely upon a favorable
opinion letter issued by the IRS regarding the plan&rsquo;s Tax-qualified status and each such related trust has not been revoked, and,
to the Knowledge of the Company, no events have occurred or circumstances exist that could reasonably be expected to cause the loss of
reliance on such determination or opinion letter or adversely affect the Tax-qualified status of any such Company Plan or related trust.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company does not maintain, sponsor or contribute to, nor within the past six&nbsp;years has it maintained, sponsored or contributed to,
or required to maintain, sponsor or contribute to, a plan subject to Title IV of ERISA or Section&nbsp;412 of the Code, including any
 &ldquo;single employer&rdquo; defined benefit plan (within the meaning of Section&nbsp;3(35) of ERISA) or any &ldquo;multiemployer plan&rdquo;
(as defined in Section&nbsp;4063 of ERISA). No Company Plan is, and none of the Company or any of its Subsidiaries has any actual or
contingent liability under, any &ldquo;multiple employer plan&rdquo; (within the meaning of Section&nbsp;413(c)&nbsp;of the Code)&nbsp;or
any &ldquo;multiple employer welfare arrangement&rdquo; as defined in Section&nbsp;3(40)&nbsp;of ERISA. Neither the Company nor any of
its Subsidiaries has any current or contingent liability or obligation with respect to any Company Plan as a consequence of at any time
being considered a single employer under Section&nbsp;414 of the Code with any other Person, trade or business, whether or not incorporated
(an &ldquo;<U>ERISA Affiliate</U>&rdquo;). In addition, during the past six&nbsp;years, no liability under (i)&nbsp;Title IV or Section&nbsp;302
of ERISA or Sections&nbsp;412 and 4971 of the Code or (ii)&nbsp;Section&nbsp;4980B of the Code as a result of a failure to comply with
the continuation coverage requirements of Section&nbsp;601 et seq. of ERISA and Section&nbsp;4980B of the Code, has, in either case,
been incurred by the Company or any ERISA Affiliate that has not been satisfied in full and, to the Knowledge of the Company, no condition
exists that presents a risk to the Company or any ERISA Affiliate of incurring such liability that would reasonably be expected to result
in material liability to the Company or any of its Subsidiaries. There has been no non-exempt prohibited transaction (within the meaning
of Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code)&nbsp;with respect to any Company Plan, except for transactions that would
not reasonably be expected to result in any material liability to the Company and its Subsidiaries taken together as a whole.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as required under applicable Law, no Company Plan provides health, medical, dental or life insurance benefits following retirement or
other termination of employment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">There
are no pending, or to the Knowledge of the Company, anticipated or threatened Actions against the Company or any of its Subsidiaries
with respect to any Company Plan, by or on behalf of any employee, former employee or beneficiary covered under any such Company Plan
(other than routine claims for benefits) that would reasonably result in material liability to the Company and its Subsidiaries. No Company
Plan is, or since January&nbsp;1, 2021 has been, the subject of an examination, investigation or audit by a Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the execution and delivery of this Agreement nor the consummation of the Transactions (either alone or in conjunction with any other
event) will (i)&nbsp;result in any severance payment or benefit becoming due to any current or former employee, officer, director or
other natural individual service provider of the Company or its Subsidiaries, (ii)&nbsp;increase, or enhance the terms of, any severance
or other compensation or benefits otherwise payable to any current or former employee, officer, director or other natural individual
service provider of the Company or its Subsidiaries, (iii)&nbsp;result in any acceleration of the time of payment, funding (through a
grantor trust or otherwise) or vesting of any such compensation or benefits to any current or former employee, officer, director or other
natural individual service provider of the Company or its Subsidiaries, (iv)&nbsp;trigger any increased or accelerated contributions
to any Company Plan or trigger any change in the funding or covenant support arrangements for any Company Plan or (v)&nbsp;limit or restrict
the right to amend, terminate or transfer the assets of any Company Plan on or following the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
consummation of the Transactions (either alone or in combination with another event) will not result in the payment (or acceleration
of vesting) of any amount or benefit that would, individually or in combination with any other payment, constitute an &ldquo;excess parachute
payment&rdquo; within the meaning of Section&nbsp;280G of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
Person is entitled to receive any additional payment (including any Tax gross-up or other payment) from the Company or any of its Subsidiaries
as a result of the imposition of the excise Taxes required by Section&nbsp;4999 of the Code or any Tax, interest or penalties imposed
by Section&nbsp;409A of the Code (or any corresponding or similar provision of state, local or non-U.S. Law).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not be expected to have a Company Material Adverse Effect, each Company Plan that constitutes a &ldquo;nonqualified deferred
compensation plan&rdquo; within the meaning of Section&nbsp;409A of the Code is and has been maintained and operated in documentary and
operational compliance with Section&nbsp;409A of the Code or an available exemption therefrom.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any of its Subsidiaries maintains any Company Plan or other similar compensation or benefit arrangement that is subject
to the Laws of any jurisdiction outside of the United States or that is registered or required to be registered or approved by a non-U.S.
Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not be expected to have a Company Material Adverse Effect, (i)&nbsp;the Company ESOP was validly authorized, established and
maintained in accordance with applicable Law, (ii)&nbsp;the trust under the Company ESOP (the &ldquo;<U>Trust</U>&rdquo;) is a tax-exempt
trust established in accordance with Section&nbsp;501(a)&nbsp;of the Code and is administered and interpreted in accordance with applicable
Law, (iii)&nbsp;the Company ESOP has received a determination from the Internal Revenue Service that the Company ESOP meets the applicable
qualification requirements of Section&nbsp;401(a)&nbsp;of the Code and, to the Knowledge of the Company, since the date of such determination
(A)&nbsp;such qualified status has not been revoked and (B)&nbsp;nothing has occurred that would reasonably be expected to cause revocation
of such qualified status or inability to rely on such determination and (iv)&nbsp;the Common Stock held by the Trust constitute &ldquo;employer
securities&rdquo; as defined in Section&nbsp;409(l)&nbsp;of the Code and &ldquo;qualifying employer securities&rdquo; as defined in Section&nbsp;407(d)(5)&nbsp;of
ERISA. As of the date hereof, no loans have been granted to or are outstanding for any participant under the Company ESOP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.11.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Labor
Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not be expected to have a Company Material Adverse Effect, (i)&nbsp;neither the Company nor any of its Subsidiaries is a party
to, or bound by, any collective bargaining agreement, labor agreement or other labor-related agreement with a labor union, labor organization,
trades council, works council or similar organization and (ii)&nbsp;(A)&nbsp;there are no, and since January&nbsp;1, 2021, have been
no, labor organizing activities or representation or certification demands, petitions or proceedings by any labor organization, labor
union, trades council, works council or similar organization or group of employees of the Company or any of its Subsidiaries to organize
or represent any employees of the Company or any of its Subsidiaries, and no pending demand for recognition or certification as the exclusive
bargaining representative of any employees has been made by or on behalf of any labor union, labor organization, trades council, works
council or similar organization, (B)&nbsp;the consent of, consultation of or the rendering of formal advice by any labor union, labor
organization, trades council, works council, employee representative body or similar organization is not required for the execution and
delivery of this Agreement by the Company or the consummation by the Company of the Transactions, (C)&nbsp;since January&nbsp;1, 2021,
there has been no actual, or, to the Knowledge of the Company, threatened strike, lockout, slowdown, work stoppage, unfair labor practice
charge, grievance or arbitration against or affecting the Company or any of its Subsidiaries, (D)&nbsp;neither the Company nor any of
its Subsidiaries is engaged in any unfair labor practice and there are not any unfair labor practice charges or complaints against the
Company or any of its Subsidiaries pending or, to the Knowledge of the Company, threatened before the National Labor Relations Board
and (E)&nbsp;there is no material charge of discrimination in employment or employment practices by the Company, including with respect
to age, gender, race, religion or other legally protected category pending or, to the Knowledge of the Company, threatened before the
United States Equal Employment Opportunity Commission or any other Governmental Authority responsible for the prevention of unlawful
employment practices in any jurisdiction in which the Company or any Subsidiary has employed or currently employs any person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Since
January&nbsp;1, 2021, (i)&nbsp;there have been no allegations of sexual harassment, sexual abuse or other sexual misconduct made against
any member of the Company Board or officer of the Company subject to the reporting requirements of Section&nbsp;16(a)&nbsp;of Exchange
Act and (ii)&nbsp;there are no Actions pending or, to the Knowledge of the Company, threatened related to any allegations of sexual harassment,
sexual abuse or other sexual misconduct by any member of the Company Board or officer of the Company subject to the reporting requirements
of Section&nbsp;16(a)&nbsp;of the Exchange Act. Since January&nbsp;1, 2021, neither the Company nor any of its Subsidiaries has entered
into any settlement agreements related to allegations of sexual harassment, sexual abuse or other sexual misconduct by any member of
the Company Board or officer of the Company subject to the reporting requirements of Section&nbsp;16(a)&nbsp;of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Company Material Adverse Effect, the Company and its Subsidiaries are in compliance with
applicable Laws respecting labor and employment matters, including discrimination in employment, employment practices, equal employment
opportunity, terms and conditions of employment, disability rights or benefits, reasonable accommodations, hiring, training and/or promotion,
payroll, tax withholding, worker classification (including the proper classification of workers as contingent workers, independent contractors
and consultants), immigration (including applicable I-9 Laws), wages, hours, workers&rsquo; compensation, plant closings, labor and collective
bargaining, employee leave issues, unemployment insurance, mandatory social security and pension schemes, privacy, employee record keeping
and occupational safety and health, other than instances of noncompliance that would not reasonably be expected to result in material
liability to the Company or any of its Subsidiaries. Neither the Company nor any of its Subsidiaries has taken any action during the
past three (3)&nbsp;years that would trigger the notice and other requirements under the Worker Adjustment and Retraining Notification
Act of 1988 and any other similar applicable foreign, state or local statutes or regulations of any jurisdiction relating to any plant
closing or mass layoff or similar triggering event for which any material liability remains unsatisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.12.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Intellectual
Property; Data Privacy and Cybersecurity</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Section&nbsp;4.12(a)</U>&nbsp;of
the Company Disclosure Letter sets forth a true and complete list, as of the date of this Agreement, of all material Company Intellectual
Property that is issued, registered or subject to an application for issuance or registration, indicating for each item (i)&nbsp;the
current owner (including, with respect to domain names, the current registrant), (ii)&nbsp;the jurisdiction where the application, registration
or issuance is filed, (iii)&nbsp;the application, registration and issue number (as applicable) and (iv)&nbsp;the application, registration
and issue date (as applicable). Except as would not reasonably be expected to have a Company Material Adverse Effect, all Company Intellectual
Property that is issued or registered is subsisting and, to the Knowledge of the Company, valid and enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Company Material Adverse Effect, the Company and its Subsidiaries are the exclusive owners
of the Company Intellectual Property, free and clear of all Liens other than Permitted Liens, and have sufficient rights (which rights
are, to the Knowledge of the Company, valid and enforceable) to use all other Intellectual Property used in the conduct of the business
of the Company and its Subsidiaries as currently conducted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Company Material Adverse Effect, (i)&nbsp;all Persons (including current and former employees
and independent contractors) who are or were involved in or contributed to the development of, or otherwise would have rights in or to,
any Company Intellectual Property have irrevocably assigned to the Company or one of its Subsidiaries all of their rights in and to such
Company Intellectual Property (and such assignments are, to the Knowledge of the Company, valid), or the Company or one of its Subsidiaries
owns such Company Intellectual Property by operation of Laws; and (ii)&nbsp;the Company and each of its Subsidiaries have taken commercially
reasonable actions to protect and preserve the secrecy of all Trade Secrets owned by the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Company Material Adverse Effect, (i)&nbsp;the Company and its Subsidiaries do not use or
distribute, nor have used or distributed, any Software licensed, provided or distributed under any open source license, including any
license meeting the Open Source Definition or the Free Software Definition (as promulgated by the Open Source Initiative or the Free
Software Foundation, respectively) or any Software that contains or is derived from any such Software (&ldquo;<U>Open Source Software</U>&rdquo;)
in any manner that would require any source code of any proprietary Software owned or purported to be owned by the Company or its Subsidiaries
to be disclosed, licensed for free, publicly distributed or dedicated to the public; and (ii)&nbsp;the Company and its Subsidiaries are
in compliance with the terms and conditions of all relevant licenses (including all requirements relating to notices and making source
code available to third parties) for all Open Source Software used in the business of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Company Material Adverse Effect, no claims, disputes or other Actions are pending or, to
the Knowledge of the Company, threatened in writing (in each case, that has not since been resolved) challenging the ownership, enforceability,
scope, validity or use by the Company or any of its Subsidiaries of any Company Intellectual Property or alleging that the Company or
any of its Subsidiaries is infringing, misappropriating or otherwise violating the Intellectual Property of any Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Company Material Adverse Effect, (i)&nbsp;to the Knowledge of the Company,&nbsp;no Person
is infringing, misappropriating or otherwise violating any Company Intellectual Property and (ii)&nbsp;the operation of the business
of the Company and its Subsidiaries as currently conducted does not infringe, misappropriate or otherwise violate the Intellectual Property
of any other Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Company Material Adverse Effect, since January&nbsp;1, 2021, the Company and its Subsidiaries
have at all times posted privacy policies addressing the collection, retention, use and distribution of Personal Information. The Company
and its Subsidiaries are not in violation of, and the Company&rsquo;s and its Subsidiaries&rsquo; use and dissemination of Personal Information
are in compliance with (i)&nbsp;any requirements of self-regulatory frameworks or organizations with which the Company and its Subsidiaries
are contractually obligated to comply, including the Company&rsquo;s and its Subsidiaries&rsquo; binding and customer-facing privacy
policies and (ii)&nbsp;all applicable Laws or directives of any Governmental Authority, together with all binding regulatory guidance,
rules&nbsp;and requirements promulgated thereunder, each as amended from time to time that relate to data privacy, data security, data
protection, cybersecurity and marketing with respect to the collection, storage, use, disclosure, destruction or other processing, and
transfer of Personal Information (collectively, &ldquo;<U>Privacy Obligations</U>&rdquo;), in each case, except as would not reasonably
be expected to have a Company Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Company Material Adverse Effect, since January&nbsp;1, 2021: (i)&nbsp;there has not been
any violation of any Privacy Obligations; (ii)&nbsp;no Actions alleging noncompliance with Privacy Obligations in connection with the
conduct of the business of the Company and its Subsidiaries are pending or threatened in writing against the Company and its Subsidiaries
with respect to any of the foregoing; and (iii)&nbsp;the Company and its Subsidiaries have not been impacted by any Cybersecurity Incident
or otherwise required under any Privacy Obligations to give notice to any Person of any actual or alleged Cybersecurity Incident.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Company Material Adverse Effect, the IT Systems are sufficient for the current needs of
the business of the Company and its Subsidiaries and, to the Knowledge of the Company, do not contain any Malware. Except as would not
reasonably be expected to have a Company Material Adverse Effect, there have been no failures, breakdowns, outages or unavailability
of any of the foregoing that have caused any material disruption to the business of the Company or its Subsidiaries. Except as would
not reasonably be expected to have a Company Material Adverse Effect, (i)&nbsp;the Company and its Subsidiaries own or have valid rights
to use and access all IT Systems and (ii)&nbsp;the Company and its Subsidiaries have taken commercially reasonable actions to protect
the integrity and security of the IT Systems and maintain reasonable information security, backup and disaster recovery plans and procedures,
and such actions, plans and procedures are designed to be consistent with applicable Privacy Obligations with respect to the foregoing
and the data stored or processed thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.13.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Anti-Takeover
Provisions.</U> No &ldquo;fair price,&rdquo; &ldquo;moratorium,&rdquo; &ldquo;control share acquisition&rdquo; or other similar anti-takeover
statute or similar statute or regulation (each, a &ldquo;<U>Takeover Law</U>&rdquo;) applies to the Company with respect to this Agreement
or the Merger.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.14.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Real
Property</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Company Material Adverse Effect, either the Company or one of its Subsidiaries owns good
and valid title in fee simple to the Owned Real Property, free and clear of all Liens, other than Permitted Liens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Company Material Adverse Effect, the Company or one of its Subsidiaries has a good and
valid leasehold or subleasehold interest in each Leased Real Property pursuant to a lease or sublease agreement (each, a &ldquo;<U>Company
Lease</U>&rdquo;), free and clear of all Liens (other than Permitted Liens). Each Company Lease is in full force and effect, except as
enforceability thereof may be limited by the Bankruptcy and Equity Exception.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Company Material Adverse Effect, neither the Company nor any of its Subsidiaries, nor,
to the Knowledge of the Company, any other party under any Company Lease, is in material default under any Company Lease, and no event
has occurred that, with notice or lapse of time or both, would constitute a material default of any Company Lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company or one of its Subsidiaries, as applicable, have obtained all certificates of occupancy and other permits or approvals required
with respect to the use and occupancy of the Leased Real Property, except where a failure to obtain any such material permits or approvals
would not reasonably be expected to have a Company Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.15.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Contracts</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
for (A)&nbsp;this Agreement, (B)&nbsp;each Company Plan, (C)&nbsp;each Contract filed as an exhibit to the Filed SEC Documents, <U>Section&nbsp;4.15(a)</U>&nbsp;of
the Company Disclosure Letter sets forth a list of all Material Contracts as of the date of this Agreement and (D)&nbsp;each arrangement
disclosed under Item 404(a)&nbsp;of Regulation S-K under the Exchange Act in the Filed SEC Documents. For purposes of this Agreement,
 &ldquo;<U>Material Contract</U>&rdquo; means all Contracts to which the Company or any of its Subsidiaries is a party or by which the
Company, any of its Subsidiaries or any of their respective properties or assets is bound (other than any Contracts to which Parent,
BAM or any of their respective Affiliates is a counterparty, Company Plans,&nbsp;IMAs, any Contracts in respect of Investment Assets
and insurance, reinsurance or retrocession treaties, agreements, slips, binders, cover notes, including the Reinsurance Agreements, or
other similar arrangements) that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">are
or would be required to be filed by the Company as a &ldquo;material contract&rdquo; pursuant to Item 601(b)(10)&nbsp;of Regulation S-K
under the Securities Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">are
with an affiliate that would be required to be disclosed under Item 404(a)&nbsp;of Regulation S-K under the Exchange Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">relate
to the formation or management of any joint venture, partnership or other similar agreement that is material to the business of the Company
and its Subsidiaries, taken as a whole (excluding Investment Assets acquired in the ordinary course of business);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">provide
for Indebtedness for borrowed money or guarantees thereof of the Company or any of its Subsidiaries having an outstanding principal amount
in excess of $25,000,000 individually, other than any Indebtedness between or among any of the Company and any of its Subsidiaries;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Split-Segment; Name: a3 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
 &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;have been entered into since January&nbsp;1,
2021, and involve the acquisition from another Person or disposition to another Person of capital stock or other equity interests of
another Person or of a business, in each case, that are material to the Company and its Subsidiaries, taken as a whole (excluding, for
the avoidance of doubt, acquisitions or dispositions of investments made pursuant to the Investment Guidelines, or of supplies, products,
properties or other assets in the ordinary course of business);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&#8239;prohibit
the payment of dividends or distributions in respect of the capital of the Company or any of its wholly owned Subsidiaries, prohibit
the pledging of the capital of the Company or any wholly owned Subsidiary of the Company or prohibit the issuance of any guarantee by
the Company or any Subsidiary of the Company (other than pursuant to applicable Laws);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">contain
provisions that prohibit the Company or any of its Subsidiaries from competing in any material respect in any material line of business
or grant a right of exclusivity to any Person which prevents the Company or any Subsidiary of the Company from entering any material
territory, market or field or freely engaging in business anywhere in the world in any material respect, other than Contracts that can
be terminated (including such restrictive provisions) by the Company or any of its Subsidiaries on 180 or fewer days&rsquo; notice without
payment by the Company or any Subsidiary of the Company of any material penalty;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">involve
the settlement of any pending or threatened claim, action or proceeding that requires payment obligations of the Company or any of its
Subsidiaries after the date hereof in excess of $25,000,000, other than claims settled under Company Insurance Policies in the ordinary
course of business and within applicable policy limits;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(A)&nbsp;grant
any right of first refusal, right of first offer or similar right with respect to any material assets, rights or properties of the Company
or any of its Subsidiaries or (B)&nbsp;obligate the Company or any of its Subsidiaries to conduct business on an exclusive or preferential
basis or that contains a &ldquo;most favored nation&rdquo; or similar covenant with any third party and that are material to the Company
and its Subsidiaries, taken as a whole; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">contain
a license or grant of rights in, to or under material Intellectual Property (excluding (A)&nbsp;non-exclusive licenses granted in the
ordinary course of business, (B)&nbsp;licenses granted to or for the benefit of the Company or any of its Subsidiaries of commercially
available, &ldquo;off-the-shelf&rdquo; Software available on standard terms, and (C)&nbsp;licenses of Open Source Software).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(i)&nbsp;Each
Material Contract is valid and binding on the Company and/or any of its Subsidiaries to the extent such Person is a party thereto, as
applicable, and, to the Knowledge of the Company, each other party thereto, and is in full force and effect, except where the failure
to be valid, binding or in full force and effect would not reasonably be expected to have a Company Material Adverse Effect, (ii)&nbsp;the
Company and each of its Subsidiaries has, as of the date of this Agreement, performed all obligations required to be performed by it
under each Material Contract, except where such noncompliance would not reasonably be expected to have a Company Material Adverse Effect,
(iii)&nbsp;neither the Company nor any of its Subsidiaries has received written notice, as of the date of this Agreement, of the existence
of any event or condition which constitutes, or, after notice or lapse of time or both, will constitute, a default on the part of the
Company or any of its Subsidiaries under any Material Contract, except where such default would not reasonably be expected to have a
Company Material Adverse Effect, (iv)&nbsp;to the Knowledge of the Company, there are no events or conditions which constitute, or, after
notice or lapse of time or both, will constitute a default on the part of any counterparty under such Material Contract, except as would
not reasonably be expected to have a Company Material Adverse Effect and (v)&nbsp;neither the Company nor any of its Subsidiaries has
received written notice, as of the date of this Agreement, from any other party to a Material Contract that such other party intends
to terminate, not renew or renegotiate in any material respect the terms of any such Material Contract, except as would not reasonably
be expected to have a Company Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.16.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Actuarial
Appraisals; Reserves</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
of the date hereof, to the Knowledge of the Company, no actuarial appraisal prepared by third-party or internal actuaries with respect
to any in-force business, or blocks or lines of business, of any of the Company Insurance Subsidiaries prepared since January&nbsp;1,
2021 that the Company has delivered to Parent (each such appraisal, an &ldquo;<U>Actuarial Appraisal</U>&rdquo;) is inaccurate in any
material respect. The factual information and data provided by the Company and its Subsidiaries for use in connection with the preparation
of each Actuarial Appraisal was complete and accurate in all material respects as of the date so provided, subject in each case to any
limitations and qualifications contained in such Actuarial Appraisal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Reserves of each Company Insurance Subsidiary contained in its respective Statutory Statements as of and for the annual periods ended
December&nbsp;31, 2020, 2021 and 2022, in each case: (i)&nbsp;were determined in all material respects in accordance with generally accepted
actuarial standards consistently applied throughout the specified period and were fairly stated in accordance with sound actuarial principles
and Applicable SAP (in each case, except as otherwise noted in such Statutory Statements) and (ii)&nbsp;satisfied the requirements of
all applicable Law in all material respects, except as otherwise noted in such Statutory Statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.17.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Reinsurance</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Section&nbsp;4.17
</U>of the Company Disclosure Letter sets forth a complete and correct list of all reinsurance agreements to which any of the Company
Insurance Subsidiaries is a party, whether as ceding company or assuming company, under which such Company Insurance Subsidiary has any
material rights or material obligations (each, a &ldquo;<U>Reinsurance Agreement</U>&rdquo;). The Company has made available to Parent
a true and correct copy or a summary of material terms of each Reinsurance Agreement. Each Reinsurance Agreement is valid and binding
on the Company or its applicable Company Insurance Subsidiary party thereto and, to the Knowledge of the Company, each other party thereto,
and is in full force and effect, except where the failure to be valid, binding or in full force and effect would not reasonably be expected
to have a Company Material Adverse Effect. Neither the Company nor any Company Insurance Subsidiary has received written notice of the
existence of any event or condition which constitutes, or, after notice or lapse of time or both, will constitute, a material default
on the part of the Company or any Company Insurance Subsidiary under any Reinsurance Agreement and, to the Knowledge of the Company,
there does not exist any event, condition or omission that would constitute, after notice or lapse of time or both, such a material default.
To the Knowledge of the Company, there are no events or conditions which constitute, or, after notice or lapse of time or both, will
constitute, a material default on the part of any counterparty under such Reinsurance Agreement. Neither the Company nor any Company
Insurance Subsidiary has received written notice from any other party to a Reinsurance Agreement that such other party intends to cancel,
terminate or amend in any material respect the terms of any such Reinsurance Agreement. There are no pending or, to the Knowledge of
the Company, threatened in writing Actions with respect to any Reinsurance Agreement, except as would not reasonably be expected to have
a Company Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as set forth in <U>Section&nbsp;4.17</U> of the Company Disclosure Letter, (i)&nbsp;to the Knowledge of the Company, no party to a Reinsurance
Agreement is insolvent or the subject of a rehabilitation, liquidation, conservatorship, receivership, bankruptcy or similar proceeding,
(ii)&nbsp;to the Knowledge of the Company, the financial condition of each party to a Reinsurance Agreement is not impaired to the extent
that a default thereunder is reasonably anticipated, (iii)&nbsp;there are no, and since January&nbsp;1, 2021 there have been no, material
disputes under any Reinsurance Agreement other than disputes (A)&nbsp;in the ordinary course for which adequate loss reserves have been
established or (B)&nbsp;that otherwise have been fully resolved, and (iv)&nbsp;each Company Insurance Subsidiary that is party to a Reinsurance
Agreement is entitled under any applicable Insurance Laws and Applicable SAP to take full reinsurance credit in its Statutory Statements
for all amounts reflected therein that are recoverable by it pursuant to any Reinsurance Agreement, and no Governmental Authority has
objected in writing to the Statutory Statements reflecting such reinsurance credit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.18.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Investment
Assets</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has provided Parent with a true, correct and complete list of all bonds, stocks, mortgage loans and other investment assets that
were subject to the Reinsurance Agreements, carried on the books and records of, or that were otherwise owned by, the Company or any
of its Subsidiaries as of May&nbsp;31, 2023 (such bonds, stocks, mortgage loans and other investment assets, together with all such other
bonds, stocks, mortgage loans and other investment assets acquired by the Company and its Subsidiaries between such date and the date
of this Agreement, the &ldquo;<U>Investment Assets</U>&rdquo;). Except for Investment Assets sold in the ordinary course of business
since May&nbsp;31, 2023, or otherwise contemplated by this Agreement, the Company and its Subsidiaries, or a trustee acting on behalf
of the Company or any such Subsidiary, has, and will have as of the Closing Date, good and valid title to all of the Investment Assets
it purports to own (including pursuant to the Reinsurance Agreements), free and clear of all Liens except Permitted Liens. The Company
has provided Parent with a true, correct and complete copy of the applicable policies of the Company with respect to the investment of
the Investment Assets, including investment guidelines that apply to Investment Assets subject to Reinsurance Agreements (the &ldquo;<U>Investment
Guidelines</U>&rdquo;), and except as approved by the Company&rsquo;s investment committee, (i)&nbsp;the Company&rsquo;s Investment Assets
comply in all material respects with such Investment Guidelines and (ii)&nbsp;all transactions involving Investment Assets have complied
in all material respects with the Investment Guidelines since January&nbsp;1, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as set forth in <U>Section&nbsp;4.18(b)</U>&nbsp;of the Company Disclosure Letter, (i)&nbsp;the Company has no material funding obligations
of any kind, or obligation to make any material additional advances or investments (including any obligation relating to any investment
funds or vehicles, separate managed accounts, limited partnerships, currency or interest rate swap, hedge or similar arrangement) in
respect of, any of the Investment Assets and (ii)&nbsp;there are no material outstanding commitments, options, put agreements or other
arrangements relating to the Investment Assets to which the Company or any of its Subsidiaries would be subject upon or after the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Section&nbsp;4.18(c)</U>&nbsp;of
the Company Disclosure Letter sets forth a complete and correct list of all material investment management agreements relating to the
assets of the Company and its Subsidiaries (each, an &ldquo;<U>IMA</U>&rdquo;). The Company has made available to Parent a true and correct
copy or a summary of material terms of each IMA. Each IMA is valid and binding on the Company or its applicable Subsidiary party thereto
and, to the Knowledge of the Company, each other party thereto, and is in full force and effect, except where the failure to be valid,
binding or in full force and effect would not reasonably be expected to have a Company Material Adverse Effect. As of the date hereof,
the Company and each of its applicable Subsidiaries and, to the Knowledge of the Company, any other party thereto, has performed all
obligations required to be performed by it under each IMA. Neither the Company nor any of its Subsidiaries has received written notice
of the existence of any event or condition which constitutes, or, after notice or lapse of time or both, will constitute, a material
default on the part of the Company or any of its Subsidiaries under any IMA and, to the Knowledge of the Company, there does not exist
any event, condition or omission that would constitute, after notice or lapse of time or both, such a material default. To the Knowledge
of the Company, there are no events or conditions which constitute, or, after notice or lapse of time or both, will constitute, a material
default on the part of any counterparty under such IMA. Neither the Company nor any of its Subsidiaries has received written notice from
any other party to an IMA that such other party intends to cancel, terminate, not renew, change the scope of rights and obligations under
or renegotiate in any material respect the terms of any such IMA. There are no pending or, to the Knowledge of the Company, threatened
in writing Actions with respect to any IMA, except as would not reasonably be expected to have a Company Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.19.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Insurance
Business</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
 &#8239;<FONT STYLE="font-size: 10pt"><U>Section&nbsp;4.19(a)</U>&nbsp;of the Company Disclosure Letter contains a true, complete and
correct list, as of the date of this Agreement, of the Company Insurance Subsidiaries, together with the jurisdiction of domicile thereof.
Except as set forth in <U>Section&nbsp;4.19(a)</U>&nbsp;of the Company Disclosure Letter, since January&nbsp;1, 2021 (i)&nbsp;no Insurance
Regulator has alleged in writing that any Company Insurance Subsidiary has violated in any material respect, nor is there any pending
or, to the Knowledge of the Company, threatened in writing, investigation by any applicable Insurance Regulator related to alleged violations
by any Company Insurance Subsidiary of, any applicable Insurance Laws, and (ii)&nbsp;each Company Insurance Subsidiary has filed all
material reports, forms, rates, notices and materials required to be filed by it with any applicable Insurance Regulator, and none of
such reports, forms, rates, notices and other materials has been objected to by such Insurance Regulator within the period provided for
objection, except where such objections have been cured or otherwise resolved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Section&nbsp;4.19(b)</U>&nbsp;of
the Company Disclosure Letter sets forth a true and correct list of all permitted accounting practices utilized by the Company Insurance
Subsidiaries in the preparation of their respective Statutory Statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
 &#8239;<FONT STYLE="font-size: 10pt">Except as set forth in <U>Section&nbsp;4.19(c)</U>&nbsp;of the Company Disclosure Letter, none of
the Company Insurance Subsidiaries is commercially domiciled under the Laws of any jurisdiction or is otherwise treated as domiciled
in a jurisdiction other than that of its jurisdiction of incorporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
 &#8239;<FONT STYLE="font-size: 10pt">Except as set forth in <U>Section&nbsp;4.19(d)</U>&nbsp;of the Company Disclosure Letter, either
the Company nor any of the Company Insurance Subsidiaries is subject to any requirement imposed by a Governmental Authority to maintain
specified capital or surplus amounts or levels or is subject to any restriction on the payment of dividends or other distributions on
its shares of capital stock, except for any such requirements or restrictions imposed by applicable Laws of general application.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has made available to Parent and its advisors true and complete copies of (i)&nbsp;any material reports on financial examination
and (ii)&nbsp;any material reports on market conduct examination, in the case of each of (i)&nbsp;and (ii), delivered by any Insurance
Regulator in respect of any Company Insurance Subsidiary since January&nbsp;1, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as required by Insurance Laws of general applicability and the insurance or reinsurance Permits maintained by the Company Insurance Subsidiaries,
there are no material written agreements, memoranda of understanding, commitment letters or similar undertakings binding on the Company
or any of its Subsidiaries or to which the Company or any of its Subsidiaries is a party, on one hand, and any Governmental Authority
is a party or addressee, on the other hand, or any orders or directives by, or supervisory letters or cease-and-desist orders from, any
Governmental Authority, nor has the Company nor any of its Subsidiaries adopted any board resolution at the request of any Governmental
Authority, in each case specifically with respect to it or any of its Subsidiaries, which materially restrict the conduct of the Company
Insurance Subsidiaries&rsquo; business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.20.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Insurance
Policies</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&#8239;All
policy and contract forms on which any Company Insurance Subsidiary has issued an Insurance Contract and all amendments, applications,
marketing materials, brochures, illustrations and certificates pertaining thereto have, to the extent required by applicable Law, been
approved by all applicable Governmental Authorities or filed with such Governmental Authorities, subject to such exceptions as would
not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company Insurance
Subsidiaries have since January&nbsp;1, 2021, been in compliance with applicable Law regulating the marketing and sale of Insurance Contracts,
including (i)&nbsp;all applicable requirements and prohibitions relating to suitability of sales and replacement of policies and annuity
products, (ii)&nbsp;all applicable requirements relating to the disclosure of the nature of insurance products as policies of insurance,
(iii)&nbsp;all applicable requirements relating to insurance product projections and illustrations and (iv)&nbsp;all applicable requirements
relating to the advertising, sales and marketing of insurance and annuity products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&#8239;All
premium rates and rating plans in use by each Company Insurance Subsidiary with respect to any Insurance Contract have to the extent
required by applicable Law been approved by all applicable Governmental Authorities or filed with such Governmental Authorities, subject
to such exceptions as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
for regular periodic assessments in the ordinary course of business or assessments based on developments that are publicly known within
the insurance industry, as of the date hereof, there are no material unpaid claims or assessments made by any state insurance guaranty
association in connection with such association&rsquo;s fund relating to insolvent insurance companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.21.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Insurance
Producers</U>. Except as, individually or in the aggregate, is not and would not be reasonably expected to have a Company Material Adverse
Effect, since January&nbsp;1, 2021, (a)&nbsp;each employee who is an Insurance Producer and, to the Knowledge of the Company, each other
Insurance Producer, (i)&nbsp;at the time such Insurance Producer solicited, negotiated, marketed, underwrote or sold or produced any
Insurance Contract, was duly and appropriately appointed by a Company Insurance Subsidiary, in compliance with applicable Law, to act
as an Insurance Producer for such Insurance Contract, and was duly and appropriately licensed as an Insurance Producer (for the type
of business sold or produced by such Insurance Producer on behalf of such Company Insurance Subsidiary), in each jurisdiction in which
such Insurance Producer was required to be so licensed and (ii)&nbsp;has not been enjoined, indicted, convicted or made the subject of
any consent decree or judgment on account of any violation of applicable Law in connection with such Insurance Producer&rsquo;s actions
in his, her or its capacity as an Insurance Producer for any Company Insurance Subsidiary, and (b)&nbsp;the Company and its Subsidiaries
have not received any written notice from any Governmental Authority with respect to any failures by such Insurance Producers to be so
licensed or appointed. There are no outstanding disputes between the Company or any Company Insurance Subsidiary, on the one hand, and
an Insurance Producer, on the other hand, concerning material amounts of commissions or other incentive compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.22.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Insurance
Product-Related Tax Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Except as would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; <FONT STYLE="font-size: 10pt">Each
Insurance Contract (i)&nbsp;provides (and since the date of issuance, assumption, exchange, modification or purchase of such
Insurance Contract has provided) the purchaser, policyholder, account holder, other holder or intended beneficiary thereof with a
Tax treatment under the Code (including, but not limited to, Sections 72, 101, 817, 7702, 7702A and 7702B of the Code) and any
similar provision of state, local, and non-U.S. Law that is not less favorable than the Tax treatment (A)&nbsp;that was purported to
apply in written materials provided at the time of issuance, assumption, exchange, modification or purchase or (B)&nbsp;for which
such Insurance Contract was intended or reasonably expected to qualify under the Code (including, but not limited to, Sections 72,
101, 817, 7702, 7702A and 7702B of the Code) and any similar provision of state, local and non-U.S. Law at the time of issuance,
assumption, exchange, modification or purchase and (ii)&nbsp;complies with, and since the date of issuance, assumption, exchange,
modification or purchase of such Insurance Contract has complied with, the requirements applicable to, or intended to be applicable
to, such Insurance Contract under the provisions of the Code (including, but not limited to, Sections 72, 101, 817, 7702, 7702A and
7702B of the Code) and any similar provision of state, local and non-U.S. Law relating to such Insurance Contract and any Treasury
Regulations and administrative guidance issued thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">
No Insurance Contract is a &ldquo;modified endowment contract&rdquo; within the meaning of Section&nbsp;7702A of the Code, except
any Insurance Contract that is being administered as a &ldquo;modified endowment contract&rdquo; and with respect to which the
policyholder has consented in writing to the treatment of such Insurance Contract as a &ldquo;modified endowment contract&rdquo; and
has not acted to revoke such consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; <FONT STYLE="font-size: 10pt">None
of the Company and its Subsidiaries has entered into any agreement or has been within the last five years involved in any
discussions or negotiations with the IRS or any other Governmental Authority, or otherwise has requested within the last five years
relief from the IRS or any other Governmental Authority, regarding the failure of any Insurance Contract currently in force to meet
its intended Tax treatment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">None
of the Company and its Subsidiaries is a party to or has received written notice of any federal, state, local or foreign audits or other
administrative or judicial Action with regard to the Tax treatment of any Insurance Contract currently in force, or of any claims by
the purchasers, holders or intended beneficiaries thereof regarding the Tax treatment thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">None
of the Company and its Subsidiaries is a party to any &ldquo;hold harmless&rdquo; or indemnification agreement or tax sharing agreement
or similar arrangement under which it is liable for the Tax treatment of any Insurance Contract currently in force.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&#8239;The
Company and its Subsidiaries have complied with all reporting, withholding and disclosure requirements of the Code, Treasury Regulations
and forms issued by the IRS and other applicable Laws that are applicable to the Insurance Contracts and distributions thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notwithstanding
anything to the contrary in this Agreement, except for the representations and warranties set forth in this <U>Section&nbsp;4.22</U>,
neither of the Company nor any of its Subsidiaries makes, and each such party hereby expressly disclaims, any express or implied representations
or warranties, statutory, common law or otherwise, of any nature, with respect to the Tax treatment of any Insurance Contract, and as
to any obligations in respect of withholding, information reporting or record-keeping in respect thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.23.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Statutory
Statements</U>. The Company has made available to Parent copies of the following statutory statements, in each case together with the
exhibits, schedules and notes thereto (collectively, the &ldquo;<U>Statutory Statements</U>&rdquo;): (i)&nbsp;the statutory annual statement
of each Company Insurance Subsidiary as of and for the annual periods ended December&nbsp;31, 2020, 2021 and 2022, in each case as filed
with the applicable Insurance Regulator for such Company Insurance Subsidiary, and (ii)&nbsp;the statutory quarterly statements of each
Company Insurance Subsidiary as of and for the quarterly period ended March&nbsp;31, 2023, in each case as filed with the Insurance Regulator
of such Company Insurance Subsidiary, subject, in the case of Statutory Statements with respect to quarterly periods, to the absence
of full footnote disclosure and normal year-end audit adjustments. The Statutory Statements were prepared in conformity with Applicable
SAP applied consistently throughout the periods presented, and present fairly, in all material respects the statutory financial position
and results of operations of the Company Insurance Subsidiaries as of their respective dates and for the respective periods covered thereby.
Except as set forth on <U>Section&nbsp;4.23</U> of the Company Disclosure Letter, as of its filing date, and, if amended, as of the date
of the last amendment prior to the date hereof, each such filing complied with applicable Law in all material respects. No Governmental
Authority has asserted any material deficiency related to any such filing that has not been resolved, to the Knowledge of the Company,
to the material satisfaction of such Governmental Authority prior to the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.24.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Opinion
of Financial Advisor</U>. The Company Board has received an oral opinion (to be confirmed by delivery of a written opinion promptly after
the date hereof) of each of J.P. Morgan Securities LLC (&ldquo;<U>JPM</U>&rdquo;) and Ardea Partners LP (&ldquo;<U>Ardea Partners</U>&rdquo;),
to the effect that, as of the date of such opinion, and based upon and subject to the various assumptions, qualifications and limitations
set forth therein, the Merger Consideration to be paid to the holders (other than Parent and its Affiliates) of Common Stock is fair
from a financial point of view to such holders of Common Stock. It is agreed and understood that such opinion is for the benefit of the
Company Board and may not be relied on by Parent or Merger Sub for any purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.25.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Brokers
and Other Advisors</U>. Except for JPM and Ardea Partners, the fees and expenses of which will be paid by the Company pursuant to the
applicable engagement letter, no broker, investment banker, financial advisor or other Person is entitled to any broker&rsquo;s, finder&rsquo;s,
financial advisor&rsquo;s or other similar fee or commission in connection with the Transactions based upon arrangements made by or on
behalf of the Company, any of its Subsidiaries or any of their respective directors, officers or employees.&nbsp; The Company has provided
an estimated calculation as of the date of this Agreement of such fees and expenses payable to JPM and Ardea Partners pursuant to their
respective engagement letters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;4.26.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Critical
Technology</U>. Neither the Company nor any of its Subsidiaries produces, designs, tests, manufactures, fabricates, or develops one or
more &ldquo;critical technologies&rdquo; as that term is defined in 31 C.F.R. &sect; 800.215, and none of them has any current intention
of engaging in such activities in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;V</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>REPRESENTATIONS AND WARRANTIES OF PARENT AND
MERGER SUB</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Parent and Merger Sub jointly and severally represent
and warrant to the Company that except as (A)&nbsp;set forth in the corresponding section of the disclosure letter delivered by Parent
and Merger Sub to the Company on the date of this Agreement (the &ldquo;<U>Parent Disclosure Letter</U>&rdquo;) (it being agreed that
disclosure set forth in one section or sub-section of the Parent Disclosure Letter shall be deemed disclosure with respect to, and shall
be deemed to apply to and qualify, the section or sub-section of this <U>Article&nbsp;V</U> to which it corresponds in number and each
other section or sub-section of this <U>Article&nbsp;V</U> to the extent the qualifying nature of such disclosure with respect to such
other section or sub-section is reasonably apparent on the face of such disclosure) or (B)&nbsp;disclosed in any report, schedule, form,
statement or other document (including exhibits) filed with, or furnished to, the SEC by Parent and publicly available at least three
business days prior to the date of this Agreement (the &ldquo;<U>Parent SEC Documents</U>&rdquo;), other than any disclosure contained
in such Parent SEC Documents under the heading &ldquo;Risk Factor&rdquo; or &ldquo;Forward-Looking Statements&rdquo; or sections of such
reports, or that otherwise constitute risk factors or forward-looking statements:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.01.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Organization;
Standing</U>. Parent is a Bermuda exempted company limited by shares duly incorporated and organized, validly existing and in good standing
under the Laws of Bermuda, and Merger Sub is an Iowa corporation duly organized and validly existing under the IBCA. Each of Parent and
Merger Sub has all requisite power and authority necessary to carry on its business as it is now being conducted, except as would not
reasonably be expected to have a Parent Material Adverse Effect. Each of Parent and Merger Sub is duly licensed or qualified to do business
and is in good standing (where such concept is recognized under applicable Law) in each jurisdiction in which the nature of the business
conducted by it or the character or location of the properties and assets owned or leased by it makes such licensing or qualification
necessary, except where the failure to be so licensed, qualified or in good standing would not reasonably be expected to have a Parent
Material Adverse Effect or prevent, materially delay or materially impair the consummation by the Parent Entities of the Transactions.
Parent has made available to the Company true, complete and correct copies of Parent&rsquo;s certificate of incorporation and memorandum
of association and bylaws, and Merger Sub&rsquo;s articles of incorporation and bylaws, each as amended to the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.02.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Authority;
Noncontravention</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; <FONT STYLE="font-size: 10pt">Each
of Parent and Merger Sub has all necessary power and authority to execute and deliver this Agreement, to perform its obligations
hereunder and, subject to obtaining the Merger Sub Shareholder Approval, to consummate the Transactions. The execution, delivery and
performance by Parent and Merger Sub of this Agreement, and the consummation by Parent and Merger Sub of the Transactions, have been
duly and unanimously authorized and approved by each of the Parent Board and the Merger Sub Board, as applicable, and, except for
obtaining the Merger Sub Shareholder Approval (which approval shall be provided by the written consent of Arches Acquisition Holdco
II Inc. immediately following the execution of this Agreement), no other action (including any shareholder vote or other action) on
the part of Parent or Merger Sub or any of their Affiliates is necessary to authorize the execution, delivery and performance by
Parent and Merger Sub of this Agreement and the consummation by Parent and Merger Sub of the Transactions (including the delivery of
BAM Class&nbsp;A Stock as Stock Consideration pursuant to this Agreement). This Agreement has been duly executed and delivered by
Parent and Merger Sub and, assuming due authorization, execution and delivery hereof by each other party, constitutes a legal, valid
and binding obligation of each of Parent and Merger Sub, enforceable against each of them in accordance with its terms, except that
such enforceability may be limited by and is subject to the Bankruptcy and Equity Exception.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
of the Parent Board and the Merger Sub Board have unanimously (i)&nbsp;determined that the terms of this Agreement are in the best interests
of Parent or Merger Sub, as applicable, (ii)&nbsp;approved and adopted and declared the advisability of this Agreement and the Transactions,
including the Merger, as of the date of this Agreement, and such resolutions have not been subsequently rescinded, modified or withdrawn
in any way.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; <FONT STYLE="font-size: 10pt">Neither
the execution and delivery of this Agreement by Parent and Merger Sub, nor the consummation by Parent or Merger Sub of the
Transactions, nor performance of or compliance by Parent or Merger Sub with any of the terms or provisions hereof, will
(i)&nbsp;conflict with or violate any provision of the certificates or articles of incorporation, memorandums of association,
bylaws, bye-laws or other comparable charter or organizational documents of (A)&nbsp;Parent or Merger Sub or (B)&nbsp;any of
Parent&rsquo;s other Subsidiaries or (ii)&nbsp;assuming (A)&nbsp;compliance with the matters set forth in <U>Section&nbsp;4.03(c)</U>&nbsp;(other
than <U>Section&nbsp;4.03(c)(ii)(A)</U>) (and assuming the accuracy of the representations and warranties made in such <U>Section&nbsp;4.03(c)</U>),
(B)&nbsp;that the actions described in <U>Section&nbsp;5.02(a)</U>&nbsp;have been completed, (C)&nbsp;that the Consents referred to
in <U>Section&nbsp;5.03</U> and, in the case of Merger Sub, the Merger Sub Shareholder Approval are obtained and (D)&nbsp;that the
filings referred to in <U>Section&nbsp;5.03 </U>are made and any waiting periods thereunder have terminated or expired, in the case
of each of the foregoing clauses (A)&nbsp;through (D), prior to the Effective Time, (x)&nbsp;assuming the accuracy of the
representations and warranties made in <U>Section&nbsp;4.26</U>,&nbsp;violate any Law applicable to Parent or any of its
Subsidiaries, (y)&nbsp;require any consent or notice, or conflict with, violate or constitute a default under any of the terms,
conditions or provisions of any material Contract to which Parent or any of its Subsidiaries is a party or give rise to any right of
purchase, termination, amendment, acceleration or cancellation under, result in the loss of any benefit under, or result in the
triggering of any payments pursuant to, obligations under any such material Contract or (z)&nbsp;result in the creation of any Lien
on any properties or assets of Parent or any of its Subsidiaries, except, in the case of clauses (ii)(y)&nbsp;and (ii)(z), as would
not reasonably be expected to have a Parent Material Adverse Effect or prevent, materially delay or materially impair the
consummation by the Parent Entities of the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Merger Sub Shareholder Approval (which approval shall be provided by the written consent of Arches Acquisition Holdco II Inc. as contemplated
by Section&nbsp;7.12) is the only vote or approval of the holders of any class or series of shares of Merger Sub that is necessary to
approve this Agreement and the Merger.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.03.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Governmental
Approvals</U>. Except for (a)&nbsp;compliance with the applicable requirements of the Exchange Act and Securities Act and the rules&nbsp;and
regulations thereunder, including the filing with the SEC of (i)&nbsp;the Proxy Statement/Prospectus, (ii)&nbsp;solely if any Stock Consideration
is included in the Merger Consideration, a registration statement on Form&nbsp;F-4 relating to the registration under the Securities
Act of the shares of BAM Class&nbsp;A Stock that will constitute Stock Consideration (the &ldquo;<U>Form&nbsp;F-4</U>&rdquo;) and declaration
of effectiveness of the Form&nbsp;F-4 and (iii)&nbsp;such other reports as are required in connection with the Transactions, (b)&nbsp;solely
if any Stock Consideration is included in the Merger Consideration, filings required under, and compliance with, the rules&nbsp;and regulations
of the NYSE, including the approvals of the NYSE to authorize the listing of such shares of BAM Class&nbsp;A Stock, (c)&nbsp;filings
required under, and compliance with other applicable requirements of, the HSR Act, and such other Consents, filings, declarations or
registrations as are required to be made or obtained under any other Antitrust Laws, (d)&nbsp;the filing with FINRA of an application
by the Broker-Dealer Subsidiary under FINRA Rule&nbsp;1017 and the receipt of FINRA&rsquo;s approval of such application, (e)&nbsp;compliance
with any applicable state securities or blue sky laws, (f)&nbsp;approvals, filings and notices under all applicable Insurance Laws as
set forth in <U>Section&nbsp;5.03</U> of the Parent Disclosure Letter (the &ldquo;<U>Parent Insurance Approvals</U>&rdquo;), (g)&nbsp;the
Company Insurance Approvals (assuming the accuracy of the representations and warranties made in <U>Section&nbsp;4.04(g)</U>&nbsp;and
the completeness of Section&nbsp;4.04(g)&nbsp;of the Company Disclosure Letter) and (h)&nbsp;such other Consents, filings, declarations
or registrations that, if not obtained, made or given, would not reasonably be expected to have a Parent Material Adverse Effect or prevent,
materially delay or impair&nbsp;the consummation by the Parent Entities of the Transactions on a timely basis, and assuming the accuracy
of the representations and warranties made in <U>Section&nbsp;4.26</U>, no Consent of, or filing, declaration or registration with, any
Governmental Authority is necessary for the execution and delivery of this Agreement by Parent and Merger Sub, the performance by Parent
and Merger Sub of their obligations hereunder and the consummation by Parent and Merger Sub of the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.04.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Ownership
and Operations of Merger Sub</U>. Parent owns beneficially and of record, indirectly through one or more wholly owned Subsidiaries as
set forth on <U>Section&nbsp;5.04</U> of the Parent Disclosure Schedule, all of the issued and outstanding shares of Merger Sub, free
and clear of all Liens. Merger Sub was formed solely for the purpose of engaging in the Transactions, has no assets, liabilities or obligations
of any nature other than those incident to its formation and pursuant to the Transactions, and prior to the Effective Time, will not
have engaged in any business activities other than those relating to the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.05.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Sufficient
Funds</U>. Parent and Merger Sub collectively have, or have available to them, as of the date of this Agreement and will continue to
have, or have available to them, through and at the Effective Time unencumbered cash or cash equivalents that are sufficient to permit
Parent to pay the aggregate Cash Consideration, consideration payable to holders of Company Awards pursuant to <U>Section&nbsp;3.03</U>
and any other amount required to be paid in connection with the consummation of the Transactions, including the Payoff Amount and any
amounts that become payable in respect of the redemption of the Senior Notes, and to pay all related fees and expenses of Parent and
Merger Sub. For the avoidance of doubt, in no event shall the receipt or availability of any funds or financing by or to Parent or any
Affiliate of Parent be a condition to any of Parent&rsquo;s or Merger Sub&rsquo;s obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.06.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Guaranty
and Voting Agreement</U>. Concurrently with the execution of this Agreement, BN has delivered to the Company a true, complete and correct
copy of its duly executed Guaranty, and the Parent Group Shareholders have delivered to the Company a true, complete and correct copy
of their duly executed Voting Agreement. The Guaranty and the Voting Agreement are in full force and effect, have not been amended or
modified and constitute a legal, valid and binding obligation of the BN and the Parent Group Shareholders, respectively, enforceable
against them in accordance with their terms, subject to the Bankruptcy and Equity Exception. No event has occurred that, with notice
or lapse of time or both, would, or would reasonably be expected to, constitute a default on the part of BN or the Parent Group Shareholders
pursuant to the Guaranty or the Voting Agreement, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.07.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Certain
Arrangements</U>. As of the date of this Agreement, there are no Contracts or other arrangements or understandings (whether oral or written)
or commitments to enter into Contracts or other arrangements or understandings (whether oral or written) (a)&nbsp;between Parent, Merger
Sub or any of their Affiliates, on the one hand, and any member of the Company&rsquo;s management or the Company Board, on the other
hand, that relate in any way to the Company or any of its Subsidiaries or the Transactions, (b)&nbsp;pursuant to which any shareholder
of the Company would be entitled to receive consideration of a different amount or nature than the Merger Consideration or pursuant to
which any shareholder of the Company agrees to vote to approve the Merger and this Agreement or agrees to vote against any Superior Proposal
or (c)&nbsp;between Parent, Merger Sub or any of their Affiliates, on the one hand, and any holder of Company Awards, on the other hand,
pursuant to which such holder would be entitled to receive consideration of a different amount or nature than the consideration payable
pursuant to <U>Section&nbsp;3.03</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.08.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Information
Supplied</U>. None of the information supplied or to be supplied by or on behalf of Parent or Merger Sub for inclusion or incorporation
by reference in the Form&nbsp;F-4 or the Proxy Statement/Prospectus to be sent to the Company&rsquo;s shareholders in connection with
the Company Shareholders Meeting (including any amendment or supplement thereto or document incorporated by reference therein) shall,
on the date the Proxy Statement/Prospectus is first mailed to the Company&rsquo;s shareholders, at the time of any amendment thereof
or supplement thereto and at the time of the Company Shareholders Meeting or at the time the Form&nbsp;F-4 (and any amendment or supplement
thereto) is declared effective, contain any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading
or omit to state a material fact necessary to correct any statement in any earlier communication with respect to the solicitation of
proxies for the Company Shareholders Meeting which has become false or misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.09.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Legal
Proceedings</U>. Except as would not reasonably be expected to, individually or in the aggregate, have a Parent Material Adverse Effect
or prevent, materially delay or materially impair the consummation by the Parent Entities of the Transactions, as of the date of this
Agreement, there is no (a)&nbsp;Action pending or, to the Knowledge of Parent, threatened in writing, against Parent or any of its Affiliates
or (b)&nbsp;outstanding injunction, order, judgment, ruling, decree or writ imposed upon the Parent Entities or any of their Affiliates,
in each case, by or before any Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.10.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Compliance
with Laws</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; <FONT STYLE="font-size: 10pt">Parent,
Merger Sub and each of their respective Affiliates and their respective officers, directors, and personnel are, and since
January&nbsp;1, 2021, have been, in compliance with all Laws, judgments, decrees and orders of Governmental Authorities and Permits,
in each case, applicable to Parent, Merger Sub and their respective Affiliates, except as would not reasonably be expected to have a
Parent Material Adverse Effect or prevent, materially delay or materially impair the consummation by the Parent Entities of the
Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; <FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Parent Material Adverse Effect or prevent, materially delay or materially impair the
consummation by the Parent Entities of the Transactions, none of Parent, Merger Sub or any of their respective Affiliates is a party
to any agreement or settlement with any Governmental Authority, under which it has any ongoing obligations or restrictions, with
respect to any actual or alleged violation of any applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; <FONT STYLE="font-size: 10pt">Parent,
Merger Sub and each of their respective Affiliates, and, to the Knowledge of Parent, each of their respective directors, officers,
employees, agents, representatives or sales intermediaries (each in their capacities as such) and any other third party acting on
behalf of any of Parent, Merger Sub or any of their respective Affiliates, has, since January&nbsp;1, 2021, complied with all
applicable Specified Business Conduct Laws, except as would not reasonably be expected to have a Parent Material Adverse Effect or
prevent, materially delay or materially impair the consummation by the Parent Entities of the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; <FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Parent Material Adverse Effect or prevent, materially delay or materially impair the
consummation by the Parent Entities of the Transactions, since January&nbsp;1, 2021, none of Parent, Merger Sub or any of their
respective Affiliates, nor, to the Knowledge of Parent, any of their respective directors, officers or employees (each in their
capacities as such) has been, subject to any actual, pending or threatened civil, criminal or administrative actions, suits,
demands, claims, hearings, notices of violation, investigations, proceedings, demand letters, settlements or enforcement actions, or
made any disclosures to any Governmental Authority, involving Parent, Merger Sub or any of their respective Affiliates, in any way
relating to any applicable Specified Business Conduct Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; <FONT STYLE="font-size: 10pt">None
of Parent, Merger Sub or any of their respective Affiliates, nor, to the Knowledge of Parent, any of their respective directors,
officers, employees, agents, representatives or sales intermediaries (each in their capacities as such) or any other third party
acting on behalf of Parent, Merger Sub or any of their respective Affiliates, is a Sanctioned Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a Parent Material Adverse Effect or prevent, materially delay or materially impair the consummation
by the Parent Entities of the Transactions, since January&nbsp;1, 2021, none of Parent, Merger Sub or any of their respective Affiliates,
nor, to the Knowledge of Parent, any of their respective directors, officers, employees, agents, representatives, sales intermediaries
or any other third party acting on their behalf, has engaged in any dealings, transactions, activity or conduct with, involving or for
the benefit of, any Sanctioned Person in violation of any Specified Business Conduct Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.11.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Ownership
of Common Stock or Preferred Stock</U>. Except as set forth in <U>Section&nbsp;5.11</U> of the Parent Disclosure Letter, none of Parent,
Merger Sub or any of their Affiliates beneficially owns (within the meaning of Section&nbsp;13 of the Exchange Act), or will prior to
the Closing Date beneficially own, any Common Stock or Preferred Stock, or is a party, or will prior to the Closing Date become a party,
to any Contract, other arrangement or understanding (whether written or oral) (other than this Agreement) for the purpose of acquiring,
holding, voting or disposing of any Common Stock or Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.12.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Brokers
and Other Advisors</U>. Except for Barclays Capital Inc. (&ldquo;<U>Barclays</U>&rdquo;), the fees and expenses of which will be paid
by Parent, no broker, investment banker, financial advisor or other Person is entitled to any broker&rsquo;s, finder&rsquo;s, financial
advisor&rsquo;s or other similar fee or commission in connection with the Transactions based upon arrangements made by or on behalf of
Parent, any of its Subsidiaries or any of their respective directors, officers or employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.13.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Pending
Transactions</U>. As of the date hereof, to the Knowledge of Parent, neither Parent nor any of its Affiliates is party to any transaction
pending (a)&nbsp;to acquire or agree to acquire by merging or consolidating with, or by purchasing a substantial portion of the assets
of or equity in, or by any other manner, any Person or portion thereof, or (b)&nbsp;to otherwise acquire or agree to acquire any assets,
where the entering into of a definitive agreement relating to or the consummation of such acquisition, merger or consolidation, in each
case, would, or would reasonably be expected to, (x)&nbsp;impose any material delay in the obtaining of, or significantly increase the
risk of not obtaining, any consents, approvals, licenses, permits, orders, qualifications, authorizations of, or registrations or other
actions by, or any filings with or notifications to, any Governmental Authority necessary to consummate the Transactions or the expiration
or termination of any applicable waiting period, (y)&nbsp;significantly increase the risk of any Governmental Authority entering a governmental
order prohibiting the consummation of the Transactions, or (z)&nbsp;materially delay the consummation of the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;5.14.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Ownership
Structure</U>. <U>Section&nbsp;5.14</U> of the Parent Disclosure Letter sets forth a true, correct and complete list of: (i)&nbsp;Merger
Sub and each person who or which, as of the date hereof, &ldquo;controls&rdquo; (as such term is defined under the Insurance Laws of
the Company Insurance Subsidiaries&rsquo; domiciliary jurisdictions), directly or indirectly, Merger Sub (such persons, the &ldquo;<U>Control
Persons</U>&rdquo;), and (ii)&nbsp;all Persons who or which, as of the date hereof, &ldquo;control&rdquo; (as such term is defined under
the Insurance Laws of the Company Insurance Subsidiaries&rsquo; domiciliary jurisdictions), directly or indirectly, each of the Control
Persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;VI</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>REPRESENTATIONS AND WARRANTIES OF BAM</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">BAM represents and warrants to the Company that
except as (A)&nbsp;set forth in the corresponding section of the disclosure letter delivered by BAM to the Company on the date of this
Agreement (the &ldquo;<U>BAM Disclosure Letter</U>&rdquo;) (it being agreed that disclosure set forth in one section or sub-section of
the BAM Disclosure Letter shall be deemed disclosure with respect to, and shall be deemed to apply to and qualify, the section or sub-section
of this <U>Article&nbsp;VI</U> to which it corresponds in number and each other section or sub-section of this <U>Article&nbsp;VI</U>
to the extent the qualifying nature of such disclosure with respect to such other section or sub-section is reasonably apparent on the
face of such disclosure) or (B)&nbsp;disclosed in any report, schedule, form, statement, registration statement, prospectus, proxy statement
or other document required to be filed or furnished by BAM with the SEC on a timely basis pursuant to the Securities Act or the Exchange
Act since November&nbsp;21, 2022 and publicly available at least three business days prior to the date of this Agreement (collectively
with any other reports, schedules, forms, certifications, statements, registration statements, prospectuses, proxy statements and other
documents, including the exhibits and other information incorporated therein, filed or furnished by BAM with the SEC after the date hereof,
the &ldquo;<U>BAM SEC Documents</U>&rdquo;), other than any disclosure contained in such BAM SEC Documents under the heading &ldquo;Risk
Factor&rdquo; or &ldquo;Forward-Looking Statements&rdquo; or sections of such reports, or that otherwise constitute risk factors or forward-looking
statements:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.01.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Organization;
Standing</U>. BAM is a British Columbia company duly organized, validly existing and in good standing under the laws of British Columbia.
BAM has all requisite power and authority necessary to carry on its business as it is now being conducted, except as would not reasonably
be expected to have a BAM Material Adverse Effect. BAM is duly licensed or qualified to do business and is in good standing (where such
concept is recognized under applicable Law) in each jurisdiction in which the nature of the business conducted by it or the character
or location of the properties and assets owned or leased by it makes such licensing or qualification necessary, except where the failure
to be so licensed, qualified or in good standing would not reasonably be expected to have a BAM Material Adverse Effect. BAM has made
available to the Company true, complete and correct copies of BAM Organizational Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.02.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Capitalization</U>.
BAM has an authorized capitalization as of the date of this Agreement consisting of an unlimited number of class A preference shares,
an unlimited number of class A limited voting shares (&ldquo;<U>BAM Class&nbsp;A Stock</U>&rdquo;) and 21,280 class B limited voting
shares (&ldquo;<U>BAM Class&nbsp;B Stock</U>&rdquo;), and as of the May&nbsp;31, 2023, no shares of class A preference shares were issued
and outstanding, 412,439,447 shares of BAM Class&nbsp;A Stock were issued and outstanding and 21,280 shares of BAM Class&nbsp;B Stock
were issued and outstanding. All the outstanding shares of capital stock or other equity interests of BAM and of BAM ULC that are owned
by BAM have been duly and validly authorized and issued, are fully paid and non-assessable and, in the case of shares of BAM ULC owned
by BAM, are owned free and clear of any lien, charge, encumbrance, security interest, restriction on voting or transfer or any other
claim of any third party, except where the failure to be so authorized and issued, fully paid and non-assessable, owned by BAM, free
and clear of any lien, charge, encumbrance, security interest, restriction on voting or transfer or any other claim could not reasonably
be expected to have a BAM Material Adverse Effect. The shares of BAM Class&nbsp;A Stock to be delivered as Stock Consideration pursuant
to this Agreement are, and shall be as of their delivery in accordance with the terms of this Agreement to the holders of Common Stock
as of immediately prior to the Effective Time, free and clear of any Lien or restriction on voting or transfer, other than Liens created
by or through the actions of such holders or any of their respective Affiliates, and any Liens arising under or relating to applicable
securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.03.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Authority;
Noncontravention</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">BAM
has all necessary power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate the
Transactions. The execution, delivery and performance by BAM of this Agreement, and the consummation by BAM of the Transactions, have
been duly authorized by BAM, and no other action (including any shareholder vote or other action) on the part of BAM or any of its Affiliates
is necessary to authorize the execution, delivery and performance by BAM of this Agreement and the consummation by BAM of the Transactions
(including the delivery BAM Class&nbsp;A Stock as Stock Consideration pursuant to this Agreement). This Agreement has been duly executed
and delivered by BAM and, assuming due authorization, execution and delivery hereof by each other party, constitutes a legal, valid and
binding obligation of BAM, enforceable against it in accordance with its terms, except that such enforceability may be limited by and
is subject to the Bankruptcy and Equity Exception.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the execution and delivery of this Agreement by BAM, nor the consummation by BAM of the Transactions, nor performance of or compliance
by BAM with any of the terms or provisions hereof, will (i)&nbsp;conflict with or violate any provision of the BAM Organizational Documents
or other comparable charter or organizational documents of (A)&nbsp;BAM or (B)&nbsp;any of BAM&rsquo;s other Subsidiaries or (ii)&nbsp;assuming
(A)&nbsp;compliance with the matters set forth in <U>Section&nbsp;4.03(c)</U>&nbsp;(other than <U>Section&nbsp;4.03(c)(ii)(A)</U>) (and
assuming the accuracy of the representations and warranties made in such <U>Section&nbsp;4.03(c)</U>), (B)&nbsp;that the actions described
in <U>Section&nbsp;6.03(a)</U>&nbsp;have been completed, (C)&nbsp;that the Consents referred to in <U>Section&nbsp;6.04</U> are obtained
and (D)&nbsp;that the filings referred to in <U>Section&nbsp;6.04</U> are made and any waiting periods thereunder have terminated or
expired, in the case of each of the foregoing clauses (A)&nbsp;through (D), prior to the Effective Time, (x)&nbsp;assuming the accuracy
of the representations and warranties in <U>Section&nbsp;4.26</U>, violate any Law applicable to BAM or any of its Affiliates, (y)&nbsp;require
any consent or notice, or conflict with, violate or constitute a default under any of the terms, conditions or provisions of any material
Contract to which BAM or any of its Subsidiaries is a party or give rise to any right of purchase, termination, amendment, acceleration
or cancellation under, result in the loss of any benefit under or result in the triggering of any payments pursuant to, obligations under
any such material Contract or (z)&nbsp;result in the creation of any Lien on any properties or assets of BAM or any of its Subsidiaries,
except, in the case of clauses (ii)(y)&nbsp;and (ii)(z), as would not reasonably be expected to have a BAM Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.04.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Governmental
Approvals</U>. Except for (a)&nbsp;compliance with the applicable requirements of the Exchange Act and Securities Act and the rules&nbsp;and
regulations thereunder, including the filing with the SEC of (i)&nbsp;the Proxy Statement/Prospectus, (ii)&nbsp;a registration statement
on Form&nbsp;F-4 and declaration of effectiveness of the Form&nbsp;F-4 and (iii)&nbsp;such other reports required in connection with
the Transactions, (b)&nbsp;filings required under, and compliance with the rules&nbsp;and regulations of the NYSE, including the approvals
of the NYSE to authorize the listing of such shares of BAM Class&nbsp;A Stock, (c)&nbsp;filings required under, and compliance with other
applicable requirements of, the HSR Act, and such other Consents, filings, declarations or registrations as are required to be made or
obtained under any other Antitrust Laws, (d)&nbsp;compliance with any applicable state securities or blue sky laws, (e)&nbsp;the Company
Insurance Approvals (assuming the accuracy of the representations and warranties made in <U>Section&nbsp;4.04(g)</U>&nbsp;and the completeness
of <U>Section&nbsp;4.04(g)</U>&nbsp;of the Company Disclosure Letter) and (f)&nbsp;such other Consents, filings, declarations or registrations
that, if not obtained, made or given, would not reasonably be expected to have a BAM Material Adverse Effect, and assuming the accuracy
of the representations and warranties made in <U>Section&nbsp;4.26</U>, no Consent of, or filing, declaration or registration with, any
Governmental Authority is necessary for the execution and delivery of this Agreement by BAM, the performance by BAM of its obligations
hereunder and the consummation by BAM of the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.05.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Investment
Company Act</U>. BAM is not, and after giving effect to the exchange of BAM Class&nbsp;A Stock for Common Stock by the holders thereof,
will not be an &ldquo;investment company&rdquo; or an entity &ldquo;controlled&rdquo; by an &ldquo;investment company&rdquo; within the
meaning of the Investment Company Act of 1940, as amended, and the rules&nbsp;and regulations of the SEC thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.06.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Certain
Arrangements</U>. As of the date of this Agreement, there are no Contracts or other arrangements or understandings (whether oral or written)
or commitments to enter into Contracts or other arrangements or understandings (whether oral or written) (a)&nbsp;between BAM or any
of its Affiliates, on the one hand, and any member of the Company&rsquo;s management or the Company Board, on the other hand, that relate
in any way to the Company or any of its Subsidiaries or the Transactions, (b)&nbsp;pursuant to which any shareholder of the Company would
be entitled to receive consideration of a different amount or nature than the Merger Consideration or pursuant to which any shareholder
of the Company agrees to vote to approve the Merger and this Agreement or agrees to vote against any Superior Proposal or (c)&nbsp;between
BAM or any of its Affiliates, on the one hand, and any holder of Company Awards, on the other hand, pursuant to which such holder would
be entitled to receive consideration of a different amount or nature than the consideration payable pursuant to <U>Section&nbsp;3.03</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.07.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Information
Supplied</U>. None of the information supplied or to be supplied by or on behalf of BAM or any of its Affiliates for inclusion or incorporation
by reference in the Form&nbsp;F-4 or the Proxy Statement/Prospectus to be sent to the Company&rsquo;s shareholders in connection with
the Company Shareholders Meeting (including any amendment or supplement thereto or document incorporated by reference therein) shall,
on the date the Proxy Statement/Prospectus is first mailed to the Company&rsquo;s shareholders, at the time of any amendment thereof
or supplement thereto and at the time of the Company Shareholders Meeting, or at the time the Form&nbsp;F-4 (and any amendment or supplement
thereto) is declared effective, contain any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading
or omit to state a material fact necessary to correct any statement in any earlier communication with respect to the solicitation of
proxies for the Company Shareholders Meeting which has become false or misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.08.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>BAM
SEC Documents; Undisclosed Liabilities</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">BAM
has filed with or furnished to (as applicable) the SEC the BAM SEC Documents. As of their respective effective dates (in the case of
BAM SEC Documents that are registration statements filed pursuant to the requirements of the Securities Act) or their respective SEC
filing dates (in the case of all other BAM SEC Documents), or, if supplemented, modified or amended since the time of filing, as of the
date of the most recent supplement, modification or amendment, the BAM SEC Documents complied in all material respects with the requirements
of the Securities Act, the Exchange Act, the Sarbanes-Oxley Act and the applicable rules&nbsp;and regulations of the SEC promulgated
thereunder, applicable to such BAM SEC Documents, and none of the BAM SEC Documents contained any untrue statement of a material fact
or omitted to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. As of the date of this Agreement, there are no outstanding or unresolved comments from the SEC staff with
respect to any BAM SEC Document.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
of the consolidated financial statements of BAM (including all related notes or schedules) included or incorporated by reference in the
BAM SEC Documents complied as to form, as of the dates and for the periods referred to therein and as of their respective dates of filing
with the SEC, in all material respects with the applicable accounting requirements and published rules&nbsp;and regulations of the SEC,
the Securities Act and the Exchange Act with respect thereto, have been prepared in all material respects in accordance with GAAP as
in effect on the date of such statement (except, in the case of unaudited quarterly statements, for normal and recurring year-end adjustments)
applied on a consistent basis during the periods involved (except (i)&nbsp;as may be indicated in the notes thereto or (ii)&nbsp;as permitted
by Regulation S-X) and fairly present in all material respects the consolidated financial position of BAM and its consolidated Subsidiaries
as of the dates thereof and the consolidated results of their operations, changes in shareholders&rsquo; equity and cash flows for the
periods shown (subject, in the case of unaudited quarterly financial statements, to normal year-end adjustments). Since November&nbsp;21,
2022, BAM has not made any material change in the accounting practices or policies applied in the preparation of its financial statements,
except as required by GAAP, SEC rule&nbsp;or policy or applicable Law. None of BAM or its Subsidiaries is a party to, or has any obligation
or other commitment to become a party to, any &ldquo;off balance sheet arrangement&rdquo; (as defined in Item 303(a)&nbsp;of Regulation
S-K promulgated by the SEC).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&#8239;&#8239;Neither
BAM nor any of its Subsidiaries has any liabilities of any nature (whether accrued, absolute, contingent or otherwise) that would be
required under GAAP, as in effect on the date of this Agreement, to be reflected on a consolidated balance sheet of BAM (including the
notes thereto) except liabilities (i)&nbsp;reflected or reserved against in the balance sheet (or the notes thereto) of BAM and its Subsidiaries
as of December&nbsp;31, 2022, included in the Filed SEC Documents, (ii)&nbsp;incurred after December&nbsp;31, 2022, in the ordinary course
of business, (iii)&nbsp;as contemplated by this Agreement or otherwise incurred in connection with the Transactions, (iv)&nbsp;as relate
to Taxes or (v)&nbsp;as would not reasonably be expected to prevent or to impede, interfere with, hinder or delay in any material respect
the consummation of the Transactions or be material to BAM and its Subsidiaries, taken as a whole.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; &#8239;<FONT STYLE="font-size: 10pt">BAM
is, and since November&nbsp;21, 2022, has been, in compliance in all material respects with the provisions of the Sarbanes-Oxley Act
that are applicable to BAM.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&#8239;&#8239;No
material weaknesses exist with respect to the internal control over financial reporting of BAM that would be required to be disclosed
by BAM pursuant to Item 308(a)(3)&nbsp;of Regulation S-K promulgated by the SEC that have not been disclosed in the BAM SEC Documents
as filed with or furnished to the SEC prior to the date of this Agreement. BAM maintains a system of internal controls over financial
reporting (as defined in Rules&nbsp;13a-15(f)&nbsp;and 15d-15(f)&nbsp;of the Exchange Act) that is designed to provide reasonable assurances
(x)&nbsp;regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with GAAP, (y)&nbsp;that receipts and expenditures of BAM are being made only in accordance with authorizations of management and the
directors of BAM and (z)&nbsp;regarding prevention or timely detection of the unauthorized acquisition, use or disposition of BAM&rsquo;s
and its Subsidiaries&rsquo; assets that could have a material effect on BAM&rsquo;s financial statements. BAM has established and maintains
disclosure controls and procedures (as such term is defined in Rule&nbsp;13a-15(e)&nbsp;and Rule&nbsp;15d-15(e), as applicable, under
the Exchange Act) as required by Rule&nbsp;13a-15 under the Exchange Act, designed to ensure that information required to be disclosed
by BAM in the reports that it files and submits under the Exchange Act is recorded, processed, summarized and reported within the time
periods specified in the SEC&rsquo;s rules&nbsp;and forms, including that the information required to be disclosed by BAM in the reports
that it files and submits under the Exchange Act is accumulated and communicated to management of BAM, as appropriate, to allow timely
decisions regarding required disclosure and to make the certifications required pursuant to Sections 302 and 906 of the Sarbanes-Oxley
Act. Since November&nbsp;22, 2022, neither BAM nor any of its Subsidiaries has received any written complaint, allegation, assertion
or claim regarding the accounting or auditing practices, procedures, methodologies or methods of BAM or any of its Subsidiaries or their
respective internal accounting controls or any allegation of fraud that involves management of BAM or any other employee of BAM or any
of its Subsidiaries who has a significant role in BAM&rsquo;s internal controls over financial reporting or disclosure controls and procedures.
BAM has disclosed, based on its most recent evaluation, to BAM&rsquo;s outside auditors and the audit committee of the Board of Directors
of BAM, (i)&nbsp;all significant deficiencies and material weaknesses in the design and operation of internal control over financial
reporting which are reasonably likely to adversely affect in any material respect BAM&rsquo;s ability to record, process, summarize and
report financial data and (ii)&nbsp;any fraud, whether or not material, that involves management or other employees who have a significant
role in BAM&rsquo;s internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&#8239;&#8239;BAM
is in compliance in all material respects with the applicable listing and corporate governance rules&nbsp;and regulations of the NYSE
and the Toronto Stock Exchange (&ldquo;<U>TSX</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
of the date hereof, except as disclosed in the BAM SEC Documents, within the last twelve (12) months, no event has occurred and no relationship
exists that would be required to be reported by BAM pursuant to Item 404 of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.09.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Absence
of Certain Changes</U>. From December&nbsp;31, 2022 through the date of this Agreement, except for (a)&nbsp;the execution, delivery and
performance of this Agreement and the discussions, negotiations and transactions related thereto (including the Transactions) and to
alternative transactions to the Transactions and (b)&nbsp;any COVID Measures, (i)&nbsp;the business of BAM has been conducted in all
material respects in the ordinary course of business and (ii)&nbsp;there has not been any event or condition that has had, or would reasonably
be expected to have, a BAM Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.10.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Legal
Proceedings</U>. Except as would not reasonably be expected to, individually or in the aggregate, have a BAM Material Adverse Effect,
as of the date of this Agreement, there is no (a)&nbsp;Action pending or, to the Knowledge of BAM, threatened in writing, against BAM
or any of its Affiliates or (b)&nbsp;outstanding injunction, order, judgment, ruling, decree or writ imposed upon BAM or any of its Affiliates,
in each case, by or before any Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.11.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Compliance
with Laws</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">BAM
and each of its Affiliates and their respective officers, directors, and personnel are, and since July&nbsp;4, 2022, have been, in compliance
with all Laws, judgments, decrees and orders of Governmental Authorities and Permits, in each case, applicable to BAM or any of its Affiliates,
except as would not reasonably be expected to have a BAM Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a BAM Material Adverse Effect neither BAM nor any of its Affiliates is a party to any agreement
or settlement with any Governmental Authority, under which it has any ongoing obligations or restrictions, with respect to any actual
or alleged violation of any applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">BAM,
each of its Affiliates, and, to the Knowledge of BAM, each of their respective directors, officers, employees, agents, representatives
or sales intermediaries (each in their capacities as such) and any other third party acting on behalf of BAM or any of its Affiliates,
has, since July&nbsp;4, 2022, complied with all applicable Specified Business Conduct Laws, except as would not reasonably be expected
to have a BAM Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a BAM Material Adverse Effect, since July&nbsp;4, 2022, neither BAM nor any of its Affiliates,
nor, to the Knowledge of BAM, any of their respective directors, officers or employees (each in their capacities as such) has been, subject
to any actual, pending or threatened civil, criminal or administrative actions, suits, demands, claims, hearings, notices of violation,
investigations, proceedings, demand letters, settlements or enforcement actions, or made any disclosures to any Governmental Authority,
involving BAM or any of its Affiliates, in any way relating to any applicable Specified Business Conduct Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
BAM nor any of its Affiliates, nor, to the Knowledge of BAM, any of their respective directors, officers, employees, agents, representatives
or sales intermediaries (each in their capacities as such) or any other third party acting on behalf of BAM or any of its Affiliates,
is a Sanctioned Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; &#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to have a BAM Material Adverse Effect, since July&nbsp;4, 2022, neither BAM nor any of its
Affiliates, nor, to the Knowledge of BAM, any of their respective directors, officers, employees, agents, representatives, sales
intermediaries or any other third party acting on their behalf, has engaged in any dealings, transactions, activity or conduct with,
involving or for the benefit of, any Sanctioned Person in violation of any Specified Business Conduct Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;6.12.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Brokers
and Other Advisors</U>. No broker, investment banker, financial advisor or other Person is entitled to any broker&rsquo;s, finder&rsquo;s,
financial advisor&rsquo;s or other similar fee or commission in connection with the Transactions based upon arrangements made by or on
behalf of BAM, any of its Subsidiaries or any of their respective directors, officers or employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;VII</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ADDITIONAL COVENANTS AND AGREEMENTS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.01.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Conduct
of Business by the Company</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">During
the period from the date of this Agreement through the earlier of the Closing and the termination of this Agreement, except as required
by applicable Law, as expressly required by an Insurance Regulator, a Governmental Authority or the National Association of Insurance
Commissioners (&ldquo;<U>NAIC</U>&rdquo;) or as expressly required or permitted by this Agreement or described in <U>Section&nbsp;7.01(a)</U>&nbsp;of
the Company Disclosure Letter, unless Parent otherwise requests or consents in writing (such consent not to be unreasonably withheld,
conditioned or delayed), (w)&nbsp;the Company shall, and shall cause each of its Subsidiaries to, carry on its business in all material
respects in the ordinary course, (x)&nbsp;to the extent consistent with clause (w)&nbsp;and subject to clause (y), the Company shall,
and shall cause its Subsidiaries to, use its and their commercially reasonable efforts to (1)&nbsp;preserve their respective business
organizations substantially intact, (2)&nbsp;preserve existing relations with Governmental Authorities, policyholders, reinsurance providers,
rating agencies, producers, service providers and other Persons with whom the Company or its Subsidiaries have significant business relationships,
and (3)&nbsp;retain the services of its and their current officers and key employees, in each case, in all material respects and (y)&nbsp;the
Company shall not, and shall not permit any of its Subsidiaries to (it being understood that no act or omission by the Company or any
of its Subsidiaries with respect to the matters specifically addressed by any provision of this clause (y)&nbsp;below shall be deemed
to be a breach of clause (w)&nbsp;or (x)):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(A)&nbsp;issue,
sell or grant, or authorize the issue, sale or grant of, any Common Stock, Preferred Stock or other equity or voting interests of the
Company, or any securities or rights convertible into, exchangeable or exercisable for, or evidencing the right to subscribe for, any
Common Stock, Preferred Stock or other equity or voting interests of the Company or any of its Subsidiaries, or any options, rights,
warrants or other commitments or agreements to acquire from the Company or any of its Subsidiaries, or that obligate the Company or any
of its Subsidiaries to issue, any share capital of, or other equity or voting interests in, or any securities convertible into or exchangeable
for shares of, or other equity or voting interests in, the Company or any of its Subsidiaries; <U>provided</U> that the Company may issue
Common Stock, Preferred Stock or other securities as required pursuant to the vesting, settlement or exercise of Company Awards or Company
Rights, in either case, that are (x)&nbsp;outstanding on the date of this Agreement in accordance with the terms of the applicable Company
Award or Company Right in effect on the date of this Agreement or (y)&nbsp;granted after the date of this Agreement in accordance with
<U>Section&nbsp;7.01(a)</U>&nbsp;of the Company Disclosure Letter; <U>provided</U>, <U>further</U>, that the Subsidiaries of the Company
may make any such issuances, sales or grants to the Company or a direct or indirect wholly owned Subsidiary of the Company, (B)&nbsp;redeem,
purchase or otherwise acquire, or propose to redeem, purchase or otherwise acquire, any outstanding Common Stock, Preferred Stock or
other equity or voting interests of the Company, or any other securities or indebtedness of the Company, or any rights, warrants or options
to acquire any Common Stock, Preferred Stock or other equity or voting interests of the Company, or any other securities or indebtedness
of the Company, except (x)&nbsp;the acquisition by the Company of Common Stock in connection with the surrender of Common Stock by a
holder of a Company Option in order to pay the exercise price of such Company Option or (y)&nbsp;the withholding or disposition of Common
Stock to satisfy Tax withholding obligations with respect to Company Awards, (C)&nbsp;in the case of the Company, establish a record
date for, declare or propose to declare, set aside for payment or pay any dividend on, or make any other distribution in respect of the
Preferred Stock or other equity or voting interests of the Company, in each case, other than cash dividends with respect to the Common
Stock and the Preferred Stock as set forth in <U>Section&nbsp;7.01(a)(i)</U>&nbsp;of the Company Disclosure Letter or (D)&nbsp;adjust,
split, combine, subdivide or reclassify, or propose to adjust, split, combine, subdivide or reclassify, any Common Stock, Preferred Stock
or other equity or voting interests of the Company or any of its Subsidiaries, or any other securities in respect thereof, in lieu thereof
or in substitution therefor;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(A)&nbsp;incur,
assume, guarantee or otherwise become responsible for any Indebtedness for borrowed money, except for (v)&nbsp;Indebtedness incurred
solely between the Company and any of its Subsidiaries or solely between its Subsidiaries, (w)&nbsp;subject to <U>Section&nbsp;7.01(a)(xx)</U>,
any incurrence, assumption or guarantee of indebtedness by any Company Insurance Subsidiary in the ordinary course (including any letters
of credit issued in connection with ordinary course reinsurance transactions), (x)&nbsp;guarantees of Indebtedness incurred in compliance
with this <U>Section&nbsp;7.01(a)(ii)</U>, (y)&nbsp;Indebtedness in replacement of or to refinance existing Indebtedness, provided that
such replacement or refinancing indebtedness is in an aggregate principal amount not greater than the principal amount of debt so replaced
or prepaid (plus any fees, premiums or penalties payable in connection with such replacement or refinancing) and (z)&nbsp;any other incurrence,
assumption or guarantee of Indebtedness so long as the aggregate principal amount thereof does not exceed $25,000,000, or (B)&nbsp;enter
into any swap or hedging transaction or other derivative agreements (or amend or modify any such transaction or agreement) other than
in the ordinary course of business and in compliance with the Investment Guidelines; provided that, in each case under this clause (ii),
the incurrence or replacement of any Indebtedness that is extinguished in full prior to, or concurrently with, the Closing in an amount
not to exceed $25,000,000 in the aggregate shall not be deemed to be a breach of this provision;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">sell,
lease or place under management to or by any Person, in a single transaction or series of related transactions, any of its owned properties
or assets (other than Intellectual Property, which is the subject of <U>Section&nbsp;7.01(a)(xix)</U>) whose value or purchase price
exceeds $10,000,000 individually, or $25,000,000 in the aggregate, except for (A)&nbsp;dispositions of obsolete, surplus or worn out
assets or assets that are no longer used or useful in the conduct of the business of the Company or any of its Subsidiaries, (B)&nbsp;transfers
among the Company and its Subsidiaries, (C)&nbsp;leases and subleases of real property owned or leased by the Company and any of its
Subsidiaries, (D)&nbsp;pursuant to Contracts in effect on the date of this Agreement (or entered into after the date of this Agreement
in compliance with this Agreement) or (E)&nbsp;subject to <U>Section&nbsp;7.01(a)(xx)</U>, other transactions in the ordinary course
of business (including portfolio management transactions by Company Insurance Subsidiaries) or consistent with the Investment Guidelines
(including in connection with cash management or investment portfolio activities);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">make
any loans, advances or capital contributions to, or investments in, any other person (other than any Subsidiary of the Company) other
than (A)&nbsp;loans by any Company Insurance Subsidiary that constitute Investment Assets subject to Section&nbsp;7.01(a)(xx)&nbsp;or
made in the ordinary course of business not to exceed $1,000,000 individually, or $25,000,000 in the aggregate, (B)&nbsp;advances for
expenses incurred in the ordinary course of business, (C)&nbsp;subject to <U>Section&nbsp;7.01(a)(xx)</U>,&nbsp;as relates to Investment
Assets made in the ordinary course of business and (D)&nbsp;in connection with transactions permitted pursuant to <U>Section&nbsp;7.01(a)(v)</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">make
any acquisition (including by merger or amalgamation) of the share capital or other equity or voting interests of any other Person or
a material portion of the assets of any other Person or any business or any corporation, partnership, joint venture, association or other
business organization or division thereof, in each case for consideration in excess of $10,000,000 individually or $25,000,000 in the
aggregate, except for and subject to <U>Section&nbsp;7.01(a)(xx)</U>,&nbsp;Investment Assets acquired in the ordinary course of business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">except
as required pursuant to the terms of any Company Plan in effect on the date of this Agreement, (A)&nbsp;grant to any Company Employee
with an annual base salary or annualized base wage rate (as applicable) of (1)&nbsp;$250,000 or above, any increase in compensation or
benefits (or pay any bonus to, or grant any loan to any such Company Employees) and (2)&nbsp;below $250,000 an increase in excess of
5% of such employee&rsquo;s annual base salary or annualized base wage rate (as applicable) in effect as of the date hereof, (B)&nbsp;grant
any new (or increase any existing) rights to any current or former director, officer or employee of the Company or any of its Subsidiaries
in respect of any severance, change in control, retention, termination or similar compensation or benefits, (C)&nbsp;make any bonus,
bonus opportunity, incentive award, equity or equity-based award to any current, former or prospective director, officer, employee, agent
or consultant of the Company or any Company Subsidiary, (D)&nbsp;take any action to accelerate the vesting or lapse of restrictions or
payment, or to fund or secure the payment of, any compensation or benefits, (E)&nbsp;establish, adopt, enter into, terminate, modify
or amend any material Company Plan (other than ministerial or other administrative changes that do not materially increase the cost to
the Company and its Subsidiaries of administering the Company Plan) or collective bargaining agreement or other agreement with a labor
union, works council, trade union, labor association or other employee representative organization, (F)&nbsp;hire or&nbsp;terminate (other
than for &ldquo;cause&rdquo;) the employment of any individual who is or would be (as applicable) a Company Employee with an annual base
salary or annualized base wage rate (as applicable) of $250,000 or above; <U>provided</U>, <U>however</U>, that the foregoing shall not
restrict the Company or any of its Subsidiaries from entering into or making available to newly hired employees or to current Company
Employees with an annual base salary or annualized base wage rate (as applicable) below $250,000 in the context of promotions based on
job performance or workplace requirements, in each case, in the ordinary course of business, plans, agreements, benefits and compensation
arrangements (excluding equity-based incentive grants)&nbsp;that have terms and a value that is consistent with the past practice of
making compensation and benefits available to newly hired or promoted employees in similar positions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">issue
or forgive any loans (other than routine travel or business expense advances issued in the ordinary course of business) to any employee,
director or independent contractor (who is a natural person) of the Company or any of its Subsidiaries;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">make
any material changes, alterations or departures in financial accounting methods, principles or practices materially affecting the consolidated
assets, liabilities or results of operations of the Company and its Subsidiaries, except insofar as may be required by (or in the reasonable
good faith judgment of the Company, advisable under) (A)&nbsp;GAAP (or any interpretation thereof), including pursuant to standards,
guidelines and interpretations of the FASB or any similar organization, (B)&nbsp;Applicable SAP (or any interpretation thereof), including
pursuant to standards, guidelines and interpretations of the NAIC or (C)&nbsp;any applicable Laws, including Regulation S-X under the
Securities Act, or any Governmental Authority;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">except
as may be required by (or, in the reasonable good faith judgment of the Company, advisable under) (A)&nbsp;GAAP (or any interpretation
thereof), including pursuant to standards, guidelines and interpretations of the FASB or any similar organization, (B)&nbsp;Applicable
SAP (or any interpretation thereof), including pursuant to standards, guidelines and interpretations of the NAIC or (C)&nbsp;any applicable
Laws or any Governmental Authority, alter, amend or depart from in any material respect any existing financial accounting practice guideline,
policy or principle of the Company or any of its Subsidiaries;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; &#8239;<FONT STYLE="font-size: 10pt">except
as may be required by (or, in the reasonable good faith judgment of the Company, advisable under) (A)&nbsp;GAAP (or any
interpretation thereof), including pursuant to standards, guidelines and interpretations of the FASB or any similar organization,
(B)&nbsp;Applicable SAP (or any interpretation thereof), including pursuant to standards, guidelines and interpretations of the NAIC
or (C)&nbsp;any applicable Laws or any Governmental Authority, alter, amend or depart, in each case, that would result in a material
deviation (with materiality measured relative to the Company and its Subsidiaries, taken as a whole) from any existing underwriting,
reserving, claim handling, actuarial, loss control, investment, reinsurance or retrocession practice guideline, policy or principle
of the Company and its Subsidiaries;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&#8239;(A)&nbsp;amend
the Company Organizational Documents or (B)&nbsp;amend in any material respect the comparable organizational documents of any of the
Subsidiaries of the Company in a manner that would reasonably be expected to prevent or to impede, interfere with, hinder or delay in
any material respect the consummation of the Transactions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">adopt
a plan or agreement of complete or partial liquidation or dissolution, merger, amalgamation, consolidation, restructuring, recapitalization
or other reorganization of the Company or any of its Subsidiaries (other than dormant Subsidiaries or, with respect to any merger, amalgamation
or consolidation, other than among the Company and any wholly owned Subsidiary of the Company or among wholly owned Subsidiaries of the
Company);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">grant
any Lien (other than Permitted Liens) on any of its material assets other than to secure Indebtedness permitted pursuant to <U>Section&nbsp;7.01(a)(ii)</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">other
than in connection with claims under Insurance Contracts or Reinsurance Agreements, settle or compromise any pending or threatened Action
against the Company or any of its Subsidiaries for a cash settlement amount of more than $10,000,000 individually or $25,000,000 in the
aggregate (net of amounts reserved for such matters by the Company or any of its Subsidiaries or amounts covered by insurance), or which
settlement imposes any material restrictions on any of the future activities of the Company and its Subsidiaries or that imposes equitable
relief on, or the admission of wrongdoing by, the Company, any of its Subsidiaries or any of their respective officers or directors;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(A)&nbsp;make
(inconsistent with past practice), change or revoke any Tax election that is material to the Company and its Subsidiaries, taken as a
whole; (B)&nbsp;settle or compromise any audit, claim, assessment or other proceeding relating to a material amount of Tax; (C)&nbsp;make
any change to any annual Tax accounting period or method of Tax accounting, which change is material to the Company and its Subsidiaries,
taken as a whole; (D)&nbsp;amend, refile or otherwise revise any previously filed material Tax Return; (E)&nbsp;request a ruling relating
to Tax (other than requests for automatic changes to methods of Tax accounting, which requests are exclusively addressed in clause (C)&nbsp;above);
(F)&nbsp;enter into or terminate any agreement with any Tax authority with respect to Tax (other than agreements to settle or compromise
such audits, claims, assessments or other proceedings referred to in clause (B), which are exclusively addressed in clause (B)); (G)&nbsp;surrender
any right to claim a refund of material Taxes; (H)&nbsp;consent to any extension or waiver of the limitation period applicable to any
Tax claim or Tax assessment that is, in each case, material to the Company and its Subsidiaries, taken as a whole; or (I)&nbsp;enter
into any Tax sharing, indemnity or similar agreement (other than any such agreement (1)&nbsp;solely among the Company or any of its Subsidiaries
or (2)&nbsp;that does not relate principally to Taxes);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(A)&nbsp;enter
into any new material line of business that is not an annuity line of business and in which the Company and its Subsidiaries do not operate
as of the date of this Agreement and which is not complementary to any existing lines of business of the Company and its Subsidiaries;
provided, that the aggregate amount of the Company&rsquo;s and its Subsidiaries&rsquo; general account assets used or reserved for use
with respect to all such new lines of business do not exceed $200,000,000 in the aggregate; or (B)&nbsp;withdraw from any existing material
line of business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(A)&nbsp;commute,
recapture, terminate, materially amend or cause or permit (to the extent within the control of the Company and its Subsidiaries) the
acceleration of any material amounts payable under any third-party Reinsurance Agreement,&nbsp;IMA or Material Contract, other than,
in the case of any Material Contract evidencing Indebtedness, any amendment or waiver obtained pursuant to, and in accordance with, <U>Section&nbsp;7.17(c)</U>&nbsp;or
(B)&nbsp;enter into any Contract that would have been a Reinsurance Agreement with a third-party or an IMA or a Material Contract had
it been entered into before the execution of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xviii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">amend
the Investment Guidelines set forth in <U>Section&nbsp;7.01(a)(xviii)</U>&nbsp;of the Company Disclosure Letter in any material respect;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xix)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">voluntarily
(A)&nbsp;abandon, dispose of or permit to lapse any Company Intellectual Property material to the Company and its Subsidiaries, taken
as a whole, other than in the ordinary course of business or at the end of the statutory term for such Company Intellectual Property,
or (B)&nbsp;fail to maintain the secrecy of any material Trade Secrets included in the Company Intellectual Property, other than in the
ordinary course of business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xx)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&#8239;acquire
or make any commitment to acquire Investment Assets, other than as set forth in <U>Section&nbsp;7.01(a)(xx)</U>&nbsp;of the Company Disclosure
Letter; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">authorize
any of, or commit or agree, in writing or otherwise, to take any of, the foregoing actions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">
 &#8239;Nothing in this Agreement is intended to give Parent, directly or indirectly, the right to control or direct the Company&rsquo;s or
its Subsidiaries&rsquo; operations prior to the Effective Time, and nothing in this Agreement is intended to give the Company,
directly or indirectly, the right to control or direct Parent&rsquo;s or its Subsidiaries&rsquo; operations. Prior to the Effective
Time, each of Parent and the Company shall exercise, consistent with the terms and conditions of this Agreement, complete control
and supervision over its and its Subsidiaries&rsquo; respective operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.02.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Conduct
of Business by BAM</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">During
the period from the date of this Agreement through the earlier of the Closing and the termination of this Agreement, except as required
by applicable Law or as expressly required or permitted by this Agreement or described in <U>Section&nbsp;7.02(a)</U>&nbsp;of the BAM
Disclosure Letter, unless the Company otherwise consents in writing (such consent not to be unreasonably withheld, conditioned or delayed),
(x)&nbsp;BAM shall, and shall cause each of its Subsidiaries to, carry on their respective businesses in all material respects in the
ordinary course, and (y)&nbsp;BAM shall not, and shall not permit any of its Subsidiaries to (it being understood that no act or omission
by BAM or any of its Subsidiaries with respect to the matters specifically addressed by any provision of this clause (y)&nbsp;below shall
be deemed to be a breach of clause (x)):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">establish
a record date for, declare or propose to declare, set aside for payment or pay in respect of the BAM Class&nbsp;A Stock any (A)&nbsp;non-cash
dividend or other non-cash distribution or (B)&nbsp;any cash dividend or other distribution other than regular quarterly cash dividends
declared in the ordinary course of business consistent with BAM&rsquo;s dividend policy as in effect on the date hereof and set forth
in the BAM SEC Documents;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(A)&nbsp;amend
the BAM Organizational Documents or (B)&nbsp;amend in any material respect the comparable organizational documents of any of the Subsidiaries
of BAM in a manner that would reasonably be expected to prevent or impede, interfere with, hinder or delay in any material respect the
consummation of the Transactions;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">adopt
a plan or agreement of complete or partial liquidation or dissolution, merger, amalgamation, consolidation, restructuring, recapitalization
or other reorganization of or involving BAM or any of its Subsidiaries (other than dormant Subsidiaries or, with respect to any merger,
amalgamation or consolidation, other than among BAM and any wholly owned Subsidiary of BAM or among wholly owned Subsidiaries of BAM);
or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&#8239;authorize
any of, or commit or agree, in writing or otherwise, to take any of, the foregoing actions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; &#8239;<FONT STYLE="font-size: 10pt">During
the period that begins five business days before the BAM Class&nbsp;A Stock Price Measuring Period through the earlier of the
Closing and the termination of this Agreement, except as required by applicable Law or as expressly required or permitted by this
Agreement or described in <U>Section&nbsp;7.02(b)</U>&nbsp;of the BAM Disclosure Letter, unless the Company otherwise consents in
writing (such consent not to be unreasonably withheld, conditioned or delayed),&nbsp;BAM shall not, and shall not permit any of its
Subsidiaries to redeem, purchase or otherwise acquire, or propose to redeem, purchase or otherwise acquire, any outstanding BAM
Class&nbsp;A Stock or other equity or voting interests of BAM, or any other securities or indebtedness of BAM, or any rights,
warrants or options to acquire any BAM Class&nbsp;A Stock or other equity or voting interests of BAM, or any other securities or
indebtedness of BAM.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.03.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>No
Solicitation by the Company; Change in Recommendation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as permitted by this <U>Section&nbsp;7.03</U>, from and after the date hereof and continuing until the earlier of the Effective Time
and the termination of this Agreement and abandonment of the Transactions pursuant to <U>Article&nbsp;IX</U>, the Company shall, and
the Company shall cause each of its Subsidiaries, and its and their respective directors, officers and employees to, and shall use its
reasonable best efforts to cause its other Representatives to, (i)&nbsp;immediately cease any solicitation, encouragement, discussions
or negotiations of or with any Persons that may be ongoing with respect to a Takeover Proposal and (ii)&nbsp;during the period from the
date of this Agreement through the earlier of the Closing and the termination of this Agreement, not, directly or indirectly, (A)&nbsp;solicit,
encourage, initiate or knowingly facilitate the submission of any inquiry or the making of any proposal, in each case, that constitutes,
or would reasonably be expected to lead to, a Takeover Proposal, (B)&nbsp;engage in or otherwise participate in any discussions or negotiations
regarding, or furnish to any other Person any material non-public information for the purpose of facilitating, a Takeover Proposal or
(C)&nbsp;approve or recommend, make any public statement approving or recommending, or enter into any letter of intent, agreement or
agreement in principle that constitutes or would reasonably be expected to lead to a Takeover Proposal. Promptly following the execution
of this Agreement, the Company shall, to the extent it had not previously done so prior to the date of this Agreement, deliver a request
to each Person that has previously executed a confidentiality agreement with the Company during the twelve (12)&nbsp;months prior to
the date of this Agreement in connection with considering or making a Takeover Proposal to promptly return to the Company or destroy
all non-public information previously furnished or made available to such Person or any of its Representatives by or on behalf of the
Company or any of its Subsidiaries in accordance with the terms of the applicable confidentiality agreement and immediately terminate
all physical and electronic dataroom access previously granted to any such Persons or their Representatives. The Company shall be liable
for any action taken by any Representative of the Company that if taken by the Company would constitute a breach of this <U>Section&nbsp;7.03</U>.
Notwithstanding the foregoing, the Company shall be permitted to waive any standstill provision to allow any Person to make a Takeover
Proposal to the Company Board on a non-public basis if the Company Board has determined in good faith, after consultation with the Company&rsquo;s
outside legal counsel, that failure to take such action would reasonably be expected to be inconsistent with the directors&rsquo; fiduciary
duties under applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; <FONT STYLE="font-size: 10pt">Notwithstanding
anything contained in <U>Section&nbsp;7.03(a)</U>&nbsp;or any other provision of this Agreement to the contrary, if at any time
prior to obtaining the Required Shareholder Approval the Company receives a bona fide Takeover Proposal, then (i)&nbsp;the Company
and its Representatives may contact such Person or group of Persons making the Takeover Proposal to clarify the terms and conditions
thereof or to request that any Takeover Proposal made orally be made in writing and (ii)&nbsp;if the Company Board has determined in
good faith, after consultation with the Company&rsquo;s financial advisors and outside legal counsel, that such Takeover Proposal
constitutes or could reasonably be expected to lead to a Superior Proposal, then the Company and its Representatives may
(x)&nbsp;enter into an Acceptable Confidentiality Agreement with the Person or group of Persons making the Takeover Proposal and
furnish pursuant thereto information (including non-public information)&nbsp;with respect to the Company and its Subsidiaries to the
Person or group of Persons who has made such Takeover Proposal; <U>provided</U> that the Company shall simultaneously provide to
Parent any information with respect to the Company and its Subsidiaries that is provided to any Person to the extent access to such
information was not previously provided to Parent and its Representatives and (y)&nbsp;after entering into an Acceptable
Confidentiality Agreement, engage in or otherwise participate in discussions or negotiations with the Person or group of Persons
making such Takeover Proposal. In no event may the Company or any of its Subsidiaries or any of their respective Representatives
directly or indirectly reimburse or pay, or agree to reimburse or pay, the fees, costs or expenses of, or provide or agree to
provide any compensation to, any Person or group of Persons (or any of its or their representatives or potential financing
sources)&nbsp;making a Takeover Proposal in connection with any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; <FONT STYLE="font-size: 10pt">The
Company shall promptly (and in any event within forty-eight (48)&nbsp;hours)&nbsp;notify Parent in the event that the Company or any
of its Subsidiaries or its or their Representatives receives a Takeover Proposal and shall disclose to Parent a summary of the
material terms and conditions of any such Takeover Proposal, including, if applicable, copies of any written requests, proposals or
offers, including proposed agreements,&nbsp;but not the identity of the Person or group of Persons making such Takeover Proposal.
The Company shall keep Parent reasonably informed on a prompt basis of any material developments with respect to any such Takeover
Proposal (including any material changes thereto). For the avoidance of doubt, all information provided to Parent pursuant to this <U>Section&nbsp;7.03 </U>will
be subject to the terms of the Confidentiality Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Split-Segment; Name: a4 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Neither
the Company Board nor any committee thereof shall (x)(A)&nbsp;withhold or withdraw the Company Board Recommendation, (B)&nbsp;modify,
qualify or amend the Company Board Recommendation in a manner adverse to Parent, (C)&nbsp;fail to include the Company Board Recommendation
in the Proxy Statement/Prospectus, (D)&nbsp;approve, adopt or publicly endorse or recommend any Takeover Proposal, (E)&nbsp;refrain from
recommending against any Takeover Proposal that is a tender offer or exchange offer, within 10&nbsp;business days after the commencement
of such tender offer or exchange offer pursuant to Rule&nbsp;14d-2 of the Exchange Act (or such fewer number of business days as remain
prior to the Company Shareholders Meeting as it may be adjourned or postponed)&nbsp;or (F)&nbsp;fail to publicly reaffirm the Company
Board Recommendation within 10&nbsp;business days after receipt of a written request by Parent to make such public reaffirmation following
the receipt by the Company of a Takeover Proposal that has not been withdrawn (or, if the Company Shareholders Meeting is scheduled to
be held within 10&nbsp;business days of such request, within five&nbsp;business days of such request and in any event, prior to the date
of the Company Shareholders Meeting)&nbsp;(other than in the case of a Takeover Proposal in the form of a tender offer or exchange offer
which shall be governed by clause (D)); <U>provided</U> that Parent may make any such request only once in any 10&nbsp;business day period
and only once for each such Takeover Proposal and once for each material amendment to such Takeover Proposal (any prohibited action described
in this clause (x)&nbsp;being referred to as an &ldquo;<U>Adverse Recommendation Change</U>&rdquo;)&nbsp;or (y)&nbsp;authorize, cause
or permit the Company or any of its Subsidiaries to execute or enter into any letter of intent, memorandum of understanding, agreement
in principle, merger agreement, acquisition agreement, amalgamation agreement or other similar agreement related to any Takeover Proposal,
other than any Acceptable Confidentiality Agreement pursuant to <U>Section&nbsp;7.03(b)</U>&nbsp;(each, a &ldquo;<U>Company Acquisition
Agreement</U>&rdquo;). Notwithstanding the foregoing or any other provision of this Agreement to the contrary, prior to the time the
Required Shareholder Approval is obtained, the Company Board may:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">in
response to an Intervening Event, if the Company Board has determined in good faith, after consultation with the Company&rsquo;s financial
advisors and outside legal counsel, that failure to take such action would be inconsistent with the directors&rsquo; fiduciary duties
under applicable Law, make an Adverse Recommendation Change; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">in
response to a Superior Proposal, if the Company Board has determined in good faith, after consultation with the Company&rsquo;s financial
advisors and outside legal counsel, that failure to take such action would be inconsistent with the directors&rsquo; fiduciary duties
under applicable Law, (A)&nbsp;make an Adverse Recommendation Change or (B)&nbsp;cause the Company to terminate this Agreement pursuant
to <U>Section&nbsp;9.01(d)(ii)</U>&nbsp;and enter into a Company Acquisition Agreement with respect to such Superior Proposal;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>provided
</U></FONT>that the Company has given Parent at least five&nbsp;business days&rsquo; prior written notice (a &ldquo;<U>Company Notice</U>&rdquo;)&nbsp;of
its intention to make an Adverse Recommendation Change or has caused the Company to terminate this Agreement pursuant to <U>Section&nbsp;9.01(d)(ii)</U>,
which notice (I)&nbsp;in the case of an Intervening Event, specifies the material effects, changes or events comprising such Intervening
Event and (II)&nbsp;in the case of a Superior Proposal, discloses (1)&nbsp;the material terms and conditions of such Superior Proposal
and the identity of the Person or group of Persons making such Superior Proposal and (2)&nbsp;a copy of the most current version of the
Company Acquisition Agreement (if any)&nbsp;with respect to such Superior Proposal; <U>provided</U>, <U>further</U>, that, (X)&nbsp;during
such five business day period (it being understood and agreed that any change to the financial or other material terms and conditions
of a Superior Proposal shall require an additional Company Notice to Parent of two&nbsp;business days running from the date of such notice),
the Company shall have, and shall have caused its Representatives to, negotiate with Parent in good faith (to the extent Parent wishes
to negotiate) to make such amendments to the terms and conditions of this Agreement as would enable the Company Board to no longer make
an Adverse Recommendation Change or a determination that a Takeover Proposal constitutes a Superior Proposal and (Y)&nbsp;the Company
Board shall have determined following the end of such five business day period (as it may be extended pursuant to this <U>Section&nbsp;7.03(d)</U>),
after considering the results of such negotiations and any amendments to this Agreement, the Guaranty and/or the Voting Agreement committed
to in writing by Parent, if any, and any other information offered by Parent, after consultation with the Company&rsquo;s financial advisors
and outside legal counsel, (i)&nbsp;that the Superior Proposal giving rise to such Company Notice continues to be a Superior Proposal
or (ii)&nbsp;that failure to make an Adverse Recommendation Change in respect of the applicable Intervening Event would continue to be
inconsistent with the directors&rsquo; fiduciary duties under applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Nothing
contained in this <U>Section&nbsp;7.03</U> or elsewhere in this Agreement shall prohibit the Company or the Company Board or any committee
thereof from (i)&nbsp;taking and disclosing to shareholders of the Company a position or communication contemplated by Rule&nbsp;14e-2(a),
Rule&nbsp;14d-9 or Item 1012(a)&nbsp;of Regulation M-A promulgated under the Exchange Act (it being understood that any such communication
to the shareholders of the Company shall not be deemed to be an Adverse Recommendation Change)&nbsp;or (ii)&nbsp;making any disclosure
or communication to shareholders of the Company that the Company Board determines in good faith, based on the advice of its outside legal
counsel, is required by the directors&rsquo; fiduciary duties, applicable Law or the rules&nbsp;and policies of the NYSE.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">As
used in this <U>Section&nbsp;7.03</U>, &ldquo;<U>group</U>&rdquo; has the meaning ascribed to it in Rule&nbsp;13d-5 promulgated under
the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.04.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Preparation
of the Proxy Statement/Prospectus, Form&nbsp;F-4; Shareholders Meeting and Approval</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">As
soon as reasonably practicable following the date of this Agreement, the Company shall prepare and file with the SEC the Proxy Statement/Prospectus
and Parent and BAM shall prepare and file with the SEC the Form&nbsp;F-4, in each case, in preliminary form. The Proxy Statement/Prospectus
will be included in and will constitute a part of the Form&nbsp;F-4. Parent, BAM and the Company shall make available to each other all
information, and provide such other assistance, as may be reasonably requested in connection with the preparation, filing and distribution
of the Proxy Statement/Prospectus and the Form&nbsp;F-4. Such information and assistance shall include, if requested by Parent or BAM,
the provision of such financial statements or other information of the Company and the Company Subsidiaries that are required to be included
or incorporated by reference into the Form&nbsp;F-4, and BAM and the Company shall use reasonable best efforts, in each case, to cause
their auditors (and any other current or former auditors of BAM or any BAM Subsidiary or the Company or any Company Subsidiary, as the
case may be) to deliver any required consents in respect of any financial statements of BAM or any BAM Subsidiary or the Company or any
Company Subsidiary, as the case may be, to be included or incorporated by reference into the Form&nbsp;F-4. The Company hereby consents
to the inclusion or incorporation by reference into the Form&nbsp;F-4 of any financial statements or other information relating to the
Company or any Company Subsidiary required to be included or incorporated by reference therein. Each of Parent, BAM and the Company shall
use its reasonable best efforts to respond as promptly as reasonably practicable to any comments of the SEC with respect thereto and
to have the Proxy Statement/Prospectus cleared by the SEC, and the Form&nbsp;F-4 declared effective by the SEC, in each case as promptly
as reasonably practicable. Parent, BAM and the Company shall notify each other promptly of the receipt of any comments from the SEC or
its staff and of any request by the SEC or its staff for amendments or supplements to the Proxy Statement/Prospectus or Form&nbsp;F-4
or for additional information and promptly shall supply each other with copies of all correspondence between it or any of its Representatives,
on the one hand, and the SEC or its staff, on the other hand, with respect to the Proxy Statement/Prospectus or Form&nbsp;F-4. Notwithstanding
the foregoing, prior to filing or mailing the Proxy Statement/Prospectus or Form&nbsp;F-4 (or any amendment or supplement thereto) or
responding to any comments of the SEC with respect thereto, each of Parent, BAM and the Company, as the case may be, (i)&nbsp;shall provide
the other party with a reasonable opportunity to review and comment on such document or response (including the proposed final version
of such document or response), (ii)&nbsp;shall consider in good faith all comments reasonably proposed by such other party and (iii)&nbsp;shall
not file or mail such document or respond to the SEC prior to receiving such other party&rsquo;s approval, which approval shall not be
unreasonably withheld, conditioned or delayed. Each of the Company and the Parent Entities shall advise the other, promptly after receipt
of notice thereof, of the time of effectiveness of the Form&nbsp;F-4, the issuance of any stop order relating thereto or the suspension
of the qualification of the shares of BAM Class&nbsp;A Stock to be issued as Stock Consideration for offering or sale in any jurisdiction,
and each of the Company, Parent and BAM will use its reasonable best efforts to have any such stop order or suspension lifted, reversed
or otherwise terminated. Each of the Company and the Parent Entities will also take any other action (other than qualifying to do business
in any jurisdiction in which it is not now so qualified) required to be taken under the Securities Act, the Exchange Act, any applicable
state securities or &ldquo;blue sky&rdquo; laws and the rules&nbsp;and regulations thereunder in connection with the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">If,
prior to (i)&nbsp;receipt of the Required Shareholder Approval in the case of the Proxy Statement/Prospectus or (ii)&nbsp;the Effective
Time in the case of the Form&nbsp;F-4, any event or change occurs that is required to be described in an amendment of, or a supplement
to, the Proxy Statement/Prospectus or Form&nbsp;F-4, BAM, Parent or the Company, as the case may be, shall promptly notify the other
party of such event or change, and BAM, Parent and the Company shall cooperate to promptly prepare and file with the SEC any necessary
amendment or supplement to the Proxy Statement/Prospectus or Form&nbsp;F-4 and, as required by applicable Law, disseminate the information
contained in any such amendment or supplement to the Proxy Statement/Prospectus or Form&nbsp;F-4 to the Company&rsquo;s shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Subject
to <U>Section&nbsp;7.04(a)</U>, the Company shall take all necessary actions in accordance with applicable Law, the Company Organizational
Documents and the rules&nbsp;of the NYSE to establish a record date for, duly call, give notice of, convene and hold a meeting of its
shareholders (including any adjournment, recess, reconvening or postponement thereof, the &ldquo;<U>Company Shareholders Meeting</U>&rdquo;)&nbsp;for
the purpose of obtaining the Required Shareholder Approval, as soon as reasonably practicable after the Form&nbsp;F-4 is declared effective
under the Securities Act. The Company shall not change the record date for the Company Shareholders Meeting without the prior written
consent of Parent (not to be unreasonably withheld, conditioned or delayed). In furtherance of the foregoing and in consultation with
Parent, as soon as reasonably practicable after the date hereof, the Company shall set one or more preliminary record dates for the Company
Shareholders Meeting and commence a broker search pursuant to Section&nbsp;14a-13 of the Exchange Act. Subject to <U>Section&nbsp;7.03</U>,
the Company shall use its reasonable best efforts to obtain the Required Shareholder Approval. Notwithstanding anything to the contrary
in this Agreement, the Company may, in its sole discretion, adjourn, recess, reconvene or postpone the Company Shareholders Meeting if
the Company reasonably believes that (i)&nbsp;such adjournment, recess, reconvening or postponement is necessary to ensure that any required
supplement or amendment to the Proxy Statement/Prospectus is provided to the Company&rsquo;s shareholders within a reasonable amount
of time in advance of the Company Shareholders Meeting, (ii)&nbsp;after consultation with Parent, at the time of the Originally Scheduled
Date, (A)&nbsp;there will be an insufficient number of shares of Common Stock present (either in person or by proxy)&nbsp;to constitute
a quorum necessary to conduct the business of the Company Shareholders Meeting or (B)&nbsp;there will be an insufficient number of proxies
to obtain the Required Shareholder Approval or (iii)&nbsp;such adjournment, recess, reconvening or postponement is required by Law or
a court or other Governmental Authority of competent jurisdiction in connection with any Actions in connection with this Agreement or
the Transactions or has been requested by the SEC or its staff; <U>provided</U> that, in the case of an adjournment, recess, reconvening
or postponement pursuant to clause (ii)&nbsp;of this <U>Section&nbsp;7.04(c)</U>, the Company Shareholders Meeting shall not be adjourned,
recessed, reconvened or postponed (x)&nbsp;to a date later than the third&nbsp;business day preceding the Outside Date or (y)&nbsp;for
more than 15&nbsp;business days from the Originally Scheduled Date, in each case, without the prior written consent of Parent. The Company
shall keep Parent updated with reasonable frequency with respect to proxy solicitation results with respect to obtaining the Required
Shareholder Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Subject
to the provisions of <U>Section&nbsp;7.03</U>, the Company shall use its reasonable best efforts to solicit from its shareholders proxies
in favor of the approval of this Agreement and the Merger and use its reasonable best efforts to take all other actions reasonably necessary
or advisable to secure the Required Shareholder Approval (to the extent permitted by Law). Without limiting the generality of the foregoing,
if, at the time of the Originally Scheduled Date, (A)&nbsp;there will be an insufficient number of Common Stock present (either in person
or by proxy)&nbsp;to constitute a quorum necessary to conduct the business of the Company Shareholders Meeting or (B)&nbsp;there will
be an insufficient number of proxies to obtain the Required Shareholder Approval, then the Company shall, at the request of Parent (to
the extent permitted by Law)&nbsp;adjourn, recess, reconvene or postpone the Company Shareholders Meeting; <U>provided</U> that the Company
shall not be required pursuant to this sentence to adjourn the Company Shareholders Meeting more than two&nbsp;times or for more than
15 business days in the aggregate from the Originally Scheduled Date. Without the prior written consent of Parent (not to be unreasonably
withheld, conditioned or delayed), the approval of this Agreement and Transactions shall be the only matters (other than matters of procedure
and matters required by Law to be voted on by the shareholders of the Company in connection with the approval of this Agreement and the
Transactions)&nbsp;that the Company shall propose to be acted on by the shareholders of the Company at the Company Shareholders Meeting.
The Company agrees that, unless this Agreement shall have been terminated in accordance with <U>Article&nbsp;IX</U>, the Company&rsquo;s
obligations to hold the Company Shareholders Meeting pursuant to this <U>Section&nbsp;7.04</U> shall not be affected by the commencement,
public proposal, public disclosure or communication to the Company of any Takeover Proposal or by any Adverse Recommendation Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.05.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Reasonable
Best Efforts</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Subject
to the terms and conditions of this Agreement, each of Parent, Merger Sub and the Company shall, and shall cause its respective Affiliates,
to, use its reasonable best efforts to (i)&nbsp;take, or cause to be taken, all actions, and do, or cause to be done, and assist and
cooperate with each other party in doing, all things necessary, proper or advisable to cause the conditions to Closing to be satisfied
as promptly as reasonably practicable (including, without limitation, with respect to obtaining all applicable regulatory approvals and
consents) and to consummate and make effective, in the most expeditious manner reasonably practicable, the Merger, including (A)&nbsp;using
reasonable best efforts to prepare and file promptly and fully all documentation to effect all necessary filings, notices, petitions,
statements, registrations, submissions of information, applications and other documents and (B)&nbsp;using reasonable best efforts to
execute and deliver any additional instruments necessary, proper or advisable to consummate the Transactions, (ii)&nbsp;obtain all Consents
from any Governmental Authority or third party necessary, proper or advisable to consummate the Transactions (including any such Consents
required with respect to the Company Insurance Approvals, the Parent Insurance Approvals and under applicable Antitrust Laws), including
by providing (following a reasonable opportunity for consultation) to a Governmental Authority any information requested by such Governmental
Authority in connection with such Consents, and (iii)&nbsp;take any and all steps that are necessary, proper or advisable to avoid each
and every impediment under any applicable Law that may be asserted by, or Action that may be entered by, any Governmental Authority with
respect to this Agreement or the Transactions, as promptly as practicable. In accordance with <U>Section&nbsp;10.12</U>, each party shall
bear its own costs and expenses for making its respective filings with, and obtaining its respective Consents from, Governmental Authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">In
furtherance and not in limitation of the foregoing, the Company and Parent shall each use its reasonable best efforts to (i)&nbsp;take
all actions necessary to ensure that no Takeover Law is or becomes applicable to any of the Transactions or this Agreement and refrain
from taking any actions that would cause the applicability of such Laws and (ii)&nbsp;if the restrictions of any Takeover Law become
applicable to any of the Transactions, take all actions necessary to ensure that the Transactions may be consummated as promptly as practicable
on the terms contemplated by this Agreement and otherwise lawfully minimize the effect of such Takeover Law on the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Without
limiting the general applicability of <U>Section&nbsp;7.05(a)</U>, each of the Company and Parent shall, in consultation and cooperation
with the other and as promptly as practicable and in no event later than 30&nbsp;business days following the date of this Agreement,
file (i)&nbsp;with the United States Federal Trade Commission and the Antitrust Division of the United States Department of Justice the
notification and report form, if any, required under the HSR Act with respect to the Transactions, (ii)&nbsp;all appropriate documents,
forms, filings or submissions required under any non-U.S. Antitrust Laws and (iii)&nbsp;with applicable Insurance Regulators, all documents,
forms, filings or other submissions required under applicable Insurance Laws with respect to the Merger, or otherwise requested by domiciliary
Insurance Regulators of any of the Company Insurance Subsidiaries (other than to the extent required, biographical affidavits, fingerprint
cards and background checks, which shall follow as promptly as reasonably practicable thereafter), including as reasonably determined
by Parent in consultation with the Company, &ldquo;Form&nbsp;A&rdquo; exemption requests or equivalent exemption requests where available;
<U>provided</U> that Parent shall not submit a &ldquo;Form&nbsp;A&rdquo; exemption request or equivalent exemption request to an Insurance
Regulator that has requested to receive a &ldquo;Form&nbsp;A&rdquo; Acquisition of Control Statement in connection with the Transactions.
All such filings shall comply in all material respects with the requirements of applicable Law. Without limiting Parent&rsquo;s other
obligations in this <U>Section&nbsp;7.05</U>, Parent shall use its reasonable best efforts to direct (i)&nbsp;the Persons specified in
<U>Section&nbsp;7.05(c)</U>&nbsp;of the Parent Disclosure Letter to provide the Filing Person Information and (ii)&nbsp;the Persons specified
in <U>Section&nbsp;7.05(c)&nbsp;</U>of the Parent Disclosure Letter to provide the Disclaiming Person Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Without
limiting the general applicability of <U>Section&nbsp;7.05(a)</U>, the Company shall use its reasonable best efforts to cause the Broker-Dealer
Subsidiary to file, promptly after the date hereof, the Rule&nbsp;1017 Application with FINRA and shall use its reasonable best efforts
to obtain FINRA&rsquo;s approval of such application. Parent will provide, as promptly as practicable following a request therefor, the
Company, the Broker-Dealer Subsidiary, their counsel or FINRA, as applicable, with such information and documentation pertaining to Parent
as are reasonably requested by the Company, its counsel or FINRA in order to prepare the Rule&nbsp;1017 Application or obtain approval
thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Each
of the Company, Parent and Merger Sub shall consult with one another with respect to the obtaining of all Consents from any Governmental
Authority necessary, proper or advisable to consummate the Transactions and each of the Company, Parent and Merger Sub shall keep the
others reasonably apprised on a prompt basis of the status of matters relating to such Consents. The Company and Parent shall have the
right to review in advance and, subject to any restrictions under applicable Law, each shall consult the other on, any filing made with,
or written materials submitted to, any Governmental Authority in connection with the Transactions and each party agrees to in good faith
consider and reasonably accept comments of each other party thereon. Parent and the Company shall promptly furnish to each other copies
of all such filings and written materials after their filing or submission, in each case subject to applicable Laws. The Company and
Parent shall promptly advise each other upon receiving any communication from any Governmental Authority with respect to any filing or
Consent necessary, proper or advisable to consummate the Transactions, including promptly furnishing each other copies of all written
or electronic communications from or with such Governmental Authorities, and shall promptly advise each other when any such communication
causes such party to believe that there is a reasonable likelihood that any such Consent will not be obtained or that the receipt of
any such Consent will be materially delayed or conditioned. The Company and Parent shall not, and shall cause their respective Affiliates
not to, permit any of their respective Representatives to participate in any meeting or engage in any conversation (other than non-substantive
or administrative telephone calls)&nbsp;with any Governmental Authority in respect of any filings, investigation or other inquiry relating
to the Transactions unless it consults with the other in advance and, to the extent permitted by applicable Law and by such Governmental
Authority, gives the other party the opportunity to attend and participate in such meeting or conversation. If any Governmental Authority
requires that a hearing or meeting be held in connection with the Consent thereof or the Transactions, Parent shall use its reasonable
best efforts to arrange for such hearing or meeting to be held as promptly as practicable after the notice that such hearing or meeting
is required has been received by Parent, its Subsidiaries or any other Affiliates. Notwithstanding the foregoing, in no event will any
party be required to disclose to any other party any Personal Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Notwithstanding
anything to the contrary set forth in this Agreement, Parent shall not be obligated by a Governmental Authority in connection with a
Required Regulatory Approval to take or refrain from taking or to agree to it, its Subsidiaries or the Company or its Subsidiaries taking
or refraining from taking any action (including any amendment, waiver or termination of any agreement, exhibit or schedule, including
this Agreement and the Exhibits and Schedules to this Agreement) or to suffer to exist any limitation, action, restriction, condition
or requirement which, individually or together with all other such limitations, actions, restrictions, conditions or requirements by
a Governmental Authority in connection with a Required Regulatory Approval, would, or would reasonably be expected to, (i)&nbsp;impose
any requirement on BN, BAM or any of their respective Affiliates to make, or commit to make, any capital contribution or enter into or
issue any capital guarantee or keepwell, (ii)&nbsp;impose any requirement on Parent or any of its Subsidiaries to make, or commit to
make, any material capital contribution or enter into or issue any material capital guarantee or material keepwell, (iii)&nbsp;impose
any requirement on BN, BAM or any of their respective Affiliates to sell, license, assign, transfer, divest, hold separate or otherwise
dispose of, before or after the Closing, any assets or businesses, (iv)&nbsp;impose any requirement on Parent or any of its Subsidiaries
to sell, license, assign, transfer, divest, hold separate or otherwise dispose of, before or after the Closing, any material assets or
material businesses, (v)&nbsp;impose any limitation, action, restriction, condition or requirement on any of BN, BAM or any of their
respective Affiliates, investment funds, permanent capital vehicles, or other collective investment vehicles or portfolio companies of
the foregoing, (vi)&nbsp;impose any limitation, action, restriction, condition or requirement on Parent or any of its Subsidiaries that
is material and adverse to Parent and its Subsidiaries, taken as a whole, or (vii)&nbsp;impose any limitation, action, restriction, condition
or requirement on the business or operations of Company or any of its Subsidiaries following the Closing that would constitute a Company
Material Adverse Effect (each, a &ldquo;<U>Burdensome Condition</U>&rdquo;). Without the prior written consent of Parent, the Company
shall not (and shall cause its Subsidiaries not to)&nbsp;take any action or agree to the taking or refraining from any action or accept
any limitation, action, restriction, condition or requirement that, individually or in the aggregate, would, or would be reasonably expected
to, result in a Burdensome Condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.06.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Public
Announcements</U>. The Company and Parent shall agree on a press release announcing the entering into of this Agreement and the Transactions.
Thereafter, the Company and Parent shall consult with each other before issuing any press release or otherwise making any public statements
(including scheduling of a press conference or conference call with investors or analysts)&nbsp;with respect to this Agreement or any
of the Transactions and shall not issue any such press release or make any such public statement without the prior consent of the other
party, which consent shall not be unreasonably withheld, conditioned or delayed; <U>provided</U>, <U>however</U>, that a party may, without
the prior consent of the other party, issue such press release or make such public statement (a)&nbsp;as may be required by Law or order,
the applicable rules&nbsp;and regulations of the NYSE or any listing agreement with the NYSE, but only if such party provides the other
party an opportunity to first review the content of the proposed disclosure considers such other party&rsquo;s comments thereon in good
faith, (b)&nbsp;with respect to any Adverse Recommendation Change made in accordance with this Agreement or (c)&nbsp;if such press release
or public statement is not materially inconsistent in tone or substance with previous press releases or public statements made by such
party in compliance with this <U>Section&nbsp;7.06</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.07.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Access
to Information; Confidentiality</U>. Subject to applicable Law, upon reasonable notice, the Company shall afford to Parent and Parent&rsquo;s
Representatives reasonable access during normal business hours to the Company&rsquo;s officers, employees, properties, books, Contracts
and records, and the Company shall furnish to Parent and Parent&rsquo;s Representatives such information concerning its business, personnel,
assets, liabilities and properties as Parent may reasonably request; <U>provided</U> that Parent and its Representatives shall conduct
any such activities in such a manner as not to interfere unreasonably with the business or operations of the Company; <U>provided</U>,
<U>further</U>, <U>however</U>, that the Company shall not be obligated to provide such access or information if the Company determines,
in good faith and in its reasonable judgment, that doing so could violate applicable Law or a Contract or obligation of confidentiality
owing to a third party, waive the protection of an attorney-client privilege or other legal privilege or expose the Company to risk of
liability for disclosure of Personal Information. Without limiting the foregoing, in the event that the Company does not provide access
or information in reliance on the immediately preceding sentence, it shall provide notice to Parent that it is withholding such access
or information and shall use its reasonable best efforts to communicate, to the extent feasible, the applicable information in a way
that would not violate the applicable Law, Contract or obligation, risk waiver of such privilege or expose the Company to such risk,
including through the use of customary &ldquo;clean room&rdquo; or other similar procedures designed to limit the disclosure of competitively
sensitive information. All requests for information made pursuant to this <U>Section&nbsp;7.07</U> shall be directed to the Person designated
by the Company. Until the Closing, the information provided will be subject to the terms of the Confidentiality Agreement, dated as of
June&nbsp;2, 2023, by and between the Company and Parent (as may in the future be amended from time to time, the &ldquo;<U>Confidentiality
Agreement</U>&rdquo;); <U>provided</U> that, prior to the Effective Time, nothing in this <U>Section&nbsp;7.07 </U>shall limit any customary
disclosures made by Parent or any of its Subsidiaries to the Debt Financing Sources, rating agencies, prospective Debt Financing Sources,
underwriters, existing lenders (and related agents) or otherwise in connection with efforts or activities by Parent, any of its Subsidiaries
or the Debt Financing Sources to obtain the Debt Financing, so long as such recipients agree to customary confidentiality arrangements
(which may include customary &ldquo;click through&rdquo; confidentiality agreements and/or confidentially provisions contained in marketing
materials used in connection with the Debt Financing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.08.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Indemnification
and Insurance</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">From
and after the Effective Time, the Surviving Company shall, and Parent shall cause the Surviving Company to, (i)&nbsp;indemnify and hold
harmless each individual who at the Effective Time is, or at any time prior to the Effective Time was, a director or officer of the Company
or of a Subsidiary of the Company (each, together with such Person&rsquo;s heirs, executors and administrators, an &ldquo;<U>Indemnitee</U>&rdquo;)&nbsp;with
respect to all claims, liabilities, losses, damages, judgments, fines, penalties, costs (including amounts paid in settlement or compromise)&nbsp;and
expenses (including fees and expenses of legal counsel)&nbsp;in connection with any Action (whether civil, criminal, administrative or
investigative), whenever asserted, based on or arising out of, in whole or in part, (A)&nbsp;the fact that an Indemnitee is or was a
director or officer of the Company or such Subsidiary or (B)&nbsp;acts or omissions by an Indemnitee in the Indemnitee&rsquo;s capacity
as a director, officer, employee or agent of the Company or such Subsidiary or taken at the request of the Company or such Subsidiary
(including in connection with serving at the request of the Company or such Subsidiary as a director, officer, employee, agent, trustee
or fiduciary of another Person (including any employee benefit plan)), in each case under clause (A)&nbsp;or (B), at, or at any time
prior to, the Effective Time (including any Action relating in whole or in part to the Transactions or relating to the enforcement of
this provision or any other indemnification or advancement right of any Indemnitee), to the fullest extent permitted under applicable
Law and (ii)&nbsp;assume all obligations of the Company and such Subsidiaries to the Indemnitees in respect of indemnification and exculpation
from liabilities for acts or omissions occurring at or prior to the Effective Time as provided in the Company Organizational Documents
and the organizational documents of such Subsidiaries as in effect on the date of this Agreement or in any agreement in existence as
of the date of this Agreement providing for indemnification between the Company or any of its Subsidiaries and any Indemnitee. Without
limiting the foregoing, Parent, from and after the Effective Time, shall cause, to the fullest extent permitted under applicable Law,
the articles of incorporation and bylaws of the Surviving Company to contain provisions no less favorable to the Indemnitees with respect
to limitation of liabilities of directors and officers and indemnification than are set forth as of the date of this Agreement in the
Company Organizational Documents, which provisions shall not be amended, repealed or otherwise modified in a manner that would adversely
affect the rights thereunder of the Indemnitees. In addition, from the Effective Time, Parent shall cause the Surviving Company to advance
the reasonable and documented expenses (including reasonable and documented fees and expenses of legal counsel)&nbsp;of any Indemnitee
under this <U>Section&nbsp;7.08</U> (including in connection with enforcing the indemnity and other obligations referred to in this <U>Section&nbsp;7.08</U>)&nbsp;as
incurred to the fullest extent permitted under applicable Law; <U>provided</U> that the individual to whom expenses are advanced provides
an undertaking to repay such advances if it shall be finally determined by a court of competent jurisdiction that such Person is not
entitled to be indemnified pursuant to this <U>Section&nbsp;7.08(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Neither
Parent nor the Surviving Company shall settle, compromise or consent to the entry of any judgment in any threatened or actual Action,
litigation, claim or proceeding relating to any acts or omissions covered under this <U>Section&nbsp;7.08</U> (each, a &ldquo;<U>Claim</U>&rdquo;)&nbsp;for
which indemnification has been sought by an Indemnitee hereunder, unless such settlement, compromise or consent includes an unconditional
release of such Indemnitee from all liability arising out of such Claim or such Indemnitee otherwise consents in writing to such settlement,
compromise or consent. Each of Parent, the Surviving Company and the Indemnitees shall cooperate in the defense of any Claim and shall
provide access to properties and individuals as reasonably requested and furnish or cause to be furnished records, information and testimony,
and attend such conferences, discovery proceedings, hearings, trials or appeals, as may be reasonably requested in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
Company may, prior to the Effective Time, purchase or, if not so purchased by the Company, Parent shall cause the Surviving Company to
put in place effective as of the Effective Time, and Parent or the Company, as applicable, shall fully prepay no later than immediately
prior to the Closing, prepaid and non-cancellable &ldquo;tail&rdquo; insurance with a claims reporting or discovery period of six years
from the Effective Time on terms and conditions providing at least equivalent benefits and coverage as the directors&rsquo; and officers&rsquo;
liability, employment practices liability and fiduciary liability insurance of the Company and its Subsidiaries in effect as of the Effective
Time (&ldquo;<U>Current D&amp;O Insurance</U>&rdquo;)&nbsp;with respect to matters existing or occurring at or prior to the Effective
Time, including the Transactions, and Parent shall cause such policy to be maintained in full force and effect without amendment to any
of the policies&rsquo; terms and conditions, for their full term, and to honor all of the Surviving Company&rsquo;s obligations thereunder;
<U>provided</U>, <U>however</U>, that Parent may elect in its sole discretion, but shall not be required, to spend (or cause the Surviving
Company to spend)&nbsp;more than 350% of the Current D&amp;O Insurance annual premium (the &ldquo;<U>Cap Amount</U>&rdquo;)&nbsp;with
respect to the annual premium for the six years of coverage under such &ldquo;tail&rdquo; policies; <U>provided</U>, <U>further</U>,
that if the cost of such insurance exceeds the Cap Amount, and Parent elects not to spend more than the Cap Amount for such purpose,
then Parent shall purchase and obtain insurance with the greatest coverage available for a cost equal to such Cap Amount. If such &ldquo;tail&rdquo;
insurance has been obtained by the Company, it shall be deemed to satisfy all obligations to obtain insurance pursuant to this <U>Section&nbsp;7.08(c),</U>&nbsp;and
Parent shall cause the Surviving Company to cause such &ldquo;tail&rdquo; insurance to be maintained in full force and effect without
amendment to any of the policies&rsquo; terms and conditions, for their full term, and to honor all of the Surviving Company&rsquo;s
obligations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
provisions of this <U>Section&nbsp;7.08</U> are (i)&nbsp;intended to be for the benefit of, and shall be enforceable by, each Indemnitee
and his or her heirs and (ii)&nbsp;in addition to, and not in substitution for, any other rights to indemnification or contribution that
any such individual may have under the Company Organizational Documents, by contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">In
the event that Parent, the Surviving Company or any of their respective successors or assigns (i)&nbsp;consolidates or amalgamates with
or merges into any other Person and is not the continuing or surviving company or entity of such consolidation, amalgamation or merger
or (ii)&nbsp;transfers or conveys all or substantially all of its properties and assets to any Person, then, and in each such case, proper
provision shall be made so that the successors and assigns of Parent or the Surviving Company shall assume all of the obligations thereof
set forth in this <U>Section&nbsp;7.08</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Nothing
in this Agreement is intended to, shall be construed to or shall release, waive or impair any rights to directors&rsquo; and officers&rsquo;
insurance claims under any policy that is or has been in existence with respect to the Company or any of its Subsidiaries for any of
their respective directors, officers or other employees, it being understood and agreed that the indemnification provided for in this
<U>Section&nbsp;7.08</U> is not prior to or in substitution for any such claims under such policies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.09.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Rule&nbsp;16b-3.
</U>Prior to the Effective Time, the Company shall take such steps as may be reasonably necessary or advisable to cause any dispositions
of Company equity securities (including derivative securities)&nbsp;resulting from the Transactions by each individual who is a director
or officer of the Company subject to the reporting requirements of Section&nbsp;16 of the Exchange Act (or who will become subject to
the reporting requirements of Section&nbsp;16 of the Exchange Act as a result of the Transactions)&nbsp;to be exempt under Rule&nbsp;16b-3
promulgated under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.10.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Employee
Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">For
a period of one year following the Effective Time (or such longer period required by applicable Law), Parent shall provide, or shall
cause the Surviving Company&nbsp;to provide, each individual who is employed by the Company or any of its Subsidiaries immediately prior
to the Effective Time (each, a &ldquo;<U>Company Employee</U>&rdquo;)&nbsp;and continues to be employed with the Company and its Subsidiaries
with (i)&nbsp;an annual base salary or annualized wage rate (as applicable) that is no less than the annual base salary or annualized
wage rate (as applicable) provided to such Company Employee by the Company and any of its Subsidiaries immediately prior to the Effective
Time, (ii)&nbsp;target short-term cash incentive opportunities that are no less favorable than those provided to such Company Employee
by the Company and any of its Subsidiaries immediately prior to the Effective Time, (iii)&nbsp;target long-term incentive opportunities
(including deferred cash and equity and equity-based incentive opportunities, but excluding any change in control and retention or other
non-recurring compensation) that are no less favorable than the target long-term incentive opportunities (including deferred cash and
equity and equity-based incentive opportunities) provided to such Company Employee by the Company and any of its Subsidiaries immediately
prior to the Effective Time; subject to the conditions set forth in Item 1 of Section&nbsp;7.10(a)&nbsp;of the Company Disclosure Letter;
(iv)&nbsp;compensation and benefits provided in connection with the Company ESOP no less than the compensation and benefits provided
in connection with the Company ESOP to such Company Employee by the Company and any of its Subsidiaries immediately prior to the Effective
Time; provided, however that the foregoing clause (iv)&nbsp;may be satisfied by (A)&nbsp;contributions to other defined contribution
plans, (B)&nbsp;equity or equity-based awards or (C)&nbsp;cash payments, and (v)&nbsp;other employee benefits (excluding non-qualified
deferred compensation, defined benefit pension, post-employment health and welfare benefits and change in control, retention or other
non-recurring compensation and benefits)&nbsp;that are substantially comparable in the aggregate to those provided to such Company Employee
by the Company and any of its Subsidiaries immediately prior to the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">For
a period of one year following the Effective Time, Parent shall honor and provide, or shall cause the Surviving Company to honor and
provide, for each Company Employee (except as provided otherwise in <U>Section&nbsp;7.01(a)(vi)</U>&nbsp;of the Company Disclosure Letter),
severance and termination benefits in an amount equal to the severance and termination benefits that would have been provided to such
Company Employee under the Transition Benefit Plan as in effect immediately prior to the Effective Time if such Company Employee experiences
a termination of employment pursuant to which severance would be owed from the Company under such plan if the termination of employment
had occurred immediately prior to the Effective Time (but including, for the avoidance of doubt, any changes to such benefits as a result
of credit for such Company Employee&rsquo;s service with Parent and its Subsidiaries in accordance with <U>Section&nbsp;7.10(d)</U>&nbsp;or
any increases in a Company Employee&rsquo;s base salary or annualized wage rate or cash incentive bonus opportunities (excluding, for
the avoidance of doubt, long-term incentives (including equity and equity-based incentive opportunities) during the one year following
the Effective Time)).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">With
respect to the employee benefit plans maintained by Parent or its Subsidiaries (including, following the Closing, the Surviving Company
and its Subsidiaries and Affiliates) in which the Company Employee is eligible to participate on or following the Effective Time&nbsp;(including
any paid time off and severance plans)&nbsp;and subject to applicable Law, for purposes of determining eligibility to participate, level
of benefits and vesting, the Surviving Company shall cause each Company Employee&rsquo;s service with the Company or any of its Subsidiaries
(as well as service with any predecessor employer of the Company or any such Subsidiary, to the extent service with the predecessor employer
was recognized by the Company or such Subsidiary)&nbsp;to be treated as service with the Surviving Company or any of its Subsidiaries
or its Affiliates; <U>provided</U>, <U>however</U>, that such service need not be recognized (i)&nbsp;for benefit accruals under any
defined benefit pension plan, (ii)&nbsp;for purposes of any post-employment welfare benefit plan or (iii)&nbsp;to the extent that such
recognition would result in any duplication of benefits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Parent
shall, or shall cause the Surviving Company to use commercially reasonable efforts to, (i)&nbsp;waive, or cause to be waived, any pre-existing
condition limitations and exclusions and (ii)&nbsp;waive, or cause to be waived, any actively-at-work requirements and waiting periods,
in each case, under any welfare benefit plan maintained by Parent (including, following the Closing, the Surviving Company or any of
its Subsidiaries or Affiliates) in which Company Employees (and their eligible dependents)&nbsp;will be eligible to participate from
and after the Effective Time, except to the extent that such pre-existing condition limitations, exclusions, actively-at-work requirements
and waiting periods would not have been satisfied or waived under the comparable Company Plan immediately prior to the Effective Time.
Parent shall, or shall cause the Surviving Company or any of its Affiliates to, use commercially reasonable efforts to recognize the
dollar amount of all co-payments, deductibles and out-of-pocket expenses incurred by each Company Employee (and his or her eligible dependents)&nbsp;during
the calendar year in which the Effective Time occurs for purposes of satisfying such year&rsquo;s deductible and co-payment limitations
under the relevant welfare benefit plans in which they will be eligible to participate from and after the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
parties agree that the consummation of the Transactions shall constitute a &ldquo;change in control,&rdquo; &ldquo;change of control&rdquo;
or term of similar import under each applicable Company Plan; provided that, for purposes of any such plans that provide for deferred
compensation within the meaning of Section&nbsp;409A of the Code, the foregoing shall not accelerate the time of payment or distribution
of any such deferred compensation (but shall accelerate vesting if provided for in accordance with the terms thereof) if the transactions
contemplated by this Agreement do not otherwise constitute a &ldquo;change in control,&rdquo; &ldquo;change of control&rdquo; or term
of similar import under the applicable plan and to so declare as a &ldquo;change in control,&rdquo; &ldquo;change of control&rdquo; or
term of similar import would result in an impermissible payment or distribution for purposes of Section&nbsp;409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Prior
to making any broad-based written communications to the directors, officers or employees of the Company or any of its Subsidiaries pertaining
to any compensation or benefit matters related to the Transactions or any other matter contemplated hereunder, whether relating to employment,
employee benefits, including Company Plans, and post-Closing terms of employment or otherwise, the Company shall consult with Parent
and consider Parent&rsquo;s comments to such communication in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">No
later than 15 business days following the date of this Agreement, the Company shall deliver to Parent a complete and correct list of
each Company Employee, as of the date of this Agreement including, with respect to each such individual, the following information, as
applicable: (i)&nbsp;name (or other unique identifier), (ii)&nbsp;job title, (iii)&nbsp;date of hire and work location (city and state,
if applicable), (iv)&nbsp;exempt or non-exempt classification status under the Fair Labor Standards Act, (v)&nbsp;leave of absence status
and anticipated date of return, if known, (vi)&nbsp; annual base salary or annualized base wage rate (as applicable), (vii)&nbsp;annual
target short-term incentive or bonus compensation opportunities for the current fiscal year (on a plan-by-plan basis) and (viii)&nbsp;target
long-term incentive compensation opportunities (on a plan-by-plan basis) (the &ldquo;<U>Company Employee List</U>&rdquo;). The Company
shall deliver to Parent an updated Company Employee List no later than five (5)&nbsp;days prior to the Effective Time to reflect any
changes in accrued but unused vacation, terminations and new hires and reallocations not in violation of this Agreement or as otherwise
consented to by Parent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">No
later than 15 business days following the date of this Agreement, the Company shall deliver to Parent a complete and accurate list of
each outstanding Company Award, including: (i)&nbsp;on an employee-by-employee basis, the name (or other unique identifier) of the holder
of such outstanding Company Award; (ii)&nbsp;on an award-by-award basis, the number of Common Stock subject to or underlying such outstanding
Company Award (with the number of Common Stock underlying Performance-Vesting Company Options and Company PSUs, in each case, reported
assuming each such Company Award&rsquo;s target level of performance); and (iii)&nbsp;the date on which such outstanding Company Award
was granted or issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">If
requested by Parent in writing no later than 10 business days prior to the Effective Time, with respect to the Company 401(k)&nbsp;Plan,
the Company Board&nbsp;(or, if appropriate, any committee thereof administering such Company 401(k)&nbsp;Plan) shall adopt such resolutions
or take such other actions as may be required to terminate, effective at least one day prior to the Effective Time, such Company 401(k)&nbsp;Plan.
Prior to the Effective Time, the Company shall provide Parent with executed resolutions of the Company&nbsp;Board (or the appropriate
committee thereof) authorizing such termination. As soon as practicable after the Effective Time, the Company shall cause, to the extent
permitted by Section&nbsp;401(k)(10)&nbsp;of the Code, the Company 401(k)&nbsp;Plan administrator to make distributions available to
the Company 401(k)&nbsp;Plan participants. In connection with any termination of the Company 401(k)&nbsp;Plan, Parent shall permit each
Company Employee who is a participant in the Company 401(k)&nbsp;Plan to (i)&nbsp;become a participant in a 401(k)&nbsp;plan of Parent
that is an &ldquo;eligible retirement plan&rdquo; (within the meaning of Section&nbsp;401(a)(31) of the Code) (the &ldquo;Parent 401(k)&nbsp;Plan&rdquo;)
immediately after the Effective Time and (ii)&nbsp;to make rollover contributions of &ldquo;eligible rollover distributions&rdquo; (within
the meaning of Section&nbsp;401(a)(31) of the Code, including all participant loans) in cash or notes (in the case of participant loans)
in an amount equal to the eligible rollover distribution portion of the account balance distributed to each such Company Employee from
the Company 401(k)&nbsp;Plan to the Parent 401(k)&nbsp;Plan effective as of the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">To
the extent permitted by applicable Law, the Trustee and the Company shall take or cause to be taken all such actions as may be necessary
to effect the actions set forth below relating to the Company ESOP prior to or simultaneous with the Closing, as applicable: (i)&nbsp;effective
at least five business days prior to the Closing (with relevant materials provided to Parent for its review and comment at least three
business days prior to such date), the Company ESOP shall be terminated (the &ldquo;<U>ESOP Termination Date</U>&rdquo;), no new participants
shall be admitted on or after the ESOP Termination Date, no further distributions in the form of &ldquo;qualifying employer securities&rdquo;
(as defined in Section&nbsp;407 of ERISA) will be permitted and all existing Company ESOP participants&rsquo; accounts shall be fully
vested and 100% non-forfeitable, (ii)&nbsp;the Company shall cause the Company ESOP&rsquo;s plan administrator to direct the Trustee
to remit a sufficient number of Common Stock to the Company to repay the outstanding ESOP Loan in full, and the proceeds of the sale
of such Common Stock shall be used to repay the outstanding balance of the ESOP Loan as of the Effective Time, with each remitted share
of Common Stock to be valued equal to the Merger Consideration, (iii)&nbsp;all remaining Common Stock held by the Company ESOP as of
the Effective Time shall be exchanged for the Merger Consideration within the Company ESOP in accordance with <U>Section&nbsp;3.01(a)</U>&nbsp;and
(iv)&nbsp;promptly, after the execution of this Agreement, the Company will take such actions as may be necessary to request a favorable
determination letter with respect to the Company ESOP&rsquo;s termination. No benefit distributions shall be made from the Company ESOP
without the prior written consent of Parent before the IRS issues a favorable determination letter with respect to the tax-qualified
status of the Company ESOP on termination, except that distributions from the Company ESOP may be made earlier if required by Law or
upon the occurrence of the Company ESOP participant&rsquo;s retirement, death, disability or termination of employment or any other event,
other than plan termination, that requires a distribution from the Company ESOP. The Company also shall take such other actions in furtherance
of terminating the Company ESOP as Parent may reasonably request prior to the Closing, including the adoption of amendments to the Company
ESOP. Notwithstanding the foregoing, the Company will continue to make regularly scheduled payments on the ESOP Loan and related share
allocations through the ESOP Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
provisions of this <U>Section&nbsp;7.10</U> are solely for the benefit of the parties to this Agreement. Nothing in this Agreement shall
be construed to confer on any Person, other than the parties, their successors and permitted assigns, any right to enforce the provisions
of this <U>Section&nbsp;7.10</U> or be construed as an amendment, or waiver of any provision, of any Company Plan or any employee benefit
plan maintained by the Company, Parent or their respective Affiliates, or the establishment or adoption of or an amendment to any employee
benefit plan for purposes of ERISA or otherwise. In addition, nothing expressed or implied in this <U>Section&nbsp;7.10</U> shall confer
upon any of the employees of the Company, Parent or their respective Subsidiaries or any other Person any additional rights or remedies,
including any additional right to employment, or continued employment for any specified period, of any nature or kind whatsoever under
or by reason of this Agreement, and nothing in this Agreement shall prevent Parent, the Surviving Company or any of their Affiliates
from, after the Effective Time, (i)&nbsp;amending or terminating any of their benefit plans in accordance with their terms or (ii)&nbsp;terminating
the employment of any Company Employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.11.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Notification
of Certain Matters; Shareholder Litigation</U>. During the period from the date of this Agreement through the earlier of the Closing
or the termination of this Agreement in accordance with its terms, Parent shall give prompt notice to the Company, and the Company shall
give prompt notice to Parent, of any Actions commenced or, to such party&rsquo;s Knowledge, threatened against such party which relate
to this Agreement or the Transactions. Each party shall provide the other with any pleadings and correspondence relating to any Actions
involving it, any of its officers or directors or any other of its Representatives relating to this Agreement or the Transactions and
will keep the other reasonably and promptly informed regarding the status of any Actions. Subject to applicable Law, each party shall
give the other party the opportunity to participate, at such other party&rsquo;s sole cost and expense, in the defense and settlement
of any litigation by any shareholder of either party against either party or its directors relating to this Agreement or the Transactions,
and no such settlement shall be agreed to without such other party&rsquo;s prior written consent (such consent not to be unreasonably
withheld, conditioned or delayed). Without limiting the preceding sentence, each party shall give the other party the right to review
and comment on all filings or responses to be made by it in connection with any such Actions, and it will in good faith take such comments
into account; <U>provided</U>, <U>however</U>, that such party shall not be obligated to provide such access or information if such party
determines, in good faith and in its reasonable judgment, that doing so could waive the protection of an attorney-client privilege or
other legal privilege; <U>provided</U>, <U>further</U>, that such party shall use its reasonable best efforts to provide such access
or information in a manner that would not risk waiver of such privilege.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.12.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Merger
Sub Shareholder Approval</U>. Immediately following the execution of this Agreement, Parent shall cause Arches Acquisition Holdco II
Inc. to execute and deliver, in accordance with applicable Law and in its capacity as the sole shareholder of Merger Sub, a written consent
approving the Merger and this Agreement (the &ldquo;<U>Merger Sub Shareholder Approval</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.13.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Stock
Exchange De-listing</U>. The Company and Parent shall cooperate and shall use their respective reasonable best efforts to take, or cause
to be taken, all actions, and to do or cause to be done all things, necessary, proper or advisable under applicable Laws and the rules&nbsp;and
policies of the NYSE and the SEC to cause the Common Stock to be de-listed from the NYSE and de-registered under the Exchange Act as
soon as reasonably practicable following the Effective Time in compliance with applicable Law. In connection therewith, Parent shall
(a)&nbsp;reasonably assist in enabling the Company or NYSE to be in a position to promptly file and cause the Surviving Company or NYSE
to file with the SEC a Form&nbsp;25 on the Closing Date and (b)&nbsp;use reasonable best efforts to cause the Surviving Company to file
a Form&nbsp;15 on the first business day that is at least ten days after the date the Form&nbsp;25 is filed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.14.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Continued
Listing of Depositary Shares</U>. From and after the Effective Time, Parent shall cause the Surviving Company to continue to cause the
Depositary Shares to be listed on the NYSE in accordance with the terms of certificate of designations establishing the Series&nbsp;A
Preferred Stock and Series&nbsp;B Preferred Stock, as applicable, as set forth in <U>Section&nbsp;3.01(f)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.15.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Notices
of Certain Events</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">From the date hereof until the earlier of the Effective
Time and the termination of this Agreement in accordance with the terms of <U>Article&nbsp;IX</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">each
of the Company and Parent shall promptly notify the other party of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">any
written notice or other written communication received by the notifying party or any of its Affiliates or Representatives from any Person
alleging that the consent of such Person is or may be required in connection with the Transactions; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">any
Actions (A)&nbsp;commenced or (B)&nbsp;to its Knowledge, threatened against such party or any of its Subsidiaries that, if pending on
the date of this Agreement, would have been required to have been disclosed pursuant to <U>Section&nbsp;4.07</U> (in the event that the
Company is the notifying party)&nbsp;or <U>Section&nbsp;5.09</U> (in the event that Parent is the notifying party);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">the
Company shall give prompt written notice to Parent of any change, circumstance, condition, development, effect, event or occurrence that
has had or would reasonably be expected to have a Company Material Adverse Effect, or would reasonably be expected to make the satisfaction
of any of the conditions in <U>Section&nbsp;8.02</U> impossible or unlikely;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Parent
shall give prompt written notice to the Company of any change, circumstance, condition, development, effect, event or occurrence that
has had or would reasonably be expected to have a Parent Material Adverse Effect, or would reasonably be expected to make the satisfaction
of any of the conditions in <U>Section&nbsp;8.03(a)</U>&nbsp;or <U>Section&nbsp;8.03(b)</U>&nbsp;impossible or unlikely; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">BAM
shall give prompt written notice to the Company of any change, circumstance, condition, development, effect, event or occurrence that
has had or would reasonably be expected to have a BAM Material Adverse Effect, or would reasonably be expected to make the satisfaction
of any of the conditions in <U>Section&nbsp;8.03(c)</U>&nbsp;or <U>Section&nbsp;8.03(d)</U>&nbsp;impossible or unlikely;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>provided</U></FONT>,
<U>however</U>, that no such notification required by <U>clause (a)</U>, <U>(b)</U>, <U>(c)</U>&nbsp;or <U>(d)</U>&nbsp;above (and no
other notification required to be given under any other Section&nbsp;of this Agreement)&nbsp;shall affect the representations, warranties,
covenants or agreements of any party or the conditions to the obligations of any party under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.16.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Investment
Assets</U>. The Company shall, or shall cause its applicable Subsidiaries to, deliver to Parent, within 15&nbsp;business days following
the end of each calendar month, starting with the first delivery to occur within 15&nbsp;business days following the end of August&nbsp;2023,
a summary report of (a)&nbsp;all Investment Assets (other than real estate)&nbsp;owned by the Company or any of its Subsidiaries as of
such month end, and if available, the market value thereof as of such month end, (b)&nbsp;all Investment Assets that are real estate
owned by the Company or any of its Subsidiaries as of such month end and the carrying values thereof as of such month end as determined
on a basis consistent with the Company&rsquo;s current practices with respect to its real estate (and, if there has been any third-party
appraisal or report completed and delivered to the Company during such month that speaks to the value of any particular real estate property,
such information will be included in the report for that month), (c)&nbsp;all Investment Assets sold or otherwise disposed of during
the preceding month, (d)&nbsp;all Investment Assets purchased by the Company or any of its Subsidiaries during the preceding month and
(e)&nbsp;all Investment Assets that are in arrears or breach or default in the payment of principal or interest or dividends or are,
or should be, classified as non-performing, non-accrual, 90&nbsp;days past due, still accruing and doubtful of collection, in foreclosure
or any comparable classification, or are permanently impaired to any extent. From and after the date hereof until the Closing, subject
to applicable Law, the Company shall cause the applicable employees having primary responsibility for Investment Assets to consult with
Representatives of Parent on all investment-related matters, including future planned or potential sales and purchases of Investment
Assets and the treatment of any impaired or potentially impaired Investment Assets, and the Company shall consider in good faith the
recommendations of Representatives of Parent in making investment decisions from and after the date of this Agreement, provided that
any such investment decisions shall be determined by the Company acting reasonably and in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.17.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Financing</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Prior
to the Closing, the Company shall use commercially reasonable efforts, and shall cause its Subsidiaries and its and their respective
Representatives to use commercially reasonable efforts, to provide such assistance in connection with any Debt Financing as may be reasonably
requested by Parent; provided that the Company shall in no event be required to provide (or cause its Subsidiaries or its or their Representatives
to provide) such assistance that shall unreasonably interfere with its or its Subsidiaries&rsquo; business operations. For the avoidance
of doubt, obtaining the Debt Financing shall not be a condition to Closing. If reasonably requested in writing by Parent, such assistance
shall include, with reasonable prior notice and at Parent&rsquo;s sole cost and expense:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">furnishing
to (A)&nbsp;Parent and any Debt Financing Source such customary and reasonably requested financial information and other pertinent information
regarding the Company and its Subsidiaries as promptly as reasonably practicable following the reasonable request therefor by Parent
or by any Debt Financing Source and (B)&nbsp;Parent such other historical financial information reasonably necessary to enable Parent
to prepare pro forma financial information (provided that the Company and its Subsidiaries shall not have any obligation to prepare such
pro forma financial information);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">providing
reasonable assistance to Parent in its preparation of (A)&nbsp;customary rating agency presentations and (B)&nbsp;bank books and confidential
information memoranda, lender presentation materials and similar documents customary for any Debt Financing (including (1)&nbsp;a &ldquo;private&rdquo;
supplement to any such materials and (2)&nbsp;customary representation and authorization letters with respect thereto (it being understood
that the Company shall not be required to make any representations with respect to projections contained in any such materials or other
forward looking information));</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">facilitating
the execution and delivery at the Closing of customary definitive financing documents (including any schedules or exhibits thereto),
including by requesting that the appropriate officers of the Company and its Subsidiaries that will continue in their positions after
the Closing be available upon reasonable notice to Parent and its counsel to sign such documents, including customary officer&rsquo;s
certificates and secretary&rsquo;s certificates (in each case to be held in escrow pending the Closing), in anticipation of the Closing;
<U>provided</U>, <U>however</U>, that no obligation of the Company under any such document, and no such certificate, shall be effective
until the Closing (other than any representation and authorization letters referred to in clause (ii)&nbsp;above and any prepayment notices
referred to in clause (vi)&nbsp;below required by the Payoff Indebtedness);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">cooperating
with Parent to satisfy the conditions precedent to the Debt Financing at the Closing to the extent within the control of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">providing
at least three business days prior to the Closing all documentation and other information about the Company and its Subsidiaries as is
reasonably requested by Parent or any Debt Financing Sources at least ten business days prior to the Closing Date with respect to applicable
 &ldquo;beneficial ownership&rdquo;, &ldquo;know your customer&rdquo; and anti-money laundering rules&nbsp;and regulations, including
the Patriot Act and 31 C.F.R. &sect; 1010.230; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">providing
reasonable cooperation in connection with the termination and pay-off of any Payoff Indebtedness, including, as applicable, delivering
prepayment notices (if such notices may be conditioned on the consummation of the Closing) and the Payoff Letters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Parent
shall indemnify, defend and hold harmless the Company and each of its Subsidiaries and each of their respective officers, directors,
managers, employees or other Representatives from and against any and all claims, losses, liabilities, damages, out-of-pocket costs or
expenses (including reasonable attorneys&rsquo; fees), judgments, fines or amounts paid in settlement that are incurred, directly or
indirectly, in connection with the Debt Financing and the Credit Agreement Amendments and any cooperation provided pursuant to <U>Section&nbsp;7.17(a)</U>&nbsp;and
(c). Parent shall promptly reimburse the Company for all reasonable and documented out-of-pocket costs (including reasonable attorneys&rsquo;
fees) incurred by the Company or any of its Subsidiaries and each of their respective officers, directors, managers, employees or other
Representatives in connection with the Debt Financing and any cooperation provided pursuant to <U>Section&nbsp;7.17(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
Company shall use commercially reasonable efforts to, and shall cause its Subsidiaries and its and their respective Representatives to
use commercially reasonable efforts to, cooperate with Parent in connection with the efforts of Parent to obtain, as soon as reasonably
practicable after the date hereof, waivers of, or amendments to, change of control or other provisions in the Credit Agreement (the &ldquo;<U>Credit
Agreement Amendments</U>&rdquo;), on such terms and conditions as specified and reasonably requested by Parent subject to the consent
of the Company (not to be unreasonably withheld, conditioned or delayed), in each case in accordance with the terms of the Credit Agreement;
provided that the Company shall in no event be required to provide (or cause its Subsidiaries or its or their Representatives to provide)
such assistance that shall unreasonably interfere with its or its Subsidiaries&rsquo; business operations. For the avoidance of doubt,
obtaining any Credit Agreement Amendment shall not be a condition to Closing. If reasonably requested in writing by Parent, with reasonable
prior notice and at Parent&rsquo;s sole cost and expense, such assistance shall include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">furnishing
to Parent and the parties to the Credit Agreement such customary and reasonably requested financial information and other pertinent information
regarding the Company and its Subsidiaries as promptly as reasonably practicable following the reasonable request therefor by Parent
or by any such party;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">providing
reasonable assistance to Parent in its preparation of bank books and confidential information memoranda, lender presentation materials
and similar documents customary for any Credit Agreement Amendment (including (1)&nbsp;a &ldquo;private&rdquo; supplement to any such
materials and (2)&nbsp;customary representation and authorization letters with respect thereto (it being understood that the Company
shall not be required to make any representations with respect to projections or other forward looking information contained in any such
materials));</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">facilitating
the execution and delivery of any Credit Agreement Amendment (including any schedules or exhibits thereto) (it being understood that
the effectiveness of such Credit Agreement Amendment may occur prior to the Closing Date, but any waivers and amendments set forth therein
shall be conditioned upon the consummation of the Closing), including by requesting that the appropriate officers of the Company and
its Subsidiaries be available upon reasonable notice to Parent and its counsel to sign such Credit Agreement Amendment and any customary
officer&rsquo;s certificates and secretary&rsquo;s certificates related thereto; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">cooperating
with Parent to satisfy the conditions precedent to the effectiveness of any Credit Agreement Amendment to the extent within the control
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the avoidance of doubt, any cooperation provided for in this clause
(c)&nbsp;shall be subject to the indemnification and expense reimbursement provisions in clause (b)&nbsp;above and the other limitations
set forth in clause (d)&nbsp;below, and nothing in this clause (c)&nbsp;shall require the Company to pay (or agree to pay) any fee or
other amount prior to the Closing (and any such fee or other amount payable at Closing shall only be payable with funds provided by or
on behalf of Parent) or to incur any liability that is not indemnifiable or reimbursable pursuant to clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Notwithstanding
anything else in this <U>Section&nbsp;7.17</U>, (A)&nbsp;none of the Company or any of its Subsidiaries or any of their respective officers,
directors, managers, employees or other Representatives shall be required to (x)&nbsp;pay (or agree to pay) any commitment or other fee,
pay any expense, provide any indemnities or incur any liability in connection with any Debt Financing prior to the Closing Date (and
any such fees or other expenses payable at Closing shall only be payable with funds provided by or on behalf of Parent) or (y)&nbsp;pay
(or agree to pay) any fee or other amount in connection with the Credit Agreement Amendment prior to the Closing (and any such fee or
other amount payable at Closing shall only be payable with funds provided by or on behalf of Parent) or to incur any liability in connection
with the Credit Agreement Amendment that is not indemnifiable or reimbursable pursuant to clause (b), (B)&nbsp;nothing in this <U>Section&nbsp;7.17
</U>shall require any director, manager, officer or other Representative of the Company or any of its Subsidiaries to execute or deliver
any document or instrument (1)&nbsp;if such Person believes in good faith that any representation, warranty or certification contained
therein is not true or (2)&nbsp;if such Person believes in good faith that execution or delivery of such document or instrument would
reasonably be expected to result in personal liability, (C)&nbsp;none of the Company, any of its Subsidiaries or any of their respective
officers, directors, managers, employees or other Representatives shall be required to take any action that would reasonably be expected
to unreasonably interfere with the operation of their respective businesses, (D)&nbsp;none of the Company, any of its Subsidiaries or
any of their respective officers, directors, managers, employees or other Representatives shall be required to disclose any information
that is legally privileged, (E)&nbsp;none of the Company, any of its Subsidiaries or any of their respective officers, directors, managers,
employees or other Representatives shall be required to take any action or provide any information to the extent it would or could reasonably
be expected to conflict with, or result in any violation of or default under, any Law, organizational documents, material Contract, or
confidentiality obligation applicable to such Person, (F)&nbsp;neither the Company nor any of its Affiliates will be required to make
any filings with the SEC in connection with any Debt Financing, (G)&nbsp;none of the Company or any of its Subsidiaries or any of their
respective officers, directors, managers, employees or other Representatives shall be required to execute, deliver or enter into, or
perform any document in connection with the Debt Financing that is contemplated to be effective prior to the Closing (and any such execution,
delivery or performance at Closing shall be performed by such officers, directors, managers, employees or other Representatives as constituted
after the Effective Time and Closing) (other than any representation and authorization letters referred to in <U>Section&nbsp;7.17(a)(ii)</U>&nbsp;above
and any prepayment notices referred to in <U>Section&nbsp;7.17(a)(vi)</U>&nbsp;above required by the Payoff Indebtedness), (H)&nbsp;none
of the board of directors (or other similar governing body) or committee or subcommittee thereof of the Company or any of its Subsidiaries
shall be required to adopt resolutions approving the Debt Financing and the documentation relating thereto that are contemplated to be
effective prior to the Closing (and any such adoption or approval at Closing shall be performed by such board of directors (or other
similar governing body) or committee or subcommittee thereof as constituted after the Effective Time and Closing), (I)&nbsp;none of the
Company, any of its Subsidiaries or any of their respective officers, directors, managers, employees or other Representatives shall be
required to take any action or provide any information to the extent it would or could reasonably be expected to (w)&nbsp;require the
Company or any of its Subsidiaries to waive or amend the terms of this Agreement or result in a breach of this Agreement or a failure
of any condition to Closing set forth in this Agreement, (x)&nbsp;constitute a default under, or give rise to any right of termination,
cancellation or acceleration of any right or obligation of the Company or such Subsidiary or to a loss of any benefit to which the Company
or such Subsidiary is entitled under any provision of any material Contract, (y)&nbsp;result in the creation or imposition of any Lien
on any asset of the Company or such Subsidiary (except any Lien on any of the Company&rsquo;s or such Subsidiary&rsquo;s respective assets
that becomes effective only upon the Closing), or (z)&nbsp;result in the Company&rsquo;s or any of its Affiliates&rsquo; directors, managers,
officers, general or limited partners, employees, counsel, financial advisors, auditors, agents and other authorized Representatives
incurring any personal liability with respect to any matters relating to any financing. The Company hereby consents to the use of the
trademarks, trade names and logos of the Company and its Subsidiaries by Parent and any Debt Financing Sources, in each case, only as
reasonably required in connection with any Debt Financing; provided that Parent shall ensure that any such trademarks, trade names and
logos are used by the above permitted parties solely in a manner that is not intended, or that is not reasonably likely, to harm, disparage
or otherwise adversely affect the Company&rsquo;s reputation or goodwill. To the extent identifying the Company or any of its Subsidiaries
by name, the Company shall have the right to review and comment on marketing materials used in connection with the arrangement of any
Debt Financing prior to the dissemination of such materials to potential Debt Financing Sources or other counterparties to any proposed
financing transaction. Any information with respect to the prospects and projections for the Company and its Subsidiaries in connection
with any Debt Financing will be the sole responsibility of Parent, and neither the Company nor any of its Affiliates nor any of their
respective officers, directors, managers, employees or other Representatives shall have any liability or incur any damages with respect
thereto or be required to provide any projections or information or make any presentations with respect to capital structure, or the
incurrence of any or other pro forma information relating thereto or the manner in which Parent intends to operate, or cause to be operated,
the Company and its Subsidiaries after the Closing. The Company and its Subsidiaries shall not be required to deliver, or cause to be
delivered, any legal opinions in connection with the Debt Financing or the Credit Agreement Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.18.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Payoff
Letters</U>. The Company shall, and shall cause its applicable Subsidiaries to, use commercially reasonable efforts to deliver to Parent,
on or prior to the Closing Date, duly executed payoff and release letters in respect of all Payoff Indebtedness (such letters, the &ldquo;<U>Payoff
Letters</U>&rdquo;), in form and substance reasonably satisfactory to Parent, providing for the satisfaction and discharge of all obligations
of the Company and its Subsidiaries in respect of all such Payoff Indebtedness (other than contingent obligations for which no claim
has been made), effective upon the payment of the amounts set forth in such Payoff Letters (such amounts, the &ldquo;<U>Payoff Amount</U>&rdquo;).
Parent shall on behalf of the Company irrevocably pay off or cause to be paid off at or prior to the Effective Time the Payoff Amount
and cooperate as may be reasonably requested by the Company to assist the Company in connection with its obligation under this <U>Section&nbsp;7.18</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.19.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Pre-Closing
Actions.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Within
five business days from the date hereof, the Company shall make available to Parent true, complete and correct copies of the organizational
documents of each of the Company&rsquo;s Subsidiaries set forth in <U>Section&nbsp;7.19(a)</U>&nbsp;of the Company Disclosure Letter,
in each case as amended and in effect as of the date so provided.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Prior
to the Closing, the Company and Parent shall, and shall cause each applicable Affiliate to, cause the actions contemplated by <U>Section&nbsp;7.19(b)</U>&nbsp;of
the Parent Disclosure Letter to occur at the times and in the manner specified therein. To the extent such actions would require an approval
or non-disapproval by and Insurance Regulator, the applicable filing shall indicate that approval or non-disapproval of such action is
not a condition to the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;7.20.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Stock
Exchange Listing.</U> BAM shall use its reasonable best efforts to cause the BAM Class&nbsp;A Stock to be delivered as Stock Consideration
to be approved for listing on the NYSE, subject to official notice of issuance, prior to the Effective Time. BAM shall use its reasonable
best efforts to obtain conditional approval for the listing and posting for trading on the TSX of the BAM Class&nbsp;A Stock to be delivered
as Stock Consideration, subject only to satisfaction of the customary listing conditions of the TSX.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;VIII</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>CONDITIONS PRECEDENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;8.01.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Conditions
to Each Party&rsquo;s Obligation To Effect the Merger.</U> The respective obligations of the Company, Parent, Merger Sub and BAM to effect
the Merger shall be subject to the satisfaction (or waiver, if permissible under applicable Law)&nbsp;on or prior to the Closing Date
of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Required
Shareholder Approval.</U> The Required Shareholder Approval shall have been obtained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Listing.
</U>The shares of BAM Class&nbsp;A Stock constituting the Stock Consideration shall have been approved for listing on the NYSE, subject
to official notice of issuance, and conditionally approved for listing on the TSX, subject to the satisfaction of customary listing conditions
of the TSX.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Other
Approvals.</U> (i)&nbsp;Any waiting period (or extension thereof)&nbsp;applicable to the Transactions under the HSR Act shall have been
terminated or shall have expired, (ii)&nbsp;the Consents of, or declarations, notifications or filings with, and the other terminations
or expirations of waiting periods required from, the Governmental Authorities set forth in <U>Section&nbsp;8.01(c)</U>&nbsp;of the Company
Disclosure Letter shall have been filed, have occurred or been obtained (collectively, the &ldquo;<U>Required Regulatory Approvals</U>&rdquo;)&nbsp;and
shall be in full force and effect and (iii)&nbsp;any timing agreement(s)&nbsp;with a Governmental Authority applicable to the consummation
of the Transactions shall have expired or otherwise not prohibit consummation of the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Injunctions or Restraints.</U> No injunction, judgment or ruling enacted, promulgated, issued, entered, amended or enforced by any Governmental
Authority of competent jurisdiction (collectively, &ldquo;<U>Restraints</U>&rdquo;)&nbsp;shall be in effect enjoining, restraining or
otherwise making illegal, preventing or prohibiting consummation of the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Form&nbsp;F-4.
</U>The Form&nbsp;F-4 shall have been declared effective under the Securities Act and shall not be the subject of any stop order suspending
the effectiveness of such registration statement or initiated or threatened proceedings seeking such a stop order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;8.02.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Conditions
to Obligations of Parent, Merger Sub and BAM</U>. The obligations of Parent, Merger Sub and BAM to effect the Merger are further subject
to the satisfaction (or waiver, if permissible under applicable Law)&nbsp;on or prior to the Closing Date of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Representations
and Warranties of the Company.</U> The representations and warranties of the Company (i)&nbsp;set forth in <U>Section&nbsp;4.02(a)</U>&nbsp;and
clause&nbsp;(ii)&nbsp;of <U>Section&nbsp;4.06 </U>shall be true and correct in all respects (except for <I>de minimis</I> inaccuracies)&nbsp;as
of the date of this Agreement and as of the Closing Date as though made as of the Closing Date (except to the extent expressly made as
of an earlier date, in which case as of such date), (ii)&nbsp;set forth in <U>Sections 4.02(b)</U>, <U>4.03(a)</U>, <U>4.03(b), 4.03(d)</U>&nbsp;and
<U>4.25</U> shall be true and correct in all material respects (without regard to any materiality qualifiers specified therein)&nbsp;as
of the date of this Agreement and as of the Closing Date with the same effect as though made as of the Closing Date (except to the extent
expressly made as of an earlier date, in which case as of such date)&nbsp;and (iii)&nbsp;set forth in this Agreement, other than those
Sections specifically identified in clauses (i)&nbsp;or (ii)&nbsp;of this <U>Section&nbsp;8.02(a)</U>, shall be true and correct (disregarding
all qualifications or limitations as to &ldquo;materiality,&rdquo; &ldquo;Company Material Adverse Effect&rdquo; and words of similar
import set forth therein, other than <U>Section&nbsp;4.15(a)</U>&nbsp;and any use of the defined term &ldquo;Material Contract&rdquo;)&nbsp;as
of the date of this Agreement and as of the Closing Date with the same effect as though made as of the Closing Date (except to the extent
expressly made as of an earlier date, in which case as of such date), except, in the case of this clause (iii), where the failure to
be so true and correct would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect.
Parent shall have received a certificate signed on behalf of the Company by an executive officer of the Company to such effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Obligations
and Agreements of the Company.</U> The Company shall have performed or complied in all material respects with the obligations and agreements
required to be performed or complied with by it under this Agreement at or prior to the Closing. Parent shall have received a certificate
signed on behalf of the Company by an executive officer of the Company to such effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Company
Material Adverse Effect.</U> Since the date hereof, no Company Material Adverse Effect shall have occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Burdensome
Condition.</U> No Burdensome Condition shall have been imposed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>FINRA
Approval.</U> FINRA&rsquo;s approval of the Rule&nbsp;1017 Application, <U>provided</U>, that Parent may, in its sole discretion and
upon written notice to the Company, waive the receipt of FINRA&rsquo;s approval of the Rule&nbsp;1017 Application as a condition upon
which the obligations of any party to effect the Merger shall be subject, but Parent shall only have the right to exercise such waiver
option in the circumstance where: (A)&nbsp;the passing of 12:01 am New York time on the thirty-first (31st) calendar day following the
date on which FINRA accepts as &ldquo;substantially complete&rdquo; the Rule&nbsp;1017 Application, and (B)&nbsp;FINRA has not provided
notice to the Broker-Dealer Subsidiary expressly stating that the Closing may not occur until FINRA approves the Rule&nbsp;1017 Application
(or if FINRA has provided such notice to Broker-Dealer Subsidiary, such notice has been withdrawn).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;8.03.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Conditions
to Obligations of the Company</U>. The obligations of the Company to effect the Merger are further subject to the satisfaction (or waiver,
if permissible under applicable Law)&nbsp;on or prior to the Closing Date of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Representations
and Warranties of the Parent Entities.</U> The representations and warranties of Parent and Merger Sub (i)&nbsp;set forth in <U>Sections
5.02 </U>and <U>5.06</U> shall be true and correct in all material respects (without regard to any materiality qualifiers specified therein)&nbsp;as
of the date of this Agreement and as of the Closing Date with the same effect as though made as of the Closing Date (except to the extent
expressly made as of an earlier date, in which case as of such date)&nbsp;and (ii)&nbsp;set forth in this Agreement, other than those
Sections specifically identified in clause (i)&nbsp;of this <U>Section&nbsp;8.03(a)</U>, shall be true and correct (disregarding all
qualifications or limitations as to &ldquo;materiality,&rdquo; &ldquo;Parent Material Adverse Effect&rdquo; and words of similar import
set forth therein)&nbsp;as of the date of this Agreement and as of the Closing Date with the same effect as though made as of the Closing
Date (except to the extent expressly made as of an earlier date, in which case as of such date), except, in the case of this clause (ii),
where the failure to be true and correct would not, individually or in the aggregate, reasonably be expected to have a Parent Material
Adverse Effect. The Company shall have received a certificate signed on behalf of Parent and Merger Sub by an executive officer of Parent
and an executive officer of Merger Sub to such effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Obligations
and Agreements of the Parent Entities.</U> Parent and Merger Sub shall have performed or complied in all material respects with the obligations
and agreements required to be performed or complied with by them under this Agreement at or prior to the Closing. The Company shall have
received a certificate signed on behalf of Parent and Merger Sub by an executive officer of Parent and an executive officer of Merger
Sub to such effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Representations
and Warranties of BAM.</U> The representations and warranties of BAM (i)&nbsp;set forth in <U>Section&nbsp;6.02</U>&nbsp;and clause&nbsp;(ii)&nbsp;of
<U>Section&nbsp;6.09</U>&nbsp;shall be true and correct in all respects (except for <I>de minimis</I> inaccuracies)&nbsp;as of the date
of this Agreement and as of the Closing Date as though made as of the Closing Date (except to the extent expressly made as of an earlier
date, in which case as of such date), (ii)&nbsp;set forth in <U>Sections 6.03 </U>and <U>6.12 </U>shall be true and correct in all material
respects (without regard to any materiality qualifiers specified therein)&nbsp;as of the date of this Agreement and as of the Closing
Date with the same effect as though made as of the Closing Date (except to the extent expressly made as of an earlier date, in which
case as of such date)&nbsp;and (iii)&nbsp;set forth in this Agreement, other than those Sections specifically identified in clauses (i)&nbsp;or
(ii)&nbsp;of this <U>Section&nbsp;8.03(c)</U>, shall be true and correct (disregarding all qualifications or limitations as to &ldquo;materiality,&rdquo;
 &ldquo;BAM Material Adverse Effect&rdquo; and words of similar import set forth therein)&nbsp;as of the date of this Agreement and as
of the Closing Date with the same effect as though made as of the Closing Date (except to the extent expressly made as of an earlier
date, in which case as of such date), except, in the case of this clause (iii), where the failure to be true and correct would not, individually
or in the aggregate, reasonably be expected to have a BAM Material Adverse Effect. The Company shall have received a certificate signed
on behalf of BAM by an executive officer of BAM to such effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Obligations
and Agreements of BAM.</U> BAM shall have performed or complied in all material respects with the obligations and agreements required
to be performed or complied with by them under this Agreement at or prior to the Closing. The Company shall have received a certificate
signed on behalf of BAM by an executive officer of BAM to such effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;8.04.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Frustration
of Closing Conditions</U>. None of the parties hereto may rely, either as a basis for not consummating the Transactions or for terminating
this Agreement, on the failure of any condition set forth in <U>Sections 8.01</U>, <U>8.02</U> or <U>8.03</U>, as the case may be, to
be satisfied if such failure was caused by such party&rsquo;s breach in any material respect of any provision of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;IX</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>TERMINATION</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;9.01.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Termination</U>.
This Agreement may be terminated and the Transactions abandoned at any time prior to the Effective Time, whether before or after receipt
of the Required Shareholder Approval (except as otherwise expressly noted):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">by
the mutual written consent of the Company and Parent duly authorized by each of the Company Board and the Parent Board;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">by
either of the Company or Parent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">if
the Merger shall not have been consummated on or prior to April&nbsp;4, 2024 (the &ldquo;<U>Outside Date</U>&rdquo;); <U>provided</U>,
<U>however</U>, that if the conditions to the Closing set forth in <U>Section&nbsp;8.01(c)</U>&nbsp;have not been satisfied or waived
on or prior to such date but all other conditions to Closing set forth in <U>Article&nbsp;VIII</U> have been satisfied or waived (other
than those conditions that by their nature are to be satisfied or waived at the Closing (so long as such conditions are reasonably capable
of being satisfied)), the Outside Date may be extended by either party to a date not beyond July&nbsp;5, 2024, by providing a written
notice thereof to the other party prior to 5:00 p.m.&nbsp;(New York time) on&nbsp;such date; <U>provided</U>, <U>further</U> that the
right to terminate this Agreement under this <U>Section&nbsp;9.01(b)(i)</U>&nbsp;shall not be available to any party if the breach by
such party of its representations and warranties set forth in this Agreement or the failure of such party to perform any of its obligations
under this Agreement, its failure to act in good faith or its failure to use its reasonable best efforts to consummate the Transactions,
including to the extent required by and subject to <U>Section&nbsp;7.05</U>, has been a proximate cause of the failure of the Merger
to be consummated on or prior to such date (it being understood that Parent, BAM and Merger Sub shall be deemed a single party for purposes
of the foregoing proviso);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">if
any Restraint having the effect set forth in <U>Section&nbsp;8.01(d)</U>&nbsp;shall be in effect and shall have become final and nonappealable;
<U>provided</U> that the party seeking to terminate this Agreement pursuant to this <U>Section&nbsp;9.01(b)(ii)</U>&nbsp;shall have performed
in all material respects its obligations under this Agreement, acted in good faith and used reasonable best efforts to prevent the entry
of and to remove such Restraint in accordance with its obligations under this Agreement (it being understood that Parent, BAM and Merger
Sub shall be deemed a single party for purposes of the foregoing proviso); or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">if
the Required Shareholder Approval shall not have been obtained following a vote thereon having been taken at the Company Shareholders
Meeting or at any postponement, recess or adjournment thereof taken in accordance with this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">by
Parent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">if
the Company shall have breached any of its representations or warranties or failed to perform any of its obligations or agreements set
forth in this Agreement, which breach or failure to perform (A)&nbsp;would give rise to the failure of a condition set forth in <U>Section&nbsp;8.02(a)</U>&nbsp;or
<U>Section&nbsp;8.02(b)</U>&nbsp;and (B)&nbsp;is not reasonably capable of being cured prior to the Outside Date, or if reasonably capable
of being cured, shall not have been cured by the earlier of the Outside Date and 30&nbsp;days following receipt by the Company of written
notice of such breach or failure to perform from Parent stating Parent&rsquo;s intention to terminate this Agreement pursuant to this
<U>Section&nbsp;9.01(c)(i)</U>&nbsp;and the basis for such termination; <U>provided</U> that Parent shall not have the right to terminate
this Agreement pursuant to this <U>Section&nbsp;9.01(c)(i)</U>&nbsp;if Parent, Merger Sub or BAM is then in material breach of any of
its representations, warranties, obligations or agreements hereunder; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">prior
to receipt of the Required Shareholder Approval, if the Company Board shall have effected and not withdrawn an Adverse Recommendation
Change; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">by
the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">if
Parent, Merger Sub or BAM shall have breached any of its representations or warranties or failed to perform any of its obligations or
agreements set forth in this Agreement, which breach or failure to perform (A)&nbsp;would give rise to the failure of a condition set
forth in <U>Sections 8.03(a)</U>, <U>8.03(b)</U>, <U>8.03(c)</U>&nbsp;or <U>8.03(d)</U>&nbsp;and (B)&nbsp;is not reasonably capable of
being cured prior to the Outside Date, or if reasonably capable of being cured, shall not have been cured by the earlier of the Outside
Date and 30&nbsp;days following receipt by Parent, Merger Sub or BAM, as applicable, of written notice of such breach or failure to perform
from the Company stating the Company&rsquo;s intention to terminate this Agreement pursuant to this <U>Section&nbsp;9.01(d)(i)</U>&nbsp;and
the basis for such termination; <U>provided</U> that the Company shall not have the right to terminate this Agreement pursuant to this
<U>Section&nbsp;9.01(d)(i)</U>&nbsp;if the Company is then in material breach of any of its representations, warranties, obligations
or agreements hereunder; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">prior
to receipt of the Required Shareholder Approval, in connection with entering into a Company Acquisition Agreement in accordance with
<U>Section&nbsp;7.03(d)(ii)</U>;&nbsp;<U>provided</U> that, prior to or concurrently with such termination, the Company pays the Company
Termination Fee in accordance with <U>Section&nbsp;9.03</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;9.02.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Effect
of Termination</U>. In the event of the termination of this Agreement as provided in <U>Section&nbsp;9.01</U>, written notice thereof
shall be given to the other party or parties, specifying the provision hereof pursuant to which such termination is made, and this Agreement
shall forthwith become null and void (other than <U>Sections 9.02</U> and <U>9.03</U>, <U>Article&nbsp;X</U>, the Confidentiality Agreement
and the Guaranty, all of which shall survive termination of this Agreement), and there shall be no liability on the part of Parent, Merger
Sub, the Company or their respective former, current or future directors, officers, partners, shareholders, managers, members and Affiliates
arising out of or in connection with this Agreement, any of the Transactions or any matters forming the basis of such termination, except
(a)&nbsp;as liability may exist pursuant to the provisions specified in the immediately preceding parenthetical that survive such termination,
(b)&nbsp;as liability may exist pursuant to the terms and conditions of the Guaranty or the Voting Agreement, and (c)&nbsp;that no such
termination shall relieve any party from liability for any Willful Breach or Fraud.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;9.03.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Termination
Fee</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">In
the event that this Agreement is terminated (A)&nbsp;by Parent pursuant to <U>Section&nbsp;9.01(c)(ii)</U>&nbsp;or (B)&nbsp;by the Company
pursuant to <U>Section&nbsp;9.01(d)(ii)</U>, then the Company shall pay Parent the Company Termination Fee. If the Company Termination
Fee is payable pursuant to clause (A)&nbsp;of the preceding sentence, the Company Termination Fee shall be paid within four&nbsp;business
days after the date of such termination, and if the Company Termination Fee is payable pursuant to clause (B)&nbsp;of the preceding sentence,
the Company Termination Fee shall be paid as described in <U>Section&nbsp;9.01(d)(ii)</U>, in each case, by wire transfer of immediately
available funds to an account designated by Parent in writing (it being understood that in no event shall the Company be required to
pay the Company Termination Fee more than once).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">If
this Agreement is terminated by either Parent or the Company pursuant to <U>Section&nbsp;9.01(b)(iii)</U>&nbsp;and (A)&nbsp;at any time
after the date of this Agreement and prior to such termination, a Takeover Proposal shall have been publicly announced or publicly made
known to the Company Board or the shareholders of the Company and not withdrawn and (B)&nbsp;within 12&nbsp;months of such termination,
the Company consummates such a Takeover Proposal or enters into a definitive agreement to consummate such a Takeover Proposal and the
Company thereafter consummates such Takeover Proposal (whether or not within such 12 month period), then the Company shall pay Parent
the Company Termination Fee; <U>provided</U> that for purposes of this <U>Section&nbsp;9.03(b)</U>, the references to &ldquo;20%&rdquo;
in the definition of Takeover Proposal shall be deemed to be references to &ldquo;50%.&rdquo; If the Company Termination Fee is payable
pursuant to this <U>Section&nbsp;9.03(b)</U>, the Company Termination Fee shall be paid upon the consummation of such Takeover Proposal
by wire transfer of immediately available funds to an account designated by Parent in writing (it being understood that in no event shall
the Company be required to pay the Company Termination Fee more than once).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Each
of the parties acknowledges that the agreements contained in this <U>Section&nbsp;9.03</U> are an integral part of the Transactions,
and that without these agreements, the other parties would not enter into this Agreement; accordingly, if the Company fails to timely
pay any amount due pursuant to this <U>Section&nbsp;9.03</U>, and, in order to obtain the payment, Parent commences an Action which results
in a judgment against the Company for the payment set forth in this <U>Section&nbsp;9.03</U>, the Company shall pay Parent for its reasonable
and documented costs and expenses (including reasonable and documented attorneys&rsquo; fees)&nbsp;in connection with such Action, together
with interest on such amount at the prime rate as published in <I>The Wall Street Journal</I> in effect on the date such payment was
required to be made through the date such payment was actually received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;X</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>MISCELLANEOUS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.01.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>No
Survival of Representations and Warranties</U>. This <U>Article&nbsp;X</U> and the agreements of the Company, Parent and Merger Sub contained
in <U>Article&nbsp;III</U> and in <U>Sections 7.08</U>, <U>7.10</U> and <U>7.11</U> shall survive the Effective Time. No other representations,
warranties, obligations or agreements in this Agreement shall survive the Effective Time, expect for those representations, warranties,
obligations or agreements set forth in this Agreement that by their terms apply, or that are to be performed in whole or in part, after
the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.02.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Amendment
or Supplement</U>. At any time prior to the Closing, this Agreement may be amended or supplemented in any and all respects, whether before
or after receipt of the Required Shareholder Approval, only by written agreement of the parties, by action taken by the Parent Board,
an authorized officer of BAM and the Company Board; <U>provided</U>, <U>however</U>, that following receipt of the Required Shareholder
Approval, there shall be no amendment or change to the provisions hereof which by applicable Law would require further approval by the
Company&rsquo;s shareholders without such approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.03.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Extension
of Time, Waiver, Etc.</U> At any time prior to the Closing, Parent and the Company may, subject to applicable Law, (a)&nbsp;waive any
inaccuracies in the representations and warranties of the other party, (b)&nbsp;extend the time for the performance of any of the obligations
or acts of the other party or (c)&nbsp;subject to the requirements of applicable Law, waive compliance by the other party with any of
the agreements contained herein or, except as otherwise provided herein, waive any of such party&rsquo;s conditions (it being understood
that Parent and Merger Sub shall be deemed a single party for purposes of the foregoing). Notwithstanding the foregoing, no failure or
delay by the Company, Parent or Merger Sub in exercising any right hereunder shall operate as a waiver thereof nor shall any single or
partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right hereunder. Any agreement on
the part of a party to any such extension or waiver shall be valid only if set forth in an instrument in writing signed on behalf of
such party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.04.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Assignment</U>.
Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned, in whole or in part, by operation
of Law or otherwise, by any of the parties without the prior written consent of the other parties. No assignment by any party shall relieve
such party of any of its obligations hereunder. Subject to the immediately preceding two sentences, this Agreement shall be binding upon,
inure to the benefit of, and be enforceable by, the parties and their respective successors and permitted assigns. Any purported assignment
not permitted under this <U>Section&nbsp;10.04</U> shall be null and void.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.05.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Counterparts</U>.
This Agreement may be executed in one or more counterparts (including by electronic mail), each of which shall be deemed to be an original
but all of which taken together shall constitute one and the same agreement, and shall become effective when one or more counterparts
have been signed by each of the parties and delivered to the other parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.06.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Entire
Agreement; No Third-Party Beneficiaries</U>. This Agreement, together with the Exhibits and Schedules attached hereto, the Company Disclosure
Letter, the Parent Disclosure Letter, the BAM Disclosure Letter, the Guaranty, the Voting Agreement and the Confidentiality Agreement,
constitute the entire agreement, and supersede all other prior agreements and understandings, both written and oral, among the parties
and their Affiliates, or any of them, with respect to the subject matter hereof and thereof. Except for: (i)&nbsp;if the Effective Time
occurs, (A)&nbsp;the right of the holders of Common Stock to receive the Merger Consideration payable in accordance with <U>Article&nbsp;III
</U>and (B)&nbsp;the right of the holders of Preferred Stock to receive preferred stock of the Surviving Company in accordance with <U>Article&nbsp;III
</U>and (ii)&nbsp;the Indemnitees with respect to&nbsp;the provisions set forth in <U>Section&nbsp;7.08</U> of this Agreement, nothing
in this Agreement, express or implied, is intended to or shall confer upon any Person other than the parties any rights or remedies hereunder.
Notwithstanding the foregoing, the Company shall have the right to recover, through an Action brought by the Company, damages from Parent
(or against BN to the extent provided for in the Guaranty) in the event of a breach of this Agreement by Parent, in which event the damages
recoverable by the Company for itself and on behalf of the Company&rsquo;s shareholders shall be determined by reference to the total
amount that would have been recoverable by such holders if all such holders brought an action against Parent and were recognized as third-party
beneficiaries hereunder. The representations, warranties, covenants and agreements in this Agreement are the product of negotiations
among the parties and are for the sole benefit of the parties and may, in certain instances, be qualified, limited or changed by confidential
disclosure letters. Any inaccuracies in such representations or warranties or failure to perform or breach of such covenants or agreements
are subject to waiver by the parties in accordance with <U>Section&nbsp;10.03</U> without notice or liability to any other Person. In
some instances, the representations, warranties, covenants and agreements in this Agreement may represent an allocation among the parties
of risk associated with particular matters regardless of the knowledge of any of the parties. Consequently, Persons other than the parties
may not rely upon the representations, warranties, covenants and agreements in this Agreement as characterizations of actual facts or
circumstances as of the date of this Agreement or as of any other date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.07.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Governing
Law; Jurisdiction</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">This
Agreement shall be governed by, and construed in accordance with, the Laws of the State of Iowa applicable to contracts executed in and
to be performed entirely within that state, regardless of the laws that might otherwise govern under any applicable conflict of laws
principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">All
Actions arising out of or relating to the interpretation and enforcement of the provisions of this Agreement and in respect of the Transactions
shall be heard and determined in the Iowa District Court for Polk County, or, if the Iowa District Court declines to accept jurisdiction
over a particular matter, any federal court within the State of Iowa, or, if both the Iowa District Court and the federal courts within
the State of Iowa decline to accept jurisdiction over a particular matter, any other state court within the State of Iowa, and, in each
case, any appellate court therefrom. The parties hereby irrevocably submit to the exclusive jurisdiction and venue of such courts in
any such Actions and irrevocably waive the defense of an inconvenient forum or lack of jurisdiction to the maintenance of any such Action.
The consents to jurisdiction and venue set forth in this <U>Section&nbsp;10.07(b)</U>&nbsp;shall not constitute general consents to service
of process in the State of Iowa and shall have no effect for any purpose except as provided in this paragraph and shall not be deemed
to confer rights on any Person other than the parties. Each party agrees that service of process upon such party in any Action arising
out of or relating to this Agreement shall be effective if notice is given by overnight courier at the address set forth in <U>Section&nbsp;10.10
</U>of this Agreement. The parties agree that a final judgment in any such Action shall be conclusive and may be enforced in other jurisdictions
by suit on the judgment or in any other manner provided by applicable Law; <U>provided</U>, <U>however</U>, that nothing contained in
the foregoing shall restrict any party&rsquo;s rights to seek any post-judgment relief regarding, or any appeal from, a final trial court
judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.08.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Specific
Enforcement</U>. The parties agree that irreparable damage for which monetary relief, even if available, would not be an adequate remedy,
would occur in the event that any provision of this Agreement is not performed in accordance with its specific terms or is otherwise
breached, including if the parties fail to take any action required of them hereunder to consummate this Agreement, subject to the terms
and conditions of this Agreement. The parties acknowledge and agree that (a)&nbsp;the parties shall be entitled to an injunction or injunctions,
specific performance or other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions
hereof (including, for the avoidance of doubt, the right of the Company to cause the Merger to be consummated on the terms and subject
to the conditions set forth in this Agreement and to enforce the obligations of BN pursuant to the terms of the Guaranty and the Voting
Agreement)&nbsp;in the courts described in <U>Section&nbsp;10.07(b)</U>&nbsp;without proof of damages or otherwise, this being in addition
to any other remedy to which they are entitled under this Agreement and (b)&nbsp;the right of specific enforcement is an integral part
of the Transactions and without that right, neither the Company nor Parent would have entered into this Agreement. The parties agree
not to assert that a remedy of specific enforcement is unenforceable, invalid, contrary to Law or inequitable for any reason, and not
to assert that a remedy of monetary damages would provide an adequate remedy or that the parties otherwise have an adequate remedy at
law. The parties acknowledge and agree that any party seeking an injunction or injunctions to prevent breaches of this Agreement and
to enforce specifically the terms and provisions of this Agreement in accordance with this <U>Section&nbsp;10.08</U> shall not be required
to provide any bond or other security in connection with any such order or injunction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.09.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>WAIVER
OF JURY TRIAL</U>. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY&nbsp;ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE
COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY
APPLICABLE LAW, ANY RIGHT IT MAY&nbsp;HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING
TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH
PARTY CERTIFIES AND ACKNOWLEDGES THAT (A)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR
OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT,&nbsp;IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B)&nbsp;IT UNDERSTANDS
AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVER, (C)&nbsp;IT MAKES SUCH WAIVER VOLUNTARILY AND (D)&nbsp;IT HAS BEEN INDUCED TO ENTER
INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS <FONT STYLE="text-transform: uppercase"><U>Section&nbsp;10.09</U></FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.10.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Notices.
</U>All notices, requests and other communications to any party hereunder shall be in writing and shall be deemed given if delivered
personally, emailed (but only if confirmation of receipt of such email is requested and received, provided that each notice party shall
use reasonable best efforts to confirm receipt of any such email correspondence promptly upon receipt of such request) or sent by overnight
courier (providing proof of delivery)&nbsp;to the parties at the following addresses:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to Parent or Merger Sub, to:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brookfield Reinsurance Ltd.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ideation House, First Floor</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">94 Pitts Bay Road</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pembroke, HM08, Bermuda</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anna Knapman-Scott</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lyndsay Hatlelid</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;anna.knapmanscott@northendre.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">lyndsay.hatlelid@brookfield.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with a copy (which shall not constitute notice)&nbsp;to:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cravath, Swaine&nbsp;&amp; Moore LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">825 Eighth Avenue</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, New York 10019</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard Hall</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in; font-size: 10pt; width: 83%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David J. Perkins</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:&nbsp;&nbsp;&nbsp;&nbsp;rhall@cravath.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dperkins@cravath.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debevoise&nbsp;&amp; Plimpton LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66 Hudson Boulevard</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, New York 10001</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Nicholas F. Potter</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:&nbsp;&nbsp;&nbsp;&nbsp;nfpotter@debevoise.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to BAM, to:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brookfield Asset Management Ltd.&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brookfield Place, Suite&nbsp;100</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">181 Bay Street, P.O.&nbsp;Box 762</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Toronto, Ontario, Canada</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">M5J 2T3</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:&nbsp;&nbsp;&nbsp;Kathy Sarpash</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: &nbsp; kathy.sarpash@brookfield.com</FONT></TD></TR>
</TABLE>

<P STYLE="font-size: 10pt; margin: 0">&nbsp;</P>

<P STYLE="margin: 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 32; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font-size: 10pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with a copy (which shall not constitute notice)&nbsp;to:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 83%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cravath, Swaine&nbsp;&amp; Moore LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">825 Eighth Avenue</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, New York 10019</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Richard Hall</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David J. Perkins</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:&nbsp;&nbsp;&nbsp;&nbsp;rhall@cravath.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">dperkins@cravath.com</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to the Company, to:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 83%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">American Equity Investment Life Holding Company</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6000 Westown Parkway</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">West Des Moines,&nbsp;Iowa 50266</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:&nbsp;&nbsp;&nbsp;Shari Wood</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: &nbsp;&nbsp;&nbsp;swood@american-equity.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with copies (which shall not constitute notice)&nbsp;to:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sullivan&nbsp;&amp; Cromwell LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">125 Broad Street</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, NY 10004</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;H. Rodgin Cohen</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;Melissa Sawyer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;Stephen M. Kotran</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cohenhr@sullcrom.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;sawyerm@sullcrom.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.625in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;kotranS@sullcrom.com</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or such other address or email address as such party may hereafter
specify by like notice to the other parties. All such notices, requests and other communications shall be deemed received on the date
of actual receipt by the recipient thereof if received prior to 5:00&nbsp;p.m.&nbsp;local time in the place of receipt and such day is
a business day in the place of receipt. Otherwise, any such notice, request or communication shall be deemed not to have been received
until the next succeeding business day in the place of receipt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.11.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Severability</U>.
If any term, condition or other provision of this Agreement is finally determined by a court of competent jurisdiction to be invalid,
illegal or incapable of being enforced by any applicable Law or public policy, all other terms, provisions and conditions of this Agreement
shall nevertheless remain in full force and effect so long as the economic or legal substance of the Transactions is not affected in
any manner materially adverse to any party or such party waives its rights under this <U>Section&nbsp;10.11</U> with respect thereto.
Upon such determination that any term, condition or other provision is invalid, illegal or incapable of being enforced, the parties shall
negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible to the fullest
extent permitted by applicable Law in an acceptable manner to the end that the Transactions are fulfilled to the extent possible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.12.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Fees
and Expenses</U>. Whether or not the Transactions are consummated, all fees and expenses incurred in connection with the Transactions
and this Agreement shall be paid by the party incurring or required to incur such fees or expenses, except as otherwise set forth in
this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.13.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Transfer
Taxes</U>. Except as otherwise provided in <U>Section&nbsp;3.02(b)</U>, all transfer, documentary, sales, use, stamp, registration, value-added
and other similar Taxes and fees incurred in connection with the Transactions shall be paid by Parent and Merger Sub when due and expressly
shall not be a liability of any holders of the Common Stock or the Company Awards or the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.14.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>No
Other Representations and Warranties</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Except
for the representations and warranties expressly set forth in <U>Article&nbsp;IV</U>, neither the Company nor any other Person on behalf
of the Company makes any express or implied representation or warranty with respect to the Company, its Subsidiaries or their respective
businesses or with respect to any other information provided to Parent, Merger Sub, BAM or their Representatives or Affiliates in connection
with the Transactions. Neither the Company nor any other Person will have or be subject to any liability to Parent, Merger Sub, BAM or
any other Person resulting from the distribution to Parent, Merger Sub, BAM or their respective Representatives or Affiliates, or Parent&rsquo;s,
Merger Sub&rsquo;s, BAM&rsquo;s or their Representatives&rsquo; or Affiliates&rsquo; use of, any such information, including any information,
documents, projections, forecasts or any other material made available to Parent, Merger Sub, BAM or their Representatives or Affiliates
in the &ldquo;data rooms&rdquo; or management presentations in connection with Parent&rsquo;s, Merger Sub&rsquo;s and BAM&rsquo;s consideration
and review of the Transactions, unless any such information is expressly included in a representation or warranty set forth in <U>Article&nbsp;IV</U>.
Except for the representations and warranties set forth in <U>Article&nbsp;IV</U>, each of Parent, Merger Sub and BAM acknowledges that
neither the Company nor any Person on behalf of the Company makes any other express or implied representation or warranty with respect
to the Company or any of its Subsidiaries or with respect to any other information provided or made available to Parent, Merger Sub or
BAM in connection with the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Except
for the representations and warranties expressly set forth in <U>Article&nbsp;V</U>, the Guaranty or the Voting Agreement, neither Parent
nor Merger Sub nor any other Person on behalf of Parent or Merger Sub makes any express or implied representation or warranty with respect
to Parent, Merger Sub or their respective Subsidiaries or their respective businesses or with respect to any other information provided
to the Company or its Representatives or Affiliates in connection with the Transactions. Except for the representations and warranties
set forth in <U>Article&nbsp;V</U>, the Guaranty or the Voting Agreement, the Company acknowledges that none of Parent, Merger Sub or
any Person on behalf of Parent or Merger Sub makes any other express or implied representation or warranty with respect to Parent or
Merger Sub or with respect to any other information provided or made available to the Company in connection with the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Except
for the representations and warranties expressly set forth in <U>Article&nbsp;VI</U>, the Guaranty or the Voting Agreement, neither BAM
nor any other Person on behalf of BAM makes any express or implied representation or warranty with respect to BAM, or its respective
Subsidiaries or its respective businesses or with respect to any other information provided to the Company or its Representatives or
Affiliates in connection with the Transactions. Except for the representations and warranties set forth in <U>Article&nbsp;VI</U>, the
Guaranty or the Voting Agreement, the Company acknowledges that none of BAM or any Person on behalf of BAM makes any other express or
implied representation or warranty with respect to BAM or with respect to any other information provided or made available to the Company
in connection with the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Notwithstanding
anything to the contrary contained in this Agreement or any other agreement, document or instrument, each of Parent, Merger Sub and BAM
acknowledges and agrees that the Company and its Subsidiaries make no representations or warranties with respect to, and nothing contained
in this Agreement or in any other agreement, document or instrument to be delivered in connection herewith is intended or shall be construed
to be a representation or warranty, express or implied, of the Company or any of its Subsidiaries, for any purposes of this Agreement
or any other agreement, document or instrument to be delivered in connection herewith, in respect of (i)&nbsp;the adequacy or sufficiency
of reserves of the Company or any of its Subsidiaries, (ii)&nbsp;the effect of the adequacy or sufficiency of reserves of the Company
or any of its Subsidiaries on any line item, asset, liability or equity amount on any financial or other document, (iii)&nbsp;whether
or not reserves of the Company or any of its Subsidiaries were determined in accordance with any actuarial, statutory, regulatory or
other standard or (iv)&nbsp;the collectability of any amounts under any Reinsurance Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Section&nbsp;10.15.</FONT><FONT STYLE="text-transform: uppercase">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>No
Other Duties and Obligations</U>. Except for the duties and obligations expressly set forth in <U>Sections 3.02(a)(ii)(B)</U>, <U>3.02(d)</U>,
<U>7.02</U>, <U>7.04</U>, <U>7.14(d)</U>, <U>7.20</U> and <U>8.03(c)</U>, neither BAM nor any other Person on behalf of BAM makes any
express or implied duties or obligations with respect to BAM or its respective Subsidiaries or its respective businesses in connection
with the Transactions. Except for the duties and obligations expressly set forth in <U>Sections 3.02(a)(ii)(B)</U>, <U>3.02(d)</U>, <U>7.02</U>,
<U>7.04</U>, <U>7.14(d)</U>, <U>7.20</U> and <U>8.03(c)</U>, the Company acknowledges that none of BAM or any Person on behalf of BAM
makes any other express or implied duties or obligations with respect to BAM or its respective Subsidiaries or its respective businesses
in connection with the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature pages&nbsp;follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">IN WITNESS WHEREOF, the parties hereto have caused
this Agreement to be duly executed and delivered as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">American Equity Investment Life Holding Company</FONT><FONT STYLE="font-size: 10pt; text-transform: uppercase">,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 44%">/s/ Anant Bhalla</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Anant Bhalla</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Executive Officer and President</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Brookfield Reinsurance Ltd.,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 44%">/s/ Anna Knapman-Scott</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:  Anna Knapman-Scott</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Corporate Secretary</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><B><I>Solely for the purposes of the sections expressly set forth in the preamble hereto</I></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Brookfield Asset Management Ltd.,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 44%">/s/ Kathy Sarpash</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT>  Kathy Sarpash</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Authorized Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ARCHES Merger Sub Inc.,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 44%">/s/ Jonathan Bayer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Jonathan Bayer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: President</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit&nbsp;A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>See attached</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>tm2320561d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">THIS AGREEMENT is entered into this 4th day of July,
2023 by and between AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY, an Iowa corporation (the &quot;<B>Company</B>&quot;), and AXEL <FONT STYLE="text-transform: uppercase">Andr&eacute;
</FONT>(the &quot;<B>Executive</B>&quot;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>WHEREAS</B></FONT>,
the Company and the Executive previously entered into a Change in Control Agreement, dated as of February&nbsp;26, 2022 (the &ldquo;<B>CIC
Agreement</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>WHEREAS</B></FONT>,
the Company&rsquo;s Board of Directors (the &quot;<B>Board</B>&quot;) has determined that it is in the best interests of the Company and
its stockholders to ensure that the Company and its Affiliates continue to have the continued dedication of the Executive, notwithstanding
the possibility, threat or occurrence of a termination of the Executive's employment in certain circumstances, including following a Change
in Control as defined herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>WHEREAS</B></FONT>,
the Board believes it is imperative to diminish the inevitable distraction of the Executive by virtue of the personal uncertainties and
risks created by a pending or threatened termination of the Executive's employment in such circumstances and to provide the Executive
with compensation and benefits arrangements upon such a termination which ensure that the compensation and benefits expectations of the
Executive will be satisfied and which are competitive with those of other corporations who may seek to employ the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>WHEREAS</B></FONT>,
the Company and the Executive desire to amend and restate the CIC Agreement to increase the (i)&nbsp;Executive&rsquo;s severance multiple
to three (rather than two) times the Executive&rsquo;s base salary and target bonus and (ii)&nbsp;length of the continued provision of
certain welfare benefits to a period of three (rather than two) years following the date of termination of employment, in each case determined
in accordance with the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>WHEREAS</B></FONT>,
in order to accomplish these objectives, the Board has caused the Company to enter into this Agreement with the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">It is hereby agreed as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Definitions</I></B>.
For purposes of this Agreement, the following terms will have the following meanings unless otherwise expressly provided in this Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&quot;<B>Affiliate</B>&quot;
shall have the meaning set forth in Rule&nbsp;12b-2 promulgated under Section&nbsp;12 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&quot;<B>Base
Amount</B>&quot; shall have the meaning set forth in Section&nbsp;280G(b)(3)&nbsp;of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&quot;<B>Beneficial
Owner</B>&quot; shall have the meaning set forth in Rule&nbsp;13d-3 promulgated under Section&nbsp;13 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&quot;<B>Beneficiary</B>&quot;
means any individual, trust or other entity named by the Executive to receive the Severance Payments in the event of the death of the
Executive during the Continuation Period. Executive may designate a Beneficiary to receive such Severance Payments by completing a form
provided by the Company and delivering it to the Secretary of the Company. Executive may change his or her designated Beneficiary at any
time (without the consent of any prior Beneficiary) by completing and delivering to the Secretary of the Company a new beneficiary designation
form. If a Beneficiary has not been designated by the Executive, or if no designated Beneficiary survives the Executive, then the Severance
Payments if any, will be paid to the Executive's estate, which shall be deemed to be the Executive's Beneficiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&quot;<B>Board</B>&quot;
means the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&quot;<B>Cause</B>&quot;
means:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
Executive's willful and continued failure to substantially perform the Executive's duties with the Company or its Affiliates (other than
any such failure resulting from the Executive's incapacity due to physical or mental illness), after a written demand for substantial
performance is delivered to the Executive by the Board which specifically identifies the manner in which the Board believes that the Executive
has not substantially performed his or her duties;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
final conviction of the Executive of, or an entering of a guilty plea or a plea of no contest by the Executive to, a felony; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
willful engaging by the Executive in illegal conduct or gross misconduct which is materially and demonstrably injurious to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">For purposes of this definition, no act or failure
to act on the part of the Executive shall be considered &quot;willful&quot; unless it is done, or omitted to be done, by the Executive
in bad faith or without a reasonable belief that the action or omission was in the best interests of the Company or its Affiliates. Any
act, or failure to act, based on authority given pursuant to a resolution duly adopted by the Board will be conclusively presumed to be
done, or omitted to be done, by the Executive in good faith and in the best interests of the Company and its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&quot;<B>Change
in Control</B>&quot; shall be deemed to have occurred if the event set forth in any one of the following paragraphs shall have occurred:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Person is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company (not including in the securities beneficially
owned by such Person any securities acquired directly from the Company or its Affiliates) representing 35% or more of the combined voting
power of the Company's then outstanding securities, excluding any Person who becomes such a Beneficial Owner in connection with a transaction
described paragraph (iii)&nbsp;below;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
following individuals cease for any reason to constitute a majority of the number of directors then serving: individuals who, on the date
hereof, constitute the Board and any new director (other than a director whose initial assumption of office is in connection with an actual
or threatened election contest, including but not limited to a consent solicitation, relating to the election of directors of the Company)
whose appointment or election by the Board or nomination for election by the Company's stockholders was approved or recommended by a vote
of at least two-thirds (2/3) of the directors then still in office who either were directors on the date hereof or whose appointment,
election or nomination for election was previously so approved or recommended;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">there
is consummated a merger or consolidation of the Company or any direct or indirect subsidiary of the Company with any other corporation,
other than (a)&nbsp;a merger or consolidation immediately following which the individuals who comprise the Board immediately prior thereto
constitute at least a majority of the board of directors of the Company, the entity surviving such merger or consolidation or, if the
Company or the entity surviving such merger is then a subsidiary, the ultimate parent thereof or (b)&nbsp;a merger or consolidation effected
to implement a recapitalization of the Company (or similar transaction) in which no Person is or becomes the Beneficial Owner, directly
or indirectly, of securities of the Company (not including in the securities Beneficially Owned by such Person any securities acquired
directly from the Company or its Affiliates) representing 35% or more of the combined voting power of the Company's then outstanding securities;
or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
stockholders of the Company approve a plan of complete liquidation or dissolution of the Company or there is consummated an agreement
for the sale or disposition by the Company of all or substantially all of the Company's assets, other than a sale or disposition by the
Company of all or substantially all of the Company's assets immediately following which the individuals who comprise the Board immediately
prior thereto constitute at least a majority of the board of directors of the entity to which such assets are sold or disposed or any
parent thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Notwithstanding the foregoing, a Change in Control
shall not be deemed to have occurred by virtue of the consummation of any transaction or series of integrated transactions immediately
following which the record holders of the common stock of the Company immediately prior to such transaction or series of transactions
continue to have substantially the same proportionate ownership in an entity which owns all or substantially all of the assets of the
Company immediately following such transaction or series of transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&quot;<B>Code</B>&quot;
means the Internal Revenue Code of 1986, as amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&quot;<B>Date
of Termination</B>&quot; means the date specified in a Notice of Termination pursuant to paragraph 3 hereof, or the Executive's last date
as an active employee of the Company and its Affiliates before a termination of employment due to death, Disability or other reason, as
the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&quot;<B>Disability</B>&quot;
means the Executive's total and permanent disability as defined under the terms of the Company's long-term disability plan in effect on
the Date of Termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">K.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&quot;<B>Effective
Period</B>&quot; means the 24-month period following any Change in Control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&quot;<B>Exchange
Act</B>&quot; means the Securities Exchange Act of 1934, as amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">M.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&quot;<B>Excise
Tax</B>&quot; shall mean any excise tax imposed under Section&nbsp;4999 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&quot;<B>Good
Reason</B>&quot; means, unless the Executive has consented in writing thereto, the occurrence of any of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
assignment to the Executive of any duties materially inconsistent with the Executive's position, including any change in status, authority,
duties or responsibilities or any other action which, in either such case, results in a material diminution in such status, authority,
duties or responsibilities, excluding for this purpose an isolated, insubstantial and inadvertent action not taken in bad faith and which
is remedied by the Company or the Executive's employer promptly after receipt of notice thereof given by the Executive;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">a
reduction by the Company or the Executive's employer in the Executive's base salary;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
relocation of the Executive's office to a location more than fifty (50) miles outside Ypsilanti, Michigan;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">unless
a plan providing a substantially similar compensation or benefit is substituted, (a)&nbsp;the failure by the Company or any of its Affiliates
to continue in effect any fringe benefit or compensation plan, retirement plan, life insurance plan, health and accident plan or disability
plan in which the Executive is participating prior to the Change in Control which adversely affects the Executive's total compensation
in a material manner, or (b)&nbsp;the taking of any action by the Company or any of its Affiliates which would materially adversely affect
the Executive's participation in or materially reduce or deprive him of his benefits under, such plans; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
failure of the Company to obtain the assumption in writing of the Company's obligation to perform this Agreement by any successor to all
or substantially all of the assets of the Company within 15 days after such succession.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The Executive's right to terminate the Executive's
employment for Good Reason shall not be affected by the Executive's incapacity due to physical or mental illness. In order for Good Reason
to exist hereunder, the Executive must provide notice to the Company of the existence of the condition or circumstance described above
within 90 days of the initial existence of the condition or circumstance (or, if later, within 90 days of the Executive's becoming aware
of such condition or circumstance), and the Company must have failed to cure such condition within 30 days of the receipt of such notice,
and the Executive must terminate employment within ten (10)&nbsp;days after the expiration of such cure period. Subject to the preceding
sentence, the Executive's continued employment shall not constitute consent to, or a waiver of rights with respect to, any act or failure
to act constituting Good Reason hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">O.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&quot;<B>Person</B>&quot;
shall have the meaning given in Section&nbsp;3(a)(9)&nbsp;of the Exchange Act, as modified and used in Sections 13(d)&nbsp;and 14(d)&nbsp;thereof,
except that such term shall not include (i)&nbsp;the Company or any of its subsidiaries, (ii)&nbsp;a trustee or other fiduciary holding
securities under an employee benefit plan of the Company or any of its Affiliates, (iii)&nbsp;an underwriter temporarily holding securities
pursuant to an offering of such securities or (iv)&nbsp;a corporation owned, directly or indirectly, by the stockholders of the Company
in substantially the same proportions as their ownership of stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">P.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">&quot;<B>Severance
Payments</B>&quot; means the severance payments and benefits listed in paragraph 4(A)&nbsp;of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Term</I></B>.
The term (&quot;<B>Term</B>&quot;) of this Agreement shall commence on the date first above written (the &quot;<B>Commencement Date</B>&quot;)
and, unless terminated earlier as provided hereunder, shall continue through December&nbsp;31, 2023; provided, however, that commencing
on January&nbsp;1, 2024 and each January&nbsp;1st thereafter, the Term shall automatically be extended for one additional year, unless
at least 90 days prior to such January&nbsp;1st date, the Company shall have given notice that it does not wish to extend this Agreement.
Upon the occurrence of a Change in Control during the Term, including any extensions thereof, the Term shall automatically be extended
until the end of the Effective Period and may not be terminated by the Company during such time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Notice
of Termination</I></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
termination of the Executive's employment by the Company, or by any Affiliate of the Company by which the Executive is employed, for Cause,
or by the Executive for Good Reason shall be communicated by Notice of Termination to the other party hereto given in accordance with
paragraph 10 of this Agreement. For purposes of this Agreement, a &quot;<B>Notice of Termination</B>&quot; for termination of employment
for Cause or for Good Reason means a written notice which: (i)&nbsp;is given at least thirty (30) days prior to the Date of Termination;
(ii)&nbsp;indicates the specific termination provision in this Agreement relied upon; (iii)&nbsp;sets forth in reasonable detail the facts
and circumstances claimed to provide a basis for termination of the Executive's employment under the provision so indicated; (iv)&nbsp;specifies
the employment termination date; and (v)&nbsp;allows the recipient of the Notice of Termination at least thirty (30) days to cure the
act or omission relied upon in the Notice of Termination. The failure to set forth in the Notice of Termination any fact or circumstance
which contributes to a showing of Good Reason or Cause will not waive any right of the party giving the Notice of Termination hereunder
or preclude such party from asserting such fact or circumstance in enforcing its rights hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">A
termination of employment of the Executive will not be deemed to be for Cause unless and until there has been delivered to the Executive
a copy of a resolution duly adopted by the affirmative vote of not less than three-quarters of the entire membership of the Board at a
meeting of the Board called and held for such purpose (after reasonable notice is provided to the Executive and the Executive is given
an opportunity, together with counsel, to be heard before the Board), finding that, in the good faith opinion of the Board, the Executive
has engaged in the conduct described in paragraph 1(F)&nbsp;hereof, and specifying the particulars of such conduct in reasonable detail.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Obligations
of the Company Upon Termination of Executive's Employment Following a Change in Control</I></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If,
(i)&nbsp;during the Effective Period, the Company terminates the Executive&rsquo;s employment other than for Cause or the Executive terminates
employment with the Company for Good Reason, or (ii)&nbsp;either (1)&nbsp;the Executive's employment is terminated by the Company other
than for Cause prior to a Change in Control (but, only if a Change in Control actually occurs) and such termination was at the request
or direction of a Person who has entered into an agreement with the Company the consummation of which would constitute a Change in Control,
(2)&nbsp;the Executive terminates his employment for Good Reason prior to a Change in Control (but, only if a Change in Control actually
occurs) and the circumstance or event which constitutes Good Reason occurs at the request or direction of such Person or (3)&nbsp;the
Executive's employment is terminated by the Company other than for Cause or by the Executive for Good Reason and such termination or the
circumstance or event which constitutes Good Reason is otherwise in connection with or in anticipation of a Change in Control (but, only
if a Change in Control actually occurs), then the Company will provide the Executive with the payments and benefits specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">a
cash lump sum in the amount of the Executive's annual base salary through the Date of Termination to the extent not theretofore paid;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">a
cash lump sum in the amount of the annual bonus that the Executive would receive for the year in which the Date of Termination occurs,
pro-rated by multiplying such bonus amount by the fraction obtained by dividing the number of days in the year through the Date of Termination
by 365, based on actual achievement of performance and payable at the same time bonuses are paid to other executives at the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">a
cash lump sum in the amount equal to the product of three times the Executive's annual base salary at the greater of (A)&nbsp;the rate
in effect at the time Notice of Termination is given or (B)&nbsp;the rate in effect immediately preceding the Change in Control, payable
within five days following the Date of Termination;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">a
cash lump sum amount equal to the product of three times the greater of (A)&nbsp;the target annual cash bonus in effect for the Executive
at the time Notice of Termination is given or (B)&nbsp;the target annual cash bonus in effect immediately preceding the Change in Control,
payable within five days following the Date of Termination; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
continuation of the provision of health insurance, dental insurance and life insurance benefits for a period of three years following
the Date of Termination (the &quot;<B>Continuation Period</B>&quot;) to the Executive and the Executive's family at least equal to those
which would have been provided to them in accordance with the plans, programs, practices and policies of the Company as in effect and
applicable generally to other peer executives and their families during the 90-day period immediately preceding the Effective Period or
on the Date of Termination, at the election of the Executive; provided, however, that if the Executive becomes re-employed with another
employer and is eligible to receive medical or other welfare benefits under another employer provided plan, the medical and other welfare
benefits described herein will be secondary to those provided under such other plan during such applicable period of eligibility.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
and all amounts paid under this Agreement in the amount of or otherwise in respect of the Executive's annual base salary and bonuses,
whether or not deferred under a deferred compensation plan or program, are intended to be and will be treated as compensation under any
and all retirement plans sponsored or maintained by the Company or by any Affiliate controlled by the Company; provided, however, to the
extent the treatment of such amounts as compensation under a retirement plan could adversely affect such plan's qualification status,
the amount of the benefits under such plan attributable to such potentially disqualifying compensation shall be paid by the Company and
not pursuant to such plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
the Executive's employment is terminated by reason of the Executive's death or Disability during the Term, this Agreement shall terminate
automatically on the date of death or, in the event of Disability, on the Date of Termination. In the event of Executive's death or Disability
during the Continuation Period, the Severance Payments will be paid or provided to the Executive, the Executive's Beneficiary and/or the
Executive&rsquo;s dependents under the applicable plans for the remainder of the Continuation Period. If the Executive's employment is
terminated by the Company for Cause during the Term, or if the Executive terminates his employment by the Company other than for Good
Reason, this Agreement shall terminate on the Date of Termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Mitigation
of Damages</I></B>. The Executive will not be required to mitigate damages or the amount of any payment provided for under this Agreement
by seeking other employment or otherwise. Except as otherwise specifically provided in this Agreement, the amount of any payment provided
for under this Agreement will not be reduced by any compensation earned by the Executive as the result of self-employment or employment
by another employer or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Stock
Options; Stock Appreciation Rights; Stock Bonus; Restricted Stock</I></B>. The foregoing benefits are intended to be in addition to the
value of any options to acquire common stock of the Company, any equity-based awards of the Company and any other incentive or similar
award or plan heretofore or hereafter adopted by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Tax
Effect</I></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notwithstanding
any other provisions of this Agreement, in the event that any payment or benefit received or to be received by the Executive (including
any payment or benefit received in connection with a Change in Control or the termination of the Executive's employment, whether pursuant
to the terms of this Agreement or any other plan, arrangement or agreement) (all such payments and benefits, including the Severance Payments,
being hereinafter referred to as the &quot;<B>Total Payments</B>&quot;) would be subject (in whole or part), to the Excise Tax, then,
after taking into account any reduction in the Total Payments provided by reason of Section&nbsp;280G of the Code in such other plan,
arrangement or agreement, the cash Severance Payments shall first be reduced, and the noncash Severance Payments shall thereafter be reduced,
to the extent necessary so that no portion of the Total Payments is subject to the Excise Tax but only if (i)&nbsp;the net amount of such
Total Payments, as so reduced (and after subtracting the net amount of federal, state and local income and employment taxes on such reduced
Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such reduced
Total Payments) is greater than or equal to (ii)&nbsp;the net amount of such Total Payments without such reduction (but after subtracting
the net amount of federal, state and local income and employment taxes on such Total Payments and the amount of Excise Tax to which the
Executive would be subject in respect of such unreduced Total Payments and after taking into account the phase out of itemized deductions
and personal exemptions attributable to such unreduced Total Payments); provided, however, that, to the extent permitted by Section&nbsp;409A
of the Code, the Executive may elect to have the noncash Severance Payments reduced (or eliminated) prior to any reduction of the cash
Severance Payments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">For
purposes of determining whether and the extent to which the Total Payments will be subject to the Excise Tax, (i)&nbsp;no portion of the
Total Payments the receipt or enjoyment of which the Executive shall have waived at such time and in such manner as not to constitute
a &quot;payment&quot; within the meaning of Section&nbsp;280G(b)&nbsp;of the Code shall be taken into account, (ii)&nbsp;no portion of
the Total Payments shall be taken into account which, in the opinion of Tax Counsel (as defined below) does not constitute a &quot;parachute
payment&quot; within the meaning of Section&nbsp;280G(b)(2)&nbsp;of the Code (including by reason of Section&nbsp;280G(b)(4)(A)&nbsp;of
the Code) and, in calculating the Excise Tax, no portion of such Total Payments shall be taken into account which, in the opinion of Tax
Counsel, constitutes reasonable compensation for services actually rendered, within the meaning of Section&nbsp;280G(b)(4)(B)&nbsp;of
the Code, in excess of the Base Amount allocable to such reasonable compensation, and (iii)&nbsp;the value of any non-cash benefit or
any deferred payment or benefit included in the Total Payments shall be determined by the Tax Counsel in accordance with the principles
of Sections 280G(d)(3)&nbsp;and (4)&nbsp;of the Code. For purposes of this Agreement, &quot;Tax Counsel&quot; will mean a lawyer, a certified
public accountant with a nationally recognized accounting firm, or a compensation consultant with a nationally recognized actuarial and
benefits consulting firm with expertise in the area of executive compensation tax law, who will be selected by the Company and will be
reasonably acceptable to the Executive, and whose fees and disbursements will be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">At
the time that payments are made under this Agreement, the Company shall provide the Executive with a written statement setting forth the
manner in which such payments were calculated and the basis for such calculations including, without limitation, any opinions or other
advice the Company has received from Tax Counsel or other advisors or consultants (and any such opinions or advice which are in writing
shall be attached to the statement). If the Executive objects to the Company's calculations, the Company shall pay to the Executive such
portion of the Severance Payments (up to 100% thereof) as the Executive determines is necessary to result in the proper application of
subparagraph A of this paragraph 7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notwithstanding
anything in this Agreement to the contrary, the amount of the Severance Payments, and the limitation on such payments set forth in this
paragraph 7, cannot be finally determined on or before the scheduled payment date, the Company shall pay to the Executive on such day
an estimate, as determined in good faith by the Executive of the minimum amount of such payments to which the Executive is clearly entitled
and shall pay the remainder of such payments (together with interest on the unpaid remainder (or on all such payments to the extent the
Company fails to make such payments when due) at 120% of the rate provided in Section&nbsp;1274(b)(2)(B)&nbsp;of the Code) as soon as
the amount thereof can be determined. In the event that the amount of the estimated payments exceeds the amount subsequently determined
to have been due, such excess shall constitute a loan by the Company to the Executive, payable on the fifth (5th) business day after demand
by the Company (together with interest at 120% of the rate provided in Section&nbsp;1274(b)(2)(B)&nbsp;of the Code).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Confidential
Information; Non-solicitation</I></B>. During the Term and any Continuation Period, the Executive covenants and agrees as follows: (a)&nbsp;to
hold in a fiduciary capacity for the benefit of the Company and its Affiliates all secret, proprietary or confidential material, knowledge,
data or any other information relating to the Company or any of its Affiliates and their respective businesses (&quot;<B>Confidential
Information</B>&quot;), which has been obtained by the Executive during the Executive's employment by the Company or any of its Affiliates
and that has not been, is not now and hereafter does not become public knowledge (other than by acts by the Executive or representatives
of the Executive in violation of this Agreement), and will not, without the prior written consent of the Company or as may otherwise be
required by law or legal process, communicate or divulge any such information, knowledge or data to anyone other than the Company and
those designated by it; the Executive further agrees to return to the Company any and all records and documents (and all copies thereof)
and all other property belonging to the Company or relating to the Company, its Affiliates or their businesses, upon termination of Executive's
employment with the Company and its Affiliates; and (b)&nbsp;not to solicit or entice any other employee of the Company or its Affiliates
to leave the Company or its Affiliates to go to work for any other business or organization which is in direct or indirect competition
with the Company or any of its Affiliates, nor request or advise a customer or client of the Company or its Affiliates to curtail or cancel
such customer's business relationship with the Company or its Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Rights
and Remedies Upon Executive's Breach</I></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Executive hereby acknowledges and agrees that the provisions contained in paragraph 8 of this Agreement (the &quot;<B>Restrictive Covenants</B>&quot;)
are reasonable and valid in duration and in all other respects. If any court of, or arbitrator with, competent jurisdiction determines
that any of the Restrictive Covenants, or any part thereof, is invalid or unenforceable, the remainder of the Restrictive Covenants will
not thereby be affected and will be given full effect without regard to the invalid portions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
the Executive breaches, or threatens to commit a breach of, any of the Restrictive Covenants, the Company will have the following rights
and remedies, each of which rights and remedies will be independent of the others and severally enforceable, and each of which is in addition
to, and not in lieu of, any other rights and remedies available to the Company under law or in equity:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Specific
Performance</I>. The right and remedy to have the Restrictive Covenants specifically enforced by any court of competent jurisdiction in
aid of arbitration, it being agreed that any breach or threatened breach of the Restrictive Covenants would cause irreparable injury to
the Company and that money damages would not provide an adequate remedy to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Accounting</I>.
The right and remedy to require the Executive to account for and pay over to the Company all compensation, profits, monies, accruals,
increments or other benefits derived or received by the Executive as the result of any action constituting a breach of the Restrictive
Covenants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><I>Cessation
of Severance Payments</I>. The right and remedy to cease any further Severance Payments from and after the commencement of such breach
by the Executive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
provisions of this subparagraph 9(C)&nbsp;shall apply to any dispute relating to this Agreement and not governed by subparagraph 9(B).
All such disputes shall be resolved exclusively by arbitration administered by JAMS (or its successor) under its Employment Arbitration
Rules&nbsp;and Procedures then in effect (the &quot;JAMS Rules&quot;). Notwithstanding the foregoing, the Company and the Executive shall
have the right to (i)&nbsp;seek a restraining order or other injunctive or equitable relief or order in aid of arbitration or to compel
arbitration, from a court of competent jurisdiction, or (ii)&nbsp;interim injunctive or equitable relief from the arbitrator pursuant
to the JAMS Rules, in each case to prevent any violation of this Agreement. The Company and the Executive must notify the other party
in writing of a request to arbitrate any such disputes within the same statute of limitations period applicable to such disputes. Any
arbitration proceeding brought under this Agreement shall be conducted before one arbitrator in Des Moines,&nbsp;Iowa or such other city
to which the parties mutually agree. The arbitrator shall be selected in accordance with the JAMS Rules, provided that the arbitrator
shall be an attorney with significant experience in employment matters. Subject to paragraph 9(D)&nbsp;below, each party to any dispute
shall pay its own expenses of the arbitration. The arbitrator will be empowered to award either party any remedy at law or in equity that
the party would otherwise have been entitled to had the matter been litigated in court, including, but not limited to, general, special
and punitive damages, injunctive relief, costs and attorney fees; provided, however, that the authority to award any remedy is subject
to whatever limitations, if any, exist in the applicable law on such remedies. The arbitrator shall issue a decision or award in writing,
stating the essential findings of fact and conclusions of law, and the arbitrators shall be required to follow the laws of the State of
Iowa. Any judgment on or enforcement of any award, including an award providing for interim or permanent injunctive relief, rendered by
the arbitrator may be entered, enforced or appealed in any court having jurisdiction thereof. Any arbitration proceedings, decision or
award rendered hereunder, and the validity, effect and interpretation of this arbitration provision, shall be governed by the Federal
Arbitration Act, 9 U.S.C. &sect; 1 et seq. It is part of the essence of this Agreement that any such disputes hereunder shall be resolved
expeditiously and as confidentially as possible. Accordingly, the Company and the Executive agree that all proceedings in any arbitration
shall be conducted under seal and kept strictly confidential. In that regard, no party shall use, disclose or permit the disclosure of
any information, evidence or documents produced by any other party in the arbitration proceedings or about the existence, contents or
results of the proceedings except as necessary and appropriate for the preparation and conduct of the arbitration proceedings, or as may
be required by any legal process, or as required in an action in aid of arbitration or for enforcement of or appeal from an arbitral award.
Before making any disclosure permitted by the preceding sentence, the party intending to make such disclosure shall give the other party
reasonable written notice of the intended disclosure and afford such other party a reasonable opportunity to protect its interests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall pay to the Executive all legal fees and expenses incurred by the Executive in disputing in good faith any issue hereunder
relating to the termination of the Executive's employment, in seeking in good faith to obtain or enforce any benefit or right provided
by this Agreement or in connection with any tax audit or proceeding to the extent attributable to the application of Section&nbsp;4999
of the Code to any payment or benefit provided hereunder. Such payments shall be made within five (5)&nbsp;business days after delivery
of the Executive's written requests for payment accompanied with such evidence of fees and expenses incurred as the Company reasonably
may require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Notices</I></B>.
Any notice provided for in this Agreement will be given in writing and will be delivered personally, telegraphed, telexed, sent by facsimile
transmission or sent by certified, registered or express mail, postage prepaid. Any such notice will be deemed given when so delivered
personally, telegraphed, telexed or sent by facsimile transmission, or, if mailed, on the date of actual receipt thereof. Notices will
be properly addressed to the parties at their respective addresses set forth below or to such other address as either party may later
specify by notice to the other in accordance with the provisions of this paragraph:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">6000 Westown Parkway</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">West Des Moines,&nbsp;IA 50266</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Chairman of the Board</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy to the Executive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Axel Andr&eacute;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: Black">[*****]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: Black">[*****]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Entire
Agreement</I></B>. This Agreement contains the entire agreement between the parties with respect to the subject matter hereof and supersedes
all prior agreements, written or oral, with respect thereto, including, without limitation, any and all prior employment or severance
agreements and related amendments entered into between the Company and the Executive; provided, however, that this Agreement shall supersede
any agreement setting forth the terms and conditions of the Executive's employment with the Company only in the event that the Executive's
employment with the Company is terminated on or following a Change in Control, by the Company other than for Cause or by the Executive
for Good Reason. Furthermore, the Severance Payments are separate and apart from and, to the extent they are actually paid, will be in
lieu of any payment under any policy of the Company or any of its Affiliates regarding severance payments generally.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Waivers
and Amendments</I></B>. This Agreement may be amended, superseded, canceled, renewed or extended, and the terms and conditions hereof
may be waived, only by a written instrument signed by the parties hereto or, in the case of a waiver, by the party waiving compliance.
No delay on the part of any party in exercising any right, power or privilege hereunder will operate as a waiver thereof, nor will any
waiver on the part of any party of any such right, power or privilege hereunder, nor any single or partial exercise of any right, power
or privilege hereunder, preclude any other or further exercise thereof or the exercise of any other right, power or privilege hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Governing
Law</I></B>. This Agreement will be governed by and construed in accordance with the laws of the state of Iowa (without giving effect
to the choice of law provisions thereof), where the employment of the Executive will be deemed, in part, to be performed, and enforcement
of this Agreement or any action taken or held with respect to this Agreement will be taken in the courts of appropriate jurisdiction in
Iowa.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Assignment</I></B>.
This Agreement, and any rights and obligations hereunder, may not be assigned by the Executive and may be assigned by the Company only
to any successor in interest, whether by merger, consolidation, acquisition or the like, or to purchasers of substantially all of the
assets of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Binding
Agreement</I></B>. This Agreement will inure to the benefit of and be binding upon the Company and its respective successors and assigns
and the Executive and his legal representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Counterparts</I></B>.
This Agreement may be executed in separate counterparts, each of which when so executed and delivered will be deemed an original, but
all of which together will constitute one and the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Headings</I></B>.
The headings in this Agreement are for reference purposes only and will not in any way affect the meaning or interpretation of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Authorization</I></B>.
The Company represents and warrants that the Board has authorized the execution of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Validity</I></B>.
The invalidity or unenforceability of any provisions of this Agreement will not affect the validity or enforceability of any other provisions
of this Agreement, which will remain in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Tax
Withholding</I></B>. The Company will have the right to deduct from all benefits and/or payments made under this Agreement to the Executive
any and all taxes required by law to be paid or withheld with respect to such benefits or payments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>Section&nbsp;409A</I></B>.
The parties intend that payments and benefits under this Agreement comply with Section&nbsp;409A of the Code and the regulations and guidance
promulgated thereunder (collectively, &quot;<B>Section&nbsp;409A</B>&quot;) and, accordingly, to the maximum extent permitted, this Agreement
shall be interpreted to be in compliance therewith. Notwithstanding anything contained herein to the contrary, the Executive shall not
be considered to have terminated employment with the Company for purposes of any payments under this Agreement which are subject to Section&nbsp;409A
until the Executive has incurred a &quot;separation from service&quot; within the meaning of Section&nbsp;409A. Each amount to be paid
or benefit to be provided under this Agreement shall be construed as a separate identified payment for purposes of Section&nbsp;409A.
Without limiting the foregoing and notwithstanding anything contained herein to the contrary, to the extent required in order to avoid
an accelerated or additional tax under Section&nbsp;409A, amounts that would otherwise be payable and benefits that would otherwise be
provided pursuant to this Agreement during the six-month period immediately following the Executive's separation from service shall instead
be paid on the first business day after the date that is six months following the Executive's separation from service (or, if earlier,
the Executive's date of death). To the extent required to avoid an accelerated or additional tax under Section&nbsp;409A, amounts reimbursable
to the Executive shall be paid to the Executive on or before the last day of the year following the year in which the expense was incurred
and the amount of expenses eligible for reimbursement (and in kind benefits provided to the Executive) during one year may not affect
amounts reimbursable or provided in any subsequent year. The Company makes no representation that any or all of the payments described
in this Agreement will be exempt from or comply with Section&nbsp;409A and makes no undertaking to preclude Section&nbsp;409A from applying
to any such payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><B><I>No
Contract of Employment</I></B>. Nothing contained in this Agreement will be construed as a contract of employment between the Company
or any of its Affiliates and the Executive, as a right of the Executive to be continued in the employment of the Company or any of its
Affiliates, or as a limitation of the right of the Company or any of its Affiliates to discharge the Executive with or without Cause.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">IN WITNESS WHEREOF the parties have executed this
Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMERICAN EQUITY INVESTMENT</FONT>&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIFE HOLDING COMPANY</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-bottom: Black 1pt solid">/s/ Anant Bhalla</TD>
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; border-bottom: Black 1pt solid">/s/ Axel Andre</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 37%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anant Bhalla</FONT></TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Axel Andr&eacute;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>tm2320561d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.5in">VOTING AGREEMENT (this &ldquo;<U>Agreement</U>&rdquo;)
dated as of July&nbsp;4, 2023, among American Equity Investment Life Holding Company, an Iowa corporation (the &ldquo;<U>Company</U>&rdquo;),
and each party listed on <U>Schedule A</U> hereto (each, a &ldquo;<U>Stockholder</U>&rdquo; and, collectively, the &ldquo;<U>Stockholders</U>&rdquo;).
The Company and Stockholders are each referred to in this Agreement as a &ldquo;<U>party</U>&rdquo; and collectively as the &ldquo;<U>parties</U>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, simultaneously with the execution and delivery
of this Agreement, the Company, Brookfield Reinsurance Ltd., a Bermuda exempted company limited by shares (&ldquo;<U>Parent</U>&rdquo;),
Arches Merger Sub Inc., an Iowa corporation and wholly owned subsidiary of Parent, and, solely for the limited purposes set for therein,
Brookfield Asset Management Ltd., a company incorporated under the laws of the Province of British Columbia, have entered into an Agreement
and Plan of Merger dated as of the date hereof (the &ldquo;<U>Merger Agreement</U>&rdquo;; capitalized terms used but not defined herein
shall have the meanings set forth in the Merger Agreement);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, each Stockholder owns the number of shares
of Common Stock set forth opposite its name on <U>Schedule A</U> hereto (such shares of Common Stock, together with any other shares of
Common Stock acquired by such Stockholder after the date hereof and during the term of this Agreement, being collectively referred to
herein as the &ldquo;<U>Subject Shares</U>&rdquo; of such Stockholder); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">WHEREAS, as a condition to its willingness to enter
into the Merger Agreement, the Company has requested that each Stockholder enter into this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">NOW, THEREFORE, the parties, intending to be legally
bound, agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION&nbsp;1.</FONT> &#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><I>Representations
and Warranties of Each Stockholder. </I>Each Stockholder hereby, severally and not jointly, represents and warrants to the Company as
of the date hereof in respect of itself as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Authority;
Execution and Delivery; Enforceability.</U> The Stockholder has all requisite power and authority to execute and deliver this Agreement,
to perform its obligations hereunder and to consummate the transactions contemplated hereby. The execution and delivery by the Stockholder
of this Agreement, the performance by it of its obligations hereunder and the consummation by it of the transactions contemplated hereby
have been duly authorized by all necessary action on the part of such Stockholder. The Stockholder has duly executed and delivered this
Agreement, and, assuming this Agreement constitutes a valid and binding obligation of the Company, this Agreement constitutes a legal,
valid and binding obligation of the Stockholder, enforceable against it in accordance with its terms, except, in each case, as enforcement
may be limited by bankruptcy, insolvency, reorganization or similar Laws affecting creditors&rsquo; rights generally and by general principles
of equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT> &#8239;&#8239;&#8239;&#8239;&nbsp; &#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Conflicts; Consents.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
execution and delivery by the Stockholder of this Agreement and the performance by it of its obligations hereunder do not, and the consummation
by it of the transactions contemplated hereby and compliance with the terms hereof will not, (A)&nbsp;conflict with, or result in any
violation of any provision of, the organizational documents of such Stockholder, (B)&nbsp;conflict with, or result in any violation of
or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancelation or acceleration
of any obligation or to loss of a material benefit under, or to increased, additional, accelerated or guaranteed rights or entitlements
of any person under, or result in the creation of any Lien upon any of the properties or assets of such Stockholder under, any provision
of any material Contract to which such Stockholder is a party or by which any of its properties or assets is bound (other than any Contract
to which the Company or any Subsidiary of the Company is a party or by which any of their respective properties or assets is bound) or
(C)&nbsp;conflict with, or result in any violation of any provision of, subject to the filings and other matters referred to in <U>Section&nbsp;1(b)(ii)</U>,
any judgments, decrees and orders of Governmental Authorities or Law, in each case applicable to such Stockholder or its properties or
assets, other than, in the case of <U>clauses (B)</U>&nbsp;and <U>(C)</U>&nbsp;above, any such items that, individually or in the aggregate,
would not reasonably be expected to prevent or materially impair the ability of the Stockholder to perform its obligations hereunder or
to consummate the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
Consent of or from, or registration, declaration, notice or filing with or made to, any Governmental Authority, or the expiry of any related
waiting period, is required to be obtained or made by or with respect to the Stockholder in connection with the execution, delivery and
performance by the Stockholder of this Agreement or the consummation by it of the transactions contemplated hereby, other than (A)&nbsp;the
filing with the SEC of such reports under Section&nbsp;13 and Section&nbsp;16 of the Exchange Act as may be required in connection with
this Agreement, the Merger Agreement and the transactions contemplated hereby and thereby, (B)&nbsp;any filings or Consents contemplated
by the Merger Agreement and (C)&nbsp;such other items that the failure of which to obtain or make, individually or in the aggregate, would
not reasonably be expected to prevent or materially impair the ability of the Stockholder to perform its obligations hereunder or to consummate
the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>The
Subject Shares.</U> The Stockholder is the record and beneficial owner of, and has good and valid title to, the Subject Shares, free and
clear of any Liens. As of the date hereof, the Stockholder does not own, of record or beneficially, any shares of capital stock of the
Company other than the Subject Shares set forth opposite its name on <U>Schedule A</U> attached hereto. None of the Stockholder&rsquo;s
Subject Shares is subject to any voting trust or other agreement, arrangement or restriction with respect to the voting or the transfer
of such Stockholder&rsquo;s Subject Shares, except as set forth in this Agreement, the organizational documents of the Company or the
Investment Agreement, dated October&nbsp;17, 2020, by and among the Company, Brookfield Corporation (formerly, Brookfield Asset Management
Inc.), and the Stockholders (as successors and assigns of Burgundy Acquisitions I Ltd.) (as amended, restated or otherwise modified from
time to time, the &ldquo;<U>Investment Agreement</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION&nbsp;2.</FONT> &#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><I>Representations
and Warranties of the Company</I>. The Company hereby represents and warrants to each Stockholder as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Authority;
Execution and Delivery; Enforceability.</U> The Company has all requisite corporate power and authority to execute and deliver this Agreement,
to perform its obligations hereunder and to consummate the transactions contemplated hereby. The execution and delivery by the Company
of this Agreement, the performance by it of its obligations hereunder and the consummation by it of the transactions contemplated hereby
have been duly authorized by all necessary corporate action on the part of the Company. The Company has duly executed and delivered this
Agreement, and, assuming this Agreement constitutes a valid and binding obligation of the Stockholders, this Agreement constitutes a legal,
valid and binding obligation of the Company, enforceable against it in accordance with its terms, except, in each case, as enforcement
may be limited by bankruptcy, insolvency, reorganization or similar Laws affecting creditors&rsquo; rights generally and by general principles
of equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Conflicts; Consents.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
execution and delivery by the Company of this Agreement and the performance by it of its obligations hereunder do not, and the consummation
by it of the transactions contemplated hereby and compliance with the terms hereof will not, (A)&nbsp;conflict with, or result in any
violation of any provision of, the Company Charter or the Company Bylaws, (B)&nbsp;conflict with, or result in any violation of or default
(with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancelation or acceleration of any obligation
or to loss of a material benefit under, or to increased, additional, accelerated or guaranteed rights or entitlements of any person under,
or result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary of the Company under, any
provision of any material Contract to which the Company or any Subsidiary of the Company is a party or by which any of their properties
or assets are bound (other than any Contract to which either Stockholder is a party or by which any of their respective properties or
assets are bound) or (C)&nbsp;conflict with, or result in any violation of any provision of, subject to the filings and other matters
referred to in <U>Section&nbsp;2(b)(ii)</U>, any judgments, decrees and orders of Governmental Authorities or Law, in each case applicable
to the Company or any Company Subsidiary or their respective properties or assets, other than, in the case of <U>clauses&nbsp;(B)</U>&nbsp;and
<U>(C)</U>&nbsp;above, any such items that, individually or in the aggregate, would not reasonably be expected to prevent or materially
impair the ability of the Company to perform its obligations hereunder or to consummate the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
Consent of or from, or registration, declaration, notice or filing with or made to, any Governmental Authority, or the expiry of any related
waiting period, is required to be obtained or made by or with respect to the Company in connection with the execution, delivery and performance
by it of this Agreement or the consummation by it of the transactions contemplated hereby other than (A)&nbsp;the filing with the SEC
of (1)&nbsp;the Proxy Statement and (2)&nbsp;such reports under Section&nbsp;13 and Section&nbsp;16 of the Exchange Act as may be required
in connection with this Agreement, the Merger Agreement and the transactions contemplated hereby and thereby, (B)&nbsp;any filings or
Consents contemplated by the Merger Agreement and (C)&nbsp;such other items that the failure of which to obtain or make, individually
or in the aggregate, would not reasonably be expected to prevent or materially impair the ability of the Company to perform its obligations
hereunder or to consummate the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION&nbsp;3.</FONT> &#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><I>Covenants
of Each Stockholder.</I> Unless this Agreement is terminated in accordance with its terms, each Stockholder, severally and not jointly,
covenants and agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">At
any meeting of the shareholders of the Company called to seek the Required Shareholder Approval or at any adjournment thereof or in any
other circumstances upon which a vote, consent or other approval (including by written consent) with respect to the Merger Agreement or
the Merger is sought, the Stockholder shall, including by executing a written consent solicitation if requested by the Company, cause
its Subject Shares to be present in person or by proxy for purposes of constituting a quorum and vote (or cause to be voted) the Subject
Shares of the Stockholder in favor of granting the Required Shareholder Approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">At
any meeting of stockholders of the Company or at any adjournment thereof or in any other circumstances upon which the Stockholder&rsquo;s
vote, consent or other approval (including by written consent) is sought, the Stockholder shall cause its Subject Shares to be present
in person or by proxy for purposes of constituting a quorum and vote (or cause to be voted) the Subject Shares against (i)&nbsp;any Takeover
Proposal and (ii)&nbsp;any amendment of the Company Charter or the Company Bylaws or other proposal or transaction involving the Company
or any Subsidiary of the Company, which amendment or other proposal or transaction would in any manner impede, frustrate, prevent or nullify
any provision of the Merger Agreement or the Merger. The Stockholder shall not commit or agree to take any action inconsistent with the
foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Other
than this Agreement, the Stockholder shall not (i)&nbsp;sell, transfer, pledge, assign or otherwise dispose of (including by gift) (collectively,
 &ldquo;<U>Transfer</U>&rdquo;), or enter into any Contract, option or other arrangement (including any profit-sharing arrangement) with
respect to the Transfer of, any Subject Shares to any person other than pursuant to the Transactions, unless prior to any such Transfer
the transferee of such Stockholder&rsquo;s Subject Shares is a party to this Agreement, enters into a voting agreement with the Company
on terms substantially identical to the terms of this Agreement or agrees to become a party to this Agreement pursuant to a customary
joinder agreement, or (ii)&nbsp;enter into any voting arrangement, whether by proxy, voting agreement or otherwise, with respect to any
Subject Shares and shall not commit or agree to take any of the foregoing actions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION&nbsp;4.</FONT> &#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><I>Waiver.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company hereby waives compliance by the Stockholders with the terms and conditions of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Section&nbsp;7.4
of the Investment Agreement to the extent that such terms and conditions would require the Stockholders to dispose of any Common Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Section&nbsp;7.5
of the Investment Agreement to the extent necessary to permit Parent to exercise its rights pursuant to Section&nbsp;7.03 of the Merger
Agreement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Section&nbsp;7.7
of the Investment Agreement, solely in order for the Stockholders to comply with their obligations set forth in <U>Sections 3(a)</U>&nbsp;and
<U>3(b)</U>&nbsp;and to the extent that such terms and conditions would require the Stockholders to vote any of the Subject Shares in
the same proportion as the unaffiliated shareholders of the Company with respect to vote any matter described in <U>Sections 3(a)</U>&nbsp;and
<U>3(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
waivers in <U>Sections 4(a)</U>&nbsp;shall expire upon the termination of the Merger Agreement in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION&nbsp;5.</FONT> &#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><I>Termination.
</I>This Agreement shall terminate, other than with respect to the liability of any party for breach hereof prior to such termination,
upon the earliest of: (a)&nbsp;the Effective Time; (b)&nbsp;the termination of the Merger Agreement in accordance with its terms; (c)&nbsp;at
any time prior to the time, but not after, the Required Shareholder Approvals are obtained, if the Company Board, or any committee thereof
has made an Adverse Recommendation Change; and (d)&nbsp;the termination of this Agreement by the mutual written consent of the parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION&nbsp;6.</FONT> &#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><I>Additional
Matters.</I> Each Stockholder shall, from time to time, execute and deliver, or cause to be executed and delivered, such additional or
further consents, documents and other instruments as the Company may reasonably require for the purpose of effectively carrying out the
transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION&nbsp;7.</FONT> &#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><I>General
Provisions</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Amendment.</U>
This Agreement may not be amended except by an instrument in writing signed on behalf of each of the parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notices.</U>
All notices, requests and other communications to any party hereunder shall be in writing and shall be deemed given if delivered personally,
emailed or sent by overnight courier (providing proof of delivery)&nbsp;to the parties at the following addresses</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">if
to any Stockholder, to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Brookfield Reinsurance Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Ideation House, 1st Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">94 Pitts Bay Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Pembroke, HM08, Bermuda</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attention: Anna Knapman-Scott</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;anna.knapmanscott@northendre.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">and to the applicable address of such Stockholder set forth
in <U>Schedule A</U> hereto, with a copy to (which will not constitute notice to any Stockholder):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Cravath, Swaine&nbsp;&amp; Moore LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">825 Eighth Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">New York, New York 10019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attention: Richard Hall</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;David J. Perkins</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Email: rhall@cravath.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in">&nbsp;&nbsp;&nbsp;&nbsp;dperkins@cravath.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">if
to the Company, to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">American Equity Investment Life Holding Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">6000 Westown Parkway</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">West Des Moines,&nbsp;Iowa 50266</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attention: Shari Wood</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Email: swood@american-equity.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">with a copy to (which will not constitute notice to the Company):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sullivan&nbsp;&amp;
Cromwell LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">125 Broad Street</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, New York 10004</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
</FONT><FONT STYLE="font-size: 10pt">H. Rodgin Cohen</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-indent: 0.75in">&#8239;&#8239;&nbsp;Melissa Sawyer&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-indent: 0.75in">&#8239;&#8239;&#8239;&#8239;Stephen M.
Kotran</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>Email:</FONT> &#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">cohenhr@sullcrom.com</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-indent: 0.75in">&#8239;&#8239;sawyerm@sullcrom.com&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-indent: 0.75in">&#8239;&#8239;kotrans@sullcrom.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or such other address or email address as such party may hereafter
specify by like notice to the other parties. All such notices, requests and other communications shall be deemed received on the date
of actual receipt by the recipient thereof if received prior to 5:00 p.m.&nbsp;local time in the place of receipt and such day is a business
day in the place of receipt. Otherwise, any such notice, request or communication shall be deemed not to have been received until the
next succeeding business day in the place of receipt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Interpretation.</U>
When a reference is made in this Agreement to an Article, Section&nbsp;or subsection, such reference shall be to an Article, Section&nbsp;or
subsection to this Agreement unless otherwise indicated. The headings contained in this Agreement are for reference purposes only and
shall not affect in any way the meaning or interpretation of this Agreement. Whenever the words &ldquo;include&rdquo;, &ldquo;includes&rdquo;
or &ldquo;including&rdquo; are used in this Agreement, they shall be deemed to be followed by the words &ldquo;without limitation&rdquo;.
The words &ldquo;hereof&rdquo;, &ldquo;herein&rdquo;, &ldquo;hereto&rdquo; and &ldquo;hereunder&rdquo; and words of similar import when
used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The term &ldquo;or&rdquo;
is not exclusive. The word &ldquo;extent&rdquo; in the phrase &ldquo;to the extent&rdquo; shall mean the degree to which a subject or
other thing extends, and such phrase shall not mean simply &ldquo;if&rdquo;. The definitions contained in this Agreement are applicable
to the singular as well as the plural forms of such terms. Any agreement, instrument or Law defined or referred to herein or in any agreement
or instrument that is referred to herein means such agreement, instrument or Law as from time to time amended, modified or supplemented,
unless otherwise specifically indicated. References to a person are also to its permitted successors and assigns. Each of the parties
has participated in the drafting and negotiation of this Agreement. If an ambiguity or question of intent or interpretation arises, this
Agreement must be construed as if it is drafted by all of the parties, and no presumption or burden of proof will arise favoring or disfavoring
any party by virtue of authorship of any of the provisions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Severability.</U>
If any term, condition or other provision of this Agreement is finally determined by a court of competent jurisdiction to be invalid,
illegal or incapable of being enforced by any applicable Law or public policy, all other terms, provisions and conditions of this Agreement
shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby
is not affected in any manner materially adverse to any party. Upon such determination that any term or other provision is invalid, illegal
or incapable of being enforced, the parties shall negotiate in good faith to modify this Agreement so as to effect the original intent
of the parties as closely as possible to the fullest extent permitted by applicable Law in an acceptable manner to the end that the transactions
contemplated hereby are fulfilled to the extent possible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Counterparts.</U>
This Agreement may be executed in one or more counterparts (including by electronic mail), each of which shall be deemed to be an original
but all of which taken together shall constitute one and the same agreement, and shall become effective when one or more counterparts
have been signed by each of the parties and delivered to the other parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Entire
Agreement; No Third-Party Beneficiaries.</U> This Agreement (i)&nbsp;constitutes the entire agreement and supersedes all prior agreements
and understandings, both written and oral, among the parties with respect to the subject matter hereof and (ii)&nbsp;is not intended to
confer upon any person (including any shareholder of any party) other than the parties any rights or remedies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Governing
Law; Consent to Jurisdiction.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">This
Agreement shall be governed by, and construed in accordance with, the Laws of the State of Iowa applicable to contracts executed in and
to be performed entirely within that state, regardless of the laws that might otherwise govern under any applicable conflict of laws principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
Actions arising out of or relating to the interpretation and enforcement of the provisions of this Agreement and in respect of the Transactions
shall be heard and determined in the Iowa District Court for Polk County, or, if the Iowa District Court declines to accept jurisdiction
over a particular matter, any federal court within the State of Iowa, or, if both the Iowa District Court and the federal courts within
the State of Iowa decline to accept jurisdiction over a particular matter, any other state court within the State of Iowa, and, in each
case, any appellate court therefrom. The parties hereby irrevocably submit to the exclusive jurisdiction and venue of such courts in any
such Actions and irrevocably waive the defense of an inconvenient forum or lack of jurisdiction to the maintenance of any such Action.
The consents to jurisdiction and venue set forth in this <U>Section&nbsp;7(g)(ii)</U>&nbsp;shall not constitute general consents to service
of process in the State of Iowa and shall have no effect for any purpose except as provided in this paragraph and shall not be deemed
to confer rights on any Person other than the parties. Each party agrees that service of process upon such party in any Action arising
out of or relating to this Agreement shall be effective if notice is given by overnight courier at the address set forth in <U>Section&nbsp;7(b)</U>.
The parties agree that a final judgment in any such Action shall be conclusive and may be enforced in other jurisdictions by suit on the
judgment or in any other manner provided by applicable Law; <U>provided</U>, <U>however</U>, that nothing contained in the foregoing shall
restrict any party&rsquo;s rights to seek any post-judgment relief regarding, or any appeal from, a final trial court judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Assignment.</U>
Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned, in whole or in part, by operation
of Law or otherwise, by any of the parties without the prior written consent of the other parties. No assignment by any party shall relieve
such party of any of its obligations hereunder. Subject to the immediately preceding two sentences, this Agreement shall be binding upon,
inure to the benefit of, and be enforceable by, the parties and their respective successors and permitted assigns. Any purported assignment
not permitted under this <U>Section&nbsp;7(h)</U>&nbsp;shall be null and void.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Enforcement.</U>
This Agreement is intended to be a voting agreement under Section&nbsp;490.731 of the Iowa Business Corporations Act (&ldquo;IBCA&rdquo;)
and shall be specifically enforceable as provided in the IBCA. The parties agree that irreparable damage would occur in the event that
any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached, and that
monetary damages, even if available, would not be an adequate remedy therefor. It is accordingly agreed that, prior to the termination
of this Agreement pursuant to <U>Section&nbsp;5</U>, the parties shall be entitled to an injunction or injunctions to prevent breaches
of this Agreement and to enforce specifically the terms and provisions of this Agreement, without proof of actual damages (and each party
hereby waives any requirement for the securing or posting of any bond in connection with such remedy), this being in addition to any other
remedy to which they are entitled at law or in equity. The parties further agree not to assert that a remedy of specific performance is
unenforceable, invalid, contrary to Law or inequitable for any reason, nor to assert that a remedy of monetary damages would provide an
adequate remedy for any such breach.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Waiver
of Jury Trial.</U> EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY&nbsp;ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE
COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE
LAW, ANY RIGHT IT MAY&nbsp;HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS
AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A)&nbsp;NO REPRESENTATIVE, AGENT
OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT,&nbsp;IN THE EVENT OF LITIGATION,
SEEK TO ENFORCE THE FOREGOING WAIVER, (B)&nbsp;IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVER, (C)&nbsp;IT MAKES SUCH
WAIVER VOLUNTARILY AND (D)&nbsp;IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS
IN THIS <U>SECTION&nbsp;7(J)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;Follows.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">IN WITNESS WHEREOF, each party has duly executed
this Agreement, all as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">american equity investment life holding company</Font></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: justify; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by</FONT></TD>
                                        <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 47%">/s/ Anant Bhalla</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:  Anant Bhalla</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Executive Officer and President</Font></TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">FREESTONE RE LTD.</Font></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: justify; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by</FONT></TD>
                                        <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 47%">/s/ Gregory McConnie</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:  Gregory McConnie</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Director</Font></TD></TR>
     </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">North
End RE (Cayman)</FONT>&nbsp;SPC acting for and on behalf of,
its own account</TD>
</TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: justify; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by</FONT></TD>
                                        <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 47%">/s/ Gregory McConnie</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Gregory McConnie</FONT></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
                                        <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Executive Officer</Font></TD></TR>
     </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to Voting Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>SCHEDULE A</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Name and Address<BR> of Stockholder</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Number of Shares of<BR> Common Stock Owned</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 72%; font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="margin-top: 0; margin-bottom: 0">Freestone Re Ltd.<BR> Ideation House, 1st Floor<BR> 94 Pitts Bay Road<BR> Pembroke, HM08, Bermuda<BR> Attention: Anna Knapman-Scott<BR> Email:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;anna.knapmanscott@northendre.com</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center">3,857,184</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">North End RE (Cayman) SPC<BR> 18 Forum Lane, 2nd Floor<BR> Camana Bay, PO Box 30487<BR> Grand Cayman KY1-1202, Cayman Islands<BR> Attention: Gregory McConnie<BR> Email:&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;&nbsp;&nbsp;gregory.mcconnie@brookfield.com</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: center">12,028,979</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>tm2320561d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Brookfield Reinsurance to Acquire AEL in $4.3
Billion Transaction</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>BROOKFIELD,
NEWS, July&nbsp;5, 2023</B></FONT> <FONT STYLE="background-color: white">&ndash; Brookfield Reinsurance (NYSE, TSX: BNRE) and American
Equity Investment Life Holding Company (NYSE: AEL) (&ldquo;AEL&rdquo;) today announced that they have entered into a definitive agreement
whereby Brookfield Reinsurance will acquire all of the outstanding shares of common stock of AEL it does not already own in a cash and
stock transaction that values AEL at approximately $4.3 billion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">As part
of the agreement, each AEL shareholder will receive $55.00 per AEL share, consisting of $38.85 in cash and 0.49707 of a Brookfield Asset
Management Ltd. (NYSE, TSX: BAM) (&ldquo;BAM&rdquo;) class A limited voting share (&ldquo;BAM Shares&rdquo;) having a value equal to
$16.15 (based on the undisturbed 90-day volume-weighted average share price (&ldquo;VWAP&rdquo;) of the BAM Shares on June&nbsp;23, 2023),
subject to adjustment in certain circumstances as described below (the &ldquo;Merger Consideration&rdquo;). The Merger Consideration
of $55.00 per share represents a 35% premium to AEL&rsquo;s undisturbed closing share price on June&nbsp;23, 2023 and a 42% premium to
AEL&rsquo;s 90-day VWAP as of such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Anant Bhalla,
President and Chief Executive Officer of AEL, said, &ldquo;We are pleased to have reached this agreement with Brookfield Reinsurance
and believe this transaction provides an excellent outcome for all AEL shareholders, policyholders and other stakeholders. The significant
premium that will be delivered to shareholders as a result of this transaction is a testament to our strong performance and AEL&rsquo;s
successful transformation under the AEL 2.0 strategy into an asset light insurer and asset manager. The transaction represents an opportunity
for AEL shareholders, through the BAM Shares, to remain invested in a market leading global alternative asset manager. I couldn&rsquo;t
be more excited about the potential opportunities for our people and benefits for policyholders as part of a preeminent global financial
institution.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">David Mulcahy,
Non-Executive Chairman of AEL&rsquo;s board, said, &ldquo;On behalf of the entire board, I am incredibly proud of AEL&rsquo;s achievements
and record of value creation for all stakeholders under the AEL 2.0 model. Thanks to Anant, the entire management team and our dedicated
employees across our platform for their role and contributions in achieving this great outcome with Brookfield Reinsurance.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Sachin
Shah, Chief Executive Officer of Brookfield Reinsurance, said, &ldquo;This transaction represents an important step in the continued
growth of our insurance business, further diversifying, and scaling, our insurance capabilities, and is a direct result of the partnership
we have developed with AEL since our initial investment in 2020. With this transaction we have now deployed or committed over $10 billion
of capital since our inception, bringing our total insurance assets to over $100 billion, and we remain on track with our growth targets
for the business. Brookfield Reinsurance remains well capitalized and committed to meeting the needs of its policyholders and clients.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Jon Bayer,
Managing Partner, Brookfield Reinsurance, said, &ldquo;Given the complementary nature of AEL&rsquo;s leading fixed annuity business to
our existing platform, we expect to accelerate growth in collaboration with our distribution partners and employees while continuing
to meet the needs of our policyholders and other stakeholders. Under its current leadership, AEL has been transformed into an innovative,
asset light insurer that is positioned for growth, and we look forward to building on our successful partnership.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Following
closing, Brookfield Reinsurance expects to maintain AEL&rsquo;s headquarters in Des Moines,&nbsp;Iowa and </FONT>that growth in the AEL
platform over time should increase net jobs in Iowa<FONT STYLE="background-color: white">. Brookfield Reinsurance also looks forward
to supporting the greater Des Moines area, including through maintaining AEL&rsquo;s existing charitable contributions and through Brookfield&rsquo;s
broader charitable foundation and other charitable initiatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Brookfield
Reinsurance also intends to continue AEL&rsquo;s focus on alternative asset strategies and expects BAM will manage a significant portion
of AEL&rsquo;s assets. As a result, AEL will gain access to BAM&rsquo;s leading direct origination platforms and asset management capabilities
while maintaining its current high-quality bias and investment grade focus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Additional
Transaction Details</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">If based
on the 10-day VWAP of the BAM Shares (measured five business days prior to closing of the transaction) (the &ldquo;BAM Final Stock Price&rdquo;),
the BAM Shares are trading at a price such that the aggregate consideration per AEL share would be less than $54.00 per share, the number
of BAM Shares delivered for each AEL Share will be increased such that the value of the aggregate consideration delivered for each AEL
Share will equal $54.00 and Brookfield Reinsurance will have the option to pay cash in lieu of some or all of the share portion of the
Merger Consideration. In the event that the BAM Final Stock Price would result in the aggregate Merger Consideration per AEL Share being
greater than $56.50, the number of BAM Shares delivered for each AEL Share will be decreased such that the value of the aggregate consideration
delivered for each AEL Share will equal $56.50.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brookfield
Reinsurance intends to acquire from&nbsp;Brookfield Corporation&nbsp;(NYSE, TSX: BN) (&ldquo;BN&rdquo;) the BAM Shares required to satisfy
the non-cash consideration offered to AEL shareholders. Subject to this occurring, BAM&rsquo;s public float will increase by approximately
10%, which is strategically important as BAM continues to broaden its shareholder base and BN&rsquo;s interest in&nbsp;BAM&nbsp;will
decrease from 75% to approximately 73%. Accordingly, there will be no net new issuance of shares of BAM, BN or Brookfield Reinsurance
and no dilution to BAM,&nbsp;BN or Brookfield Reinsurance shareholders as a result of this transaction.</FONT> <FONT STYLE="background-color: white">The
cash portion will be funded from excess liquidity within Brookfield Reinsurance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">The transaction
is not subject to any financing condition or contingency. Each of Brookfield Reinsurance&rsquo;s and AEL&rsquo;s boards of directors
unanimously approved the merger agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">The merger
is expected to close in the first half of 2024, subject to approval by AEL shareholders and other closing conditions customary for a
transaction of this type, including receipt of insurance regulatory approvals in relevant jurisdictions and the expiration or termination
of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Upon the
closing of the proposed transaction, AEL Shares will be delisted from the New York Stock Exchange and shares of AEL&rsquo;s series A
noncumulative preferred stock (NYSE:AELPRA) and series B preferred stock (NYSE:AELPRB) will remain listed on the New York Stock Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Under the
terms of the merger agreement, AEL has agreed to suspend the payment of dividends on its common stock through the closing of the transaction,
unless the transaction does not close by April&nbsp;4, 2024, in which case the AEL Board may decide to reinstate the payment of dividends
on its common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">For further
information regarding the definitive merger agreement, please see AEL&rsquo;s current report on Form&nbsp;8-K, which will be filed with
the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) and will contain a summary of the material terms and conditions of
the merger agreement, as well as a copy of the merger agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Advisors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Barclays
is serving as lead financial advisor to Brookfield Reinsurance and BMO Capital Markets is also acting as an advisor to Brookfield Reinsurance
on this transaction. Cravath, Swaine&nbsp;&amp; Moore LLP is serving as legal advisor to Brookfield Reinsurance and Debevoise&nbsp;&amp;
Plimpton LLP is serving as Brookfield Reinsurance&rsquo;s insurance counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Ardea Partners
and J.P. Morgan are serving as financial advisors and Sullivan&nbsp;&amp; Cromwell LLP is acting as legal advisor to AEL on this transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>About
AEL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">At American
Equity Investment Life Holding Company, our policyholders work with over 40,000 independent agents and advisors affiliated with independent
market organizations (IMOs), banks and broker-dealers through our wholly-owned operating subsidiaries. Advisors and agents choose one
of our leading annuity products best suited for their clients' personal needs to create financial dignity in retirement. To deliver on
its promises to policyholders, American Equity has re-framed its investment focus &mdash; building a stronger emphasis on insurance liability
driven asset allocation and specializing in alternate, private asset management while partnering with world renowned, public fixed income
asset managers. American Equity is headquartered in West Des Moines, Iowa with additional offices in Charlotte, NC and New York, NY and
Miami, FL. For more information</FONT>, please visit <FONT STYLE="background-color: white"><U>www.american-equity.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Communications&nbsp;&amp; Media:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">FGS Global</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jared Levy / Robin Weinberg</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: <U>ael@fgsglobal.com</U></P></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Steven D. Schwartz</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tel: (515) 273-3763<BR>
    Email: <U>sschwartz@american-equity.com</U></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>About
Brookfield Reinsurance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Brookfield
Reinsurance Ltd.&nbsp;(NYSE, TSX: BNRE) operates a leading capital solutions business providing insurance and reinsurance services to
individuals and institutions. Through its operating subsidiaries, Brookfield Reinsurance offers a broad range of insurance products and
services, including life insurance and annuities, and personal and commercial property and casualty insurance. Each class A exchangeable
limited voting share of Brookfield Reinsurance is exchangeable on a one-for-one basis with a class A limited voting share of Brookfield
Corporation (NYSE, TSX: BN).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, please visit our website at <U>http://bnre.brookfield.com</U></FONT> or contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 49%; padding-right: 2.65pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Communications&nbsp;&amp; Media:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kerrie
    McHugh </FONT>Hayes</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tel: (212) 618-3469</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: <U>kerrie.mchugh@brookfield.com</U></P></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 49%; padding-right: 2.65pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rachel Powell<BR>
Tel: (416) 956-5141<BR>
Email: <U>rachel.powell@brookfield.com</U></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About&nbsp;Brookfield Asset Management</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Brookfield Asset Management&nbsp;Ltd. (NYSE,
TSX: BAM) is a leading global alternative asset manager with over&nbsp;$825 billion&nbsp;of assets under management across renewable,
infrastructure, real estate, private equity, credit and other. We invest client capital for the long-term with a focus on real assets
and essential service businesses that form the backbone of the global economy. We offer a range of alternative investment products to
investors around the world &mdash; including public and private pension plans, endowments and foundations, sovereign wealth funds, financial
institutions, insurance companies and private wealth investors. We draw on Brookfield&rsquo;s heritage as an owner and operator to invest
for value and generate strong returns for its clients, across economic cycles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, please visit our website at&nbsp;<U>https://bam.brookfield.com</U></FONT>&nbsp;or contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 49%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Communications&nbsp;&amp;
    Media:</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
    Relations:</B></FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kerrie
    McHugh Hayes</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason
    Fooks</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
    (212) 618-3469</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
    (212) 417-2442</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:&nbsp;<U>kerrie.mchugh@brookfield.com</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:&nbsp;<U>jason.fooks@brookfield.com</U></FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>No Offer or Solicitation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>No person has commenced soliciting proxies
in connection with the proposed transaction referenced in this press release, and this press release is not an offer or a solicitation
of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities or a solicitation of any vote
or approval in any jurisdiction, in contravention of applicable law, nor shall there be any sale, issuance or transfer of securities
in any jurisdiction in contravention of applicable law.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Cautionary Notice Regarding Forward-Looking
Statements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Except for historical information, all other
information in this press release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform
Act of 1995. These forward-looking statements, and related oral statements AEL, Brookfield Reinsurance or BAM may make, are subject to
risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. For example,
(1)&nbsp;conditions to the closing of the proposed transaction may not be satisfied, (2)&nbsp;regulatory approvals required for the proposed
transaction may not be obtained, or required regulatory approvals may delay the proposed transaction or result in the imposition of conditions
that could have a material adverse effect on AEL, Brookfield Reinsurance or BAM or cause certain conditions to closing not to be satisfied,
which could result in the termination of the merger agreement, (3)&nbsp;the timing of completion of the proposed transaction is uncertain,
(4)&nbsp;the business of AEL, Brookfield Reinsurance or BAM may suffer as a result of uncertainty surrounding the proposed transaction,
(5)&nbsp;events, changes or other circumstances could occur that could give rise to the termination of the merger agreement, (6)&nbsp;there
are risks related to disruption of management&rsquo;s attention from the ongoing business operations of AEL, Brookfield Reinsurance or
BAM due to the proposed transaction, (7)&nbsp;the announcement or pendency of the proposed transaction could affect the relationships
of AEL, Brookfield Reinsurance or BAM with its clients, operating results and business generally, including on each of AEL&rsquo;s, Brookfield
Reinsurance&rsquo;s and BAM&rsquo;s ability to retain employees, (8)&nbsp;the announcement, pendency or consummation of the proposed
transaction may have negative effects on the market price of AEL&rsquo;s common stock or BAM&rsquo;s class A limited voting shares and/or
AEL&rsquo;s, Brookfield Reinsurance&rsquo;s or BAM&rsquo;s operating results, (9)&nbsp;the outcome of any legal proceedings initiated
against AEL, Brookfield Reinsurance or BAM following the announcement of the proposed transaction could adversely affect AEL, Brookfield
Reinsurance or BAM, including their ability to consummate the proposed transaction and (10)&nbsp;AEL, Brookfield Reinsurance or BAM may
be adversely affected by other economic, business, and/or competitive factors as well as managements response to any of the aforementioned
factors.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The foregoing review of important factors
should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included herein
or elsewhere, including the risk factors included in AEL&rsquo;s most recent Annual Report on Form&nbsp;10-K and Quarterly Report on
Form&nbsp;10-Q, Brookfield Reinsurance&rsquo;s Form&nbsp;20-F, BAM&rsquo;s Form&nbsp;20-F and other documents of AEL, Brookfield Reinsurance
or BAM on file with, or furnished to, the SEC. Any forward-looking statements made in this press release are qualified by these cautionary
statements, and there can be no assurance that the actual results or developments anticipated by AEL, Brookfield Reinsurance or BAM will
be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, AEL, Brookfield Reinsurance
or BAM or their business or operations. None of AEL, Brookfield Reinsurance or BAM undertake any obligation to update publicly or revise
any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by the federal
securities laws. All subsequent written or oral forward-looking statements attributable to AEL, Brookfield Reinsurance or BAM and/or
any person acting on behalf of any of them are expressly qualified in their entirety by this paragraph. References to additional information
about AEL, Brookfield Reinsurance and BAM have been provided as a convenience, and the information contained on such websites is not
incorporated by reference into this press release.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Additional Information about the Proposed
Transaction and Where to Find It</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>In
connection with the proposed transaction, AEL will file with the SEC a proxy statement on Schedule 14A that will be combined with a registration
statement filed by BAM on Form&nbsp;F-4 with respect to the BAM Shares to be issued as part of the proposed transaction (such combined
proxy statement and Form&nbsp;F-4, the &ldquo;proxy statement/prospectus&rdquo;) and AEL, Brookfield Reinsurance or BAM may file or furnish
other documents with the SEC and, in the case of Brookfield Reinsurance and BAM, with the applicable Canadian securities regulatory authorities,
regarding the proposed transaction. This press release is not a substitute for the proxy statement/prospectus (if and when available)
or any other document that AEL, Brookfield Reinsurance or BAM may file with the SEC, or in the case of Brookfield Reinsurance and BAM,
with the applicable Canadian securities regulatory authorities, with respect to the proposed transaction. INVESTORS IN AND SECURITY HOLDERS
OF AEL ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED OR FURNISHED OR WILL BE FILED
OR WILL BE FURNISHED WITH THE SEC OR APPLICABLE CANADIAN SECURITIES REGULATORY AUTHORITIES, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS
TO THOSE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION
AND RELATED MATTERS. Investors and security holders may obtain free copies of the proxy statement/prospectus (if and when available)
and other documents filed with, or furnished to, the SEC or the applicable Canadian securities regulatory authorities by Brookfield Reinsurance
or BAM through the website maintained by the SEC or applicable Canadian securities regulatory authorities, as applicable, at www.sec.gov
or www.sedar.com, respectively, or on Brookfield Reinsurance's or BAM&rsquo;s investor relations website, as applicable, at https://bnre.brookfield.com/reports-filings/regulatory-filings
and https://bam.brookfield.com/reports-filings/regulatory-filings, respectively. Investors and security holders may obtain free copies
of the proxy statement/prospectus (if and when available) and other documents filed with, or furnished to, the SEC by AEL through the
website maintained by the SEC at www.sec.gov, on AEL&rsquo;s investor relations website at https://ir.american-equity.com/</I></FONT><I>.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Participants in the Solicitation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>AEL,
Brookfield Reinsurance, BAM and their respective directors and executive officers may be deemed to be participants in the solicitation
of proxies from AEL&rsquo;s shareholders in connection with the proposed transaction. Information regarding AEL&rsquo;s directors and
executive officers, including a description of their direct interests, by security holdings or otherwise, is contained in AEL&rsquo;s
annual proxy statement filed with the SEC on April&nbsp;28, 2023 and in other filings with the SEC. A more complete description will
be available in the proxy statement on Schedule 14A that will be filed with the SEC in connection with the proposed transaction. Information
regarding Brookfield Reinsurance&rsquo;s directors and executive officers is contained in Brookfield Reinsurance&rsquo;s Form&nbsp;20-F
filed on March&nbsp;31, 2023. Information regarding BAM&rsquo;s directors and executive officers is contained in BAM&rsquo;s Form&nbsp;20-F
filed on April&nbsp;3, 2023. You may obtain free copies of these documents as described in the preceding paragraph filed with, or furnished
to, the SEC. All such documents, when filed or furnished are available free of charge on the SEC&rsquo;s website (www.sec.gov), on AEL,
Brookfield Reinsurance or BAM&rsquo;s respective investor relations webpages&nbsp;listed above</I></FONT><I>.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ael-20230704.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaWOKbOdzZR+uYkxtmB/bQnKnyIubdvAcyal907GkSgI -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:ael="http://american-equity.com/20230704" elementFormDefault="qualified" targetNamespace="http://american-equity.com/20230704">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://american-equity.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="ael-20230704_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ael-20230704_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ael-20230704_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>ael-20230704_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://american-equity.com/role/Cover" xlink:href="ael-20230704.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://american-equity.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentDescription_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAnnualReport_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentTransitionReport_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_50" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCountryRegion_50" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode_50" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber_50" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiExtension_50" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications_50" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial_50" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer_50" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_50" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle_50" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag_50" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol_50" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName_50" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12gTitle_50" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityReportingObligation_50" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAnnualInformationForm_50" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_50" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_50" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers_50" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_50" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_50" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFilerCategory_50" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntitySmallBusiness_50" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_50" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod_50" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityShellCompany_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPublicFloat_50" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_50" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>ael-20230704_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentInformationLineItems_lbl" xml:lang="en-US">Document Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>ael-20230704_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://american-equity.com/role/Cover" xlink:href="ael-20230704.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://american-equity.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiDocumentInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140265764248128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 04, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul.  04,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-31911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001039828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">42-1447959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">IA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6000
    Westown Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">West
    Des Moines<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">50266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">221-0002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
stock, par value $1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AEL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/1,000th interest in a share of 5.95% Fixed-Rate Reset Non-Cumulative Preferred Stock,
Series A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AELPRA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary
    Shares, each representing a 1/1,000th interest in a share of 6.625% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series
    B<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AELPRB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>tm2320561d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ael-20230704.xsd" xlink:type="simple"/>
    <context id="From2023-07-04to2023-07-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001039828</identifier>
        </entity>
        <period>
            <startDate>2023-07-04</startDate>
            <endDate>2023-07-04</endDate>
        </period>
    </context>
    <context id="From2023-07-042023-07-04_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001039828</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-04</startDate>
            <endDate>2023-07-04</endDate>
        </period>
    </context>
    <context id="From2023-07-042023-07-04_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001039828</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-04</startDate>
            <endDate>2023-07-04</endDate>
        </period>
    </context>
    <context id="From2023-07-042023-07-04_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001039828</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-04</startDate>
            <endDate>2023-07-04</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-07-04to2023-07-04">0001039828</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-07-04to2023-07-04">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-07-04to2023-07-04">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-07-04to2023-07-04">2023-07-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-07-04to2023-07-04">AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-07-04to2023-07-04">IA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-07-04to2023-07-04">001-31911</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-07-04to2023-07-04">42-1447959</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-07-04to2023-07-04">6000     Westown Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2023-07-04to2023-07-04">West     Des Moines</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-07-04to2023-07-04">IA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-07-04to2023-07-04">50266</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-07-04to2023-07-04">515</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-07-04to2023-07-04">221-0002</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-07-04to2023-07-04">true</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-07-04to2023-07-04">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-07-04to2023-07-04">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-07-04to2023-07-04">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-07-042023-07-04_us-gaap_CommonStockMember">Common stock, par value $1</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-07-042023-07-04_us-gaap_CommonStockMember">AEL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-07-042023-07-04_us-gaap_CommonStockMember">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2023-07-042023-07-04_us-gaap_SeriesAPreferredStockMember">Depositary Shares, each representing a 1/1,000th interest in a share of 5.95% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series A</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-07-042023-07-04_us-gaap_SeriesAPreferredStockMember">AELPRA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-07-042023-07-04_us-gaap_SeriesAPreferredStockMember">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2023-07-042023-07-04_us-gaap_SeriesBPreferredStockMember">Depositary     Shares, each representing a 1/1,000th interest in a share of 6.625% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series     B</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-07-042023-07-04_us-gaap_SeriesBPreferredStockMember">AELPRB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-07-042023-07-04_us-gaap_SeriesBPreferredStockMember">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-07-04to2023-07-04">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MHVQSQ1FLR^T)\/U"2O.T8]^\[WXXZ?X'4$L#!!0    ( #PTY5:?H!OPL0(
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M3AI_YHOA/UY_ 5!+ 0(4 Q0    ( #PTY58'04UB@0   +$    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ /#3E5KN\
M@ZGN    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ /#3E5IE<G",0!@  G"<  !,              ( !S $
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  \-.56/,'UJ8L%  !$
M&0  &               @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ /#3E5I^@&_"Q @  X@P   T              ( !S@T
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  \-.56EXJ[',     3 @  "P
M            @ &J$   7W)E;',O+G)E;'-02P$"% ,4    "  \-.56JL0B
M%C,!   B @  #P              @ &3$0  >&PO=V]R:V)O;VLN>&UL4$L!
M A0#%     @ /#3E5B0>FZ*M    ^ $  !H              ( !\Q(  'AL
M+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ /#3E5F60>9(9
M 0  SP,  !,              ( !V!,  %M#;VYT96YT7U1Y<&5S72YX;6Q0
52P4&      D "0 ^ @  (A4

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2320561d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://american-equity.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2320561d1_8k.htm">tm2320561d1_8k.htm</File>
    <File>ael-20230704.xsd</File>
    <File>ael-20230704_def.xml</File>
    <File>ael-20230704_lab.xml</File>
    <File>ael-20230704_pre.xml</File>
    <File>tm2320561d1_ex10-1.htm</File>
    <File>tm2320561d1_ex10-2.htm</File>
    <File>tm2320561d1_ex2-1.htm</File>
    <File>tm2320561d1_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2320561d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 28
   },
   "contextCount": 4,
   "dts": {
    "definitionLink": {
     "local": [
      "ael-20230704_def.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2320561d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ael-20230704_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ael-20230704_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ael-20230704.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 66,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 3,
   "nsprefix": "ael",
   "nsuri": "http://american-equity.com/20230704",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2320561d1_8k.htm",
      "contextRef": "From2023-07-04to2023-07-04",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://american-equity.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2320561d1_8k.htm",
      "contextRef": "From2023-07-04to2023-07-04",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 3,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://american-equity.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001104659-23-077802-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-23-077802-xbrl.zip
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MB!R?'H+]K=G7[1Y5L.Q\50E4W53-#/\"4$L#!!0    ( #PTY5;\K+2=\P@
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M4J]$[0+04CPC5A>!OHE"D"S%]?[R]J9+_HEOUIOX7TM<$K[E=U!+ P04
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M@+@P<,XVFUN23,)T; E#2JN-%ZQ]U&< P1H\F-&M2*]*F=$_T?VIT'U'HOO
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M)F+DU+ 1$D>R;G)5$3[55M+-8,)6&JWII01O##^L#DQ0A*M]#R;S6 O+47V
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M_U&4=(BI);KIJSQ:HE@[[O.@V:&IE@_DS57Q&NFK*?4DW.8^0)&6*&IP/-*
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MK?!GT_A<T?/FPP1FE^@1<P=YN27#093EU86NIF4%X^ILPKLRS\L2A%*JJ\4
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M7[+>AN&[%RH=(\U9VB5E ^ZUSA,>HWNR"Q6#0'+,&=^%6@C])KS0[@(C7X]
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ME>R?8#CE=6DXTKU6?#K#(XF-I&#:3A3S=HE<H( S?<2VPCPNJO8ULWH_FE+
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M%V#L@@A%LM493 C7:7)8G-5"+YV!6;BP]9H\"F$$F$X^>(<PC[I2WI[=ZRR
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M/+@OH_?H 7@(=M/>ZG;3K1DQUYS9LS<?CWY[C?]X=_;A_>O_#U!+ P04
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M%'X>78KD#/8Q$6LYND_@B^)Y 0IMQ4"&B3B2\53&8I"-X#3XS6J2QS5< )7
M"J.+$*9)LE&BQLJ++_&\\?@-)LPD"G#/)U%,*S. S3,8+H$)$YF:'V-8(4#B
MK+F5X,]'7NA-F=;,PLTZ56C@@C$SV!(]BW=!)Q__/HFC<X5(@\^[L4I5<@;X
M#;+92'D-<>:=P^Z$J43R5B$0."S8[@8?W), OH.W-6Y<UH(3X&<ZM?"YQ ST
M&U4\:EOXWERE("_^BP<+-C(168);EJ4BC%(@DHE"W#)>ZC78QR!@>'&2F?1"
MX$T6@4!H=#2E*$^Z?G.T?[>'B7B/PY&0V)AUA+![^'FBJ9L.$AP:X.K\@H.5
M: Z$!C0G5)J(T)O)J]ENDL&D^LR4!H6S&4TE$BH?;"3 B#[:Y^NU A2>#X(E
MUN<P*ZW&FZ2:7%T*(OZ0Q2AV\"<D#%'!)482GRBP58=+UVM,-8NL%@[VW_"&
M&!#$+IM&9)9 7"?F_4BIA\22'X5C13P+11<0P(4* L!<*),$OZ*37Z_1P:\Z
M.P5V#(<O 2S_)Y,DO=,S+UVD41I1Z '=/7MD(NVX]QG>063N]_H=QH.6TPU<
MG@Q)-8)ECH#?RBDP)Y!GHRA#IN_AHG$')D"@T47R_G&M_<-^#S1-9]SG$V^F
M@LOWWQN9GDV HS,@SW8&G?:PVSMFF#>!!'#D'?';_WVW]?+W[>I_>'T+(+C#
M?NCN].4<#C# 3"(Y84GUV8M!0< ]PN/<*=%F4WQXT=TI?TN,9P2Z1B)!)\%M
M)!Z$(NCO"#8:]<G83):P[.=IZ 2YY\-+M$939&G A^#M.;(=_)0F,I@4B8.P
M\JO2R)JWKC%P)5G\X#_?(20PH++T+ *]Z'*[7NL4U-0]K:9NBTX(LM27WD@%
M\&"3!"::#@4R0H8+&@HR2$4"=QY=H)B#D3PS!_%<FD2ZFG!9O-5K\-Q<QC#K
MC-AV- *[FBF=J(I5/1P!'@0FGV2S&5(<B4R@S<3S^6'X+07=.""=C2F]2:!7
M:^0HJ-/BPI8JZ1H^4LCA-66H^RI@X34++<YMWUL%<)#JJ/V-I Q!1<!SRFC]
M+RL8B/Q0^B#94 _G<5#7,9R[2L(W*[>1!M?;-';Q0U)/P2EW4$%:OI? FEAG
M*=B&N-A4I3 .2N-ST'9YO)%B\9&CRB#!FCY7CD0"!\ADE1&=U8%.:2@9%#]O
MZH%)E>(.H*KD@RDQIMTD[0YWDM1R>.F;+^<IBCV6][Z72%(P]&AL*LR\2Y*%
MN>DU\L*O<39/_4M\%RRA<QGZQ$ZC> KJ^W\UG#':C2KP8G&(AHLWF:!2A_H=
M8%RE49S\%B>DI)%?*1%3&3JL&F;27X@Y*(Z^F@=:)9;DUV@^> ;[+(?M_SQ_
M+O;1^'L/=N14;L/SH'#!KL"PXOES[<O[L-?]9.;DD9ZGT1P>V9JG9NSGHRA-
MH]E[\0:_&\'FRMA^MQMXH)]OPN2P+6H, )P4QR/(W(5^> %S5DP_BJ7W]?E(
M B4 C'."V07I305$".9UIW00\P(QP\AXB+MYR^)RM+ZZ&O7/-:W3G>,(K;IP
M$B@_3;:!086D"9$4?/ GB_]_A2OYYO9%W9\: T*L7EM9HB_:TU8X7U.FCR/4
MDQN5LAV,H>L(=^TFA2]5+H.,!R QJC2:KSSE6FN=2<77I$EO-%"8@+*=!2S3
M0E :SE446(&(:OH</6()?\&JC"N.0(J,(S^;D;9?H3+ U+NK32W<F4$>Q>C3
M\O#W-5I=Q'Z4B!U>"EUTL0B\>4*^NA3(C<8$IGFVSLX]^CR%?05!"$^AMXY%
M(KT B%(AS=< $0U(#*Q\!>$N QGKC=%X<%6%& <+HH26[ E4)F,%J!B!8)W
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M 'Z;FV"1YHM.XJPSN3X7$P5( 39 7^5/KNL;"B4]R$"C<Z0O*SBD$PARW O
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M#46QYD#%-5 B+S=$5WT-L<$G,[]'03D"DRSF**?.%&LXI2'RI'B,Z\7FVZ1
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MACY(75K&RBKBF2/7?0&G56? P)-\B;_R:K[VW)D4FR7E\,SVZBIO3#)6X^9
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MD7X!PJ/3X2D0G)X3Y]';JJ&NUPAK,![J!87JPVM_/I(N#U66V[.=__W0W1G
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M47^6EUX'?C;"M^[\UVU()'NY'X>A-TEAU^F_?J#-\O/EN7[!E4HR4.!#O1)
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M>O?/NQH2P3]8;/%+N9##E&?,+RJQ+EFF[FKOI>YJ8=W5_!5O5#%,91CKJ4^
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M%$,7;YN7NK*_BI3Q,T5>/^<2Q^/U[]!,XH5*J_167&1)WL_R9(W)E/<FTDN
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MMY!GD0V#!],*P2EM!=?]"ND%-Y0IC;>4";S=+*GTQV_=\V[GPA5Q@K-#\>(
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M\-8$Y)0X#.L'$+.X_W*!WDZ295Q^<NE-0+&_DK ]O":(J9QH=X=2HW0".QH
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M0MF(YVB0S:G:A,]9(#E*ID]:5B#JEVPZ9P,;:^I0+!>3E2^0!,&;"XZ1=\N
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MH'%<&S1^(Y$.@1,<E*H(9K-H5@. Z&C\0W%OE $0>U4 1/6( (A:XM$&JP5
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M5F""72N+]O,@#>@B3G@H?>5@)7M!*/INJ^>E+&X4@7#*9^HL'Z42TB@\W<(
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M#)0!+W-&\;CX[3I.OE(J(I $LW$X%!13RB L?,9I\Q@-RC,?N,EU)%$,'?9
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M!CY7_\4:\TQQ70$596A_01QM6I6(FF\IJ8(J*K!H@3C7QLWEMG52;&I5E%8
M"@C/"+:Y[B6+(,MIIOL X[U#%0\3;S(*^E1():S(Q<&9E'%P51V7JRQB/V9G
MQ=47<%1@6T=K=#4 "CPT'J:%R:.GCFX1&^ 'ET570=L5)JE&B-.@M?H!Q3H1
M3DPQ_4T+I4T_T2#G%&6Y\"S7QK&EM=%0NP02QCO6SE^AC A&;ZJ@3$E)'0/"
MZ;5UK(=(&:M=OFHO2S4%3J\-R!0! ]&X1?29L'H$UBC@[)R("_<$>82VRT#
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MG(TYP?:Z!H0-B+@O%UO8_>"<4DII^A,^5\1\$6]X\RP"#F]> @Y-D[5KQ",
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M[42CQ*&36?OOIF6B91J&$!:&L&!T!*19L"K/PD0]*5=D4W\?9JP*8F0=LD;
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MH+4>J3V>)S(-P7O\)7%()<G)3?2@TG-$JZ6:L&_5L^:.CT,\6H']ZH3[PWB
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MGM_XV\,$+I.7^P!Z,>EFC=<;@;[K0CWI_6EOH.7*#EY'/T@.]-E=RX&>WN=
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M7HA4H"#"V^H*-(MKLUVI'(8MZ,:"\I]L$HQ>*/_KTIP@,U BAK06*=UTAQ'
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M9^XN88,YI\&F>;%"DX)7ETR?]2TQ88;O60W8S-*\8[UCE<JM(=S$7L>$<=
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MDU_*X ">#)S-4^0$)BP&A:* WNVB.+FWS(,M\XN#L<RO0MIWX&7ZB;7E[]E
M#HD-!&NV3*7>QL^3=^NG]",V/;6N<@.F WGDAV"++==]B"ZF*K#Q+><Y:,V
M,%]&(@4IU<LQC<F<(VFRJ*:D=[[<+-:%_2HSB\%W0#,NQ6RW,6GT9SIKRBE]
M,$,ZDIXL1D"5Z$#&L+!]RB]K_AMK]YEJH[90SZB=L[/-6X3:")2YO![5?+Z/
M)]3EYHQ'7YV->Z 0H1>4C$>=RQ2@IL/6&Z):L9"6F.G,RX9J7Q!"PJG5H")?
M.34Q'A;(^&5X"ATI L8M29V/5> R@:8W0_J"SE?>N:Z4J13$NL?T15DULYCG
MFX6-RJ*4*#;FX@6&I1RH[?,=L*P"/-H;V&\@ZD<F 5^UK* K=#D1XYD5"ZAE
MP7JI%C,:1I,M<TN<8[_ [Q0_HBQ.UUV^9'%:'WP\^NZ+T[%8G''<?5WGFRM"
M39Y_YNK[965)%CU-!-CKO!<U'8L%>=,K/?RC=6!1Y^5=*^H\N2_JW ;7[299
M+] <8SO=5S":WU=>8V]0C-_$35 1W139Y.LU=[]8WK7Q*!Y%IE[G1K%VW> E
MZ09I3DMJ35W7A1UWC&_(/-2&O$Z$KYCY)G4>,L<4T0;=ZP=OEW_<3FX=\J2=
M\4YJT^W]![=2GO)=+14/N2!)<EWFZN<8%T"^VO7!7#+C3+;(&;JQS.T&.,);
M44*R 'VD53;E6($0FL>2Z[=YM**>\9;)6+VYHQV..-RZ(@>S/])>;UHH;218
M4ZO]HX 7?[89_U?LHK[#\$L"D_'HUMFQ.[^/;["!^7:??WW[:<^S$94PVT%&
M6_.^(S4?LU5!9GZW[7'=X4K?EM@8\'1,;41$L:'4&J;%96$^G-8%=!C2(3HS
M_\EA\Z6H)\*%"\JDF)4Y@T@<:P+&/N593>SB3 T/#RDG,"24C%U=VR/=0K&I
M2F0OERR0S!SN(IX$38)2MY>1X#I@?AV'Z6RL/]#E=Q#,CXN[B@B[Y\TZH5M/
MY2+P*';8V#MOI6ZR=WU/WIB.S1PM[US#[S#;\=SR"G\UO\/#77\UMP,]_H\9
M5=1R3(<:TW[GU_(W;66\/W%O[,2-10?A)DWC6[2]_\P9%VQ &@)M0^)RR<OS
M[)QYVN <RS/6Z%A[TP;_<8F]A;7DEDF+PAUGT*C)*5]68D5E"]SBK1T,-]3Q
M,=[]UI]@P_*8CT[N6A[SZ7T>\S:<*C<(3O<\)$_RRMG<;2KFF(4]K=R]S3H4
M:_08=/!A2VA4]@5!+N.K_\O$(E(LL0R-&6..P:JBJND&(#E@TJ3_N4U"KWL=
MJ4+9-7@TM\+(EUI>'DB4K/%%Z5Y7Z'^#,$ADX6#@'@$,@Q[U%;&*9[L$FXV9
MH\NB@1\Z.D^_K==1Q(:2<4C12\IB6&D-VSJ#.J ^.54]T/88XRLSD4M^"=!L
M2!29DX!9;'#070,4!\/<C]?';G#>=_1%$+EUW9+AP9]F!X-C>GDP.*9/V5_C
MT:\99@GN44LWBUJZ1B R!-N[TSX<_"NG___P:5$&+Q__]E5??W'CE#K#L6MP
M8@HO-9#(3C,\X0F+8C_A#@MB%R :FM9W]:?'R=$Z^XP@#W/85;:M/;DT'L8,
M.51*1WH)? [<+<64<15>Y1C= " /(]@,!7'&V"0?\O6F+CM$KT#P7 Z7)5/;
M<ZN>I4SH% JD9HT_C2/3S+BPF<BX]*VIS;I]^X?)F84.T7#4C\8CGI7$FQ2L
M"EGB0L7="[< _K]4!"G)/4+9RW5W<V(J"*9P[I:"56-FVZLVO+MWM8@$U&RC
M2)JY<YLHWZ%%;I,C6;*YFGOZ8R5/0$L%(O%B1J3C]I-L9N;4C'*QC?(>QWAV
M<,1G*N-[]O[P#Z#O:8V^J3G:3>U%2RT&#AC24@6+C94SD8P!*9@RH5SDS=Y5
M5F!D+F+G"82&5U$5$B (:1I&HAI?G.K;?IG%W/-/\S.2:' %DHZR35'*<W(&
MAS?;7-H)=CWU_?KUUN^W6< [3U"U:MX5>4G\7_PN2[V F:QJ#PH8U\WS7F1%
M\![W;UZ_^<L;>/'74C,X.N.FIZM,F(D84@^_613F'6?B3<3-0TVPK9FUCN(E
MD<FP7I)O1)7]PF8C2SA#,L=R]90]&!Q>+?>B_JN >*S.E\B YG02J/L,Z<)*
MKYD\XLBQ[^;Y2B)0'V]Y!0'PGYVP.<)E</3 9G@)G@Y5H+E1#$MCC9G116;_
M1/#Q[H/ *Q#3=$N/K#33G@/#;CZS(BC@*U:-Y4M;HP H3[F=.N[:R?:\:^&=
M'$>O^-'Q)CA)O  X1P<E=.HWY-NJU-PL;Z9U,>$^8R]#\/STT:DS2;,<'79<
MESQU0CV/":>@1P2RRT!'!*_Q779UC,68O+8=*&:Z"^+YLU?[@DGA"<>7P-V'
MF,V,O7RHP>33"^!)6P#(NS">X#)?5N;=S3(U'BCF*@PD_[C?73A\VSNPDG)Z
MURHIS^XK*;?M;/\V1_NW.>$#@#4:1>!;M,TG( N '<PP7<N2*\(MRXC'KM/
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M1AFE9<7)LU6V!>DT5,_UN6@A5@7@_,)8 I=8"1B+6?0O^!+0VN*O&TC$* (
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M.?)<N(PL?1[K8A;+1MY_JI2T=(P0I&G[K'+MBOV6?F6H14>2%M;,DPQQ20
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M'"/3.82AGZ]FCZ9EP_B.<S]K:(MLC#DKNVE;3< .)YX2G$]T<>0I?7I)LN&
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MA8Y;T:=*F@C).[Y#/#96,:R=N0&-LP7G[JEU_V*M+OAF\7#^,J]V4ZG&;*L
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MF"HE6=.2_T< ").'M+_+)4-(.2VW7N#@#Z[4ZC7(%-J;4LIXZ=N6P8-P7[P
MN 5)1T.6[0SAVWQ(82DD_I8;+US7+3JY^0R-(/)[5K/LZ*)>4P?2O*149[FH
MU@O2R2B718VF552H$^]QRW,=AT2;WG";I<I;.KU6@Y?AGJ)N8+5U85-W_[G9
MX&>SIB36 =C:[F7\[T=/\P</'N#_X<$I40 6=!$ 1OB7[JJX@"^<E[,SS(_X
M->E]"^?N59>,CO=Y!V#[1\DV=&- R^W:!SC1=?1GQ\;?P#;K,10+(=V4>K%O
M/ ;H[^L*J"V6$,,'*S+T=I3,T20]W<9@[2+_KNCM!MNA9UB%K]8=4&[BUD0[
MZFXV7]>U$O'F7-+A+#67:?*@&L=; %\H*C0@IV?O/?9:_$T:6I.T63]'BP^K
M.=_=/_U'@GP>WS60ST][D,_WYUU^"_=RLU\)V7UGW^J2DS=HU-@.&BY'RK6R
MDT05/JJ4 <3YK"YC@]Z5DNE2SI\0]NL=0TI10? %J5U&ZC,#])&)/M^X'52#
MY,S:G6_OZ.O7N?00=YRX(%?177K05:S(5SR&%)E[9N <I2>7%!9F*:B!OG1A
M[O]^^,#86$^K@K9[DP$.'6GQWTT> ^>G ;&@<H7!98MN2 -\/^T2$F;H$Y2<
MTC>DV*QL"5Z FYYU1X5\][_N=%%5,@8X<TQIN8[&QICJ%A#PB,"WBX;K)-;1
M3_Q6<BFXM)0SF?^%"P/XTOD]\BIP@\$OS.+$51A,'!Y$]Y*XWV;-7P!M:,'H
M@E&IY2-LL(-8?$;EA6UY9?10^JZ'_0HB3(Y>W3R4$4?(8H%'"!/9: 2XXN;N
MF JHIH,+3C9&/!7H7C+FQ,(M!IVKPP-S]X27C FDD"'6 +7]<+DI .Z_^P[)
MMSPP+F_]O(!\)$79=5.@)9]=DH1OTVJ5#QE[.4O9B9OKWS35W'P01 PL@;''
MIHVAJ@4'"<C*OO26%0<T*I!G88$E9;^"Q7Q"5M9LU*%=*I &J-_,RJ'D@-V:
MD>_^\%./%37+.O=S& :J1Q!%M<\";!F3L=,WL$U\=R'TPZ*4G\/# Y[$L?."
ML?%+GWKOE22LR?*@/&OLAT9\B0/>&Q%C1';)AMA2E3DZW!Y>E.T9)?6+15&?
M%:3;<"R6($(5C$NM>XO##3^P:XRH"/*)>WD3<;V2/Z3N(/6IZ-]"6(V\<] B
M!_#3\^HBS_YLW$@R8'I<MY25],C55LR9N9Q' E+MBQ%9-J/OLQ9S.:-G0D0/
M'W^<LK<WY,"F#8V;D:0#&V$JQYF(OF'E.NH8V[3[NW9D+N+)7<M%_+S/17QW
MI\)7345L/@]*WW@]B']26)%U[M[5Q7)L=)=[1Y$@BISAEFN]8CRP4/F!#[J$
M5 ,T8 (*!_W0EO^*XD7XR16L(!0I. I$G?"H4ORWL[-D9.$*D^:2,3'NR&LQ
M\\)QI//?Q.A#2R>V.E,F7? !DV:Y5I>:'D2<<7FB %PAC\6$RHH?)PRO#@OG
MT8]%#X_#@Z?_1P$; IGV:B.?.4/^U45$LW+,J:>+3TH^P](MZB.,)WB\\$>I
M/AT+$I3G0N'?V$&^0 0%M;EJEZMM<AV?','0WZ O"*EX66*LD1L)=E8O 9S]
MBB35\K"QQC<(1RM >MVMDZYP$%P'N5LDN!Z:"_!=UDODU@/.@2558P#7DANO
MB/[K'O44XZ?11.4R382'Z#4'ZZQY/@&F$R U)A "KE>$ $[-I/S3!V,F>[.2
MA^,\(L*NIF5=M@(_910DYHF*"W(7+#D@[AM&U>1<HIROJ02%& FZC.)N&*6\
M8>(E<Z.H'XAXFPMH?X)3E%'&\D+=9%"EBY*86/TB6"B[F('EL@$O<4S1E]2=
MC:BG:%%Q"G#6!#H\M3$FE/T#18(F[#E*9>IP\<[T]E%N#\;).2#,O6+'BCNB
M"O=]; Z)%:[-G\B.NA<U@;?B%B<L_:NF_0! WO5R"D1;[M%FD&[&S_";2=_8
M;]"0LB+PE-W;>LUOZ[Q""!8O*WDY/.&<-P"GEAO#L.U'6\(0LH;WL\4][SFC
MBE'%>5K6:8@M6]$SP%GB6#D\^,1SI7><I+&HY\T5F*0(BPK^%=%L:H406[%P
M%XTT?P0EQRW 85;#:#5<%I>%,VC,4^OLM5N<YWBJ>PXWVIMBGA4*^\I+17VA
M4S@ZZ'QR'!PJ>#008FTLUP+@U_YL)ED@?X Y^0]4'6$GA?E]>]U#6U,N[BJ8
M.=-:>:X6)V.A0#5'[LRSK ]'[F3F(#FPY=[F$TS82HQB>Q7Y3YA&YY*'%*A3
MV=T+T#,1O3QT _C-!I82KN8'/O3.Z21Q4QR\?X"?\;&GY9#=#_B^J4-^BQXY
MMS"0UW2&KH1D?(-3JVW6[CS&ZM]EB0>7YC X&^GSPQX$M66#'(M/HAZ&%ZX5
M1#2P-W(G*!9YH,C"9KG(G*U?MY#/P63-\7BG;K\ PP7X=5;@V.2@.DWL]X ,
MZ(HS7'B S$"<F<22 5CCF7B\\"9K>>8"C>)>"I4"M?X3R2R*!P1F$=(J!;+@
M4B[0N2BL'"UM9R6XNU3'O?!#"]=;NC[*J;7*W65>8!,ZM(%8R:?)-<<YU)6F
M#<:'!V?0)#HOP%H+T7P/Q8UT1&B/L9A_[,-?D*$F=!:Z->[Y+Z"5=F42C,=6
M0->&XMC!@6!Y-PJM^S$*RUY)9^'UR>ESV7)B\2.O38*\$T,F>J,A8M-*8HS9
MN"$"*0"6:5\8?%Y(8]#9"0G4M?[E%8 /#TX]#AMEF/D)TGP&NV]M1N8WG]ZQ
M_.9/#_;YS>_M-$/4S^V6O4R:,VWJ\[ZMS[Z:J<?,P$A;/]*.?I*I=T;S2QQ'
M7\;4'QZ K=]LMMD-R3VXF?P0"HF'1)IMDC+MJFBXI4\"S9C(U4$N"SLP>W?V
MDPS 5]W_XPAF;]D ,*_K5]Q=6PW X<'G.WN?;P PL-WD['V: 8A304;)E>($
M LQZ^J-9><EYSB/,O,@GD*Q?D&+EC"EP+LNX\3L=54 *?0G!1($=X.4Q6:7
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M+,#8E:E8POUFZ<-/<P6*\%,N"<2-."\N3HP<F3,7W5T@!IT/<W:[,.9/.5X
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M&Y!M^],DY:JQ1_@*T *PP>E&6-TJ_?;+S<%AVU#P'3'^@M/UN=P)X<_NO]6
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MK%><-##-#<2,R<!H]A2./E6<"BG\&%<N 6F0)A(.@1YF5,@9;S;-1HDEM<M
M%QG299!S '4S6X(S,]C%4WAX,%@U%FH.)#)O/J#,4]%.SP-8<& )'CXI[CU\
MG*+@@)J4,E$-PG%2>/,1@2\M[>WKNM_170A[;]2C[6D#!@JP"V!&K):4B&SJ
M$B%O;<EE0]KT_0U?VNV^?2%7\W!" @K7NBHOI5[F4W3H =[4YD!,K;89;.42
MY=\47B@>*O1(J#]I<] CG,N(0G2;7RE\'4$^L5@T:V:)67%T5,PN[>;;-)TV
M%3B$YM:-N0J24_#?O[75&20>W>2?"A^).X+<HYKV3[3>F12SD>RC6X,\4 6S
MY'EG?*K)C7CA[DZI)$Z#9T=$FX2E=&W)F6 R\J.TPT A4NOB(#_L)K%=+\(W
M";9KS0+9BOL?,5=!A^K8AX+15=RL,79+<@C\V>O7!E$$SH0I 1T?0U+Q=Z1%
M@9^X&Y\010=%E<A/BECT./&48@<]\>Y+/X<3P)OE' Y4K+CG#0EQ@KI[JL"1
MYFS)>RPRRZW31APD=MZL'1=Z%'T5&T0KGJ#W&7M[R7440(R5'2E'SBDW0,I#
MLG$,29,\4PMV+>/Q!^AK3B'B]CROVAE])VQJ@8MKW> W!@&_9!TG)6E!+VE!
M4J#NB@^?]B]E*G:I_9_1]@\1 H/N1];S/@+O!QW)B,ER?3'#^B^7=-02SEN*
MRZY[M2XT$8$,F/;?Q%]->X2!0^"/SIV/\_]:Q'DVWEI9^ V:[V$\\R?Y3[Q:
M:*VCY;%;6<TZT&<5EXW*L&G9*=%:Q_'8K\POY/XY8AP:*=K"0> :FTP<EJO=
MG*A0$L05Y8@3)VHT# 02W='A'/O_XAT,#K04E+(S9Z%:8B.*/7UGSJKY:*<A
M^T2?89RG@!.SR57(OHFG@#1M6UV%FSCO"2D"D7=<<9S(;&4^MA,ML*%7S<[@
MEW'7M[/VBX7GXU!]EEZ;);Q:@OHT<FAN?Q'^)-.>WQ5:.09WZ.>'!P^?1LR'
M_ **LS-0^(- >^NQY[?)B(-N*,P&X.<V$>@QMB;PKY0&#^L'P$2W*( NK0MJ
MD/(W6HW.7\!N);B8?!+[E#3\RV9%[4;LL&WJ91HH\FTWG(<']HGB]M >%[J(
M5L.>FXX?7G2YU*J*N+:QV;UC%U1EP1,=?5B+1@_7UY-3Z;X1*JY&"&Q25V=2
M2FTH';=U6XSI87Z"VS7T53%WY?URRU,*94(BR[Q0B@;^@^]\Z[<01FRB#&!(
M*5R*&MW&'KS==\G&E5Z>[$LO7'KY>5]ZV?E0X$:M1$]OKY7HO;K9AP?/P2UZ
M17[VO@7HV[< Q<'<.'Z2/F23HREWN33 P=*R>"UQ(Q%T,@? :D'BT@#L&!&4
MV9;Z$O$AS%CG858D7L'."@UBUO2^"M+"N>E$(4BXQV2@/V QU0CY "DF MUB
M+1&2]29;3=(D!'$+HD'/JF>FV/W]A6<" '4,=YYV !]#0/@(U/N1T5"YLE$B
MM_(,IUAPAGQMDU%A37NMWF G$T)M#,?TCBET QF8%14AL85)*VN:"$2:)=!E
MPH===\)9GWZ0W$3G5LA%@U*(#LXVBM7W8#-^^N O:X@84->&B[3J ]'8HXHP
M :F[G$NOH#E3KNBUY0S%(UD9F#EHDBIXL7GQ]8[HD&W[%LVW)YJAA34+RL8:
MO.(C;]@)AP?"QXP+W'39!+!Y-S:^^HA5ZE]MG"6VU0H.D6'&7FB3"T9H</>A
MK'9+^5'>1Y\UF+BJS?0S,A0-E#:IR[V!HA(Z_A+1=[D%DB8^I[Q1S/AR HC3
M=NW>C0O*NF.S? \/)B(JAXO9]U4.PM+G35@&.B:FTX$YI9C.=OR8[#U.BOWA
MX8'_92(2#"8QC['D"J)%@PD%WE5Y8=KCMK]/%!E"@\I08S<R-Y %F B,U'AF
MES'LC&XBB@9=5[;TA&C13Z:>TDKHHL"#YF]L6)!4^@Y61U0K26R"R"P'C3IO
MDN%D6)!^</_A(XHH\62AO< X_4E9L'37U9*U[7">1-P.DR9$:A*=HVRM\)[T
MYKRAC[XJ+Q@S*GEZ;JKR.\#1_<6PODN4"E7P!KQ#B/RKI3G/^XG>,'WB&ZC)
MY\(E=E.7RFU.[SP-U^&7C<\4P!ZM,*\W@<1 V=D-S(U!//2X\)A(-[$6#)\H
M*\_B(S_#^S.-E[I5<L=*,N)HSGX1('Q/-]=MB55;3=77#5(?\$#T*&XVQCQ*
M[FL%6V>N-PULMOQYU^MY-&9&>]'(:8]IH!+SZ5LIZN**_*"%,PT+M_JH[D#^
MCTQ9, E\K^^K"V!<FN?I/LU#:9Z?'^S3/-_#B?2-$;9<33D\2%4=^^8VD<5^
MJB#<1%=9[[3*>]A$2DA0.(X-!EJPX'ILOSD\@"H2W%%5C0U8XW%2HVD4[8D[
MEBH,O"T+,'S_CR4*_B#8K,M>ES.<)V<Y9_C,'!1JHL1'#2\KJ]027^@E1+4K
M;H?)_M/]@+L6L:_3]PS2R0F!!/([>%91#88\Y/4?I^^1Q"\5'@W%?)PO<*Y]
MB\2Y&K3"C+@;=KEZH=CGX:/@: #8P-(L[_UQ__1^%#O%,4<,P/8AV7M)5W1Y
M$-2G1\.20!O&E+H'CB@U19*F"-H4@]!KUBRJ*62V !B0&K5X'-&>\%\-.$AL
MF3 $"\ASY-FD:L[:XN+</48-Q:)J5EQ6*YP'8 L&C:45<'.T,YKFB3NF@&(.
M]MAY.?W02?,NN8ZT%\9R+T"9'2&,-OJ-?N )@3$L]IS+&SELE1'/H[I/I,NQ
M_.@\'QOW$N^YFQ$7K,/%$U\@WD]EW'GFS/X&"3)?@</%L_+*36.&LVTTJLO#
M+QT4EWB!9"I5Y]>5]F*7&X=AJ<L1I;%<M4WM0;"C.CT/#T[J6FAU:!])R]KB
M F6,,Z(O8NIPWB%&BIY7II(!1!2Y?4P+3;F";[G/SI98-[ G/J5S)GAM(P(?
M(MFTA,>E$LP+U3X<(KA*^L?;U,B:2',EC>"E+[O^0M)H!(5#YB;XWFMB9V""
M^S<1N478A-D;$4*?!D8D/LT??[OAB/ +!4#T4\/:?:__KX6W^Y+>UR=A\'QD
M_1Q[+>Z]+)T9<SO2L 41X4C9HUE0]\FVAQART@</?X2DJN3"R6B\?O/V_8DI
M&&T9HT5UXT][;!0:T9JTN[#I$+R-E_^FK%X6YFS9;L-S8:/6RM JY?W9"JBG
M5LC/Q9R_V-P*P\:;>^.8FUQL3'D35BZ<6ZQP61%8P+(1D94EN-]"D=0<9S<>
M#AA9(FDP)94MKP_\(*X(\-0K"_;NFXUQR8(?]LD"3A8\W"<+OH?CZALS\;_"
MJLX&WA@#%?"T1\[K)W/78$.KX>V*(BY?S6 FKZ"*T2ORV$+7Y]49QU#B]!X-
M&R;P9, G"J(@L) 5\\,7?.@ 8WRE8$BH+:_Q7Q[WZ7G\@B)=V*S:2_\+M=WA
M05N=G:\,Y95I5$/6A\[W0E)_G<F-IP4&24(Y>),^,4-4I5)$=\\QHW)8CF!P
M >5*\-!Q<$4QSL:2W8C0Q;\RIL1BA&@3\FL1KJ&:<1K)OB%4_0V(S'H@$#K=
MO#>1IO=0EV*^;I?0Z1W2NQ(W'0DLQ<$64LWVYDF]*^='>*8WG]>(" ;M6PU>
M7W_A2 MP/')FU#*C7E]@ "N<8,+YYE&EVW  \?XV"P7ZGWAM?RY8P6<AXK<
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MID?($D_@V14-DW:X-5*C/CSPP]9RTJCQ9W[XO1\&SZ&?!@_T-5Y*AQ=W_A$
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MDRHA*?AC 268612GAOACR"6'Y4/+^XLCSF9K/*27,&2?F\B<B6U5]2[F%&Z
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M6F,2PPPEA<PH"9_0&0+VB2OF]";Y8<QT$@TO$V#G7C<H7C8W\'/%1M(ZL75
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MOQD0F20@.4."W!MNI1L[CL)3DH;T?_?3DDAU]=(E/LV36 6'!Y1,-"<B!%A
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M@1&Z(.(NE+*IQ @5R#B<;W#6I=69/L^M@XS:T""9TFW"&;)J@_P\6++B7+H
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MFG.^%">]F<#K38[0(.<-VFCCD5)T$H4FX>P<C':GU(;FMB%7+Y,GHILU-PN
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M<O@+KEC1CJMV59:U;+/[7]5/G:JZ%EE/UYQ8UW3L@ >AX#PN%H\W@X\/> M
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MO(U+:1[0H-]N1)%#N7;;^T4.%X-%BAY?E!0H+PJ>%0'>"YQ#9[F$.[7I\,C
M)BI6>KN@:ADE11\.J,CJLX%"[+3BT21KZ"HGB?J=E1+&4/CN<8P83+-.ZSD)
MVBY&1/*PZ'SLFRH1Z\A,Y("A@ZO,$;3VNK%EGWK>>.I2I62P!3Y86T![!4\*
M##:A>TV-/1D//#0JUG<*;RDI.>BDB"\W66*A+5&S2ES-3\SG6E 4E]YD5ES
MW@=17("5"C-29'-)1G-XISLR@=U"&_*0RQT4W-,IR,WU#V? =38 M4\D?B0<
MUDNN^$6##J/Q/:/N;H5.;E!G)\#:&#7%HT[QO(7C]CK"D;&C;O6X]574C0M-
M5:S]K";C=;%M0-$PG=WIIR,Z3(SN*:[16]NNBU OSQ@)56@&6A+O7(93'ZY2
M>PC, H'G>IH"O(L8#\J4:X5),*:G9X3H:97=(!X[ROA,J1TE9F(FF:6^6K>6
M"RJ :25#O_5 7HI-&E$M@WH2%Y:1O7AQEHX=N&1&JO4> IU'M:7.-#DV"UYQ
MXZOGMN@]VAE@9H<"*@AN*GTEJH+4[NE>FN0,[YP3KW52+]'1C>3O<3*K]0,"
MN=^]4P?_FD_0/UE;CUY>B7I]@M"HL#*-:"-_@0ZZ&AF 1N+_MG:\I1FM^IO*
M/FU7L(U$.(6I+!F F&(DF.D?E77N2H9015A#*ZV/B-CIR=$<EC__=:K+/,1C
M(J<V/+>!^<:%$BJLWK1 FT6.O$;DX%>G"7^OL0U<Z'D4Q2>7*OE99S6BCT.)
M5EAI<8*@YXBXAW\'>325H&]6G!;+H1>8O.N%&%Z5FS4=\A*(FC6D79Q[S2?[
MV'U./4R2(V:S\6-P>GEWC_L][C(>RW,+1YNU&P1TQC,NUEFBF/M+YC.(B"GB
M%I>>XZG&-*8X# KW!ZNW3"T2,FE*.0T)##PJ82F1+#$@X1'3I^!X&9X*?T.
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MQ.XA'*UW7#DWFC2R#=RSU)37B'02Y5F[7*XZ"RD7UL^AT.>25:<+LK)Q?K1
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M=^_49WG=11K79_B^[7]<1V3+T3"&H8IF%6P2]==/)-O^=7RH7@##3:0AZG@
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MVT:RWUG%_S#/Y62E*I"Z?>JIEI*HF(FN):EX_7$(#,FQ08#!(9KY]:^/&6#
M0Y(=>Y^L33[$(@D,>KI[^N[&X;O^Q?E1O7;XKMTZA7\%_G?8[_3/VT>'6_PO
M_+IE?CX\OCK]('K]#^?M_WTVC*/LC=C9GF:BKR<J%9=J)KKQ1$8>?^&)GDKT
M\!G<"+=>V_LF,AGIZ(W8?G;T<S1(IV\/MZ[77?)69.ISUI"A'L''1(_&V;.C
MP^.C]N>Q'NA,O'[=W#G<.CZZ8XGU3WGH!MZ*8C&X= $F7T692@BHXR2./PVU
M"@/153I*\T1&OA)9+%K^'[E.E&BUSX6.Q//]YEZ]=JS#4,>1Z,-EJ?0S^'OU
M5KX2SN^\\8]YFNGA''9^=G79=Y=N#.5$A_,W]RU.UZ;Z3\6PO!4#Z7\:)7$>
M!0T_#N/DC9B-=:88N=VKJ]_..NWS4Z]>NVR_[WGBUSR<\Q8//+&[O;O'Z$-P
MCD0%JK4+_QP%,AV_%6M(MW'YH=<&L'O_?B..+[OM32&C0+0F +\OHWJM#63-
MYJ(3W:HTFP GB',]5.)=' 8Z&HF3>#*5T9R7>8/4WQ0;/X?!'WG\%C[\G-!?
MF\ A@9S#TA% Z*M 9&.9P?_47(SEK1+$8?"UCH"5I C44$<ZT_"+'"5*X7/K
MM=D8KAG,U^UD!LPFI&%#"7_'0WR"B/,LS6!3"&XZE@G0"W[QX\D$.#/-8O\3
M?B:^S400P\]1G,$"B9+!7,2S"/E9"A^PB+BIU_B>K.1IWLVM#'.X&1>"3W(Z
M3>+/>B(S%<[I.(@!GX:FH=^/?0K6\ELK%5.9 +D,^@L">D))?TSX(3*,@854
MPF1+E*^0VL\/#IK;VV(*WQ?7>4"K*-4 !! 0%GV^]ZKYZ@")8DDBMIO[KU]N
MO\1?I<L>K315 ,F%C.1(,?-F0;/*\ZV+DF/A0\&Q?BA3H*8(]03V%8C;."LX
MR+U!](BGBON G_$ZR?P@U!^Y#(']Z[7G.R^:.P=B8R!36(ZX1@G '^PL3P;P
MU>OM!AZ2VSC,)ZHQ4Z@*X&LX'PF ;YX\A7-9/O_W]ZWKXLD&X25,^)!?\T@Q
M>^SNL0C9!.F2YH./RL]0<,L "4S(092J))/XKT[\?(+GQH=U9 I',O43C6 .
M5!C/Q 8^RD!QH9(14.P$R00DE7@F+%1-T8<+5UU!'.(0G/>7J"E #M# 4\7>
MP4^P8371^81T# J4%)=-*XCSPS@M:<,86KEU8A8I]G?=9>LU=UU#!$0L;AM
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M,$9C06/T:U/P83"02_DYD,B.B5Z<V/E4N7$<*B*:THEVH_2C'/SL.)D7X%
M*E&AND7)^3%/=!IHWXWD4-Q,6XD/%H9*)L9K+^N:IE,0XA2KF4G-X6*@0QPX
MV<-W,LD:/1\<LD8W!A@Q;9CI+('=B<Z$^(MRE" V">R=UR]?/''6NIFRNU&$
M+HO,5!)/8RH7*4GME?936JFXH+(!$JMX*X+](4X^&2NS_=D'BW#$.JY4+^[I
M3V%;6*M7KX&:]_,)L@BZ-=-$@7I'_<Y%?ES6"'=>=UM<&6GN/+[KTN--6]5&
M.2<#KG&SU@#[U,ENSP0<984A+T/U1<%:9B?H*S;+\G2JS+D$UX7B622WL?@'
MS<28;9Q*2:=;?K+>*_50YAM/L%KO4A2"LL!#"09.9\@XW?>,L /JLFGFHVUD
M"P:.4;< \N;H3P",7/."-2'H-*S;!CGBB_MXXFQQ!L+5Y+NQ:*8L9$('*PEL
M$-^I!UYF&"XS@X-9C0S;T&BBT"I#'H&'&1?B5>,W:U,7IIH.3?Z;S?^;9@_L
M>06K<*40GOU"L)Q@=C=-$5 WJM%KGQ1N!N7 <&TT5B@\#'P\(95F61^=5\RL
M\X$PY1Y6 \9#AF-YO]*DG,F(]>/I?-U9>N*\0T&\6YV"Y?;THW7',O%#.4_)
M'@,=Q#7&G%XH"\^$9(207[0F:X9^W\65.#'5%A=4=I=2R0@F7%#\\=)8*WC?
M<B9XN. ^B9-$WDK,!/? -+)%N#_+R?2MN(BQ0N_\_%HL;F3T8/A/U4#=QCIU
M%Z[7KD-PAS. 9WGQ>WP#IY0&4)^J\(F?G%82*&D++4R!W*_-ZR80)QDAV1/E
M8F^)O5A8]?(PU&!"N]0] 9.,A).A0<E-2_1%1;F*>1X]ZA^6G=K].SOU=W;J
MZQ4;5BY38\+35VVM[(O;S;P5M5 S]*FX[ HK4/:WO>WM;1#M@4+G@?H81J9*
M,W $V1 ,/XW5N7RO<WV]9DK222CJ/R4;9AN=BZMTTQ,#J@2FBO$D_@2G%61J
MB(!8SP-!G %TX;P1S[!$*IY2$!D;5?)!J@,MT95LBI8K50V0_CA&MR..% 4<
M<"U;26#+UL!A#G*L:!A@W#;-J>2]K"$VE83_P*A$BGE.4TB&,1Q*G#AR/< *
MB&S.<1$L9B;S4?1CFS41%*/#BD40\*!X:9D*_KV"B,+0$)VX1#6&B:3:,K0Q
M2JIRW<;/$^Y-+"K#I.E_@">JR116T.S=%0H::$4U$?-Z+4BH]H_K)F08QGY9
M3@,.(VY,_TF%$F5UB/(P=7B+NU^JM^ *"U.)AO<10P!;4;(J(AIZ1>R>*@AU
MA'77MD;.="8@11=0H2N%5MSQ\!ZIYI1;44D4/U,6N6E,-VCLP((;3L8R"4%Z
MPAXN3VB7-I0 7WS@UL0++2?:$V?G3?1VN!O"<:N,("E\)N [G3TPRGUX<S2;
MS9K2;*VA:&M-0,#AULW1]U?;_=;Q>5N<M,_/>]>MD\[E+__[;/L9?;YNG9[:
MSU_\T)D.LC%>NOU3H7>IE'.:@BZS?STC%738[UI5U#^UCX+3D6$ZQDH_T'C%
MJONO?_HZ9;UH<!P?H<N91YIY/*U8U HDR9NRKYK@^^O///NE)WZAQI9ONNRO
M$OG_7-W.Q1;<,*"3H*,!^*[?]#GMB=3A&P%<*U7XS^$HY28=RZ]L6_1/[Z<G
M&RP%27=_6I''M*SZD/6^$W^PQH0SWU4A\\BW9XE>AOE]<=H4/7\\ UGVYS==
MOJ^ 8!L'.P>;8O?E7F/OY8N]PV-[XDIZIJEY^#_7R**"MO _OAW^0.EQ]-_1
M\%+:CZO]WJ=O4JZK*\#N[U6% CCV@*TSC/05EE;1D1*'IM"W*'OBUE.V+MS0
M1.*FG-&%]A7W%8!AB8'>'--/7)M9= A2KRG;C&@EK383UU9X4T$"0DWI?I%0
M@+*2 BL,19Y>8*!R,V<AVMC5C;"56704%4:D;6Y1"5F.F+4! 3?G[V4*^R,[
MTJ:Q.3UK>^F5":!BUJQ>6]E9OS:3*R@16=Y/1;]H(#? O&G OUC7H%-C0=W=
MOE]Y2+WFE)$LS,/8?/SAB.]>I .&)+A""Y;D@@E)OHX";D7#.D,I/<ZRZ9NM
MK4&4J.:@P'4IHKG PB3SI9^]^=MR7+ ,WH(O$N#Q;-!0(# ]FB\.JD&3'\J@
M_'8<^9M*0"0R8!?^.Q2<AJ'>R;E*OX-1LKNSNRE>[+QJ[.V_>/V=[-1/M*OF
MQ!_#AOZYZLP\$I/U.S/F?\*2[>(DBE!<QQBL9B.3";V_\V)3O#YXT3C8V=_A
M'TH*)717<TIWW46A[V%X?H\XMC$4E^HJ:6Z.*,?F_)!#N^[8#P/@S ("\A?#
M@+1K MXWAJ*,./*:SU_M'MC>8_X&AT5P?S+7!3D1)S,$(%&1FJ%)XU$./)%I
MEH"]EF,E>J+@Z8H*!\K0%;L[GJ A"%E92=4$5]H$V4SXKS!A;5=S&,.QQ82S
MM9.*!BIZ$D/*&2$P<\W,#&,R%M:O2KDRFOK]J%<:#/$!FF F$VVPID"WQY,Y
M@45F*E9=6OO41:D3&"R,53::611@!P":^;0X1^1LZ+ T8DUDCJQ5@ZBIBE+3
M:14!\Z@HB&>3(@A<MN#!;RG24 $'@1T#H(VI=A.[\5<.]2#KN4P:8E#:%@G8
M9YMEBBT0%H)$SA#9RTV" N@'E,*J)9ZP,HO,8!;V!SAIQJMQDSK7I.,5(V @
MZD8VPV,2!<P3\003*BCA4+!G&8[I KCRYWY(_86/]6C__]JQ9C-LS*9HS<K)
M>F/6'/>_+=H[#(<EHGP[\MYETAI3T;%KC5.WROHIK*:O,)*6>K@K@;YON5=K
M)3%<BZ;2TO8*@^3!9/N.I%IAOQO#?059_C(1OB7DO\H4,V$(Q1EVGC]V3*-1
MRT LNC"/'=.+D._OO&SL[N_O/G:,L[=0:([[G;K'3HB%#7W$$] <(O,_;#M/
M+@8/\K5S=!GCY"A,C">BAWEPL-TXP]HY^B&])=X3AWDI=4]!7IK5F_+^R,;&
M?B\<1T #;Z)(^>6TFW5%_((*Y7DI;0J^<&162CT88'MYINMB\7MAFH*DZ;JC
M]E0+C2R:,8J?L20A3_PQ+4D.T4QCIQMW$%)G"L\P1<,8/F*=&L[_*ZX,=#JE
MJHLA=1^E9?7OTI/M-;=QAA4:2=GK@M4&\(/;5N+Q?* (D(+]L?;VLH$DE#,/
MMDK]QP 4]\T-%$,A0^QR*3KF$C.RAQM<2QB))HM/?L"#F\RRCY5='U9MM_=W
MM=W?U7:K)?6))(\="^\OXPS#&-VBM^",YP8USD&/44MY#P,M%"'XD05Y^S/.
MS2/W'X0J. EH+U2]7FKS7VZ[6"F?[?QM:MHQHY8:(:-,I 7&;$,KMR+(R.FX
MN38Q$:>?XAS^&?%#N\C*DWJM:()[?4#S9U-UQ],\DVX-J78O3F3H@D(SB=<E
M3!-JE<;VG(G\A-H'RYV+KL5Z#<2GJ>S#6?4T#YM II@7S9P5OLQ)LV38SL^-
MQ%02%VC21+:U(YS;)C54*Z @/E(?)<(.G*BG!G;LXPZU"KAH2WV6.,G.J]<V
M=C:99YR^$&HM7VII6JEW<8>H/T&1<&>[QD=O[)I%5W9&%NWP-F!H5ZZV8#I+
MQP-$$*X,=Q2WKUR<.Z)"^/]:F&D-=S $MKBGVJJN$A'8'5.0@V9<R+*C1@8X
M.E,)!=3PJ??G 0R!D1LB:S$#O8)UBW'<-C;7NTBE\4R8YUXQV<+I'5W?]+:Q
M9XA"=^B)(2W/-'1O78DTG9:<BFRS[RQ65"S82=WWGXHTYUAMM4F^/ MX14+Q
M6-N?M;)W$P Y,(#06! XLIR]3PNK:V',/*./AB:XAVV$(>($#33#_ ]#Z8L2
M"PG6:":TR*>T$!IT7M,DG]J%RM!\V3:>9<9P*KI-XV@4X\9+S$[-<(@'(+E>
M0RP'>;&7U6VO&R\=$MJW9G#'( ZKQOID?WXG3S#J)!\ O"JQ(:*QGJ9VOME]
M[, UT6X(N:Q.L6*/2J M+C@4'>+TAS(R#^ HTZ7O=.AY8DV93J5GWYV;84I_
MN9V2CF@Q0Q-0]FH-RCP'812<I3Z\58=J6<;Q'%L<]H(\R.(DM9V\ICS<O&^@
MVF!<?;U(4MG&7:4IM.DMY),UF%K9P+3P@"4: 79>.]BQ\Z*-#\.M.8 $7RFD
M5VJ'#R)&),ZV2[.',,O0CJ44RUQ[/Z>RR,;!"\RS"P^L%G+Q$ZM#'+'HW>&0
M@M!J_:.1P39VM@UJ'B8>:<S\(K3X6HRYD6DVN^(Y,YV9J"3/09P3,PVESYFM
MLIVSE#\HI, 7C5CF(9'LU &T^B<LDI \9I5'[L2M-U5QT@1NB45JHFXU+(C5
M:\5D&[/#>LV,$S5F!Y(W2W(<XXMU86.)B][:GG\[Y O?X6-\X(_ C-5@A5%!
MI7_@&)"D?B3EBI##X#&H17",.%IH8:KH940+#$CZI2!L<>?"R-5)G&8TJP(V
MUXHBM""[*WJ4=[8;O]%N_L5= \!KQ67U6N6Z?]TK(,K+=[<;9]5I1-7?G+D<
M00RZF;!QM[(@G) %%5$;-6&8S,%AGD0ZI7=^Q#R:J]<^:<*NYW?Y$1,<5;G:
M$T&*T)A+-+OPR&7D)I0TQ+<S55T$#J9@,P;/( +9:]]:5DR.J]KQ<6(GHMM<
M<6FL\R23^]4FSDQB_N.9X!APHN)I/:0X%+(V.PCV$D^4[\2J#FXKQJ\@SYN0
M1TH815XL=)+W,!K9_J#2?$D<"Z8)3G*D'F@L4D$##IYF"34(K4<',BN?!I2!
MIZ1\.&?#_A:,."PNN(/\V)>OB/T6[$^:&^6ZL,.<1GQ72.6&\SP:N32EV5B%
M7\(L(X8*!WJ%6 U;>*2AG&'K#F >"41XSL0LP2GNY)>0CWD'VX*I2!.!*;#&
M#:[W(=#J>L2(";V:CMG8?0M&*?\G= * (?!4 %;+L\#>!M"5WT:!8V#GY@3)
M!,QB.1TWT=/F2"R/5BO;C!S$ C3TVI2[P#>&&;,HC1$WK^()[%2""'A=*YK7
M;D?JN'$&,Q2!IZ+0J#V3=4]-T!?#$KXIRV6R%5%D'E.^+!Q^4!U(0:IR&JGH
M.&@J7V!S79BH_07[Y3W)-\#(F89/G>S'#5Q]7<J*S(@.L.U#\Q'.W.9"6UG=
M1*-%X\^.*8 ,VL/75N5PZ<Y^2U3>_@0&W8#8V%13@2&C:40?':1R$9XN@N\N
M9#59ZMRSQC[?C 9?,3NP,J*0HPV8 >#S9=]!M-:LW: 396'#%U=5MX1L4X&
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MUF[U".(6P'?*,,*:O1M8E'8'R("]PWV]=KD-#Y[4;9_=G)]_H"T#'@&@3E?
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M>>M=_^+\Z/\ 4$L! A0#%     @ /#3E5N@&"PM! P  JPP  !
M     ( !     &%E;"TR,#(S,#<P-"YX<V102P$"% ,4    "  \-.56_*RT
MG?,(  "%:P  %               @ %O P  865L+3(P,C,P-S T7V1E9BYX
M;6Q02P$"% ,4    "  \-.56P(UT[,X+   AD@  %               @ &4
M#   865L+3(P,C,P-S T7VQA8BYX;6Q02P$"% ,4    "  \-.56K#D4OT0(
M   ;9@  %               @ &4&   865L+3(P,C,P-S T7W!R92YX;6Q0
M2P$"% ,4    "  \-.56'ZSK%G$U  !C$@$ $@              @ $*(0
M=&TR,S(P-38Q9#%?.&LN:'1M4$L! A0#%     @ /#3E5BT=;-"V.   ET(!
M !8              ( !JU8  '1M,C,R,#4V,60Q7V5X,3 M,2YH=&U02P$"
M% ,4    "  \-.56"0N5B_<F  "'[0  %@              @ &5CP  =&TR
M,S(P-38Q9#%?97@Q,"TR+FAT;5!+ 0(4 Q0    ( #PTY5:[VMTRL,4! (;
M"P 5              "  <"V  !T;3(S,C U-C%D,5]E>#(M,2YH=&U02P$"
M% ,4    "  \-.56"T(I?H0?  "5A@  %@              @ &C? ( =&TR
I,S(P-38Q9#%?97@Y.2TQ+FAT;5!+!08     "0 ) %,"  !;G (    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
